data_1th5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1th5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.422 ' CD2' HG23 ' A' ' 216' ' ' ILE . 3.2 mp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.769 0.319 . . . . 75.219999999999999 110.945 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.42 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 0.7 OUTLIER -109.18 -11.41 14.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 73.310000000000002 110.882 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 29.2 tp 59.62 92.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 72.420000000000002 110.955 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 157' ' ' ASN . 0.1 OUTLIER -175.31 175.21 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 110.86 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 9.6 mt-10 -42.7 -55.39 3.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 74.099999999999994 110.895 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 160' ' ' ASN . 0.0 OUTLIER -51.01 -30.97 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 72.239999999999995 110.905 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 162' ' ' GLU . 21.1 m-20 -96.59 -72.53 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 110.932 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' A' ' 158' ' ' GLU . 30.3 m -33.94 -34.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.540000000000006 111.13 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -55.16 -57.59 11.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.019999999999996 110.903 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -53.04 -54.45 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 75.109999999999999 110.898 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.87 -29.57 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 63.520000000000003 111.088 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.53 HD13 ' CD1' ' A' ' 182' ' ' PHE . 15.1 mt -71.39 -32.49 68.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 73.120000000000005 110.919 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -72.38 -5.58 37.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.329999999999998 110.905 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -93.16 -9.53 39.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 71.329999999999998 110.873 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.85 -31.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 65.349999999999994 111.147 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -51.16 -60.67 5.2 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.535 0.683 . . . . 71.530000000000001 110.901 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.9 Cg_endo -69.78 2.54 3.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.668 2.245 . . . . 64.340000000000003 112.343 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.468 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -96.41 -28.72 14.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 71.239999999999995 110.959 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 9.2 mt -72.79 -34.46 66.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.868 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -85.77 -11.31 53.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.099999999999994 111.1 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -88.69 2.86 84.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 73.409999999999997 112.456 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.5 t -130.57 9.92 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 74.400000000000006 111.178 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.52 -56.8 0.58 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 72.230000000000004 112.487 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 169.09 162.03 20.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 60.299999999999997 112.475 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -173.58 -160.68 22.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.75 . . . . 72.329999999999998 112.486 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.97 110.02 0.24 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 73.450000000000003 112.499 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 193' ' ' ARG . 3.7 pp -113.18 -31.73 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.745 0.307 . . . . 72.120000000000005 110.887 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.458 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.4 OUTLIER 33.63 90.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 70.0 110.906 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.53 ' CD1' HD13 ' A' ' 165' ' ' LEU . 28.0 t80 -42.4 114.06 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 62.219999999999999 110.876 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.98 -79.61 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 110.897 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 27.5 ptm -167.67 -170.81 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 75.049999999999997 110.847 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 7.3 mt -131.61 144.44 37.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 72.5 111.104 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.8 68.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 73.430000000000007 110.929 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 83.13 -141.87 21.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 64.420000000000002 112.502 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -1.18 8.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.231 . . . . 74.299999999999997 112.372 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 47.6 mt -117.92 124.25 72.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.400000000000006 111.138 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 191' ' ' LYS . 1.4 p -108.72 155.1 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 74.310000000000002 111.153 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.442 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 13.9 mtmt -116.26 141.04 48.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 72.129999999999995 110.915 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.454 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 43.7 t -151.53 155.46 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 71.319999999999993 111.134 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -94.81 172.06 8.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.129999999999995 110.886 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.415 ' CD1' ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -167.67 86.21 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.510000000000005 110.929 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.1 p -123.83 177.95 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.219999999999999 111.14 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 87.13 -172.16 43.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 70.019999999999996 112.477 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -1.33 8.27 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.65 2.233 . . . . 72.340000000000003 112.382 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.03 57.51 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 70.109999999999999 111.14 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 194' ' ' LEU . . . -99.89 -94.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 64.420000000000002 111.105 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.26 59.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 74.530000000000001 111.105 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.12 30.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 63.539999999999999 111.123 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.0 OUTLIER 67.56 133.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 75.400000000000006 110.865 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.411 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 0.6 OUTLIER 78.54 -51.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 63.329999999999998 111.162 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 47.9 t -40.5 -51.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 64.129999999999995 111.113 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.17 -35.4 80.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.530000000000001 110.888 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 18.1 mt -64.1 -50.36 77.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 70.0 111.11 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.98 -36.77 29.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 111.103 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.467 HG11 ' N ' ' A' ' 209' ' ' SER . 58.0 t -59.22 -83.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 74.420000000000002 111.157 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.467 ' N ' HG11 ' A' ' 208' ' ' VAL . 29.0 t -48.86 -20.54 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.019999999999996 110.837 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -58.55 -46.22 87.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 72.310000000000002 110.89 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 -46.62 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 63.310000000000002 110.937 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.431 ' O ' ' CG1' ' A' ' 216' ' ' ILE . 1.6 mm? -47.18 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 73.329999999999998 110.899 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.65 -52.2 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 110.9 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -41.21 -80.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.883 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.48 -51.41 55.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 63.130000000000003 110.865 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.445 ' CD1' HG11 ' A' ' 161' ' ' VAL . 5.2 pt -107.16 82.77 1.22 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.595 0.712 . . . . 74.319999999999993 111.096 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -5.69 16.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.667 2.244 . . . . 73.209999999999994 112.337 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 23.3 t -66.38 -22.95 66.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 72.530000000000001 110.862 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 7.3 mt -57.89 158.67 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 75.450000000000003 111.169 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.517 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 1.1 mt-30 -134.84 -33.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.894 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.408 HG12 ' C ' ' A' ' 220' ' ' GLN . 37.5 mm -154.13 106.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 61.049999999999997 111.123 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 76.8 t -80.42 114.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 64.230000000000004 111.148 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -96.78 113.59 25.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 71.400000000000006 110.901 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 12.0 mt -100.53 102.72 13.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 110.893 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.91 -176.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 64.109999999999999 110.887 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.439999999999998 110.88 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.9 mt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.797 0.332 . . . . 74.140000000000001 110.924 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -117.54 -0.82 11.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 73.209999999999994 110.873 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.4 tp 52.86 97.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 75.400000000000006 110.867 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -159.14 164.43 35.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 75.510000000000005 110.876 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.41 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 16.8 mt-10 -45.15 -30.57 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 73.439999999999998 110.871 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.36 -44.45 52.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.945 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -80.51 -59.64 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 74.310000000000002 110.861 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.569 HG22 ' CZ ' ' A' ' 182' ' ' PHE . 21.7 m -39.09 -33.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.107 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.34 -51.09 62.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.91 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -40.51 68.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 70.140000000000001 110.929 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.429 HG12 ' CD2' ' A' ' 212' ' ' LEU . 21.5 t -79.47 -34.79 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 111.083 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 27.9 mt -71.12 -21.31 62.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 110.912 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.415 ' O ' ' CD ' ' A' ' 170' ' ' PRO . 61.3 m-20 -74.5 -12.26 60.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 75.200000000000003 110.901 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -83.01 -14.16 54.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 71.319999999999993 110.876 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 208' ' ' VAL . 3.2 pt -121.14 -31.16 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 72.349999999999994 111.09 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.455 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . 1.1 mtt180 -49.04 -60.86 4.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.643 0.735 . . . . 74.150000000000006 110.871 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 169' ' ' ARG . 54.0 Cg_endo -69.72 1.92 3.98 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.741 2.294 . . . . 74.530000000000001 112.341 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.511 ' CD2' HD22 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -105.66 -17.57 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 72.219999999999999 110.907 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.511 HD22 ' CD2' ' A' ' 171' ' ' TYR . 2.9 mt -77.84 -28.9 50.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 110.912 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.9 42.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 72.129999999999995 111.065 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -132.87 -33.59 0.37 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 53.450000000000003 112.499 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.9 t -144.59 9.51 1.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.787 0.327 . . . . 61.439999999999998 111.107 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 149.63 90.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.733 . . . . 63.43 112.488 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . -125.08 168.55 17.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 71.120000000000005 112.495 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 154.44 -14.07 0.53 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 71.109999999999999 112.502 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -134.42 116.89 1.7 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 74.430000000000007 112.553 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.3 OUTLIER -173.9 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 73.430000000000007 110.898 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 180' ' ' LEU . 8.3 tp60 -36.22 99.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 75.439999999999998 110.953 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.569 ' CZ ' HG22 ' A' ' 161' ' ' VAL . 15.0 t80 -46.52 116.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 71.540000000000006 110.878 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 80.3 mt -76.0 -73.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 110.876 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 28.0 ptm -173.4 -168.95 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 75.140000000000001 110.902 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.0 mt -136.25 129.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 75.129999999999995 111.137 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.37 56.14 1.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 110.911 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.91 -145.59 16.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.758 -0.734 . . . . 64.230000000000004 112.486 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 3.27 2.91 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.688 2.258 . . . . 74.109999999999999 112.322 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.21 130.49 69.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.539999999999999 111.123 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.464 HG23 ' CD1' ' A' ' 219' ' ' ILE . 84.0 t -104.6 148.59 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 75.420000000000002 111.087 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.455 ' N ' HG12 ' A' ' 190' ' ' VAL . 10.2 mtmt -116.79 140.88 48.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 71.519999999999996 110.887 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 193' ' ' ARG . 21.4 t -151.95 166.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 73.319999999999993 111.143 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.41 ' N ' ' CG1' ' A' ' 192' ' ' VAL . 0.1 OUTLIER -92.87 143.11 26.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 74.230000000000004 110.909 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.61 87.31 1.92 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.888 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.05 -171.47 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 72.150000000000006 111.118 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.81 -169.85 55.01 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.723 -0.751 . . . . 63.109999999999999 112.506 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 0.43 5.59 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 54.509999999999998 112.397 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 201' ' ' VAL . . . -103.68 -5.6 22.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 62.420000000000002 111.104 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -80.53 42.06 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 75.140000000000001 111.069 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.4 p 179.34 -29.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 111.093 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 198' ' ' ALA . 27.5 m -56.93 127.09 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 111.109 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -79.71 77.5 6.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 73.219999999999999 110.9 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 t 176.03 -44.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 63.229999999999997 111.155 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.21 -42.68 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 70.200000000000003 111.149 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -65.88 -7.13 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.838 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.55 -57.54 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 111.115 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.28 -20.48 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 73.510000000000005 111.093 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.418 ' HA ' ' CD1' ' A' ' 168' ' ' ILE . 88.9 t -72.29 -62.28 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 72.010000000000005 111.119 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.1 t -80.59 14.5 2.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 74.400000000000006 110.853 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -39.86 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 75.409999999999997 110.932 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.62 -35.68 22.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 75.540000000000006 110.903 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.429 ' CD2' HG12 ' A' ' 164' ' ' VAL . 7.7 mt -68.72 -65.4 0.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 73.150000000000006 110.91 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.03 -21.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 110.878 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.409 ' N ' ' C ' ' A' ' 212' ' ' LEU . 20.9 tt0 -85.14 -72.49 0.48 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 74.439999999999998 110.881 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -51.51 -54.04 31.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 74.319999999999993 110.92 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 2.0 pt -103.37 95.07 6.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.589 0.709 . . . . 62.020000000000003 111.15 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 -24.94 29.53 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.711 2.274 . . . . 75.349999999999994 112.358 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 46.0 t -47.37 -29.16 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 62.210000000000001 110.855 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.464 ' CD1' HG23 ' A' ' 190' ' ' VAL . 3.3 mt -59.37 153.3 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 73.409999999999997 111.122 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.434 ' N ' HG21 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -139.66 -38.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.299999999999997 110.886 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.8 mt -140.67 98.53 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 71.109999999999999 111.12 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 67.1 t -74.89 109.15 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.349999999999994 111.135 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -97.68 138.89 34.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.966 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.2 mt -122.01 127.33 50.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.150000000000006 110.915 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.444 ' N ' ' CD2' ' A' ' 225' ' ' LEU . 2.1 mm? -96.63 172.16 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 75.310000000000002 110.888 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 64.430000000000007 110.8 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.419 HD22 ' CG2' ' A' ' 216' ' ' ILE . 4.8 mp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.779 0.323 . . . . 72.510000000000005 110.912 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -108.88 -13.23 14.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 64.310000000000002 110.875 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.455 HD13 ' CG1' ' A' ' 161' ' ' VAL . 15.7 tp 58.29 100.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.919 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -167.08 161.24 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 70.420000000000002 110.882 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -34.89 -35.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 75.209999999999994 110.869 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' ASN . 0.2 OUTLIER -71.82 -53.68 12.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.857 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.403 ' CG ' HD22 ' A' ' 154' ' ' LEU . 12.2 m-20 -67.78 -56.17 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 74.310000000000002 110.878 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.455 ' CG1' HD13 ' A' ' 156' ' ' LEU . 33.6 m -48.79 -27.87 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 73.540000000000006 111.147 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.46 -58.59 7.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 72.420000000000002 110.878 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -45.07 45.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 73.409999999999997 110.892 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.415 ' CG1' ' HA ' ' A' ' 212' ' ' LEU . 1.3 t -68.63 -42.31 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 72.329999999999998 111.134 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' A' ' 182' ' ' PHE . 49.7 mt -63.41 -20.64 65.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 110.941 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.485 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 16.3 m-20 -76.48 -9.48 58.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 74.319999999999993 110.862 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.65 1.75 56.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 110.847 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 208' ' ' VAL . 1.1 pt -131.75 -45.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.040000000000006 111.148 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -46.23 -60.28 3.82 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.607 0.718 . . . . 74.400000000000006 110.858 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 166' ' ' ASN . 54.1 Cg_endo -69.79 -11.12 30.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.653 2.235 . . . . 63.329999999999998 112.397 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.55 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -88.15 -12.4 44.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 72.230000000000004 110.885 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.454 ' N ' HD21 ' A' ' 172' ' ' LEU . 5.3 mt -84.27 -53.57 5.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 74.349999999999994 110.961 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 175' ' ' THR . . . -58.12 -54.3 48.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 111.134 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -35.02 -31.59 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 71.099999999999994 112.44 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 173' ' ' ALA . 1.2 t -134.21 64.86 1.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 74.310000000000002 111.191 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.93 -69.71 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.744 . . . . 74.430000000000007 112.519 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . 120.34 175.75 15.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 72.519999999999996 112.443 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -158.56 -123.37 0.72 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.723 -0.751 . . . . 53.049999999999997 112.468 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 163.32 114.49 0.31 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.725 -0.75 . . . . 74.439999999999998 112.502 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.454 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 3.4 pp -133.56 -39.5 0.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.744 0.307 . . . . 74.219999999999999 110.919 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 180' ' ' LEU . 20.9 tp60 34.3 90.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 73.409999999999997 110.904 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.497 ' CD1' HD11 ' A' ' 165' ' ' LEU . 25.9 t80 -36.96 107.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 73.209999999999994 110.89 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 36.0 mt -68.38 -79.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 74.510000000000005 110.935 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.2 ptp -165.3 -171.67 2.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 110.915 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.28 134.43 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 65.420000000000002 111.085 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.75 66.53 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 74.549999999999997 110.887 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 89.62 -146.0 18.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 52.219999999999999 112.452 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 3.2 2.89 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.674 2.249 . . . . 72.329999999999998 112.36 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mt -123.23 110.46 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 74.0 111.18 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.6 p -96.25 132.3 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 111.132 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.441 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 14.8 mtmt -89.49 146.27 24.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 75.299999999999997 110.946 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.454 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 97.4 t -158.93 156.56 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 75.420000000000002 111.17 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.12 172.5 8.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.010000000000005 110.85 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.6 81.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 110.919 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.0 p -114.24 -169.66 1.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 75.420000000000002 111.15 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 74.11 -179.09 42.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 62.399999999999999 112.513 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -2.1 9.61 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.68 2.253 . . . . 72.299999999999997 112.342 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.57 -17.45 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.310000000000002 111.092 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.27 -62.68 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 72.349999999999994 111.118 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.32 97.76 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 75.209999999999994 111.153 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 7.3 p -159.79 -33.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.420000000000002 111.123 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 201' ' ' VAL . 9.9 ttp180 85.35 142.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.400000000000006 110.859 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.479 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 2.7 m 83.03 -32.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 61.399999999999999 111.156 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.472 ' CG2' HG11 ' A' ' 201' ' ' VAL . 33.3 t -70.14 -71.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 111.148 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -40.22 -43.39 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 75.030000000000001 110.912 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.409 HD12 ' CA ' ' A' ' 203' ' ' THR . 3.1 mp -60.11 -44.13 94.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 73.329999999999998 111.116 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.39 -36.55 22.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.400000000000006 111.091 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 209' ' ' SER . 55.1 t -65.77 -85.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 74.209999999999994 111.149 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 208' ' ' VAL . 40.9 m -34.01 -43.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 64.200000000000003 110.853 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -47.84 -51.45 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 74.040000000000006 110.909 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.465 ' HA ' ' CE ' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -61.87 -66.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 75.129999999999995 110.899 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 211' ' ' LYS . 1.4 mm? -35.0 -73.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 73.019999999999996 110.956 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.34 -35.28 0.96 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 74.519999999999996 110.856 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 211' ' ' LYS . 2.6 tp10 -57.14 -72.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 71.040000000000006 110.883 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -63.57 -48.73 76.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.911 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.419 ' CG2' HD22 ' A' ' 154' ' ' LEU . 7.1 pt -107.03 83.24 1.28 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.639 0.733 . . . . 74.099999999999994 111.104 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -5.35 16.03 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.701 2.267 . . . . 74.329999999999998 112.33 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.15 -11.7 43.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 110.897 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 5.1 mt -68.77 158.3 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 71.239999999999995 111.151 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.49 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.2 OUTLIER -136.89 -34.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 71.140000000000001 110.907 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 220' ' ' GLN . 4.5 mp -150.61 108.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 75.310000000000002 111.123 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 79.1 t -86.57 112.69 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 73.430000000000007 111.116 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -100.59 115.59 30.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.209999999999994 110.916 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 mt -103.51 101.71 11.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 72.400000000000006 110.921 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.35 174.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 74.239999999999995 110.904 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 110.824 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.467 HD23 ' ND2' ' A' ' 160' ' ' ASN . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.031 0 CA-C-O 120.769 0.318 . . . . 73.439999999999998 110.937 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -101.62 -2.79 29.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.209999999999994 110.894 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.9 tp 54.48 89.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 64.420000000000002 110.938 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.441 ' O ' ' CG2' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -149.76 178.98 8.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.881 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.32 -48.93 77.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.409999999999997 110.857 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -58.84 -46.61 87.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.329999999999998 110.889 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.467 ' ND2' HD23 ' A' ' 154' ' ' LEU . 98.1 m-20 -71.07 -69.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 74.239999999999995 110.925 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 182' ' ' PHE . 20.7 m -36.95 -31.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 75.409999999999997 111.127 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.7 mt-10 -55.38 -58.08 9.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 70.420000000000002 110.951 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -39.59 56.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 75.209999999999994 110.93 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 215' ' ' LYS . 21.4 t -64.3 -53.45 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 111.13 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.477 HD13 ' CD1' ' A' ' 182' ' ' PHE . 16.2 mt -58.15 -24.56 59.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 110.897 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -72.23 -6.85 45.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 63.020000000000003 110.865 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.66 4.92 43.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 110.886 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.7 -34.54 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 75.400000000000006 111.099 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -54.71 -60.58 7.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 73.129999999999995 110.889 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.0 Cg_endo -69.82 -5.94 17.45 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.71 2.273 . . . . 50.130000000000003 112.286 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.559 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -86.42 -22.45 26.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 71.400000000000006 110.889 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 171' ' ' TYR . 7.2 mt -78.21 -53.61 7.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.340000000000003 110.954 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -36.73 -51.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 111.078 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -39.41 -44.44 2.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.79 -0.719 . . . . 74.030000000000001 112.452 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 53.2 p -88.15 -33.38 18.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 71.019999999999996 111.126 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 170.38 -42.28 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.68 -0.771 . . . . 72.549999999999997 112.461 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.1 162.83 28.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 73.219999999999999 112.478 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -151.05 -94.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 75.420000000000002 112.446 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 169.99 122.34 0.63 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.69 -0.767 . . . . 64.439999999999998 112.459 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 181' ' ' GLN . 1.1 pp -150.07 13.15 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 75.349999999999994 110.902 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 182' ' ' PHE . 0.5 OUTLIER -35.34 105.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 75.310000000000002 110.917 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.501 ' CE2' HG21 ' A' ' 161' ' ' VAL . 8.8 t80 -34.25 121.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 110.877 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 77.5 mt -80.82 -68.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 73.219999999999999 110.923 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 12.1 ptp -177.51 -175.65 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 74.019999999999996 110.897 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.2 mt -130.31 124.32 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 75.450000000000003 111.126 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.32 74.99 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.951 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 85.24 -149.04 23.51 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 73.219999999999999 112.495 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 3.53 2.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.704 2.269 . . . . 73.209999999999994 112.369 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.2 mt -117.06 123.48 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 74.219999999999999 111.101 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 41.0 t -99.09 143.69 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 74.310000000000002 111.136 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -107.56 142.33 37.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 74.5 110.887 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.5 t -154.4 155.41 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 65.040000000000006 111.159 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -94.26 154.74 17.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 72.319999999999993 110.849 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.91 76.84 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 75.329999999999998 110.922 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.5 p -108.17 -169.55 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 111.119 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.01 -178.15 33.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.766 -0.731 . . . . 71.140000000000001 112.48 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -0.78 7.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.699 2.266 . . . . 75.129999999999995 112.388 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.76 -6.39 59.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 54.210000000000001 111.116 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.03 -50.64 26.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 111.087 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.0 71.85 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 63.450000000000003 111.131 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 15.1 t -155.02 117.54 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 73.310000000000002 111.097 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 71.17 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.886 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.403 ' CA ' HD13 ' A' ' 206' ' ' ILE . 14.6 t -179.35 -33.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 73.0 111.146 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 20.0 t -67.69 -68.96 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.450000000000003 111.16 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -45.97 -33.14 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 72.340000000000003 110.868 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.403 HD13 ' CA ' ' A' ' 203' ' ' THR . 2.7 mp -71.22 -42.84 75.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 74.549999999999997 111.134 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.74 -33.68 76.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 54.310000000000002 111.125 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.5 t -62.57 -75.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 75.209999999999994 111.125 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.6 t -53.55 -15.61 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 71.400000000000006 110.853 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -40.65 86.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 73.319999999999993 110.898 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -86.81 -35.04 19.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 75.409999999999997 110.909 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.46 ' CD2' HG11 ' A' ' 164' ' ' VAL . 8.5 mt -66.41 -64.45 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 70.219999999999999 110.927 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -22.19 1.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.886 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -83.95 -79.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 72.450000000000003 110.884 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.466 ' CB ' HG23 ' A' ' 164' ' ' VAL . 14.8 mmtt -41.23 -55.9 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 75.109999999999999 110.927 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 4.4 pt -108.35 85.58 2.89 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 111.161 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.8 9.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.638 2.225 . . . . 71.340000000000003 112.316 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -6.29 40.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 72.340000000000003 110.857 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 220' ' ' GLN . 3.2 mt -73.36 154.69 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 63.100000000000001 111.146 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.45 ' N ' HG23 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -126.3 -33.7 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 110.882 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.413 HG12 ' C ' ' A' ' 220' ' ' GLN . 30.1 mm -151.74 107.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 75.540000000000006 111.147 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.8 t -78.77 109.07 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.073 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -99.44 119.69 38.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 74.040000000000006 110.907 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.7 mt -110.86 105.7 14.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.510000000000005 110.887 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.45 162.98 23.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.340000000000003 110.9 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 63.409999999999997 110.881 -179.95 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.489 ' CD2' ' O ' ' A' ' 215' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.734 0.302 . . . . 74.329999999999998 110.931 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.468 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 17.7 tt0 -112.01 -0.32 15.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.430000000000007 110.912 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.502 ' C ' ' CG ' ' A' ' 157' ' ' ASN . 8.0 tp 61.73 110.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 75.420000000000002 110.896 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.745 HD22 ' ND2' ' A' ' 160' ' ' ASN . 0.1 OUTLIER 169.64 164.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.129999999999995 110.876 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -33.97 -60.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 73.0 110.887 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -44.92 -60.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.409999999999997 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.745 ' ND2' HD22 ' A' ' 157' ' ' ASN . 53.1 m-20 -73.86 -67.39 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 75.019999999999996 110.912 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 157' ' ' ASN . 90.0 t -33.29 -46.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 65.239999999999995 111.137 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 30.0 mm-40 -47.39 -56.78 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 110.885 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.79 -49.8 19.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 73.519999999999996 110.89 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.9 t -63.44 -42.72 97.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 73.430000000000007 111.137 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 182' ' ' PHE . 75.9 mt -61.18 -28.9 69.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 110.924 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -71.25 -6.06 36.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.902 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.67 -12.08 24.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 70.439999999999998 110.864 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.75 -34.19 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 62.399999999999999 111.12 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.465 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.05 -60.96 5.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 75.239999999999995 110.925 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 169' ' ' ARG . 53.4 Cg_endo -69.75 1.36 4.5 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.66 2.24 . . . . 72.319999999999993 112.363 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.506 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.2 OUTLIER -94.89 -23.43 17.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 63.200000000000003 110.932 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.444 HD21 ' CD2' ' A' ' 171' ' ' TYR . 4.9 mt -80.98 -36.28 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 75.209999999999994 110.887 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.69 60.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 111.078 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.72 -44.78 80.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 71.439999999999998 112.481 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.8 t -143.2 99.99 3.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.895 0.379 . . . . 74.129999999999995 111.15 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.43 63.59 3.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.778 -0.725 . . . . 71.319999999999993 112.497 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.407 ' HA2' ' CB ' ' A' ' 172' ' ' LEU . . . -62.56 100.31 0.31 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 75.0 112.454 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -79.96 -153.34 8.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.753 -0.737 . . . . 72.340000000000003 112.477 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -136.67 115.0 1.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 74.540000000000006 112.435 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.6 OUTLIER -121.24 21.03 11.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 62.439999999999998 110.95 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -34.57 107.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 110.939 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.463 ' CD1' HD12 ' A' ' 165' ' ' LEU . 24.5 t80 -50.42 104.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 64.319999999999993 110.852 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.82 -74.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 74.209999999999994 110.91 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.446 ' CG ' ' HE3' ' A' ' 191' ' ' LYS . 1.8 ptt? -169.24 -171.37 1.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 72.420000000000002 110.898 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.8 mt -132.61 125.94 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 73.400000000000006 111.139 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.63 77.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 74.450000000000003 110.885 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 75.75 -142.37 28.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.772 -0.728 . . . . 74.530000000000001 112.446 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.406 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.5 Cg_endo -69.78 3.3 2.86 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.711 2.274 . . . . 75.439999999999998 112.328 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.6 mt -120.55 122.9 69.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 73.030000000000001 111.128 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.2 p -106.25 135.2 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 72.540000000000006 111.125 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.446 ' HE3' ' CG ' ' A' ' 184' ' ' MET . 15.7 mtmt -93.77 142.47 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 70.549999999999997 110.877 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 85.9 t -156.65 130.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 74.219999999999999 111.137 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.61 167.43 18.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 110.842 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.26 85.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 71.430000000000007 110.883 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.1 p -114.15 -177.22 3.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 73.409999999999997 111.161 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.41 -177.54 51.6 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 71.200000000000003 112.471 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -12.84 33.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.661 2.24 . . . . 73.239999999999995 112.358 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -100.92 60.18 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 63.020000000000003 111.125 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -124.83 3.71 8.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 51.039999999999999 111.06 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 200' ' ' VAL . 9.5 p -169.0 76.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 75.010000000000005 111.138 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.448 ' O ' ' CG2' ' A' ' 201' ' ' VAL . 7.1 p -137.19 7.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 75.140000000000001 111.142 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.37 47.74 19.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 75.239999999999995 110.873 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.9 m -163.91 -64.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 75.049999999999997 111.14 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 77.3 t -47.75 -59.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 75.049999999999997 111.104 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.8 -22.99 6.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 75.109999999999999 110.877 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.9 mm -77.52 -47.16 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 75.439999999999998 111.139 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.25 -18.8 17.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 65.439999999999998 111.135 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.451 HG11 ' N ' ' A' ' 209' ' ' SER . 59.9 t -73.81 -83.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 65.310000000000002 111.118 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.451 ' N ' HG11 ' A' ' 208' ' ' VAL . 2.7 t -42.28 -23.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 70.040000000000006 110.84 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 208' ' ' VAL . 19.5 mttt -58.8 -59.45 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 110.897 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -65.34 -45.25 84.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 74.129999999999995 110.899 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.433 ' CD2' ' O ' ' A' ' 208' ' ' VAL . 1.5 mm? -54.03 -65.93 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.230000000000004 110.942 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -49.54 -32.35 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 74.150000000000006 110.897 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.4 -71.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.030000000000001 110.896 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.489 ' O ' ' CD2' ' A' ' 154' ' ' LEU . 7.5 mptt -56.65 -52.34 65.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 73.209999999999994 110.942 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 8.4 pt -106.48 86.24 2.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.593 0.711 . . . . 73.329999999999998 111.144 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -7.05 20.09 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.726 2.284 . . . . 61.149999999999999 112.296 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.76 -3.91 10.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 73.319999999999993 110.883 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.4 mt -74.19 152.59 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 74.420000000000002 111.152 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 221' ' ' ILE . 0.0 OUTLIER -132.02 -37.1 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 72.129999999999995 110.904 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 220' ' ' GLN . 4.6 mp -150.81 104.89 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 74.530000000000001 111.122 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.97 114.74 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 73.430000000000007 111.133 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.09 129.85 51.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.877 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mt -118.76 126.83 52.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 73.230000000000004 110.899 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.1 mp -94.42 168.32 10.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.120000000000005 110.923 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 110.859 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.764 0.316 . . . . 74.430000000000007 110.931 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.49 -13.53 16.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.894 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.401 ' HA ' ' CG2' ' A' ' 216' ' ' ILE . 6.7 tp 58.24 109.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 110.928 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.585 ' N ' HD21 ' A' ' 157' ' ' ASN . 0.0 OUTLIER -177.52 -171.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.925 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -69.86 -4.35 19.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.865 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.484 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 7.2 mm-40 -102.15 -41.59 6.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 71.540000000000006 110.849 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -88.13 -41.9 12.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 65.150000000000006 110.841 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.482 ' CG1' ' O ' ' A' ' 157' ' ' ASN . 2.8 p -58.99 -30.34 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 111.175 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.77 -57.34 12.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 73.109999999999999 110.875 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.34 -44.37 23.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.868 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.474 HG13 ' CD2' ' A' ' 212' ' ' LEU . 20.6 t -68.04 -45.84 82.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 111.18 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 48.3 mt -61.03 -24.91 66.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 72.109999999999999 110.891 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -76.81 -2.01 31.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 74.299999999999997 110.893 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -102.62 8.7 39.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 64.230000000000004 110.919 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -142.96 -37.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 75.129999999999995 111.178 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -48.7 -60.7 4.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.596 0.713 . . . . 75.530000000000001 110.868 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.78 2.86 3.17 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.715 2.276 . . . . 65.310000000000002 112.301 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.46 ' CD2' HD21 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -98.3 -21.41 16.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 72.010000000000005 110.923 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.46 HD21 ' CD2' ' A' ' 171' ' ' TYR . 6.9 mt -82.51 -45.88 14.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 75.519999999999996 110.87 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -50.1 -20.67 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 71.230000000000004 111.149 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -92.56 42.69 2.67 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 74.5 112.521 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 176.73 -50.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 75.530000000000001 111.113 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -178.63 70.58 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 74.129999999999995 112.498 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -57.05 163.13 6.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.714 -0.755 . . . . 63.420000000000002 112.496 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -144.84 -102.58 0.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 63.439999999999998 112.481 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.58 112.53 0.53 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.741 . . . . 74.430000000000007 112.477 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.528 ' CD2' ' C ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -136.62 6.26 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 75.519999999999996 110.912 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 180' ' ' LEU . 2.5 tp60 -35.12 109.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 75.200000000000003 110.886 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.47 ' CE1' HG23 ' A' ' 161' ' ' VAL . 22.7 t80 -43.81 121.51 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 72.129999999999995 110.879 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 19.4 mt -83.7 -73.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 74.019999999999996 110.875 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.6 -170.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.120000000000005 110.86 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 7.6 mt -136.22 138.27 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 111.13 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -130.25 48.37 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 72.129999999999995 110.872 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 100.54 -138.67 13.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 72.349999999999994 112.46 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 0.35 5.81 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.635 2.223 . . . . 74.450000000000003 112.326 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.84 101.35 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 73.540000000000006 111.13 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.91 142.11 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 111.134 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.456 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 5.5 mtmt -100.42 146.31 27.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.944 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 98.5 t -159.13 147.48 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 73.540000000000006 111.117 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.5 165.34 23.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 72.010000000000005 110.892 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -161.77 71.5 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 72.030000000000001 110.92 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 17.1 p -113.89 176.53 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 63.439999999999998 111.081 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.19 -163.22 26.44 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 73.420000000000002 112.486 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -38.21 8.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.691 2.26 . . . . 73.519999999999996 112.358 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.451 ' HB2' ' CG1' ' A' ' 204' ' ' VAL . . . -83.26 49.39 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 71.519999999999996 111.087 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 194' ' ' LEU . . . -105.93 -62.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 63.210000000000001 111.115 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.1 m -95.15 28.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 73.219999999999999 111.122 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.66 136.7 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 111.14 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.408 ' C ' HG22 ' A' ' 203' ' ' THR . 5.2 mmt180 -89.96 84.76 6.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 70.319999999999993 110.872 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.408 HG22 ' C ' ' A' ' 202' ' ' ARG . 0.7 OUTLIER 168.54 -45.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 74.329999999999998 111.135 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' A' ' 198' ' ' ALA . 75.4 t -73.12 -55.35 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 74.439999999999998 111.155 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -51.14 -34.41 30.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 75.540000000000006 110.895 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 6.1 mt -68.78 -58.63 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 73.420000000000002 111.133 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -39.36 -50.25 2.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 72.120000000000005 111.106 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.5 t -45.34 -84.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.049999999999997 111.1 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.8 m -47.85 -34.57 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 62.509999999999998 110.834 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -40.19 42.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 74.420000000000002 110.889 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -86.35 -38.64 17.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 72.219999999999999 110.874 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.474 ' CD2' HG13 ' A' ' 164' ' ' VAL . 15.1 mt -62.6 -67.65 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 73.439999999999998 110.887 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.1 -31.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 72.200000000000003 110.867 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.86 -73.24 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.120000000000005 110.842 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -51.69 -51.2 57.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 73.109999999999999 110.913 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.401 ' CG2' ' HA ' ' A' ' 156' ' ' LEU . 1.7 pt -105.53 89.79 3.61 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.595 0.712 . . . . 74.540000000000006 111.12 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -16.33 37.67 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.702 2.268 . . . . 53.229999999999997 112.374 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 47.4 m -58.27 -19.85 37.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.836 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.449 HG21 ' CG2' ' A' ' 222' ' ' VAL . 3.3 mt -67.99 152.28 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 111.121 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.431 ' N ' HG22 ' A' ' 219' ' ' ILE . 0.2 OUTLIER -133.42 -37.92 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 64.120000000000005 110.904 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 220' ' ' GLN . 50.9 mt -145.38 96.26 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.111 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.449 ' CG2' HG21 ' A' ' 219' ' ' ILE . 58.1 t -74.13 104.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 111.144 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.4 113.98 24.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.889 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.3 mt -110.26 100.82 9.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.42 . . . . 75.230000000000004 110.934 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.3 mp -65.76 159.5 25.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 74.010000000000005 110.917 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.84 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.0 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.744 0.307 . . . . 65.209999999999994 110.96 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -96.46 -9.4 29.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 70.219999999999999 110.903 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.45 ' CD1' HD11 ' A' ' 216' ' ' ILE . 13.3 tp 51.77 100.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 73.010000000000005 110.915 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -171.07 167.28 7.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.849 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.451 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 4.5 mt-10 -37.64 -54.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 64.329999999999998 110.898 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -48.79 -52.5 23.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 72.439999999999998 110.869 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 163' ' ' LYS . 37.0 m-20 -73.87 -70.32 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.510000000000005 110.883 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 158' ' ' GLU . 13.3 m -33.78 -37.74 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 63.299999999999997 111.127 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 166' ' ' ASN . 0.8 OUTLIER -60.08 -50.01 75.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 52.420000000000002 110.879 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.0 OUTLIER -55.83 -54.19 47.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 73.340000000000003 110.895 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.42 HG23 ' CB ' ' A' ' 215' ' ' LYS . 3.5 t -61.86 -41.11 89.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 75.099999999999994 111.144 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 37.4 mt -61.2 -27.78 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 62.109999999999999 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 162' ' ' GLU . 45.1 m-80 -71.07 -8.67 55.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 74.040000000000006 110.881 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -88.57 -15.73 34.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 72.209999999999994 110.929 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.72 -33.13 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.530000000000001 111.098 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.467 ' HG3' ' CD2' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -50.42 -60.29 5.61 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.596 0.712 . . . . 74.430000000000007 110.849 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.79 -3.42 11.99 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.643 2.229 . . . . 74.519999999999996 112.34 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.574 ' CD2' ' CD2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -92.29 -16.81 25.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.310000000000002 110.908 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.574 ' CD2' ' CD2' ' A' ' 171' ' ' TYR . 6.8 mt -83.44 -28.94 28.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 72.239999999999995 110.897 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 175' ' ' THR . . . -79.81 -39.29 31.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.115 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -36.87 -33.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.744 -0.741 . . . . 71.230000000000004 112.485 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 173' ' ' ALA . 1.7 t -154.42 74.46 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.802 0.334 . . . . 74.219999999999999 111.158 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 146.93 -106.95 0.38 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 65.430000000000007 112.523 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -145.54 -98.39 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 73.319999999999993 112.483 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 129.85 123.12 2.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 74.049999999999997 112.542 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.45 107.37 0.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 71.340000000000003 112.504 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.473 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 4.3 pp -144.11 -40.16 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.776 0.322 . . . . 72.230000000000004 110.93 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.465 ' N ' HD12 ' A' ' 180' ' ' LEU . 13.5 tp60 34.24 90.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 75.150000000000006 110.923 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 181' ' ' GLN . 31.5 t80 -34.49 113.76 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 74.0 110.919 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 14.2 mt -66.78 -79.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 110.923 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 18.5 ptp -171.88 -174.59 1.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 74.129999999999995 110.852 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.47 143.55 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 75.420000000000002 111.122 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.88 39.19 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 73.310000000000002 110.931 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 112.7 -139.3 15.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.687 -0.768 . . . . 72.140000000000001 112.503 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 0.27 5.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.668 2.245 . . . . 74.010000000000005 112.347 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.78 127.72 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 62.530000000000001 111.122 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.78 145.25 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 71.129999999999995 111.095 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.426 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 22.2 mtmt -112.81 145.49 40.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 75.230000000000004 110.869 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 21.7 t -158.23 154.12 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 111.089 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.484 ' O ' ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -91.67 169.84 10.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.847 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.484 ' CD2' ' O ' ' A' ' 193' ' ' ARG . 0.2 OUTLIER -163.33 92.31 0.73 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 75.040000000000006 110.929 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.13 167.92 19.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 73.109999999999999 111.134 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 100.19 -160.96 19.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 74.430000000000007 112.473 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.94 7.65 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.665 2.243 . . . . 72.420000000000002 112.33 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.46 ' O ' ' CD1' ' A' ' 194' ' ' LEU . . . -137.88 50.14 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 72.450000000000003 111.103 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.425 ' C ' HD12 ' A' ' 194' ' ' LEU . . . -74.88 -27.32 60.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 71.200000000000003 111.09 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 1.1 p 166.14 92.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 74.530000000000001 111.132 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 8.5 p -116.76 -36.94 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 74.030000000000001 111.148 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 201' ' ' VAL . 0.6 OUTLIER 162.96 -85.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 70.319999999999993 110.899 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 37.0 p -59.63 -25.7 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 75.230000000000004 111.161 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.457 ' CG2' ' HB1' ' A' ' 198' ' ' ALA . 53.9 t -58.23 -56.21 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 64.409999999999997 111.141 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -32.03 60.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 110.874 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.01 -56.78 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 111.186 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.01 -32.45 54.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 75.409999999999997 111.12 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.458 ' CG1' HD21 ' A' ' 212' ' ' LEU . 55.3 t -63.12 -86.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 111.166 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 208' ' ' VAL . 24.5 m -33.94 -45.4 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 72.530000000000001 110.844 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -44.46 -50.3 9.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 72.109999999999999 110.906 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 214' ' ' GLU . 0.0 OUTLIER -64.93 -66.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.200000000000003 110.889 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.458 HD21 ' CG1' ' A' ' 208' ' ' VAL . 1.0 OUTLIER -37.4 -67.36 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.912 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -29.54 3.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 74.329999999999998 110.835 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.9 OUTLIER -68.25 -75.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 75.239999999999995 110.938 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.42 ' CB ' HG23 ' A' ' 164' ' ' VAL . 2.7 mptt -56.63 -52.88 63.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 75.230000000000004 110.878 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 156' ' ' LEU . 5.6 pt -107.16 84.46 1.68 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.661 0.743 . . . . 72.420000000000002 111.152 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -11.3 30.53 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.665 2.243 . . . . 74.310000000000002 112.32 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 45.5 t -58.26 -22.09 51.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 73.540000000000006 110.875 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 220' ' ' GLN . 3.7 mt -57.7 155.51 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 74.549999999999997 111.118 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.451 ' N ' HG22 ' A' ' 219' ' ' ILE . 1.1 tt0 -132.48 -34.57 1.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 71.0 110.875 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 27.9 mm -149.25 106.56 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 63.329999999999998 111.157 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 95.1 t -74.71 110.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 72.519999999999996 111.161 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -96.41 104.24 16.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 71.310000000000002 110.919 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.54 115.39 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.0 mp -98.66 159.83 14.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 71.319999999999993 110.953 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 72.530000000000001 110.833 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.414 HD13 ' CG ' ' A' ' 160' ' ' ASN . 10.4 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.8 0.333 . . . . 75.519999999999996 110.911 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -102.54 -1.29 30.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.129999999999995 110.887 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.4 tp 60.1 108.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 72.129999999999995 110.877 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.51 ' ND2' ' ND2' ' A' ' 160' ' ' ASN . 0.0 OUTLIER -168.22 -178.98 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.891 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.11 -49.07 79.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 74.099999999999994 110.899 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -59.58 -32.53 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 110.901 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.51 ' ND2' ' ND2' ' A' ' 157' ' ' ASN . 77.4 m-20 -83.48 -70.28 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.914 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 160' ' ' ASN . 29.5 m -35.63 -30.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 74.299999999999997 111.084 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 160' ' ' ASN . 2.8 mt-10 -55.31 -58.85 6.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 110.868 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -51.06 56.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 110.903 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.4 t -65.25 -31.03 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 74.030000000000001 111.121 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 14.1 mt -72.6 -32.14 65.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 110.895 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 60.7 m-20 -67.39 -14.29 62.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.219999999999999 110.921 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -89.53 4.98 47.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 71.400000000000006 110.871 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 169' ' ' ARG . 0.3 OUTLIER -139.91 -55.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 63.530000000000001 111.148 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.499 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -35.34 -58.89 0.73 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.709 . . . . 74.25 110.879 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.69 -27.87 26.26 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.281 . . . . 75.200000000000003 112.366 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.54 ' CD2' HD22 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -73.08 -16.03 61.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 71.319999999999993 110.91 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.54 HD22 ' CD2' ' A' ' 171' ' ' TYR . 5.6 mt -75.61 -46.37 32.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 73.120000000000005 110.909 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 174' ' ' GLY . . . -58.03 -42.56 85.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 62.520000000000003 111.101 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -34.82 -78.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 63.299999999999997 112.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.1 t -94.97 40.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 73.099999999999994 111.152 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . 96.67 94.93 1.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 73.400000000000006 112.542 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . -82.98 171.48 50.74 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 64.340000000000003 112.47 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -126.22 -87.36 0.64 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 44.049999999999997 112.468 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 157.63 109.72 0.29 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.757 -0.735 . . . . 55.229999999999997 112.453 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.45 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 2.9 pp -112.1 -34.15 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 75.040000000000006 110.879 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.5 OUTLIER 33.85 89.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 75.420000000000002 110.919 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -38.52 107.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.150000000000006 110.881 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 225' ' ' LEU . 14.4 mt -66.22 -80.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.420000000000002 110.948 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -166.08 -168.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 75.299999999999997 110.896 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.53 124.79 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 75.439999999999998 111.166 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.76 72.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 73.420000000000002 110.887 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 82.87 -140.71 20.39 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 72.519999999999996 112.488 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 54.0 Cg_endo -69.75 0.01 6.25 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 73.019999999999996 112.36 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 25.5 mt -117.76 136.16 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 74.450000000000003 111.099 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.51 130.86 73.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 75.209999999999994 111.131 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -90.54 142.58 27.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 72.549999999999997 110.946 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.45 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 55.7 t -153.67 151.43 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 75.430000000000007 111.156 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.482 ' O ' ' CD2' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -86.73 163.55 17.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 74.099999999999994 110.914 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.482 ' CD2' ' O ' ' A' ' 193' ' ' ARG . 0.3 OUTLIER -158.21 79.63 0.83 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 75.230000000000004 110.944 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 p -113.32 171.34 7.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.483 . . . . 71.439999999999998 111.115 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 86.83 -169.56 40.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.707 -0.759 . . . . 74.150000000000006 112.498 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -19.29 36.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.69 2.26 . . . . 65.519999999999996 112.34 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -97.83 42.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 64.25 111.14 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -96.14 92.03 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 62.32 111.089 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 76.8 t 45.06 90.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 75.209999999999994 111.151 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 43.5 t -125.66 -82.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 72.439999999999998 111.127 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.402 ' O ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -176.21 47.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 110.869 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.402 ' CG2' ' O ' ' A' ' 202' ' ' ARG . 0.7 OUTLIER -174.57 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.230000000000004 111.13 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 205' ' ' ARG . 93.4 t -58.75 -70.89 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 71.420000000000002 111.136 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 204' ' ' VAL . 0.0 OUTLIER -35.33 -44.22 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.530000000000001 110.872 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.9 mt -54.11 -50.42 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.114 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -62.71 -32.86 74.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.239999999999995 111.1 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.493 ' O ' ' CD2' ' A' ' 212' ' ' LEU . 40.8 t -80.38 0.99 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 72.439999999999998 111.164 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -134.57 7.38 3.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 75.329999999999998 110.897 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.59 -40.64 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 74.439999999999998 110.887 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -80.64 -27.32 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 75.129999999999995 110.878 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.493 ' CD2' ' O ' ' A' ' 208' ' ' VAL . 2.4 mm? -69.08 -71.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.120000000000005 110.894 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -45.18 -21.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 75.25 110.869 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 212' ' ' LEU . 1.2 tp10 -70.77 -66.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 74.5 110.867 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.22 -44.3 79.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.120000000000005 110.926 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.402 ' CD1' HG13 ' A' ' 161' ' ' VAL . 4.8 pt -111.57 89.18 10.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 73.209999999999994 111.101 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -20.68 34.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 71.420000000000002 112.354 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.06 -22.88 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 72.129999999999995 110.815 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.6 mt -58.51 148.14 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.319999999999993 111.156 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.41 ' C ' HG12 ' A' ' 221' ' ' ILE . 0.9 OUTLIER -129.44 -39.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.92 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.41 HG12 ' C ' ' A' ' 220' ' ' GLN . 27.3 mm -150.67 114.43 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 75.420000000000002 111.087 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 85.6 t -86.81 121.49 37.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.019999999999996 111.103 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -108.5 122.87 47.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.340000000000003 110.961 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 24.8 mt -115.27 102.2 9.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.519999999999996 110.921 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.427 ' CD1' HD13 ' A' ' 183' ' ' LEU . 2.2 mt -72.71 173.35 9.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 72.400000000000006 110.897 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.6 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 71.129999999999995 110.896 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.79 0.329 . . . . 62.509999999999998 110.892 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -97.77 -13.2 21.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 63.210000000000001 110.884 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.507 ' C ' ' CG ' ' A' ' 157' ' ' ASN . 5.3 tp 58.56 113.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 75.420000000000002 110.915 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.516 ' N ' ' ND2' ' A' ' 157' ' ' ASN . 0.0 OUTLIER 174.7 166.43 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 71.150000000000006 110.934 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.36 -26.32 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 73.239999999999995 110.853 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.42 ' CD ' ' HB2' ' A' ' 157' ' ' ASN . 11.5 pm0 -78.58 -33.28 47.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 71.129999999999995 110.886 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 162' ' ' GLU . 24.9 m-20 -100.87 -60.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 75.519999999999996 110.912 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.525 HG11 ' CE1' ' A' ' 182' ' ' PHE . 9.3 p -42.18 -23.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 73.409999999999997 111.122 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 161' ' ' VAL . 4.3 mt-10 -64.67 -55.01 22.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 60.350000000000001 110.891 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -40.78 45.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 74.540000000000006 110.889 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.437 HG13 ' CD2' ' A' ' 212' ' ' LEU . 25.2 t -71.38 -33.41 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.349999999999994 111.144 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.1 mt -71.02 -28.78 64.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 72.329999999999998 110.931 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.486 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 29.4 m-80 -71.02 -8.21 51.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 62.5 110.898 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.94 -3.88 50.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 74.409999999999997 110.849 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.88 -36.9 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 72.239999999999995 111.127 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.518 ' NH2' ' NE2' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -52.99 -59.93 7.86 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 74.219999999999999 110.876 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.486 ' CG ' ' O ' ' A' ' 166' ' ' ASN . 53.7 Cg_endo -69.79 -20.79 34.22 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.717 2.278 . . . . 74.109999999999999 112.331 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.557 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -69.2 -19.77 63.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.927 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.545 HD22 ' CD2' ' A' ' 171' ' ' TYR . 5.8 mt -79.51 -55.36 5.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 75.549999999999997 110.935 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -43.43 -28.66 0.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 63.399999999999999 111.086 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.57 -39.38 93.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 65.209999999999994 112.504 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 43.3 p -107.18 1.74 24.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 71.010000000000005 111.185 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 149.38 -56.09 0.48 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 63.219999999999999 112.46 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 110.5 173.78 20.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 74.329999999999998 112.476 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -161.04 -111.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 71.310000000000002 112.532 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -178.73 119.83 0.67 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.757 -0.735 . . . . 73.099999999999994 112.506 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.468 ' CD2' HD11 ' A' ' 172' ' ' LEU . 0.5 OUTLIER -149.55 11.99 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.754 0.311 . . . . 64.219999999999999 110.91 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.518 ' NE2' ' NH2' ' A' ' 169' ' ' ARG . 6.0 tp-100 -35.02 104.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 53.509999999999998 110.907 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.525 ' CE1' HG11 ' A' ' 161' ' ' VAL . 22.0 t80 -34.69 125.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.310000000000002 110.858 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 89.8 mt -86.66 -74.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.919 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 22.8 ptp -165.11 -173.66 2.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 74.049999999999997 110.895 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.84 136.94 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 71.319999999999993 111.163 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -136.15 71.98 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 75.0 110.855 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.89 -145.3 24.61 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 73.219999999999999 112.527 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 3.27 2.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 72.340000000000003 112.347 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mp -122.83 112.09 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 70.140000000000001 111.156 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.16 142.1 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 62.5 111.098 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -99.87 141.56 32.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 70.239999999999995 110.933 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.7 t -154.51 147.87 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 75.150000000000006 111.122 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.93 166.82 14.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 110.869 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.16 96.63 1.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 72.109999999999999 110.938 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 15.7 p -125.5 179.94 4.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 74.010000000000005 111.157 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.96 -177.91 54.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 51.130000000000003 112.517 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -20.53 34.79 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.732 2.288 . . . . 74.430000000000007 112.349 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.24 -24.24 47.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 64.439999999999998 111.101 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -49.94 -63.03 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 75.099999999999994 111.145 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.99 96.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.116 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 10.2 p -162.85 22.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 111.092 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.7 OUTLIER 59.46 152.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 110.862 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 2.5 m 81.15 -68.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.0 111.151 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 205' ' ' ARG . 92.7 t -44.39 -67.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 65.409999999999997 111.158 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 204' ' ' VAL . 6.8 ptm180 -36.72 -36.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 71.150000000000006 110.871 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 3.8 mp -77.26 -51.17 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 72.329999999999998 111.136 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -51.94 -16.43 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 65.420000000000002 111.152 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 86.3 t -89.51 -52.52 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 75.329999999999998 111.152 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.3 t -84.14 24.48 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.200000000000003 110.808 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.24 -40.21 4.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 74.099999999999994 110.916 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -31.73 33.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 110.882 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.437 ' CD2' HG13 ' A' ' 164' ' ' VAL . 6.6 mt -69.54 -65.21 0.74 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 70.349999999999994 110.925 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -28.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.921 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -75.51 -68.19 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 64.430000000000007 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.32 -56.61 18.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 75.519999999999996 110.896 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 3.5 pt -104.77 92.22 4.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.654 0.74 . . . . 73.209999999999994 111.095 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -22.53 31.72 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.655 2.237 . . . . 72.109999999999999 112.359 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.22 -20.45 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 110.842 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.6 mt -62.54 154.02 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 75.420000000000002 111.109 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.443 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -136.29 -37.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 71.310000000000002 110.928 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.409 HG12 ' C ' ' A' ' 220' ' ' GLN . 29.6 mm -152.09 105.31 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 74.200000000000003 111.151 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 74.3 t -81.29 118.77 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 111.124 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -101.91 108.03 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 73.030000000000001 110.913 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 mt -96.65 102.35 14.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 110.918 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 226' ' ' SER . 9.1 mp -70.94 173.42 7.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 74.019999999999996 110.904 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 225' ' ' LEU . 44.4 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.219999999999999 110.842 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.41 HD12 ' ND2' ' A' ' 160' ' ' ASN . 10.5 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.782 0.325 . . . . 72.409999999999997 110.898 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.87 -7.99 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 73.540000000000006 110.858 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.8 tp 50.89 98.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 74.549999999999997 110.887 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.57 ' N ' HD21 ' A' ' 157' ' ' ASN . 0.0 OUTLIER -166.17 169.85 13.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.519999999999996 110.884 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.458 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 3.7 mt-10 -44.53 -29.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.876 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.459 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 3.7 pt-20 -70.66 -42.88 70.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 74.319999999999993 110.884 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 162' ' ' GLU . 96.1 m-20 -86.53 -63.5 1.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 74.200000000000003 110.864 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.458 ' CG2' ' HA ' ' A' ' 158' ' ' GLU . 33.8 m -37.51 -30.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 71.140000000000001 111.123 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.4 mt-10 -64.85 -51.93 59.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 74.540000000000006 110.883 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -58.57 -50.43 73.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 75.340000000000003 110.904 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.7 t -62.24 -30.2 48.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 74.409999999999997 111.085 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.466 ' CD1' ' HB2' ' A' ' 182' ' ' PHE . 18.2 mt -73.63 -28.48 61.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 75.099999999999994 110.926 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.487 ' O ' ' CD ' ' A' ' 170' ' ' PRO . 37.9 m-80 -71.38 -11.97 61.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 73.219999999999999 110.861 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.22 -18.33 39.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 110.938 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.99 -24.54 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 62.549999999999997 111.163 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -55.97 -60.43 8.82 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.593 0.711 . . . . 73.510000000000005 110.908 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.487 ' CD ' ' O ' ' A' ' 166' ' ' ASN . 53.7 Cg_endo -69.81 -2.01 9.49 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 53.240000000000002 112.361 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.575 ' CD2' HD21 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -88.94 -42.89 11.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 72.420000000000002 110.899 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.575 HD21 ' CD2' ' A' ' 171' ' ' TYR . 5.4 mt -57.05 -45.79 82.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 73.120000000000005 110.929 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -45.43 107.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 64.299999999999997 111.134 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 133.5 -50.38 0.88 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.76 . . . . 61.020000000000003 112.487 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.9 t -133.23 22.34 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 73.519999999999996 111.092 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -153.6 -79.46 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 63.32 112.456 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 56.22 15.82 12.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.778 -0.725 . . . . 71.299999999999997 112.477 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.34 -93.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 64.140000000000001 112.507 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 193' ' ' ARG . . . 175.03 123.92 0.77 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 60.100000000000001 112.442 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.483 ' O ' ' C ' ' A' ' 181' ' ' GLN . 2.7 pp -135.27 -0.22 2.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 74.530000000000001 110.941 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -30.73 117.62 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.510000000000005 110.873 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.466 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 19.3 t80 -55.63 129.62 39.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.856 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.417 HD11 ' C ' ' A' ' 192' ' ' VAL . 43.0 mt -89.67 -74.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 72.200000000000003 110.889 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 16.6 ptp -167.45 -170.77 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 110.844 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 35.0 mt -138.36 133.46 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 111.097 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -130.91 59.8 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 73.129999999999995 110.925 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 99.12 -146.74 18.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.725 -0.75 . . . . 72.150000000000006 112.514 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 3.04 3.0 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.705 2.27 . . . . 70.209999999999994 112.335 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.4 mt -115.81 118.34 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.019999999999996 111.155 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 66.8 t -91.27 139.73 17.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 111.083 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.411 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 7.8 mtmt -107.49 145.83 32.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 75.120000000000005 110.901 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 193' ' ' ARG . 70.6 t -158.73 158.18 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 111.112 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.459 ' N ' ' CG1' ' A' ' 192' ' ' VAL . 5.8 ttt180 -99.5 137.81 37.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.120000000000005 110.903 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -130.46 84.47 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 74.209999999999994 110.926 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -112.32 170.09 8.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.319999999999993 111.145 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.42 ' N ' ' OG1' ' A' ' 195' ' ' THR . . . 84.06 -163.25 39.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 63.020000000000003 112.462 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -35.45 12.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.686 2.258 . . . . 74.319999999999993 112.338 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -84.59 32.29 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 111.063 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.19 -52.2 17.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 72.519999999999996 111.123 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -164.66 69.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 75.0 111.111 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 202' ' ' ARG . 56.1 t -88.83 -83.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 74.340000000000003 111.1 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.424 ' N ' HG13 ' A' ' 201' ' ' VAL . 0.0 OUTLIER 172.08 41.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 75.409999999999997 110.9 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.461 ' CA ' HD12 ' A' ' 206' ' ' ILE . 23.1 m -166.83 -57.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 71.510000000000005 111.186 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 31.9 t -60.11 -63.96 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 71.230000000000004 111.127 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -44.56 -29.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 73.420000000000002 110.855 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.461 HD12 ' CA ' ' A' ' 203' ' ' THR . 3.0 mt -79.8 -45.25 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 71.030000000000001 111.149 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.28 -15.07 31.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 111.113 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 209' ' ' SER . 54.1 t -80.25 -85.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.349999999999994 111.143 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 208' ' ' VAL . 1.6 t -33.43 -41.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 74.030000000000001 110.854 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.44 -54.7 7.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 70.329999999999998 110.896 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -56.31 19.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 75.040000000000006 110.862 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.448 HD22 ' CG1' ' A' ' 208' ' ' VAL . 1.6 mm? -45.7 -74.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 71.530000000000001 110.881 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 212' ' ' LEU . 3.9 ttp180 -37.39 -52.49 1.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 74.049999999999997 110.874 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -46.36 -92.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.857 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.26 -54.26 1.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 70.129999999999995 110.883 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.455 ' CD1' HG12 ' A' ' 161' ' ' VAL . 11.2 pt -106.17 88.19 2.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.602 0.715 . . . . 74.430000000000007 111.122 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -23.21 31.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.648 2.232 . . . . 74.329999999999998 112.376 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.7 t -45.63 -28.54 1.0 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 72.549999999999997 110.862 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -55.65 157.15 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 75.420000000000002 111.1 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.498 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.5 OUTLIER -141.68 -37.84 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 73.299999999999997 110.964 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.411 HG13 ' C ' ' A' ' 220' ' ' GLN . 11.2 mt -140.93 85.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 111.128 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.04 115.9 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 111.094 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -95.76 152.77 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 73.510000000000005 110.889 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.4 mt -139.7 100.01 3.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 74.150000000000006 110.9 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 225' ' ' LEU . 0.3 OUTLIER -57.56 177.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.926 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 70.120000000000005 110.857 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.815 0.34 . . . . 75.420000000000002 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.91 -18.05 14.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 70.519999999999996 110.911 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.487 ' C ' ' CG ' ' A' ' 157' ' ' ASN . 6.6 tp 61.92 106.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.977 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.487 ' CG ' ' C ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -176.25 166.76 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 75.019999999999996 110.853 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -42.22 -38.97 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 74.310000000000002 110.834 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -65.18 -56.26 13.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 73.109999999999999 110.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 162' ' ' GLU . 53.1 m-20 -76.52 -61.87 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 73.019999999999996 110.901 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.46 ' N ' ' O ' ' A' ' 157' ' ' ASN . 6.1 p -38.69 -28.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 111.113 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 160' ' ' ASN . 2.4 mm-40 -59.52 -59.96 4.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.843 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -36.71 23.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 74.140000000000001 110.894 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.47 HG12 ' CD2' ' A' ' 212' ' ' LEU . 41.9 t -70.64 -45.85 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 74.040000000000006 111.121 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.468 HD12 ' CD1' ' A' ' 182' ' ' PHE . 75.7 mt -61.09 -24.08 65.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.932 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.41 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 24.3 m-80 -74.57 -5.86 45.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 64.420000000000002 110.894 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.09 -8.06 40.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 75.549999999999997 110.85 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.3 pt -123.22 -43.68 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 75.319999999999993 111.14 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -44.22 -59.95 3.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.576 0.703 . . . . 74.310000000000002 110.914 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.79 -30.48 22.09 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 75.519999999999996 112.373 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.547 ' CD2' HD21 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -63.76 -14.51 53.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 110.948 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.547 HD21 ' CD2' ' A' ' 171' ' ' TYR . 4.5 mt -79.56 -55.62 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 74.120000000000005 110.917 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.51 -54.24 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 111.127 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -40.71 -60.33 2.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.747 . . . . 75.030000000000001 112.452 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 82.8 p -64.92 -50.38 66.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 75.209999999999994 111.164 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -169.54 -40.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 63.32 112.455 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 127.44 164.44 11.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 71.400000000000006 112.509 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.21 -178.74 41.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 74.430000000000007 112.524 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -140.42 99.98 0.26 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 71.019999999999996 112.494 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.5 OUTLIER -118.31 25.84 10.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.751 0.31 . . . . 74.519999999999996 110.89 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -35.77 119.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 110.944 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.468 ' CD1' HD12 ' A' ' 165' ' ' LEU . 19.5 t80 -48.5 116.2 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 73.140000000000001 110.862 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.26 -73.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 73.540000000000006 110.905 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 14.1 ptp -171.32 -171.05 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 110.912 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -131.78 131.12 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 73.140000000000001 111.132 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -135.43 74.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 62.32 110.931 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.33 -144.77 24.84 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 63.520000000000003 112.446 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 3.52 2.74 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.689 2.259 . . . . 72.400000000000006 112.314 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.453 HG21 ' N ' ' A' ' 190' ' ' VAL . 44.5 mt -109.63 149.72 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 73.129999999999995 111.128 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.453 ' N ' HG21 ' A' ' 189' ' ' ILE . 56.7 t -126.39 135.33 64.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 70.319999999999993 111.146 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.453 ' N ' HG13 ' A' ' 190' ' ' VAL . 13.6 mtmt -105.0 133.95 48.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 71.540000000000006 110.878 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 66.3 t -153.41 129.63 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 73.230000000000004 111.12 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 179.42 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 72.420000000000002 110.833 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.25 67.92 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 71.239999999999995 110.919 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 73.4 p -90.42 -179.8 5.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 75.439999999999998 111.187 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 91.76 173.64 42.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 72.049999999999997 112.482 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -16.84 37.52 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.25 . . . . 71.430000000000007 112.345 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.46 -18.92 59.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 53.520000000000003 111.104 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.62 -45.63 81.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 111.107 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 30.9 m -92.0 49.3 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 71.219999999999999 111.159 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 83.6 t -138.81 125.57 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 75.120000000000005 111.164 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -55.79 158.05 3.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 73.120000000000005 110.879 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.428 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 1.9 m 79.73 -55.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.479 . . . . 74.540000000000006 111.191 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 76.1 t -38.88 -60.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.049999999999997 111.121 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -43.97 39.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 74.230000000000004 110.87 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.64 -53.77 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.150000000000006 111.168 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -44.53 -27.74 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 75.239999999999995 111.12 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.05 -56.47 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 74.299999999999997 111.162 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.31 20.39 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 73.310000000000002 110.85 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -103.66 -40.26 6.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 75.530000000000001 110.895 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.38 -34.12 25.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 72.319999999999993 110.889 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.47 ' CD2' HG12 ' A' ' 164' ' ' VAL . 7.4 mt -68.32 -67.3 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 75.129999999999995 110.898 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.59 -24.16 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 71.230000000000004 110.904 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -78.7 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.904 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.29 -51.43 14.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 72.510000000000005 110.931 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 2.2 pt -107.02 91.96 7.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.593 0.711 . . . . 72.430000000000007 111.141 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -17.64 37.46 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.667 2.245 . . . . 74.129999999999995 112.329 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.6 t -54.46 -28.44 44.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 52.049999999999997 110.833 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.8 mt -57.64 153.12 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 75.510000000000005 111.127 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.429 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 2.0 mt-30 -133.12 -37.38 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.219999999999999 110.907 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.8 mp -145.74 102.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 111.088 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.72 107.58 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 74.140000000000001 111.113 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -93.2 94.51 8.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.889 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.9 117.22 24.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 73.439999999999998 110.916 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.68 170.93 15.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 71.430000000000007 110.889 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 73.430000000000007 110.893 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.462 ' CB ' HG22 ' A' ' 216' ' ' ILE . 28.6 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.728 0.299 . . . . 75.409999999999997 110.946 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -110.69 -8.75 14.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 64.430000000000007 110.907 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.435 ' CD1' HD13 ' A' ' 216' ' ' ILE . 26.8 tp 58.19 97.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 73.049999999999997 110.9 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.06 164.27 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.922 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -46.58 -21.94 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.510000000000005 110.924 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -41.14 18.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 74.519999999999996 110.899 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.15 -57.13 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 74.420000000000002 110.873 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.452 HG22 ' CZ ' ' A' ' 182' ' ' PHE . 29.5 m -45.96 -26.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 71.420000000000002 111.093 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -61.08 -59.44 5.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.91 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -42.33 42.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 72.329999999999998 110.907 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.471 HG13 ' CD2' ' A' ' 212' ' ' LEU . 2.0 t -70.6 -42.1 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 65.329999999999998 111.144 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.555 HD12 ' CD1' ' A' ' 182' ' ' PHE . 31.0 mt -61.86 -32.93 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 75.530000000000001 110.948 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -69.95 -3.66 17.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 74.040000000000006 110.887 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -94.43 -2.01 52.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.875 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.452 ' CD1' HG11 ' A' ' 208' ' ' VAL . 4.1 pt -136.59 -35.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 72.219999999999999 111.159 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -45.95 -60.02 4.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.535 0.683 . . . . 75.230000000000004 110.836 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.0 Cg_endo -69.73 3.29 2.84 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.713 2.276 . . . . 72.340000000000003 112.349 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.4 OUTLIER -102.39 -23.56 13.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 70.409999999999997 110.927 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.487 HD23 ' CD2' ' A' ' 171' ' ' TYR . 2.5 mt -84.31 -36.95 22.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 70.409999999999997 110.889 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.27 -13.37 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 71.349999999999994 111.052 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.17 -40.96 8.25 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.71 -0.757 . . . . 74.120000000000005 112.425 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.0 t -105.16 4.49 31.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 75.439999999999998 111.108 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -179.24 -101.5 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 70.129999999999995 112.469 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.31 69.75 0.4 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.716 -0.754 . . . . 54.409999999999997 112.496 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.88 -123.31 1.89 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 53.229999999999997 112.477 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -138.14 112.47 0.89 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 73.510000000000005 112.455 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -122.11 6.65 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.729 0.299 . . . . 74.430000000000007 110.933 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 182' ' ' PHE . 0.0 OUTLIER -37.94 96.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 71.439999999999998 110.893 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.555 ' CD1' HD12 ' A' ' 165' ' ' LEU . 17.6 t80 -37.49 119.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 73.450000000000003 110.887 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.0 mt -77.54 -73.41 0.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 63.420000000000002 110.905 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 15.0 ptp -174.15 -174.36 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 73.349999999999994 110.891 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.3 mt -133.33 137.01 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 74.439999999999998 111.178 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.8 57.05 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.862 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 91.72 -135.24 12.67 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 73.420000000000002 112.451 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 2.4 3.52 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.716 2.277 . . . . 72.219999999999999 112.342 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.434 ' CD1' ' HB ' ' A' ' 221' ' ' ILE . 26.9 mm -125.41 124.46 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 71.349999999999994 111.13 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.466 HG22 ' N ' ' A' ' 191' ' ' LYS . 6.4 p -109.97 137.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 65.450000000000003 111.17 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.466 ' N ' HG22 ' A' ' 190' ' ' VAL . 15.0 mtmt -101.16 146.46 27.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.109999999999999 110.9 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 91.0 t -158.94 152.69 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 74.439999999999998 111.127 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.5 155.26 22.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 75.420000000000002 110.877 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 198' ' ' ALA . 0.1 OUTLIER -153.16 84.41 1.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.530000000000001 110.941 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 11.9 p -120.18 -170.94 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.439999999999998 111.143 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 73.13 -168.6 53.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 61.240000000000002 112.503 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -15.69 37.13 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.256 . . . . 74.239999999999995 112.348 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 194' ' ' LEU . . . -96.21 52.25 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 72.219999999999999 111.087 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.465 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -142.99 141.73 31.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 73.140000000000001 111.068 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.451 ' CB ' ' O ' ' A' ' 199' ' ' ALA . 2.7 t 81.45 -40.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 74.25 111.14 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 202' ' ' ARG . 87.9 t -47.46 139.24 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 74.409999999999997 111.129 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.465 ' N ' HG11 ' A' ' 201' ' ' VAL . 1.7 tpt85 -85.55 78.23 9.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 70.140000000000001 110.879 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.446 ' CG2' HG13 ' A' ' 201' ' ' VAL . 2.5 t 174.33 -42.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 74.0 111.117 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 45.7 t -70.08 -44.33 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.219999999999999 111.095 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -4.81 18.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 110.861 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.31 -66.88 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 111.107 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -45.71 -21.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 75.409999999999997 111.091 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.452 HG11 ' CD1' ' A' ' 168' ' ' ILE . 87.7 t -74.79 -75.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 71.430000000000007 111.136 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 33.7 t -57.43 -12.5 2.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 74.519999999999996 110.852 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -40.27 67.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 73.129999999999995 110.906 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.03 -32.92 51.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.852 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.471 ' CD2' HG13 ' A' ' 164' ' ' VAL . 9.2 mt -72.16 -60.37 2.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 73.010000000000005 110.945 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -46.33 -26.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 71.099999999999994 110.854 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.96 -74.27 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 75.120000000000005 110.88 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.422 ' C ' HD11 ' A' ' 154' ' ' LEU . 0.8 OUTLIER -53.21 -52.71 58.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 75.099999999999994 110.914 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.462 HG22 ' CB ' ' A' ' 154' ' ' LEU . 6.8 pt -106.2 87.75 2.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.722 . . . . 74.120000000000005 111.159 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -5.82 17.12 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.664 2.243 . . . . 75.219999999999999 112.332 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.9 t -69.22 -1.6 8.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.873 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -78.96 154.84 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 111.192 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -138.12 -35.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.898 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.434 ' HB ' ' CD1' ' A' ' 189' ' ' ILE . 47.2 mt -152.71 103.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 111.146 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 93.8 t -78.13 107.95 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 111.107 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -94.0 118.5 31.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.519999999999996 110.923 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -114.41 102.48 10.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 75.549999999999997 110.88 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.1 mp -69.9 162.77 27.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.947 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 75.239999999999995 110.834 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.775 0.321 . . . . 75.310000000000002 110.925 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -103.37 -12.74 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.230000000000004 110.885 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 11.2 tp 60.85 115.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 74.040000000000006 110.942 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 160' ' ' ASN . 16.8 p30 174.76 -173.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.898 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -37.4 87.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.150000000000006 110.847 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.92 -24.2 60.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 73.25 110.869 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 162' ' ' GLU . 91.7 m-20 -101.07 -67.74 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 72.239999999999995 110.877 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.486 HG13 ' CZ ' ' A' ' 182' ' ' PHE . 4.0 p -36.82 -29.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 71.030000000000001 111.166 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.6 mt-10 -55.01 -59.32 4.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.340000000000003 110.92 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -36.39 62.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 110.866 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 212' ' ' LEU . 93.1 t -65.23 -42.01 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 74.219999999999999 111.145 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.409 HD11 ' CD1' ' A' ' 182' ' ' PHE . 62.0 mt -69.43 -21.81 63.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 73.5 110.887 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -72.88 -16.12 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 110.877 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -89.72 6.35 41.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 110.86 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.76 -34.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.319999999999993 111.122 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.7 -61.03 5.23 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.539 0.685 . . . . 75.450000000000003 110.889 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.78 -11.37 30.67 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.684 2.256 . . . . 74.299999999999997 112.335 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -84.86 -13.18 51.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 73.519999999999996 110.959 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.541 ' CD1' ' CD2' ' A' ' 180' ' ' LEU . 6.4 mt -80.39 -41.89 23.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.931 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -39.21 -48.59 1.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.409999999999997 111.119 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.3 -55.66 29.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 72.25 112.485 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.8 p -77.08 2.46 15.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.795 0.331 . . . . 71.349999999999994 111.12 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 151.1 -64.32 0.38 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.73 . . . . 72.510000000000005 112.496 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 124.44 32.41 0.83 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 75.349999999999994 112.482 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -46.35 174.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 72.510000000000005 112.483 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -126.69 117.57 2.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.752 -0.737 . . . . 64.319999999999993 112.487 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.541 ' CD2' ' CD1' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -118.14 25.23 10.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.788 0.328 . . . . 71.0 110.901 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 182' ' ' PHE . 0.0 OUTLIER -34.35 124.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 75.219999999999999 110.89 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 161' ' ' VAL . 17.8 t80 -52.5 135.61 33.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.912 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 53.8 mt -94.28 -71.51 0.66 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 75.340000000000003 110.884 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 6.8 ptp -176.06 -162.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 74.310000000000002 110.851 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.7 mt -146.41 127.42 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 75.540000000000006 111.12 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.13 48.66 1.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.310000000000002 110.875 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 106.73 -140.13 15.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 75.120000000000005 112.507 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 3.09 3.0 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.683 2.255 . . . . 65.299999999999997 112.357 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.49 135.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 111.126 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 76.5 t -109.83 137.03 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 111.106 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -107.75 140.62 40.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.239999999999995 110.906 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 90.8 t -152.48 144.8 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 75.549999999999997 111.159 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.14 166.96 17.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 73.129999999999995 110.842 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.91 84.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 74.150000000000006 110.864 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.6 p -99.97 158.42 15.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 111.126 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 90.36 -177.58 42.57 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.659 -0.781 . . . . 63.140000000000001 112.435 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 0.74 5.16 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.707 2.271 . . . . 72.439999999999998 112.352 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.404 ' CB ' HG13 ' A' ' 204' ' ' VAL . . . -87.93 16.87 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 44.329999999999998 111.104 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -120.52 49.39 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 71.319999999999993 111.075 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.3 p -177.56 -35.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 64.239999999999995 111.149 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 20.2 t -47.94 137.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.140000000000001 111.122 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.36 42.85 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 74.030000000000001 110.893 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.1 m -160.59 -46.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 74.109999999999999 111.14 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.404 HG13 ' CB ' ' A' ' 198' ' ' ALA . 43.4 t -61.55 -64.78 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 75.519999999999996 111.12 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -50.59 -30.23 12.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 74.310000000000002 110.839 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 18.5 mt -73.65 -35.69 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 72.439999999999998 111.113 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -58.32 -44.31 88.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 111.073 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.1 t -53.68 -80.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 71.25 111.157 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.4 t -42.84 -39.28 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 73.150000000000006 110.857 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.41 -40.31 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.934 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 212' ' ' LEU . 0.4 OUTLIER -85.11 -59.84 2.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 72.140000000000001 110.897 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 211' ' ' LYS . 2.3 mt -32.72 -69.9 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 75.25 110.956 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.421 ' NH2' ' HB ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -49.35 -40.92 37.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.88 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 211' ' ' LYS . 2.0 mt-10 -64.53 -80.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 75.099999999999994 110.943 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -40.99 -58.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 73.5 110.869 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 9.4 pt -106.97 88.42 3.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.625 0.726 . . . . 73.310000000000002 111.148 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -9.26 25.68 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.714 2.276 . . . . 73.340000000000003 112.365 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.69 -14.13 62.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 74.129999999999995 110.877 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 mt -61.11 146.02 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 75.450000000000003 111.135 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 221' ' ' ILE . 13.0 mp0 -116.88 -38.28 3.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 73.219999999999999 110.873 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 220' ' ' GLN . 4.7 mp -153.27 103.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 72.230000000000004 111.11 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.421 ' HB ' ' NH2' ' A' ' 213' ' ' ARG . 0.9 OUTLIER -72.9 115.56 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 71.209999999999994 111.09 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -100.66 108.11 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 71.120000000000005 110.948 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mt -99.37 113.6 26.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 75.200000000000003 110.944 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.9 mp -93.93 176.06 6.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 110.917 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 72.340000000000003 110.834 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.753 0.311 . . . . 74.319999999999993 110.91 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -102.22 -21.56 14.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.010000000000005 110.886 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.519 ' C ' ' CG ' ' A' ' 157' ' ' ASN . 5.5 tp 61.07 113.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 71.340000000000003 110.917 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.599 ' N ' ' ND2' ' A' ' 157' ' ' ASN . 0.0 OUTLIER 174.71 -178.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 72.299999999999997 110.847 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -6.64 4.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 74.439999999999998 110.892 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.46 -43.68 7.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 54.439999999999998 110.895 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -94.62 -49.48 5.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 74.010000000000005 110.902 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.463 ' CG2' HD13 ' A' ' 156' ' ' LEU . 86.6 t -43.08 -44.02 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 72.129999999999995 111.155 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.49 -34.46 69.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 73.400000000000006 110.85 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -62.61 -45.13 94.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.919 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' A' ' 212' ' ' LEU . 23.1 t -70.4 -31.79 47.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 111.129 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 182' ' ' PHE . 46.5 mt -70.03 -27.8 64.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 75.510000000000005 110.936 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 14.5 m-80 -69.9 -9.35 54.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 75.549999999999997 110.83 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -87.94 -15.6 36.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 110.869 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.422 HD11 ' CG2' ' A' ' 208' ' ' VAL . 1.5 pt -118.34 -30.04 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 75.510000000000005 111.154 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.51 -61.05 5.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.703 . . . . 73.200000000000003 110.877 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.5 Cg_endo -69.74 1.78 4.12 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.702 2.268 . . . . 73.209999999999994 112.33 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.53 ' CD2' HD22 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -94.12 -31.53 14.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 75.230000000000004 110.924 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.53 HD22 ' CD2' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -77.61 -60.39 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 74.340000000000003 110.972 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -38.27 -52.38 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 73.150000000000006 111.076 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -38.71 -44.16 1.79 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 74.219999999999999 112.512 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.2 p -99.91 -15.09 18.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.373 . . . . 74.400000000000006 111.162 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -176.05 -88.08 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 53.340000000000003 112.473 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 114.18 99.67 2.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.695 -0.764 . . . . 73.340000000000003 112.452 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -93.25 -92.36 1.53 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 52.310000000000002 112.515 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.72 119.75 0.56 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.715 -0.755 . . . . 74.030000000000001 112.483 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.4 OUTLIER -139.78 17.8 2.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.756 0.312 . . . . 75.439999999999998 110.934 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.4 OUTLIER -34.28 96.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 74.230000000000004 110.945 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' A' ' 180' ' ' LEU . 91.4 t80 -36.47 118.71 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 72.540000000000006 110.861 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 46.8 mt -82.02 -78.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 72.439999999999998 110.922 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.9 -166.19 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 72.510000000000005 110.898 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.466 HG12 ' CG2' ' A' ' 190' ' ' VAL . 32.5 mt -142.55 139.91 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 74.530000000000001 111.182 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -128.5 69.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 73.140000000000001 110.917 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 89.8 -139.7 15.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 71.530000000000001 112.445 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.417 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.6 Cg_endo -69.81 1.22 4.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.626 2.218 . . . . 75.329999999999998 112.333 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.5 127.55 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 73.540000000000006 111.141 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.466 ' CG2' HG12 ' A' ' 185' ' ' ILE . 6.2 p -105.17 144.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 73.5 111.169 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 10.7 mtmt -103.84 146.18 29.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 75.239999999999995 110.88 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 88.1 t -157.97 136.9 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 71.010000000000005 111.098 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.408 ' O ' ' CD2' ' A' ' 194' ' ' LEU . 11.3 ttt180 -73.69 161.35 30.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 73.439999999999998 110.848 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 199' ' ' ALA . 0.2 OUTLIER -157.99 102.64 1.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.911 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.0 p -129.78 161.89 29.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 72.040000000000006 111.152 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.2 -177.78 38.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 74.439999999999998 112.519 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -43.8 2.46 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 74.420000000000002 112.326 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 199' ' ' ALA . . . -62.8 -25.76 68.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 64.120000000000005 111.127 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.449 ' HA ' ' CD1' ' A' ' 194' ' ' LEU . . . -34.06 -85.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 72.349999999999994 111.149 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.03 112.2 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 71.319999999999993 111.18 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 1.6 p -137.79 -61.49 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.17 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 201' ' ' VAL . 1.1 mtt-85 162.23 35.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 110.855 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.468 ' N ' ' CD1' ' A' ' 206' ' ' ILE . 43.7 m -168.29 -56.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 64.329999999999998 111.124 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 207' ' ' ALA . 59.3 t -48.63 -70.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 73.400000000000006 111.098 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.49 -22.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.310000000000002 110.876 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 203' ' ' THR . 3.1 mp -89.89 -33.02 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 73.340000000000003 111.145 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -74.31 -11.67 60.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.519999999999996 111.066 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.422 ' CG2' HD11 ' A' ' 168' ' ' ILE . 64.1 t -85.53 -74.81 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 75.510000000000005 111.117 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.8 t -53.46 -15.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 72.030000000000001 110.872 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -64.65 -40.26 95.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.909 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.7 -41.23 12.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 75.209999999999994 110.911 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 164' ' ' VAL . 24.7 mt -52.63 -66.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 75.019999999999996 110.903 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -50.43 -24.23 2.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 74.400000000000006 110.908 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.33 -68.46 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.906 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -48.3 82.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.912 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 1.7 pt -109.6 93.76 14.9 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.645 0.736 . . . . 64.409999999999997 111.17 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -22.09 32.96 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 72.109999999999999 112.324 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 21.0 t -54.71 -15.42 1.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 72.329999999999998 110.877 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.7 mt -70.87 143.53 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 72.230000000000004 111.159 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -127.05 -42.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 75.340000000000003 110.881 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.1 mt -140.91 102.64 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 74.219999999999999 111.123 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.21 116.22 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 111.077 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.51 135.2 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 64.400000000000006 110.91 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 30.1 mt -121.97 103.03 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 63.039999999999999 110.906 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.4 171.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.939 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 63.130000000000003 110.84 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.5 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.793 0.33 . . . . 72.439999999999998 110.928 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.436 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 4.4 mt-10 -108.55 -6.23 16.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 72.010000000000005 110.925 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.466 ' CD1' ' CG2' ' A' ' 161' ' ' VAL . 3.2 tp 61.17 119.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.549999999999997 110.943 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 161' ' ' VAL . 5.8 p30 169.37 179.53 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 74.450000000000003 110.891 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -26.5 65.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.857 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.407 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 11.6 pt-20 -84.24 -30.96 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.865 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 155' ' ' GLU . 89.5 m-20 -97.32 -62.29 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 71.340000000000003 110.922 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.57 HG13 ' CE1' ' A' ' 182' ' ' PHE . 50.0 t -38.78 -46.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 75.310000000000002 111.156 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.14 -56.02 5.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.854 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -43.07 30.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 72.430000000000007 110.902 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.459 HG21 ' CB ' ' A' ' 215' ' ' LYS . 33.6 t -70.14 -42.94 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 111.149 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.531 HD13 ' CD1' ' A' ' 182' ' ' PHE . 56.5 mt -63.84 -24.7 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 73.439999999999998 110.905 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -69.17 -10.84 59.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.299999999999997 110.876 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -84.73 -25.74 28.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 110.884 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 169' ' ' ARG . 1.7 pt -106.98 -45.33 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.147 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.508 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 2.8 mtt180 -34.48 -58.71 0.63 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.631 0.729 . . . . 74.450000000000003 110.877 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.76 -30.8 21.72 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 72.010000000000005 112.379 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.512 ' CD2' HD21 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -74.34 -15.0 60.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 73.219999999999999 110.915 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 171' ' ' TYR . 3.8 mt -76.5 -43.02 41.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 61.530000000000001 110.912 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.19 -22.62 48.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 60.219999999999999 111.118 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -46.32 -49.37 15.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 64.120000000000005 112.459 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.7 t -125.98 48.78 2.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 70.310000000000002 111.167 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.18 -97.65 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 73.319999999999993 112.489 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.03 125.46 4.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 73.219999999999999 112.511 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -128.81 -102.54 1.07 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 64.230000000000004 112.492 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -169.34 119.33 0.82 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.709 -0.758 . . . . 65.430000000000007 112.465 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -140.95 6.08 1.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 75.040000000000006 110.893 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -35.0 111.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 74.400000000000006 110.9 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.57 ' CE1' HG13 ' A' ' 161' ' ' VAL . 27.3 t80 -37.78 122.19 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 75.040000000000006 110.865 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 38.1 mt -81.01 -77.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 75.409999999999997 110.965 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.419 ' C ' HG13 ' A' ' 185' ' ' ILE . 12.5 ptm -169.99 -172.91 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 74.430000000000007 110.883 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.419 HG13 ' C ' ' A' ' 184' ' ' MET . 2.4 mt -133.73 130.52 56.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 75.209999999999994 111.134 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.09 75.83 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 71.25 110.954 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 87.19 -151.16 23.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 61.340000000000003 112.496 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 2.93 3.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.687 2.258 . . . . 75.140000000000001 112.303 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 24.0 mt -113.71 124.38 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 74.030000000000001 111.118 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.0 137.97 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 111.177 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -104.94 142.16 35.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 73.5 110.901 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.431 HG11 ' N ' ' A' ' 193' ' ' ARG . 56.1 t -156.91 142.83 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 73.319999999999993 111.152 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.431 ' N ' HG11 ' A' ' 192' ' ' VAL . 1.0 OUTLIER -73.69 163.1 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 64.319999999999993 110.887 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -164.49 93.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 110.915 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 5.9 p -132.49 -168.84 2.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 61.219999999999999 111.094 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.79 -158.13 42.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 75.239999999999995 112.476 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.26 18.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.678 2.252 . . . . 74.439999999999998 112.364 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.475 ' HB3' ' CG1' ' A' ' 204' ' ' VAL . . . -90.22 -162.41 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 73.239999999999995 111.131 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 200' ' ' VAL . . . 74.01 144.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 111.062 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 199' ' ' ALA . 22.0 m 34.05 42.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 72.340000000000003 111.169 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 23.0 t -99.12 -16.63 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 111.16 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 70.47 40.17 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 75.120000000000005 110.859 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.83 -44.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 72.209999999999994 111.133 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 198' ' ' ALA . 53.6 t -72.64 -47.34 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 72.230000000000004 111.125 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -61.54 -40.89 96.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.340000000000003 110.893 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.72 -37.3 58.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.349999999999994 111.104 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.8 -29.95 69.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 111.107 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.438 HG11 ' CD1' ' A' ' 212' ' ' LEU . 67.3 t -65.04 -75.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 74.420000000000002 111.125 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.423 ' OG ' ' CZ ' ' A' ' 213' ' ' ARG . 1.9 t -55.33 -19.0 7.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 73.120000000000005 110.872 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.409 ' O ' ' OE1' ' A' ' 214' ' ' GLU . 3.8 mtpp -61.93 -40.32 95.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 72.129999999999995 110.855 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.86 -32.81 17.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 75.450000000000003 110.87 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.446 ' CD2' HG13 ' A' ' 164' ' ' VAL . 10.5 mt -69.29 -67.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 74.109999999999999 110.932 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . 0.423 ' CZ ' ' OG ' ' A' ' 209' ' ' SER . 0.7 OUTLIER -45.07 -27.95 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 75.409999999999997 110.862 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 210' ' ' LYS . 0.4 OUTLIER -81.68 -76.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 110.902 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.459 ' CB ' HG21 ' A' ' 164' ' ' VAL . 16.4 mmtt -42.24 -59.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 72.349999999999994 110.893 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 3.4 pt -103.94 95.42 7.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.659 0.743 . . . . 75.120000000000005 111.167 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -22.04 32.58 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.673 2.249 . . . . 75.209999999999994 112.33 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 17.0 t -49.06 -35.74 16.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 73.329999999999998 110.851 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -48.37 154.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.349999999999994 111.129 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.446 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.8 OUTLIER -134.94 -35.53 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.450000000000003 110.927 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.4 mt -146.76 91.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 72.200000000000003 111.147 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.05 109.82 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 73.030000000000001 111.096 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -100.9 130.58 46.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 110.856 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 14.2 mt -117.07 114.09 23.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 64.25 110.909 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.52 177.88 7.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 74.439999999999998 110.925 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.450000000000003 110.879 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.811 0.338 . . . . 71.219999999999999 110.897 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -104.13 -17.82 14.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.919 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.435 ' CD1' HD13 ' A' ' 216' ' ' ILE . 8.9 tp 59.71 111.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 73.420000000000002 110.95 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -175.99 171.96 2.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 71.530000000000001 110.867 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.18 -20.51 1.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 64.420000000000002 110.869 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.51 -35.22 25.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 73.150000000000006 110.903 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -90.0 -55.85 3.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 73.400000000000006 110.882 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.439 HG11 ' CD1' ' A' ' 216' ' ' ILE . 26.6 m -47.46 -26.72 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 63.32 111.092 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -62.79 -42.02 99.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.893 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -34.08 69.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 74.219999999999999 110.944 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 212' ' ' LEU . 30.4 t -73.37 -42.93 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 71.540000000000006 111.087 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.452 HD21 ' CD1' ' A' ' 180' ' ' LEU . 85.0 mt -65.89 -23.59 66.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 75.329999999999998 110.915 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -73.37 -8.64 56.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 71.450000000000003 110.861 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.19 1.59 49.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 74.120000000000005 110.916 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.465 ' CD1' HG12 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -132.91 -35.19 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 64.420000000000002 111.103 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.481 ' NH2' ' NE2' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -52.19 -60.56 5.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 75.129999999999995 110.874 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.4 Cg_endo -69.77 -4.73 14.63 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.691 2.261 . . . . 62.229999999999997 112.305 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.537 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -90.53 -22.1 21.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 64.140000000000001 110.924 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.474 HD21 ' CD2' ' A' ' 171' ' ' TYR . 5.3 mt -76.37 -44.81 34.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 75.319999999999993 110.912 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.5 -38.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 71.109999999999999 111.13 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.69 152.1 19.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 52.119999999999997 112.501 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.0 t 40.14 56.26 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.33 . . . . 74.439999999999998 111.132 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 156.37 -86.72 0.12 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 63.399999999999999 112.46 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 89.34 89.24 1.23 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 73.510000000000005 112.526 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.33 -158.81 7.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 63.210000000000001 112.515 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.92 152.68 24.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 64.430000000000007 112.458 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.463 ' CD2' ' HG3' ' A' ' 169' ' ' ARG . 0.6 OUTLIER -140.9 25.7 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 74.439999999999998 110.919 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.481 ' NE2' ' NH2' ' A' ' 169' ' ' ARG . 2.5 tp60 -32.71 110.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.956 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -46.95 133.15 11.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 75.540000000000006 110.889 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.79 -69.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 72.310000000000002 110.905 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.1 ptp -178.13 -176.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 64.310000000000002 110.859 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.2 mt -131.29 125.27 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 111.145 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -124.9 56.41 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 71.239999999999995 110.913 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 95.71 -141.77 15.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.747 -0.74 . . . . 52.109999999999999 112.424 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.7 Cg_endo -69.72 3.28 2.84 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 72.010000000000005 112.358 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.02 118.3 58.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 111.127 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 191' ' ' LYS . 66.7 t -97.22 135.53 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 54.229999999999997 111.15 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.455 ' N ' HG13 ' A' ' 190' ' ' VAL . 10.9 mtmt -109.76 139.58 44.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 74.349999999999994 110.907 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.2 t -152.23 160.58 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 72.349999999999994 111.117 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.37 166.65 12.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 110.854 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -156.42 70.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 71.439999999999998 110.91 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 76.4 p -89.09 173.3 8.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 111.156 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 86.24 -179.49 49.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.761 . . . . 75.219999999999999 112.455 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -24.43 29.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.709 2.273 . . . . 73.239999999999995 112.342 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' A' ' 194' ' ' LEU . . . -79.85 103.43 9.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 73.409999999999997 111.074 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -165.0 -74.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 61.009999999999998 111.103 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 28.5 m -61.92 -11.01 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 111.146 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 13.2 t -64.02 128.82 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 111.131 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -77.58 58.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 73.209999999999994 110.871 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 96.6 m -163.65 -55.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 74.530000000000001 111.13 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 59.8 t -54.47 -61.44 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 64.129999999999995 111.112 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -53.73 -25.69 19.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.510000000000005 110.873 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.01 -28.73 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 111.114 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.93 -32.34 72.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 70.549999999999997 111.075 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.465 HG12 ' CD1' ' A' ' 168' ' ' ILE . 3.8 t -67.07 -70.26 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 65.120000000000005 111.114 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 7.8 t -50.35 -17.91 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 74.430000000000007 110.854 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -66.96 -41.09 87.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 73.239999999999995 110.918 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -88.49 -33.99 17.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 75.400000000000006 110.905 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.462 ' CD2' HG12 ' A' ' 164' ' ' VAL . 11.3 mt -63.88 -67.14 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.340000000000003 110.901 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -16.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 74.409999999999997 110.85 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.96 -78.45 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.239999999999995 110.871 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -47.09 -55.87 7.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 73.450000000000003 110.863 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.439 ' CD1' HG11 ' A' ' 161' ' ' VAL . 4.1 pt -108.05 91.53 8.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 75.349999999999994 111.152 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -16.06 37.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.63 2.22 . . . . 74.540000000000006 112.37 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.78 -23.94 7.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 71.510000000000005 110.821 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 5.2 mt -58.81 158.14 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 72.230000000000004 111.112 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.498 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -137.59 -35.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 75.340000000000003 110.903 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.408 HG13 ' C ' ' A' ' 220' ' ' GLN . 72.9 mt -150.71 96.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 75.430000000000007 111.143 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 28.7 m -67.89 121.52 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.129999999999995 111.134 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.63 119.18 38.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.91 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.48 119.16 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 110.959 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.31 168.87 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 110.928 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.230000000000004 110.852 -179.907 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.747 0.308 . . . . 70.319999999999993 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -104.12 -17.05 15.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 75.319999999999993 110.894 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.493 ' C ' ' CG ' ' A' ' 157' ' ' ASN . 9.4 tp 58.15 113.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.896 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.493 ' CG ' ' C ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER 175.52 -177.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 110.875 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -45.38 67.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 72.430000000000007 110.823 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -57.93 -56.17 25.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 72.030000000000001 110.927 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 162' ' ' GLU . 94.8 m-20 -74.52 -65.85 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.909 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.544 HG21 ' CE1' ' A' ' 182' ' ' PHE . 2.5 p -34.75 -33.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 71.430000000000007 111.147 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -56.22 -57.1 13.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.901 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.96 -43.71 77.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.908 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' A' ' 212' ' ' LEU . 17.8 t -63.81 -40.89 90.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 63.450000000000003 111.177 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.51 HD13 ' CD1' ' A' ' 182' ' ' PHE . 54.0 mt -66.35 -32.79 74.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 110.891 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 4.5 m-80 -63.97 -13.13 43.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.310000000000002 110.844 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.02 1.13 48.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 70.109999999999999 110.877 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.15 -34.61 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 73.5 111.157 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.42 -60.77 5.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 74.340000000000003 110.851 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' CG ' ' O ' ' A' ' 166' ' ' ASN . 53.8 Cg_endo -69.76 -0.39 6.83 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 72.040000000000006 112.34 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.504 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -92.99 -27.1 17.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 73.310000000000002 110.943 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.446 HD21 ' CD2' ' A' ' 171' ' ' TYR . 6.1 mt -75.63 -39.95 57.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 74.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -44.36 -50.33 9.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 75.209999999999994 111.157 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -45.3 -43.74 9.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 54.210000000000001 112.504 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.9 t -113.76 37.43 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 74.310000000000002 111.124 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.71 109.08 0.46 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 75.25 112.469 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -74.9 137.56 22.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.704 -0.76 . . . . 60.030000000000001 112.507 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.01 -106.44 2.9 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.718 -0.753 . . . . 74.030000000000001 112.474 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.08 113.81 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.752 . . . . 71.030000000000001 112.471 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.429 ' CD2' HD12 ' A' ' 172' ' ' LEU . 1.7 pp -142.55 6.68 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.736 0.303 . . . . 72.239999999999995 110.905 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 182' ' ' PHE . 2.2 tp60 -36.19 105.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 74.519999999999996 110.897 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.544 ' CE1' HG21 ' A' ' 161' ' ' VAL . 10.0 t80 -34.09 129.44 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 62.229999999999997 110.876 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 89.0 mt -95.6 -72.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 74.510000000000005 110.923 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.06 -173.31 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 72.109999999999999 110.861 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.1 mt -135.52 143.92 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 75.530000000000001 111.116 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . 0.47 ' CG ' ' HB ' ' A' ' 189' ' ' ILE . 7.9 ptpt -121.4 38.43 4.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.872 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 93.35 -112.23 4.25 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 72.340000000000003 112.49 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -22.89 31.18 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.723 2.282 . . . . 74.439999999999998 112.314 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.47 ' HB ' ' CG ' ' A' ' 186' ' ' LYS . 2.6 mp -106.45 146.66 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 111.115 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.69 137.54 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 72.430000000000007 111.165 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -98.25 140.13 33.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 73.430000000000007 110.922 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.4 t -151.03 149.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 62.219999999999999 111.109 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.97 161.4 20.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 110.842 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.407 HD13 ' C ' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -173.12 61.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 74.340000000000003 110.983 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 22.6 p -80.42 -49.3 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 75.430000000000007 111.133 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -45.87 173.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.711 -0.757 . . . . 72.349999999999994 112.498 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.18 2.93 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 73.129999999999995 112.345 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.407 ' C ' HD13 ' A' ' 194' ' ' LEU . . . -78.42 6.9 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 74.0 111.102 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -91.76 -61.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 75.340000000000003 111.063 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.12 50.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 52.549999999999997 111.115 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.89 146.17 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.530000000000001 111.172 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -95.5 35.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 75.310000000000002 110.869 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.7 m -156.68 -66.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.439999999999998 111.144 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 57.9 t -44.78 -58.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 74.010000000000005 111.125 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -56.69 -21.86 30.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.230000000000004 110.896 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 15.6 mm -80.96 -52.22 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 73.409999999999997 111.158 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.98 -35.7 25.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 65.129999999999995 111.107 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.9 t -59.53 -83.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 71.010000000000005 111.117 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.0 t -49.22 -18.49 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 64.510000000000005 110.863 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -60.48 -40.23 90.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 61.420000000000002 110.909 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 214' ' ' GLU . 1.4 mmtt -86.59 -54.56 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.847 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.471 ' CD2' HG11 ' A' ' 164' ' ' VAL . 1.5 mt -37.07 -70.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 74.140000000000001 110.877 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -53.49 -22.46 8.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.86 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -77.39 -67.42 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 70.310000000000002 110.923 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -60.72 -46.39 90.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 75.129999999999995 110.916 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 212' ' ' LEU . 4.4 pt -111.68 86.26 6.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.657 0.742 . . . . 74.120000000000005 111.111 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 0.26 5.92 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.688 2.259 . . . . 73.439999999999998 112.319 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.6 t -76.6 1.68 16.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.120000000000005 110.857 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 6.3 mt -83.65 157.88 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 74.450000000000003 111.13 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.501 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.1 OUTLIER -132.43 -33.13 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 74.010000000000005 110.932 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.415 HG12 ' C ' ' A' ' 220' ' ' GLN . 33.6 mm -153.62 108.89 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 75.019999999999996 111.13 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.2 t -82.52 117.83 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 71.420000000000002 111.087 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -107.87 136.25 47.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 110.891 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.8 mt -124.05 104.32 8.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 70.340000000000003 110.944 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.18 168.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.140000000000001 110.915 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 110.862 -179.908 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.451 ' CD1' HG23 ' A' ' 216' ' ' ILE . 11.4 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.815 0.341 . . . . 74.200000000000003 110.895 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.85 -18.09 18.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 62.200000000000003 110.873 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.507 ' C ' ' CG ' ' A' ' 157' ' ' ASN . 5.6 tp 61.49 113.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 64.430000000000007 110.926 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.563 ' N ' ' ND2' ' A' ' 157' ' ' ASN . 0.0 OUTLIER 171.8 173.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 75.209999999999994 110.883 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 162' ' ' GLU . 3.6 mt-10 -49.49 -37.03 24.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 63.420000000000002 110.901 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.8 -54.12 25.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 63.420000000000002 110.924 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 161' ' ' VAL . 86.6 m-20 -79.32 -62.82 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.561 HG12 ' CE1' ' A' ' 182' ' ' PHE . 72.7 t -34.56 -50.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 74.329999999999998 111.133 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 20.7 mm-40 -40.34 -60.2 1.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 75.030000000000001 110.865 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.28 -36.86 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 64.340000000000003 110.929 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.47 HG12 ' CD2' ' A' ' 212' ' ' LEU . 40.2 t -73.44 -34.39 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 71.549999999999997 111.082 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.467 ' CD1' ' HB2' ' A' ' 182' ' ' PHE . 27.8 mt -72.79 -30.93 64.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 73.230000000000004 110.927 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.82 -6.85 44.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.894 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -90.98 -12.87 34.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.319999999999993 110.871 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.51 -28.33 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 73.129999999999995 111.119 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.467 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -51.61 -60.87 5.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 74.409999999999997 110.844 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 169' ' ' ARG . 53.9 Cg_endo -69.73 2.62 3.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.675 2.25 . . . . 72.010000000000005 112.37 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.498 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -97.61 -28.44 13.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.927 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.498 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.3 mt -76.31 -43.08 42.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 110.925 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.17 38.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.200000000000003 111.062 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.53 -20.16 3.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 35.240000000000002 112.476 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.1 t -161.95 30.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 70.150000000000006 111.174 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -165.29 -69.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 73.140000000000001 112.507 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.98 127.34 3.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.698 -0.763 . . . . 72.239999999999995 112.493 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 158.86 176.16 30.6 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 74.209999999999994 112.475 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.23 -171.98 12.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 74.530000000000001 112.513 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.469 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.6 OUTLIER -163.66 30.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.816 0.341 . . . . 75.25 110.962 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 180' ' ' LEU . 9.3 tp60 -32.19 107.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 73.019999999999996 110.886 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.561 ' CE1' HG12 ' A' ' 161' ' ' VAL . 35.7 t80 -48.22 108.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 71.510000000000005 110.877 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 46.9 mt -64.92 -78.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 110.912 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 7.3 ptp -168.49 -174.64 2.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 73.099999999999994 110.885 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.1 mt -127.88 123.97 61.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 72.209999999999994 111.143 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.73 79.18 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 74.239999999999995 110.901 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 76.49 -146.56 33.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.724 . . . . 74.239999999999995 112.532 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 3.18 2.9 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.688 2.259 . . . . 73.25 112.363 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.9 mt -121.31 115.31 46.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.145 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.16 140.24 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 73.439999999999998 111.123 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.421 ' C ' HG23 ' A' ' 192' ' ' VAL . 11.5 mtmt -101.94 136.64 41.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 73.409999999999997 110.89 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.447 HG13 ' N ' ' A' ' 193' ' ' ARG . 82.5 t -140.42 156.46 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 75.019999999999996 111.162 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.447 ' N ' HG13 ' A' ' 192' ' ' VAL . 2.8 ttt180 -91.25 174.2 7.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 75.150000000000006 110.855 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.24 81.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 74.439999999999998 110.896 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 62.5 p -100.99 179.1 4.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 75.430000000000007 111.153 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.49 175.84 48.12 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.765 -0.731 . . . . 64.409999999999997 112.432 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -0.12 6.5 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.685 2.257 . . . . 73.430000000000007 112.305 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.39 5.39 35.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 73.099999999999994 111.089 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -94.28 170.07 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 63.43 111.127 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 200' ' ' VAL . 8.3 p 39.56 38.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 73.530000000000001 111.104 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.467 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 1.5 p -113.1 -15.3 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 62.100000000000001 111.155 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.482 ' O ' ' CG1' ' A' ' 206' ' ' ILE . 0.0 OUTLIER 80.7 -58.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 110.855 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.6 m -51.35 -63.24 1.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.010000000000005 111.111 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.9 t -49.47 -65.05 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 75.109999999999999 111.087 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . 0.456 ' HB2' ' CD1' ' A' ' 224' ' ' LEU . 0.1 OUTLIER -51.74 -34.03 37.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.878 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 202' ' ' ARG . 14.1 mt -66.1 -56.72 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 70.329999999999998 111.163 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.78 -34.02 18.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 73.129999999999995 111.073 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.473 HG13 ' CD1' ' A' ' 212' ' ' LEU . 98.6 t -60.7 -69.23 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 72.010000000000005 111.094 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.3 -17.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 75.230000000000004 110.837 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -73.93 -39.74 63.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 74.510000000000005 110.89 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.92 -34.4 26.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 74.049999999999997 110.867 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.473 ' CD1' HG13 ' A' ' 208' ' ' VAL . 8.2 mt -68.59 -70.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.889 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -21.82 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 72.349999999999994 110.866 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.82 -81.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.329999999999998 110.898 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -46.4 -47.74 18.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 75.409999999999997 110.893 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.451 HG23 ' CD1' ' A' ' 154' ' ' LEU . 2.5 pt -112.95 91.49 18.24 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.631 0.729 . . . . 73.099999999999994 111.092 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -13.53 34.89 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.689 2.259 . . . . 74.109999999999999 112.354 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.18 -11.17 5.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 73.450000000000003 110.873 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 220' ' ' GLN . 1.1 mt -71.67 143.84 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.439999999999998 111.115 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 219' ' ' ILE . 2.9 mt-30 -126.19 -41.53 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 74.439999999999998 110.89 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.4 mp -141.93 104.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 73.239999999999995 111.164 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.73 121.47 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 111.14 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -114.79 129.07 56.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.450000000000003 110.908 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' A' ' 205' ' ' ARG . 10.2 mt -113.14 140.56 47.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 73.230000000000004 110.917 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.91 164.07 14.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 73.319999999999993 110.942 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 64.219999999999999 110.877 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.77 0.319 . . . . 75.5 110.904 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.401 ' O ' ' O ' ' A' ' 156' ' ' LEU . 2.0 tp10 -91.0 -23.88 20.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 63.310000000000002 110.9 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.437 HD11 ' CG1' ' A' ' 219' ' ' ILE . 9.6 tt 53.99 107.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 73.409999999999997 110.913 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 185' ' ' ILE . 9.1 p30 -174.91 171.63 3.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 73.209999999999994 110.859 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -48.8 -22.84 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 73.420000000000002 110.805 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.96 -52.36 6.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 75.109999999999999 110.871 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -68.38 -53.78 21.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 74.040000000000006 110.937 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.6 m -49.5 -27.46 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 64.400000000000006 111.108 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.38 -48.23 73.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 71.549999999999997 110.862 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.06 -40.3 80.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 64.140000000000001 110.919 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.44 ' CG2' ' HB2' ' A' ' 215' ' ' LYS . 4.1 t -78.22 -35.69 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 111.166 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.425 HD13 ' CD1' ' A' ' 182' ' ' PHE . 32.5 mt -68.0 -25.3 65.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 70.319999999999993 110.941 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.416 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 19.9 m-20 -72.84 -9.5 58.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 75.439999999999998 110.847 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -94.38 -5.72 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.906 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.93 -40.19 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 72.299999999999997 111.155 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 1.8 mtt180 -48.01 -58.63 7.4 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.727 . . . . 71.420000000000002 110.829 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.69 -29.93 23.41 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.713 2.275 . . . . 74.439999999999998 112.355 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.557 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -58.91 -28.68 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 73.129999999999995 110.944 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.557 HD23 ' CD2' ' A' ' 171' ' ' TYR . 3.4 mt -68.57 -53.44 22.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 71.239999999999995 110.916 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -50.05 -26.53 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 73.319999999999993 111.137 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -47.78 -63.95 3.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 73.140000000000001 112.494 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.9 t -109.44 -1.76 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 72.040000000000006 111.164 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.35 101.02 0.2 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 55.009999999999998 112.483 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.462 ' HA2' ' CB ' ' A' ' 172' ' ' LEU . . . -82.1 164.02 43.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.76 -0.733 . . . . 70.209999999999994 112.518 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -136.03 -102.53 0.67 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.766 -0.73 . . . . 74.409999999999997 112.522 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -173.43 113.78 0.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.713 -0.756 . . . . 75.329999999999998 112.488 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.7 OUTLIER -135.43 23.49 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 75.209999999999994 110.896 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 180' ' ' LEU . 1.1 tp60 -33.92 111.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 73.400000000000006 110.918 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.426 ' HB2' ' NH2' ' A' ' 169' ' ' ARG . 40.6 t80 -57.11 125.01 20.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 74.239999999999995 110.927 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.18 -77.01 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 72.540000000000006 110.915 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' MET . . . . . 0.416 ' C ' HG13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -169.9 -173.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 72.5 110.905 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 1.7 mt -132.63 132.11 59.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 73.209999999999994 111.154 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -124.21 66.26 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 74.540000000000006 110.915 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 90.78 -139.01 14.66 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.752 -0.737 . . . . 72.430000000000007 112.492 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -4.99 15.2 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.68 2.253 . . . . 71.340000000000003 112.335 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.6 mt -114.63 120.86 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.439999999999998 111.143 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 191' ' ' LYS . 25.1 t -100.25 136.04 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 54.210000000000001 111.155 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.41 ' N ' HG11 ' A' ' 190' ' ' VAL . 19.5 mtmt -104.31 156.81 17.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.140000000000001 110.926 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 2.6 p 179.05 147.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 75.439999999999998 111.144 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.37 170.76 13.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 74.549999999999997 110.905 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.32 88.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 73.239999999999995 110.932 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.2 p -116.78 -174.49 2.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 54.520000000000003 111.13 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.54 179.14 51.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.784 -0.722 . . . . 75.019999999999996 112.507 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 2.26 3.71 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.7 2.266 . . . . 73.230000000000004 112.323 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.16 42.32 1.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 74.030000000000001 111.149 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -96.67 -53.93 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 74.340000000000003 111.151 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.5 p -142.15 86.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 75.040000000000006 111.151 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.485 ' O ' ' CG2' ' A' ' 201' ' ' VAL . 9.0 p -125.67 24.64 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 75.349999999999994 111.117 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.87 39.08 13.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 72.329999999999998 110.883 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.8 m -164.5 -66.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 70.109999999999999 111.175 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.434 HG22 ' CG1' ' A' ' 201' ' ' VAL . 97.7 t -53.16 -70.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 111.117 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -38.96 -30.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 72.120000000000005 110.875 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . 0.461 ' CG2' ' HE2' ' A' ' 210' ' ' LYS . 3.5 mt -80.66 -44.53 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.109999999999999 111.108 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -52.67 -29.8 28.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 74.140000000000001 111.096 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 210' ' ' LYS . 62.9 t -69.2 -85.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 71.040000000000006 111.13 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.474 ' N ' HG13 ' A' ' 208' ' ' VAL . 44.8 t -39.61 -25.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 75.400000000000006 110.844 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 208' ' ' VAL . 1.2 mttt -61.6 -46.45 89.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 74.319999999999993 110.878 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -49.54 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.888 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.457 HD21 ' CG1' ' A' ' 208' ' ' VAL . 2.2 mm? -52.05 -74.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 74.519999999999996 110.909 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.01 -29.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.869 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.41 -74.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 73.010000000000005 110.922 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.44 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 1.6 mptt -62.49 -48.27 80.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 75.530000000000001 110.892 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 11.6 pt -106.52 87.64 2.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.622 0.725 . . . . 74.329999999999998 111.152 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -21.44 33.84 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.232 . . . . 75.140000000000001 112.4 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.5 t -46.31 -40.03 11.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 62.32 110.862 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.8 mt -39.41 155.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 74.349999999999994 111.103 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.478 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -135.69 -34.4 0.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 110.947 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 33.2 mm -153.05 104.93 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 71.400000000000006 111.128 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.63 115.39 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 74.409999999999997 111.153 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -105.29 129.51 53.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 70.439999999999998 110.922 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.8 mt -119.07 109.11 15.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 110.926 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.35 165.41 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 73.510000000000005 110.897 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 110.864 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.759 0.314 . . . . 75.329999999999998 110.956 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.498 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 1.6 mp0 -119.0 -2.58 10.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 110.893 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.48 ' O ' ' CB ' ' A' ' 157' ' ' ASN . 20.2 tp 60.81 126.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 74.439999999999998 110.937 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 3.6 p30 162.19 179.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 74.129999999999995 110.884 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.05 -19.28 62.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 63.350000000000001 110.86 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.407 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 10.7 pt-20 -90.07 -34.69 15.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 75.019999999999996 110.847 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.498 ' ND2' ' H ' ' A' ' 155' ' ' GLU . 94.1 m-20 -93.29 -59.75 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 74.25 110.841 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.416 ' CG2' HD12 ' A' ' 156' ' ' LEU . 63.3 t -38.97 -43.35 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 73.219999999999999 111.115 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -45.82 -56.13 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 110.914 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -34.04 64.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 74.299999999999997 110.873 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.468 HG23 ' CB ' ' A' ' 215' ' ' LYS . 73.6 t -69.91 -50.89 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 53.420000000000002 111.128 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 22.1 mt -59.0 -22.92 61.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 74.140000000000001 110.893 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -72.32 -6.32 42.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 74.049999999999997 110.936 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -98.57 7.99 45.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 72.540000000000006 110.903 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -143.36 -35.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 72.319999999999993 111.188 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -50.37 -60.6 5.0 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.575 0.702 . . . . 75.530000000000001 110.845 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.79 0.87 5.04 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.678 2.252 . . . . 74.209999999999994 112.339 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.481 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.2 OUTLIER -97.15 -21.43 17.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 110.928 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 171' ' ' TYR . 6.4 mt -81.22 -43.95 18.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 72.239999999999995 110.935 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.58 -50.52 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 72.430000000000007 111.102 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.37 -45.0 97.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.801 -0.714 . . . . 74.140000000000001 112.501 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.0 p -88.41 21.88 2.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 74.25 111.109 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 177' ' ' GLY . . . 90.48 79.02 1.36 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 71.239999999999995 112.487 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 176' ' ' GLY . . . -37.05 156.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.789 -0.72 . . . . 51.340000000000003 112.489 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.67 -113.62 1.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 73.150000000000006 112.493 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -164.01 114.18 0.59 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.693 -0.765 . . . . 74.340000000000003 112.445 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.503 ' CD2' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -138.75 14.15 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 74.120000000000005 110.882 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -32.15 95.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 75.129999999999995 110.899 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.465 ' N ' ' O ' ' A' ' 180' ' ' LEU . 54.9 t80 -36.04 118.9 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 72.109999999999999 110.894 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 42.2 mt -78.3 -78.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 74.239999999999995 110.915 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -167.59 -159.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 74.030000000000001 110.867 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 74.8 mt -146.24 135.83 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.349999999999994 111.092 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -128.55 57.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 110.933 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.58 -140.34 14.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 63.409999999999997 112.488 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -3.35 11.84 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 73.010000000000005 112.349 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 21.8 mt -110.94 138.28 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 74.109999999999999 111.126 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.9 t -115.31 132.95 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 111.083 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.3 mtmt -98.25 142.55 29.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 73.519999999999996 110.873 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 193' ' ' ARG . 88.0 t -155.35 139.61 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 111.159 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . 0.427 ' N ' HG13 ' A' ' 192' ' ' VAL . 3.1 ttt180 -73.92 169.75 16.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 110.932 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -160.88 96.84 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 74.040000000000006 110.93 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.15 153.84 38.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 75.409999999999997 111.108 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 121.12 -172.56 15.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 65.239999999999995 112.497 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -8.69 24.24 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 72.430000000000007 112.313 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.65 8.49 11.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.450000000000003 111.105 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 194' ' ' LEU . . . -51.49 -61.59 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.030000000000001 111.099 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.07 107.96 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 74.200000000000003 111.142 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 42.4 t -146.81 -79.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 62.43 111.104 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ARG . . . . . 0.409 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -175.25 137.11 0.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.439999999999998 110.898 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 204' ' ' VAL . 0.2 OUTLIER 77.86 -60.86 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.443 . . . . 71.400000000000006 111.153 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 203' ' ' THR . 98.9 t -35.44 -71.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 111.11 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.55 -49.3 1.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 63.009999999999998 110.855 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.39 -58.3 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.140000000000001 111.125 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -40.51 -35.72 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 111.059 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.59 -76.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 75.25 111.109 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.4 t -54.97 -14.15 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.310000000000002 110.858 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -65.13 -39.93 93.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 74.530000000000001 110.86 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 214' ' ' GLU . 0.9 OUTLIER -87.03 -62.61 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.418 . . . . 75.420000000000002 110.958 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 211' ' ' LYS . 9.8 mt -31.72 -69.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.109999999999999 110.946 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -38.0 32.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.874 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.3 OUTLIER -66.91 -79.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 74.430000000000007 110.898 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.468 ' CB ' HG23 ' A' ' 164' ' ' VAL . 11.8 mmtm -45.16 -52.75 8.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 71.530000000000001 110.916 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 212' ' ' LEU . 6.5 pt -110.57 93.68 17.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 75.239999999999995 111.136 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -23.24 31.23 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.714 2.276 . . . . 74.150000000000006 112.364 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.08 -26.28 2.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 73.329999999999998 110.838 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.9 mt -59.71 152.56 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 75.329999999999998 111.16 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLN . . . . . 0.415 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 2.2 mt-30 -131.19 -37.49 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 73.319999999999993 110.917 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.8 mt -141.72 112.38 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 111.086 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.09 114.29 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 72.439999999999998 111.074 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -103.91 129.54 51.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 72.409999999999997 110.94 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 14.2 mt -119.32 102.41 8.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 63.020000000000003 110.903 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.9 mp -82.18 160.23 23.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 75.209999999999994 110.931 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 72.120000000000005 110.842 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.792 0.329 . . . . 72.400000000000006 110.91 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.422 ' CD2' HG23 ' A' ' 216' ' ' ILE . 3.2 mp -90.28 -170.91 2.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 75.219999999999999 110.945 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.42 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 0.7 OUTLIER -109.18 -11.41 14.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 73.310000000000002 110.882 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 29.2 tp 59.62 92.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 72.420000000000002 110.955 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 157' ' ' ASN . 0.1 OUTLIER -175.31 175.21 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 110.86 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.461 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 9.6 mt-10 -42.7 -55.39 3.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 74.099999999999994 110.895 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.417 ' HG3' ' N ' ' A' ' 160' ' ' ASN . 0.0 OUTLIER -51.01 -30.97 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 72.239999999999995 110.905 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.478 ' O ' ' N ' ' A' ' 162' ' ' GLU . 21.1 m-20 -96.59 -72.53 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 110.932 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' A' ' 158' ' ' GLU . 30.3 m -33.94 -34.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.540000000000006 111.13 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -55.16 -57.59 11.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.019999999999996 110.903 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -53.04 -54.45 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 75.109999999999999 110.898 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.4 t -62.87 -29.57 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 63.520000000000003 111.088 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.53 HD13 ' CD1' ' A' ' 182' ' ' PHE . 15.1 mt -71.39 -32.49 68.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 73.120000000000005 110.919 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -72.38 -5.58 37.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.329999999999998 110.905 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -93.16 -9.53 39.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 71.329999999999998 110.873 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.85 -31.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 65.349999999999994 111.147 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -51.16 -60.67 5.2 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.535 0.683 . . . . 71.530000000000001 110.901 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.9 Cg_endo -69.78 2.54 3.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.668 2.245 . . . . 64.340000000000003 112.343 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.468 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -96.41 -28.72 14.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 71.239999999999995 110.959 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 9.2 mt -72.79 -34.46 66.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.868 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -85.77 -11.31 53.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.099999999999994 111.1 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -88.69 2.86 84.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 73.409999999999997 112.456 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.5 t -130.57 9.92 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 74.400000000000006 111.178 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.52 -56.8 0.58 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 72.230000000000004 112.487 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 169.09 162.03 20.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 60.299999999999997 112.475 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -173.58 -160.68 22.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.75 . . . . 72.329999999999998 112.486 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.97 110.02 0.24 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 73.450000000000003 112.499 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 193' ' ' ARG . 3.7 pp -113.18 -31.73 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.745 0.307 . . . . 72.120000000000005 110.887 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.458 ' NE2' ' HA ' ' A' ' 181' ' ' GLN . 0.4 OUTLIER 33.63 90.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 70.0 110.906 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.53 ' CD1' HD13 ' A' ' 165' ' ' LEU . 28.0 t80 -42.4 114.06 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 62.219999999999999 110.876 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.98 -79.61 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 110.897 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 27.5 ptm -167.67 -170.81 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 75.049999999999997 110.847 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.409 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 7.3 mt -131.61 144.44 37.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 72.5 111.104 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.8 68.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 73.430000000000007 110.929 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 83.13 -141.87 21.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 64.420000000000002 112.502 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -1.18 8.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.231 . . . . 74.299999999999997 112.372 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 47.6 mt -117.92 124.25 72.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.400000000000006 111.138 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 191' ' ' LYS . 1.4 p -108.72 155.1 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 74.310000000000002 111.153 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.442 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 13.9 mtmt -116.26 141.04 48.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 72.129999999999995 110.915 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.454 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 43.7 t -151.53 155.46 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 71.319999999999993 111.134 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -94.81 172.06 8.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.129999999999995 110.886 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.415 ' CD1' ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -167.67 86.21 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.510000000000005 110.929 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.1 p -123.83 177.95 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.219999999999999 111.14 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 87.13 -172.16 43.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 70.019999999999996 112.477 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -1.33 8.27 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.65 2.233 . . . . 72.340000000000003 112.382 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.03 57.51 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 70.109999999999999 111.14 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 194' ' ' LEU . . . -99.89 -94.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 64.420000000000002 111.105 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.26 59.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 74.530000000000001 111.105 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.12 30.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 63.539999999999999 111.123 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.0 OUTLIER 67.56 133.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 75.400000000000006 110.865 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.411 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 0.6 OUTLIER 78.54 -51.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 63.329999999999998 111.162 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 47.9 t -40.5 -51.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 64.129999999999995 111.113 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.17 -35.4 80.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.530000000000001 110.888 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 18.1 mt -64.1 -50.36 77.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 70.0 111.11 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.98 -36.77 29.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 111.103 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.467 HG11 ' N ' ' A' ' 209' ' ' SER . 58.0 t -59.22 -83.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 74.420000000000002 111.157 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.467 ' N ' HG11 ' A' ' 208' ' ' VAL . 29.0 t -48.86 -20.54 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.019999999999996 110.837 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -58.55 -46.22 87.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 72.310000000000002 110.89 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 -46.62 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 63.310000000000002 110.937 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.431 ' O ' ' CG1' ' A' ' 216' ' ' ILE . 1.6 mm? -47.18 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 73.329999999999998 110.899 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.65 -52.2 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 110.9 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -41.21 -80.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.883 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.48 -51.41 55.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 63.130000000000003 110.865 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.445 ' CD1' HG11 ' A' ' 161' ' ' VAL . 5.2 pt -107.16 82.77 1.22 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.595 0.712 . . . . 74.319999999999993 111.096 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -5.69 16.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.667 2.244 . . . . 73.209999999999994 112.337 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 23.3 t -66.38 -22.95 66.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 72.530000000000001 110.862 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 7.3 mt -57.89 158.67 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 75.450000000000003 111.169 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.517 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 1.1 mt-30 -134.84 -33.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.894 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.408 HG12 ' C ' ' A' ' 220' ' ' GLN . 37.5 mm -154.13 106.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 61.049999999999997 111.123 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 76.8 t -80.42 114.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 64.230000000000004 111.148 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -96.78 113.59 25.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 71.400000000000006 110.901 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 12.0 mt -100.53 102.72 13.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 110.893 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.91 -176.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 64.109999999999999 110.887 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.439999999999998 110.88 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.818 0.342 . . . . 74.530000000000001 110.868 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.9 mt -117.65 -175.75 2.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 74.140000000000001 110.924 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -117.54 -0.82 11.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 73.209999999999994 110.873 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.4 tp 52.86 97.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 75.400000000000006 110.867 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -159.14 164.43 35.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 75.510000000000005 110.876 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.41 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 16.8 mt-10 -45.15 -30.57 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 73.439999999999998 110.871 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.36 -44.45 52.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.945 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -80.51 -59.64 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 74.310000000000002 110.861 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.569 HG22 ' CZ ' ' A' ' 182' ' ' PHE . 21.7 m -39.09 -33.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.107 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.34 -51.09 62.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.91 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -40.51 68.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 70.140000000000001 110.929 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.429 HG12 ' CD2' ' A' ' 212' ' ' LEU . 21.5 t -79.47 -34.79 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 111.083 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 27.9 mt -71.12 -21.31 62.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 110.912 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.415 ' O ' ' CD ' ' A' ' 170' ' ' PRO . 61.3 m-20 -74.5 -12.26 60.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 75.200000000000003 110.901 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -83.01 -14.16 54.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 71.319999999999993 110.876 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 208' ' ' VAL . 3.2 pt -121.14 -31.16 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 72.349999999999994 111.09 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.455 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . 1.1 mtt180 -49.04 -60.86 4.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.643 0.735 . . . . 74.150000000000006 110.871 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 169' ' ' ARG . 54.0 Cg_endo -69.72 1.92 3.98 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.741 2.294 . . . . 74.530000000000001 112.341 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.511 ' CD2' HD22 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -105.66 -17.57 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 72.219999999999999 110.907 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.511 HD22 ' CD2' ' A' ' 171' ' ' TYR . 2.9 mt -77.84 -28.9 50.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 74.310000000000002 110.912 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.9 42.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 72.129999999999995 111.065 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -132.87 -33.59 0.37 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 53.450000000000003 112.499 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.9 t -144.59 9.51 1.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.787 0.327 . . . . 61.439999999999998 111.107 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 149.63 90.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.733 . . . . 63.43 112.488 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . -125.08 168.55 17.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 71.120000000000005 112.495 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 154.44 -14.07 0.53 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 71.109999999999999 112.502 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -134.42 116.89 1.7 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 74.430000000000007 112.553 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.3 OUTLIER -173.9 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 73.430000000000007 110.898 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 180' ' ' LEU . 8.3 tp60 -36.22 99.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 75.439999999999998 110.953 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.569 ' CZ ' HG22 ' A' ' 161' ' ' VAL . 15.0 t80 -46.52 116.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 71.540000000000006 110.878 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 80.3 mt -76.0 -73.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 110.876 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 28.0 ptm -173.4 -168.95 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 75.140000000000001 110.902 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.0 mt -136.25 129.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 75.129999999999995 111.137 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.37 56.14 1.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 110.911 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.91 -145.59 16.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.758 -0.734 . . . . 64.230000000000004 112.486 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 3.27 2.91 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.688 2.258 . . . . 74.109999999999999 112.322 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.21 130.49 69.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.539999999999999 111.123 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.464 HG23 ' CD1' ' A' ' 219' ' ' ILE . 84.0 t -104.6 148.59 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 75.420000000000002 111.087 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.455 ' N ' HG12 ' A' ' 190' ' ' VAL . 10.2 mtmt -116.79 140.88 48.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 71.519999999999996 110.887 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' A' ' 193' ' ' ARG . 21.4 t -151.95 166.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 73.319999999999993 111.143 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.41 ' N ' ' CG1' ' A' ' 192' ' ' VAL . 0.1 OUTLIER -92.87 143.11 26.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 74.230000000000004 110.909 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.61 87.31 1.92 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.888 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.05 -171.47 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 72.150000000000006 111.118 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.81 -169.85 55.01 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.723 -0.751 . . . . 63.109999999999999 112.506 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 0.43 5.59 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 54.509999999999998 112.397 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 201' ' ' VAL . . . -103.68 -5.6 22.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 62.420000000000002 111.104 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -80.53 42.06 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 75.140000000000001 111.069 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.4 p 179.34 -29.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 111.093 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 198' ' ' ALA . 27.5 m -56.93 127.09 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 111.109 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -79.71 77.5 6.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 73.219999999999999 110.9 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 t 176.03 -44.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 63.229999999999997 111.155 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.21 -42.68 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 70.200000000000003 111.149 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -65.88 -7.13 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.838 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.55 -57.54 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 111.115 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.28 -20.48 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 73.510000000000005 111.093 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.418 ' HA ' ' CD1' ' A' ' 168' ' ' ILE . 88.9 t -72.29 -62.28 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 72.010000000000005 111.119 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.1 t -80.59 14.5 2.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 74.400000000000006 110.853 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -39.86 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 75.409999999999997 110.932 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.62 -35.68 22.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 75.540000000000006 110.903 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.429 ' CD2' HG12 ' A' ' 164' ' ' VAL . 7.7 mt -68.72 -65.4 0.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 73.150000000000006 110.91 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.03 -21.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 110.878 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.409 ' N ' ' C ' ' A' ' 212' ' ' LEU . 20.9 tt0 -85.14 -72.49 0.48 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 74.439999999999998 110.881 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -51.51 -54.04 31.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 74.319999999999993 110.92 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 2.0 pt -103.37 95.07 6.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.589 0.709 . . . . 62.020000000000003 111.15 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 -24.94 29.53 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.711 2.274 . . . . 75.349999999999994 112.358 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 46.0 t -47.37 -29.16 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 62.210000000000001 110.855 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.464 ' CD1' HG23 ' A' ' 190' ' ' VAL . 3.3 mt -59.37 153.3 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 73.409999999999997 111.122 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.434 ' N ' HG21 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -139.66 -38.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.299999999999997 110.886 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 21.8 mt -140.67 98.53 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 71.109999999999999 111.12 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 67.1 t -74.89 109.15 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.349999999999994 111.135 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -97.68 138.89 34.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.966 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.2 mt -122.01 127.33 50.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 74.150000000000006 110.915 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.444 ' N ' ' CD2' ' A' ' 225' ' ' LEU . 2.1 mm? -96.63 172.16 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 75.310000000000002 110.888 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 64.430000000000007 110.8 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.785 0.326 . . . . 75.340000000000003 110.902 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.419 HD22 ' CG2' ' A' ' 216' ' ' ILE . 4.8 mp -86.01 -176.31 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 72.510000000000005 110.912 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -108.88 -13.23 14.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 64.310000000000002 110.875 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.455 HD13 ' CG1' ' A' ' 161' ' ' VAL . 15.7 tp 58.29 100.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 74.409999999999997 110.919 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -167.08 161.24 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 70.420000000000002 110.882 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -34.89 -35.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 75.209999999999994 110.869 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' ASN . 0.2 OUTLIER -71.82 -53.68 12.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.857 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.403 ' CG ' HD22 ' A' ' 154' ' ' LEU . 12.2 m-20 -67.78 -56.17 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 74.310000000000002 110.878 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.455 ' CG1' HD13 ' A' ' 156' ' ' LEU . 33.6 m -48.79 -27.87 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 73.540000000000006 111.147 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.46 -58.59 7.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 72.420000000000002 110.878 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -45.07 45.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 73.409999999999997 110.892 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.415 ' CG1' ' HA ' ' A' ' 212' ' ' LEU . 1.3 t -68.63 -42.31 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 72.329999999999998 111.134 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.497 HD11 ' CD1' ' A' ' 182' ' ' PHE . 49.7 mt -63.41 -20.64 65.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 110.941 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.485 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 16.3 m-20 -76.48 -9.48 58.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 74.319999999999993 110.862 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.65 1.75 56.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 110.847 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.446 ' CD1' HG12 ' A' ' 208' ' ' VAL . 1.1 pt -131.75 -45.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.040000000000006 111.148 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -46.23 -60.28 3.82 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.607 0.718 . . . . 74.400000000000006 110.858 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 166' ' ' ASN . 54.1 Cg_endo -69.79 -11.12 30.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.653 2.235 . . . . 63.329999999999998 112.397 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.55 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -88.15 -12.4 44.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 72.230000000000004 110.885 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.454 ' N ' HD21 ' A' ' 172' ' ' LEU . 5.3 mt -84.27 -53.57 5.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 74.349999999999994 110.961 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 175' ' ' THR . . . -58.12 -54.3 48.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 111.134 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -35.02 -31.59 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 71.099999999999994 112.44 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 173' ' ' ALA . 1.2 t -134.21 64.86 1.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 74.310000000000002 111.191 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.93 -69.71 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.744 . . . . 74.430000000000007 112.519 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . 120.34 175.75 15.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 72.519999999999996 112.443 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -158.56 -123.37 0.72 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.723 -0.751 . . . . 53.049999999999997 112.468 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 163.32 114.49 0.31 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.725 -0.75 . . . . 74.439999999999998 112.502 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.454 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 3.4 pp -133.56 -39.5 0.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.744 0.307 . . . . 74.219999999999999 110.919 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 180' ' ' LEU . 20.9 tp60 34.3 90.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 73.409999999999997 110.904 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.497 ' CD1' HD11 ' A' ' 165' ' ' LEU . 25.9 t80 -36.96 107.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 73.209999999999994 110.89 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 36.0 mt -68.38 -79.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 74.510000000000005 110.935 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.2 ptp -165.3 -171.67 2.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 110.915 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.28 134.43 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 65.420000000000002 111.085 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.75 66.53 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 74.549999999999997 110.887 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 89.62 -146.0 18.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 52.219999999999999 112.452 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 3.2 2.89 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.674 2.249 . . . . 72.329999999999998 112.36 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mt -123.23 110.46 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 74.0 111.18 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.6 p -96.25 132.3 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 111.132 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.441 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 14.8 mtmt -89.49 146.27 24.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 75.299999999999997 110.946 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.454 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 97.4 t -158.93 156.56 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 75.420000000000002 111.17 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.12 172.5 8.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.010000000000005 110.85 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.6 81.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 110.919 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.0 p -114.24 -169.66 1.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 75.420000000000002 111.15 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 74.11 -179.09 42.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 62.399999999999999 112.513 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -2.1 9.61 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.68 2.253 . . . . 72.299999999999997 112.342 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -82.57 -17.45 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.310000000000002 111.092 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.27 -62.68 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 72.349999999999994 111.118 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.32 97.76 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 75.209999999999994 111.153 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 7.3 p -159.79 -33.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.420000000000002 111.123 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 201' ' ' VAL . 9.9 ttp180 85.35 142.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.400000000000006 110.859 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.479 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 2.7 m 83.03 -32.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 61.399999999999999 111.156 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.472 ' CG2' HG11 ' A' ' 201' ' ' VAL . 33.3 t -70.14 -71.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 111.148 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -40.22 -43.39 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 75.030000000000001 110.912 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.409 HD12 ' CA ' ' A' ' 203' ' ' THR . 3.1 mp -60.11 -44.13 94.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 73.329999999999998 111.116 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.39 -36.55 22.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.400000000000006 111.091 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.46 ' O ' ' C ' ' A' ' 209' ' ' SER . 55.1 t -65.77 -85.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 74.209999999999994 111.149 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.46 ' C ' ' O ' ' A' ' 208' ' ' VAL . 40.9 m -34.01 -43.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 64.200000000000003 110.853 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -47.84 -51.45 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 74.040000000000006 110.909 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.465 ' HA ' ' CE ' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -61.87 -66.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 75.129999999999995 110.899 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 211' ' ' LYS . 1.4 mm? -35.0 -73.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 73.019999999999996 110.956 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.34 -35.28 0.96 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 74.519999999999996 110.856 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 211' ' ' LYS . 2.6 tp10 -57.14 -72.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 71.040000000000006 110.883 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -63.57 -48.73 76.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.911 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.419 ' CG2' HD22 ' A' ' 154' ' ' LEU . 7.1 pt -107.03 83.24 1.28 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.639 0.733 . . . . 74.099999999999994 111.104 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -5.35 16.03 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.701 2.267 . . . . 74.329999999999998 112.33 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.15 -11.7 43.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 110.897 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 5.1 mt -68.77 158.3 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 71.239999999999995 111.151 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.49 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.2 OUTLIER -136.89 -34.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 71.140000000000001 110.907 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 220' ' ' GLN . 4.5 mp -150.61 108.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 75.310000000000002 111.123 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 79.1 t -86.57 112.69 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 73.430000000000007 111.116 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -100.59 115.59 30.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.209999999999994 110.916 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.0 mt -103.51 101.71 11.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 72.400000000000006 110.921 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.35 174.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 74.239999999999995 110.904 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 74.340000000000003 110.824 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.846 0.355 . . . . 74.049999999999997 110.838 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.467 HD23 ' ND2' ' A' ' 160' ' ' ASN . 1.0 OUTLIER -96.72 -175.08 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 73.439999999999998 110.937 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -101.62 -2.79 29.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.209999999999994 110.894 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 10.9 tp 54.48 89.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 64.420000000000002 110.938 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.441 ' O ' ' CG2' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -149.76 178.98 8.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.881 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.32 -48.93 77.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.409999999999997 110.857 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -58.84 -46.61 87.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 74.329999999999998 110.889 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.467 ' ND2' HD23 ' A' ' 154' ' ' LEU . 98.1 m-20 -71.07 -69.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 74.239999999999995 110.925 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.501 HG21 ' CE2' ' A' ' 182' ' ' PHE . 20.7 m -36.95 -31.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 75.409999999999997 111.127 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.7 mt-10 -55.38 -58.08 9.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 70.420000000000002 110.951 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -39.59 56.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 75.209999999999994 110.93 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.466 HG23 ' CB ' ' A' ' 215' ' ' LYS . 21.4 t -64.3 -53.45 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 111.13 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.477 HD13 ' CD1' ' A' ' 182' ' ' PHE . 16.2 mt -58.15 -24.56 59.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 110.897 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -72.23 -6.85 45.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 63.020000000000003 110.865 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.66 4.92 43.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 72.329999999999998 110.886 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.7 -34.54 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 75.400000000000006 111.099 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -54.71 -60.58 7.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 73.129999999999995 110.889 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.0 Cg_endo -69.82 -5.94 17.45 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.71 2.273 . . . . 50.130000000000003 112.286 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.559 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -86.42 -22.45 26.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 71.400000000000006 110.889 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.423 HD22 ' CD2' ' A' ' 171' ' ' TYR . 7.2 mt -78.21 -53.61 7.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.340000000000003 110.954 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -36.73 -51.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 111.078 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -39.41 -44.44 2.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.79 -0.719 . . . . 74.030000000000001 112.452 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 53.2 p -88.15 -33.38 18.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 71.019999999999996 111.126 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 170.38 -42.28 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.68 -0.771 . . . . 72.549999999999997 112.461 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.1 162.83 28.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 73.219999999999999 112.478 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -151.05 -94.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 75.420000000000002 112.446 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 169.99 122.34 0.63 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.69 -0.767 . . . . 64.439999999999998 112.459 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 181' ' ' GLN . 1.1 pp -150.07 13.15 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 75.349999999999994 110.902 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 182' ' ' PHE . 0.5 OUTLIER -35.34 105.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 75.310000000000002 110.917 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.501 ' CE2' HG21 ' A' ' 161' ' ' VAL . 8.8 t80 -34.25 121.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 110.877 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 77.5 mt -80.82 -68.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 73.219999999999999 110.923 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 12.1 ptp -177.51 -175.65 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 74.019999999999996 110.897 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.2 mt -130.31 124.32 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 75.450000000000003 111.126 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.32 74.99 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.951 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 85.24 -149.04 23.51 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 73.219999999999999 112.495 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 3.53 2.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.704 2.269 . . . . 73.209999999999994 112.369 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.2 mt -117.06 123.48 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 74.219999999999999 111.101 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 41.0 t -99.09 143.69 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 74.310000000000002 111.136 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -107.56 142.33 37.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 74.5 110.887 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.5 t -154.4 155.41 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 65.040000000000006 111.159 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -94.26 154.74 17.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 72.319999999999993 110.849 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.91 76.84 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 75.329999999999998 110.922 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.5 p -108.17 -169.55 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 111.119 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.01 -178.15 33.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.766 -0.731 . . . . 71.140000000000001 112.48 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -0.78 7.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.699 2.266 . . . . 75.129999999999995 112.388 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -85.76 -6.39 59.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 54.210000000000001 111.116 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.03 -50.64 26.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 111.087 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.0 71.85 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 63.450000000000003 111.131 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 15.1 t -155.02 117.54 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 73.310000000000002 111.097 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 71.17 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.886 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.403 ' CA ' HD13 ' A' ' 206' ' ' ILE . 14.6 t -179.35 -33.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 73.0 111.146 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 20.0 t -67.69 -68.96 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.450000000000003 111.16 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -45.97 -33.14 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 72.340000000000003 110.868 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.403 HD13 ' CA ' ' A' ' 203' ' ' THR . 2.7 mp -71.22 -42.84 75.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 74.549999999999997 111.134 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.74 -33.68 76.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 54.310000000000002 111.125 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 94.5 t -62.57 -75.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 75.209999999999994 111.125 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 5.6 t -53.55 -15.61 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 71.400000000000006 110.853 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -40.65 86.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 73.319999999999993 110.898 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -86.81 -35.04 19.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 75.409999999999997 110.909 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.46 ' CD2' HG11 ' A' ' 164' ' ' VAL . 8.5 mt -66.41 -64.45 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 70.219999999999999 110.927 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -22.19 1.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.886 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -83.95 -79.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 72.450000000000003 110.884 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.466 ' CB ' HG23 ' A' ' 164' ' ' VAL . 14.8 mmtt -41.23 -55.9 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 75.109999999999999 110.927 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 4.4 pt -108.35 85.58 2.89 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 111.161 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.8 9.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.638 2.225 . . . . 71.340000000000003 112.316 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -6.29 40.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 72.340000000000003 110.857 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.45 HG23 ' N ' ' A' ' 220' ' ' GLN . 3.2 mt -73.36 154.69 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 63.100000000000001 111.146 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.45 ' N ' HG23 ' A' ' 219' ' ' ILE . 0.0 OUTLIER -126.3 -33.7 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 110.882 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.413 HG12 ' C ' ' A' ' 220' ' ' GLN . 30.1 mm -151.74 107.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 75.540000000000006 111.147 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.8 t -78.77 109.07 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.073 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -99.44 119.69 38.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 74.040000000000006 110.907 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.7 mt -110.86 105.7 14.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.510000000000005 110.887 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.45 162.98 23.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.340000000000003 110.9 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 63.409999999999997 110.881 -179.95 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 4.7 mtp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.844 0.354 . . . . 74.150000000000006 110.904 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.489 ' CD2' ' O ' ' A' ' 215' ' ' LYS . 0.2 OUTLIER -115.43 -149.58 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.931 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.468 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 17.7 tt0 -112.01 -0.32 15.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.430000000000007 110.912 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.502 ' C ' ' CG ' ' A' ' 157' ' ' ASN . 8.0 tp 61.73 110.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 75.420000000000002 110.896 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.745 HD22 ' ND2' ' A' ' 160' ' ' ASN . 0.1 OUTLIER 169.64 164.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.129999999999995 110.876 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -33.97 -60.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 73.0 110.887 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -44.92 -60.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.409999999999997 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.745 ' ND2' HD22 ' A' ' 157' ' ' ASN . 53.1 m-20 -73.86 -67.39 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 75.019999999999996 110.912 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 157' ' ' ASN . 90.0 t -33.29 -46.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 65.239999999999995 111.137 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 30.0 mm-40 -47.39 -56.78 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 110.885 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.79 -49.8 19.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 73.519999999999996 110.89 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.9 t -63.44 -42.72 97.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 73.430000000000007 111.137 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 182' ' ' PHE . 75.9 mt -61.18 -28.9 69.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 110.924 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -71.25 -6.06 36.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.902 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.67 -12.08 24.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 70.439999999999998 110.864 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.75 -34.19 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 62.399999999999999 111.12 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.465 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.05 -60.96 5.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 75.239999999999995 110.925 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 169' ' ' ARG . 53.4 Cg_endo -69.75 1.36 4.5 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.66 2.24 . . . . 72.319999999999993 112.363 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.506 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.2 OUTLIER -94.89 -23.43 17.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 63.200000000000003 110.932 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.444 HD21 ' CD2' ' A' ' 171' ' ' TYR . 4.9 mt -80.98 -36.28 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 75.209999999999994 110.887 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.69 60.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 111.078 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.72 -44.78 80.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 71.439999999999998 112.481 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.8 t -143.2 99.99 3.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.895 0.379 . . . . 74.129999999999995 111.15 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.43 63.59 3.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.778 -0.725 . . . . 71.319999999999993 112.497 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.407 ' HA2' ' CB ' ' A' ' 172' ' ' LEU . . . -62.56 100.31 0.31 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 75.0 112.454 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -79.96 -153.34 8.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.753 -0.737 . . . . 72.340000000000003 112.477 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -136.67 115.0 1.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 74.540000000000006 112.435 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.6 OUTLIER -121.24 21.03 11.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 62.439999999999998 110.95 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -34.57 107.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 110.939 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.463 ' CD1' HD12 ' A' ' 165' ' ' LEU . 24.5 t80 -50.42 104.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 64.319999999999993 110.852 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.82 -74.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 74.209999999999994 110.91 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.446 ' CG ' ' HE3' ' A' ' 191' ' ' LYS . 1.8 ptt? -169.24 -171.37 1.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 72.420000000000002 110.898 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.8 mt -132.61 125.94 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 73.400000000000006 111.139 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.63 77.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 74.450000000000003 110.885 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.406 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 75.75 -142.37 28.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.772 -0.728 . . . . 74.530000000000001 112.446 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.406 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.5 Cg_endo -69.78 3.3 2.86 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.711 2.274 . . . . 75.439999999999998 112.328 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.6 mt -120.55 122.9 69.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 73.030000000000001 111.128 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.2 p -106.25 135.2 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 72.540000000000006 111.125 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.446 ' HE3' ' CG ' ' A' ' 184' ' ' MET . 15.7 mtmt -93.77 142.47 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 70.549999999999997 110.877 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 85.9 t -156.65 130.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 74.219999999999999 111.137 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.61 167.43 18.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 110.842 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.26 85.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 71.430000000000007 110.883 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.1 p -114.15 -177.22 3.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 73.409999999999997 111.161 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.41 -177.54 51.6 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 71.200000000000003 112.471 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -12.84 33.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.661 2.24 . . . . 73.239999999999995 112.358 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -100.92 60.18 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 63.020000000000003 111.125 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -124.83 3.71 8.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 51.039999999999999 111.06 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 200' ' ' VAL . 9.5 p -169.0 76.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 75.010000000000005 111.138 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.448 ' O ' ' CG2' ' A' ' 201' ' ' VAL . 7.1 p -137.19 7.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 75.140000000000001 111.142 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.37 47.74 19.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 75.239999999999995 110.873 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.9 m -163.91 -64.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 75.049999999999997 111.14 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 77.3 t -47.75 -59.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 75.049999999999997 111.104 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.8 -22.99 6.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 75.109999999999999 110.877 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.9 mm -77.52 -47.16 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 75.439999999999998 111.139 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.25 -18.8 17.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 65.439999999999998 111.135 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.451 HG11 ' N ' ' A' ' 209' ' ' SER . 59.9 t -73.81 -83.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 65.310000000000002 111.118 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.451 ' N ' HG11 ' A' ' 208' ' ' VAL . 2.7 t -42.28 -23.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 70.040000000000006 110.84 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 208' ' ' VAL . 19.5 mttt -58.8 -59.45 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 110.897 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -65.34 -45.25 84.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 74.129999999999995 110.899 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.433 ' CD2' ' O ' ' A' ' 208' ' ' VAL . 1.5 mm? -54.03 -65.93 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 75.230000000000004 110.942 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -49.54 -32.35 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 74.150000000000006 110.897 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.4 -71.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.030000000000001 110.896 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.489 ' O ' ' CD2' ' A' ' 154' ' ' LEU . 7.5 mptt -56.65 -52.34 65.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 73.209999999999994 110.942 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 8.4 pt -106.48 86.24 2.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.593 0.711 . . . . 73.329999999999998 111.144 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -7.05 20.09 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.726 2.284 . . . . 61.149999999999999 112.296 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.76 -3.91 10.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 73.319999999999993 110.883 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.4 mt -74.19 152.59 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 74.420000000000002 111.152 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 221' ' ' ILE . 0.0 OUTLIER -132.02 -37.1 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 72.129999999999995 110.904 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 220' ' ' GLN . 4.6 mp -150.81 104.89 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 74.530000000000001 111.122 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.97 114.74 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 73.430000000000007 111.133 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.09 129.85 51.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.877 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.2 mt -118.76 126.83 52.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 73.230000000000004 110.899 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.1 mp -94.42 168.32 10.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 74.120000000000005 110.923 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 110.859 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 5.1 mmt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.805 0.336 . . . . 75.140000000000001 110.874 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 16.3 mt -123.13 -174.46 2.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 74.430000000000007 110.931 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.49 -13.53 16.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.894 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.401 ' HA ' ' CG2' ' A' ' 216' ' ' ILE . 6.7 tp 58.24 109.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 110.928 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.585 ' N ' HD21 ' A' ' 157' ' ' ASN . 0.0 OUTLIER -177.52 -171.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.925 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -69.86 -4.35 19.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.865 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.484 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 7.2 mm-40 -102.15 -41.59 6.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 71.540000000000006 110.849 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -88.13 -41.9 12.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 65.150000000000006 110.841 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.482 ' CG1' ' O ' ' A' ' 157' ' ' ASN . 2.8 p -58.99 -30.34 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 111.175 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.77 -57.34 12.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 73.109999999999999 110.875 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.34 -44.37 23.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.868 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.474 HG13 ' CD2' ' A' ' 212' ' ' LEU . 20.6 t -68.04 -45.84 82.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 111.18 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 48.3 mt -61.03 -24.91 66.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 72.109999999999999 110.891 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -76.81 -2.01 31.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 74.299999999999997 110.893 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -102.62 8.7 39.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 64.230000000000004 110.919 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -142.96 -37.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 75.129999999999995 111.178 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -48.7 -60.7 4.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.596 0.713 . . . . 75.530000000000001 110.868 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.78 2.86 3.17 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.715 2.276 . . . . 65.310000000000002 112.301 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.46 ' CD2' HD21 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -98.3 -21.41 16.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 72.010000000000005 110.923 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.46 HD21 ' CD2' ' A' ' 171' ' ' TYR . 6.9 mt -82.51 -45.88 14.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 75.519999999999996 110.87 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -50.1 -20.67 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 71.230000000000004 111.149 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -92.56 42.69 2.67 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 74.5 112.521 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 176.73 -50.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 75.530000000000001 111.113 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -178.63 70.58 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 74.129999999999995 112.498 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -57.05 163.13 6.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.714 -0.755 . . . . 63.420000000000002 112.496 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -144.84 -102.58 0.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 63.439999999999998 112.481 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.58 112.53 0.53 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.741 . . . . 74.430000000000007 112.477 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.528 ' CD2' ' C ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -136.62 6.26 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 75.519999999999996 110.912 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 180' ' ' LEU . 2.5 tp60 -35.12 109.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 75.200000000000003 110.886 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.47 ' CE1' HG23 ' A' ' 161' ' ' VAL . 22.7 t80 -43.81 121.51 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 72.129999999999995 110.879 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 19.4 mt -83.7 -73.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 74.019999999999996 110.875 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.6 -170.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.120000000000005 110.86 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 7.6 mt -136.22 138.27 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 111.13 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -130.25 48.37 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 72.129999999999995 110.872 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 100.54 -138.67 13.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 72.349999999999994 112.46 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 0.35 5.81 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.635 2.223 . . . . 74.450000000000003 112.326 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.84 101.35 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 73.540000000000006 111.13 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.91 142.11 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 111.134 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.456 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 5.5 mtmt -100.42 146.31 27.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.944 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 98.5 t -159.13 147.48 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 73.540000000000006 111.117 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.5 165.34 23.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 72.010000000000005 110.892 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -161.77 71.5 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 72.030000000000001 110.92 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 17.1 p -113.89 176.53 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 63.439999999999998 111.081 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.19 -163.22 26.44 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 73.420000000000002 112.486 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -38.21 8.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.691 2.26 . . . . 73.519999999999996 112.358 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.451 ' HB2' ' CG1' ' A' ' 204' ' ' VAL . . . -83.26 49.39 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 71.519999999999996 111.087 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 194' ' ' LEU . . . -105.93 -62.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 63.210000000000001 111.115 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.1 m -95.15 28.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 73.219999999999999 111.122 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.66 136.7 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 111.14 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.408 ' C ' HG22 ' A' ' 203' ' ' THR . 5.2 mmt180 -89.96 84.76 6.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 70.319999999999993 110.872 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.408 HG22 ' C ' ' A' ' 202' ' ' ARG . 0.7 OUTLIER 168.54 -45.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 74.329999999999998 111.135 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.451 ' CG1' ' HB2' ' A' ' 198' ' ' ALA . 75.4 t -73.12 -55.35 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 74.439999999999998 111.155 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -51.14 -34.41 30.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 75.540000000000006 110.895 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 6.1 mt -68.78 -58.63 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 73.420000000000002 111.133 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -39.36 -50.25 2.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 72.120000000000005 111.106 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.5 t -45.34 -84.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 73.049999999999997 111.1 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.8 m -47.85 -34.57 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 62.509999999999998 110.834 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -40.19 42.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 74.420000000000002 110.889 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -86.35 -38.64 17.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 72.219999999999999 110.874 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.474 ' CD2' HG13 ' A' ' 164' ' ' VAL . 15.1 mt -62.6 -67.65 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 73.439999999999998 110.887 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.1 -31.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 72.200000000000003 110.867 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.86 -73.24 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.120000000000005 110.842 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -51.69 -51.2 57.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 73.109999999999999 110.913 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.401 ' CG2' ' HA ' ' A' ' 156' ' ' LEU . 1.7 pt -105.53 89.79 3.61 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.595 0.712 . . . . 74.540000000000006 111.12 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -16.33 37.67 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.702 2.268 . . . . 53.229999999999997 112.374 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 47.4 m -58.27 -19.85 37.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.836 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.449 HG21 ' CG2' ' A' ' 222' ' ' VAL . 3.3 mt -67.99 152.28 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 111.121 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.431 ' N ' HG22 ' A' ' 219' ' ' ILE . 0.2 OUTLIER -133.42 -37.92 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 64.120000000000005 110.904 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 220' ' ' GLN . 50.9 mt -145.38 96.26 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 111.111 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.449 ' CG2' HG21 ' A' ' 219' ' ' ILE . 58.1 t -74.13 104.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 111.144 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.4 113.98 24.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.889 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.3 mt -110.26 100.82 9.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.42 . . . . 75.230000000000004 110.934 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.3 mp -65.76 159.5 25.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 74.010000000000005 110.917 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.84 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.846 0.355 . . . . 72.430000000000007 110.855 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.0 mt -96.15 -171.55 2.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 65.209999999999994 110.96 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -96.46 -9.4 29.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 70.219999999999999 110.903 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.45 ' CD1' HD11 ' A' ' 216' ' ' ILE . 13.3 tp 51.77 100.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 73.010000000000005 110.915 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -171.07 167.28 7.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 110.849 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.451 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 4.5 mt-10 -37.64 -54.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 64.329999999999998 110.898 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -48.79 -52.5 23.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 72.439999999999998 110.869 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 163' ' ' LYS . 37.0 m-20 -73.87 -70.32 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.510000000000005 110.883 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 158' ' ' GLU . 13.3 m -33.78 -37.74 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 63.299999999999997 111.127 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 166' ' ' ASN . 0.8 OUTLIER -60.08 -50.01 75.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 52.420000000000002 110.879 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.0 OUTLIER -55.83 -54.19 47.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 73.340000000000003 110.895 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.42 HG23 ' CB ' ' A' ' 215' ' ' LYS . 3.5 t -61.86 -41.11 89.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 75.099999999999994 111.144 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 37.4 mt -61.2 -27.78 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 62.109999999999999 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 162' ' ' GLU . 45.1 m-80 -71.07 -8.67 55.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 74.040000000000006 110.881 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -88.57 -15.73 34.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 72.209999999999994 110.929 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.72 -33.13 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.530000000000001 111.098 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.467 ' HG3' ' CD2' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -50.42 -60.29 5.61 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.596 0.712 . . . . 74.430000000000007 110.849 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.79 -3.42 11.99 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.643 2.229 . . . . 74.519999999999996 112.34 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.574 ' CD2' ' CD2' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -92.29 -16.81 25.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.310000000000002 110.908 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.574 ' CD2' ' CD2' ' A' ' 171' ' ' TYR . 6.8 mt -83.44 -28.94 28.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 72.239999999999995 110.897 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 175' ' ' THR . . . -79.81 -39.29 31.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.115 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -36.87 -33.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.744 -0.741 . . . . 71.230000000000004 112.485 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 173' ' ' ALA . 1.7 t -154.42 74.46 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.802 0.334 . . . . 74.219999999999999 111.158 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 146.93 -106.95 0.38 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 65.430000000000007 112.523 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -145.54 -98.39 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 73.319999999999993 112.483 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 129.85 123.12 2.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 74.049999999999997 112.542 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.45 107.37 0.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 71.340000000000003 112.504 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.473 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 4.3 pp -144.11 -40.16 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.776 0.322 . . . . 72.230000000000004 110.93 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.465 ' N ' HD12 ' A' ' 180' ' ' LEU . 13.5 tp60 34.24 90.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 75.150000000000006 110.923 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.451 ' C ' ' O ' ' A' ' 181' ' ' GLN . 31.5 t80 -34.49 113.76 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 74.0 110.919 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 14.2 mt -66.78 -79.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 110.923 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 18.5 ptp -171.88 -174.59 1.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 74.129999999999995 110.852 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.47 143.55 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 75.420000000000002 111.122 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.88 39.19 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 73.310000000000002 110.931 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 112.7 -139.3 15.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.687 -0.768 . . . . 72.140000000000001 112.503 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 0.27 5.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.668 2.245 . . . . 74.010000000000005 112.347 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.78 127.72 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 62.530000000000001 111.122 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.78 145.25 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 71.129999999999995 111.095 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.426 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 22.2 mtmt -112.81 145.49 40.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 75.230000000000004 110.869 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.473 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 21.7 t -158.23 154.12 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 111.089 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.484 ' O ' ' CD2' ' A' ' 194' ' ' LEU . 0.0 OUTLIER -91.67 169.84 10.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.847 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.484 ' CD2' ' O ' ' A' ' 193' ' ' ARG . 0.2 OUTLIER -163.33 92.31 0.73 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 75.040000000000006 110.929 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.13 167.92 19.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 73.109999999999999 111.134 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 100.19 -160.96 19.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 74.430000000000007 112.473 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.94 7.65 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.665 2.243 . . . . 72.420000000000002 112.33 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.46 ' O ' ' CD1' ' A' ' 194' ' ' LEU . . . -137.88 50.14 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 72.450000000000003 111.103 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.425 ' C ' HD12 ' A' ' 194' ' ' LEU . . . -74.88 -27.32 60.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 71.200000000000003 111.09 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 1.1 p 166.14 92.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 74.530000000000001 111.132 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 8.5 p -116.76 -36.94 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 74.030000000000001 111.148 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.469 ' CB ' ' O ' ' A' ' 201' ' ' VAL . 0.6 OUTLIER 162.96 -85.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 70.319999999999993 110.899 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 37.0 p -59.63 -25.7 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 75.230000000000004 111.161 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.457 ' CG2' ' HB1' ' A' ' 198' ' ' ALA . 53.9 t -58.23 -56.21 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 64.409999999999997 111.141 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -32.03 60.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 74.230000000000004 110.874 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.01 -56.78 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 111.186 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.01 -32.45 54.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 75.409999999999997 111.12 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.458 ' CG1' HD21 ' A' ' 212' ' ' LEU . 55.3 t -63.12 -86.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 111.166 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 208' ' ' VAL . 24.5 m -33.94 -45.4 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 72.530000000000001 110.844 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.2 mtmt -44.46 -50.3 9.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 72.109999999999999 110.906 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 214' ' ' GLU . 0.0 OUTLIER -64.93 -66.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 74.200000000000003 110.889 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.458 HD21 ' CG1' ' A' ' 208' ' ' VAL . 1.0 OUTLIER -37.4 -67.36 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.912 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -29.54 3.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 74.329999999999998 110.835 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.9 OUTLIER -68.25 -75.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 75.239999999999995 110.938 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.42 ' CB ' HG23 ' A' ' 164' ' ' VAL . 2.7 mptt -56.63 -52.88 63.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 75.230000000000004 110.878 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.45 HD11 ' CD1' ' A' ' 156' ' ' LEU . 5.6 pt -107.16 84.46 1.68 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.661 0.743 . . . . 72.420000000000002 111.152 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -11.3 30.53 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.665 2.243 . . . . 74.310000000000002 112.32 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 45.5 t -58.26 -22.09 51.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 73.540000000000006 110.875 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 220' ' ' GLN . 3.7 mt -57.7 155.51 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 74.549999999999997 111.118 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.451 ' N ' HG22 ' A' ' 219' ' ' ILE . 1.1 tt0 -132.48 -34.57 1.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 71.0 110.875 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 27.9 mm -149.25 106.56 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 63.329999999999998 111.157 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 95.1 t -74.71 110.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 72.519999999999996 111.161 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -96.41 104.24 16.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 71.310000000000002 110.919 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.54 115.39 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.0 mp -98.66 159.83 14.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 71.319999999999993 110.953 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 72.530000000000001 110.833 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.798 0.332 . . . . 74.319999999999993 110.876 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.414 HD13 ' CG ' ' A' ' 160' ' ' ASN . 10.4 mt -159.36 -177.2 6.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.911 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -102.54 -1.29 30.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.129999999999995 110.887 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 12.4 tp 60.1 108.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 72.129999999999995 110.877 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.51 ' ND2' ' ND2' ' A' ' 160' ' ' ASN . 0.0 OUTLIER -168.22 -178.98 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.891 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.11 -49.07 79.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 74.099999999999994 110.899 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -59.58 -32.53 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 110.901 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.51 ' ND2' ' ND2' ' A' ' 157' ' ' ASN . 77.4 m-20 -83.48 -70.28 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.914 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 160' ' ' ASN . 29.5 m -35.63 -30.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 74.299999999999997 111.084 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 160' ' ' ASN . 2.8 mt-10 -55.31 -58.85 6.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 110.868 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -51.06 56.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 110.903 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.4 t -65.25 -31.03 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 74.030000000000001 111.121 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 14.1 mt -72.6 -32.14 65.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 110.895 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 60.7 m-20 -67.39 -14.29 62.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 74.219999999999999 110.921 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -89.53 4.98 47.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 71.400000000000006 110.871 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 169' ' ' ARG . 0.3 OUTLIER -139.91 -55.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 63.530000000000001 111.148 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.499 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -35.34 -58.89 0.73 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.709 . . . . 74.25 110.879 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.69 -27.87 26.26 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.281 . . . . 75.200000000000003 112.366 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.54 ' CD2' HD22 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -73.08 -16.03 61.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 71.319999999999993 110.91 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.54 HD22 ' CD2' ' A' ' 171' ' ' TYR . 5.6 mt -75.61 -46.37 32.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 73.120000000000005 110.909 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 174' ' ' GLY . . . -58.03 -42.56 85.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 62.520000000000003 111.101 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -34.82 -78.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 63.299999999999997 112.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.1 t -94.97 40.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 73.099999999999994 111.152 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . 96.67 94.93 1.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 73.400000000000006 112.542 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . -82.98 171.48 50.74 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 64.340000000000003 112.47 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -126.22 -87.36 0.64 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 44.049999999999997 112.468 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 157.63 109.72 0.29 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.757 -0.735 . . . . 55.229999999999997 112.453 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.45 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 2.9 pp -112.1 -34.15 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 75.040000000000006 110.879 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.5 OUTLIER 33.85 89.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 75.420000000000002 110.919 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -38.52 107.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 75.150000000000006 110.881 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.427 HD13 ' CD1' ' A' ' 225' ' ' LEU . 14.4 mt -66.22 -80.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.420000000000002 110.948 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -166.08 -168.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 75.299999999999997 110.896 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.53 124.79 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 75.439999999999998 111.166 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.76 72.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 73.420000000000002 110.887 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 82.87 -140.71 20.39 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 72.519999999999996 112.488 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 54.0 Cg_endo -69.75 0.01 6.25 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 73.019999999999996 112.36 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 25.5 mt -117.76 136.16 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 74.450000000000003 111.099 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.51 130.86 73.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 75.209999999999994 111.131 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -90.54 142.58 27.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 72.549999999999997 110.946 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.45 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 55.7 t -153.67 151.43 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 75.430000000000007 111.156 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.482 ' O ' ' CD2' ' A' ' 194' ' ' LEU . 0.2 OUTLIER -86.73 163.55 17.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 74.099999999999994 110.914 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.482 ' CD2' ' O ' ' A' ' 193' ' ' ARG . 0.3 OUTLIER -158.21 79.63 0.83 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 75.230000000000004 110.944 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 p -113.32 171.34 7.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.483 . . . . 71.439999999999998 111.115 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 86.83 -169.56 40.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.707 -0.759 . . . . 74.150000000000006 112.498 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -19.29 36.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.69 2.26 . . . . 65.519999999999996 112.34 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -97.83 42.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 64.25 111.14 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -96.14 92.03 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 62.32 111.089 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 76.8 t 45.06 90.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 75.209999999999994 111.151 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 43.5 t -125.66 -82.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 72.439999999999998 111.127 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.402 ' O ' ' CG2' ' A' ' 203' ' ' THR . 0.0 OUTLIER -176.21 47.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 110.869 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.402 ' CG2' ' O ' ' A' ' 202' ' ' ARG . 0.7 OUTLIER -174.57 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.230000000000004 111.13 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 205' ' ' ARG . 93.4 t -58.75 -70.89 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 71.420000000000002 111.136 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 204' ' ' VAL . 0.0 OUTLIER -35.33 -44.22 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.530000000000001 110.872 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.9 mt -54.11 -50.42 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.114 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -62.71 -32.86 74.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.239999999999995 111.1 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.493 ' O ' ' CD2' ' A' ' 212' ' ' LEU . 40.8 t -80.38 0.99 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 72.439999999999998 111.164 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -134.57 7.38 3.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 75.329999999999998 110.897 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.59 -40.64 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 74.439999999999998 110.887 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -80.64 -27.32 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 75.129999999999995 110.878 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.493 ' CD2' ' O ' ' A' ' 208' ' ' VAL . 2.4 mm? -69.08 -71.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.120000000000005 110.894 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -45.18 -21.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 75.25 110.869 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 212' ' ' LEU . 1.2 tp10 -70.77 -66.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 74.5 110.867 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.22 -44.3 79.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.120000000000005 110.926 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.402 ' CD1' HG13 ' A' ' 161' ' ' VAL . 4.8 pt -111.57 89.18 10.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 73.209999999999994 111.101 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -20.68 34.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 71.420000000000002 112.354 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.06 -22.88 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 72.129999999999995 110.815 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.6 mt -58.51 148.14 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.319999999999993 111.156 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.41 ' C ' HG12 ' A' ' 221' ' ' ILE . 0.9 OUTLIER -129.44 -39.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.92 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.41 HG12 ' C ' ' A' ' 220' ' ' GLN . 27.3 mm -150.67 114.43 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 75.420000000000002 111.087 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 85.6 t -86.81 121.49 37.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.019999999999996 111.103 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -108.5 122.87 47.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.340000000000003 110.961 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 24.8 mt -115.27 102.2 9.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.519999999999996 110.921 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.427 ' CD1' HD13 ' A' ' 183' ' ' LEU . 2.2 mt -72.71 173.35 9.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 72.400000000000006 110.897 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.6 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 71.129999999999995 110.896 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.436 ' HB2' ' CG ' ' A' ' 217' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.764 0.316 . . . . 75.340000000000003 110.922 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.85 -174.07 4.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 62.509999999999998 110.892 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -97.77 -13.2 21.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 63.210000000000001 110.884 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.507 ' C ' ' CG ' ' A' ' 157' ' ' ASN . 5.3 tp 58.56 113.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 75.420000000000002 110.915 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.516 ' N ' ' ND2' ' A' ' 157' ' ' ASN . 0.0 OUTLIER 174.7 166.43 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 71.150000000000006 110.934 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.36 -26.32 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 73.239999999999995 110.853 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.42 ' CD ' ' HB2' ' A' ' 157' ' ' ASN . 11.5 pm0 -78.58 -33.28 47.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 71.129999999999995 110.886 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 162' ' ' GLU . 24.9 m-20 -100.87 -60.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 75.519999999999996 110.912 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.525 HG11 ' CE1' ' A' ' 182' ' ' PHE . 9.3 p -42.18 -23.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 73.409999999999997 111.122 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.472 ' N ' HG13 ' A' ' 161' ' ' VAL . 4.3 mt-10 -64.67 -55.01 22.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 60.350000000000001 110.891 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -40.78 45.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 74.540000000000006 110.889 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.437 HG13 ' CD2' ' A' ' 212' ' ' LEU . 25.2 t -71.38 -33.41 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 71.349999999999994 111.144 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.1 mt -71.02 -28.78 64.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 72.329999999999998 110.931 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.486 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 29.4 m-80 -71.02 -8.21 51.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 62.5 110.898 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.94 -3.88 50.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 74.409999999999997 110.849 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.88 -36.9 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 72.239999999999995 111.127 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.518 ' NH2' ' NE2' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -52.99 -59.93 7.86 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 74.219999999999999 110.876 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.486 ' CG ' ' O ' ' A' ' 166' ' ' ASN . 53.7 Cg_endo -69.79 -20.79 34.22 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.717 2.278 . . . . 74.109999999999999 112.331 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.557 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -69.2 -19.77 63.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.927 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.545 HD22 ' CD2' ' A' ' 171' ' ' TYR . 5.8 mt -79.51 -55.36 5.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 75.549999999999997 110.935 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -43.43 -28.66 0.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 63.399999999999999 111.086 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.57 -39.38 93.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 65.209999999999994 112.504 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 43.3 p -107.18 1.74 24.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 71.010000000000005 111.185 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 149.38 -56.09 0.48 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 63.219999999999999 112.46 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 110.5 173.78 20.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 74.329999999999998 112.476 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -161.04 -111.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 71.310000000000002 112.532 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -178.73 119.83 0.67 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.757 -0.735 . . . . 73.099999999999994 112.506 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.468 ' CD2' HD11 ' A' ' 172' ' ' LEU . 0.5 OUTLIER -149.55 11.99 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.754 0.311 . . . . 64.219999999999999 110.91 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.518 ' NE2' ' NH2' ' A' ' 169' ' ' ARG . 6.0 tp-100 -35.02 104.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 53.509999999999998 110.907 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.525 ' CE1' HG11 ' A' ' 161' ' ' VAL . 22.0 t80 -34.69 125.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.310000000000002 110.858 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 89.8 mt -86.66 -74.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.919 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 22.8 ptp -165.11 -173.66 2.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 74.049999999999997 110.895 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.9 mt -130.84 136.94 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 71.319999999999993 111.163 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -136.15 71.98 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 75.0 110.855 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.89 -145.3 24.61 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 73.219999999999999 112.527 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 3.27 2.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 72.340000000000003 112.347 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mp -122.83 112.09 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 70.140000000000001 111.156 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.4 p -92.16 142.1 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 62.5 111.098 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -99.87 141.56 32.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 70.239999999999995 110.933 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.7 t -154.51 147.87 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 75.150000000000006 111.122 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.93 166.82 14.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 110.869 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.16 96.63 1.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 72.109999999999999 110.938 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 15.7 p -125.5 179.94 4.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 74.010000000000005 111.157 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.96 -177.91 54.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 51.130000000000003 112.517 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -20.53 34.79 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.732 2.288 . . . . 74.430000000000007 112.349 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.24 -24.24 47.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 64.439999999999998 111.101 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -49.94 -63.03 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 75.099999999999994 111.145 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.99 96.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.116 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 10.2 p -162.85 22.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 111.092 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.7 OUTLIER 59.46 152.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 110.862 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 2.5 m 81.15 -68.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.0 111.151 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 205' ' ' ARG . 92.7 t -44.39 -67.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 65.409999999999997 111.158 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 204' ' ' VAL . 6.8 ptm180 -36.72 -36.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 71.150000000000006 110.871 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 3.8 mp -77.26 -51.17 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 72.329999999999998 111.136 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -51.94 -16.43 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 65.420000000000002 111.152 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 86.3 t -89.51 -52.52 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 75.329999999999998 111.152 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.3 t -84.14 24.48 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.200000000000003 110.808 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.24 -40.21 4.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 74.099999999999994 110.916 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -31.73 33.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 110.882 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.437 ' CD2' HG13 ' A' ' 164' ' ' VAL . 6.6 mt -69.54 -65.21 0.74 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 70.349999999999994 110.925 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -28.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.921 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -75.51 -68.19 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 64.430000000000007 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.32 -56.61 18.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 75.519999999999996 110.896 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 3.5 pt -104.77 92.22 4.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.654 0.74 . . . . 73.209999999999994 111.095 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.436 ' CG ' ' HB2' ' A' ' 153' ' ' MET . 53.5 Cg_endo -69.81 -22.53 31.72 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.655 2.237 . . . . 72.109999999999999 112.359 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.22 -20.45 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 110.842 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.6 mt -62.54 154.02 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 75.420000000000002 111.109 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.443 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -136.29 -37.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 71.310000000000002 110.928 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.409 HG12 ' C ' ' A' ' 220' ' ' GLN . 29.6 mm -152.09 105.31 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 74.200000000000003 111.151 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 74.3 t -81.29 118.77 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 111.124 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -101.91 108.03 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 73.030000000000001 110.913 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.3 mt -96.65 102.35 14.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 110.918 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 226' ' ' SER . 9.1 mp -70.94 173.42 7.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 74.019999999999996 110.904 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 225' ' ' LEU . 44.4 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.219999999999999 110.842 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 49.2 mtt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.85 0.357 . . . . 73.329999999999998 110.916 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.41 HD12 ' ND2' ' A' ' 160' ' ' ASN . 10.5 mt -119.99 -174.71 2.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 72.409999999999997 110.898 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.87 -7.99 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 73.540000000000006 110.858 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.8 tp 50.89 98.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 74.549999999999997 110.887 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.57 ' N ' HD21 ' A' ' 157' ' ' ASN . 0.0 OUTLIER -166.17 169.85 13.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.519999999999996 110.884 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.458 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 3.7 mt-10 -44.53 -29.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 110.876 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.459 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 3.7 pt-20 -70.66 -42.88 70.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 74.319999999999993 110.884 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 162' ' ' GLU . 96.1 m-20 -86.53 -63.5 1.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 74.200000000000003 110.864 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.458 ' CG2' ' HA ' ' A' ' 158' ' ' GLU . 33.8 m -37.51 -30.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 71.140000000000001 111.123 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.4 mt-10 -64.85 -51.93 59.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 74.540000000000006 110.883 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -58.57 -50.43 73.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 75.340000000000003 110.904 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 1.7 t -62.24 -30.2 48.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 74.409999999999997 111.085 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.466 ' CD1' ' HB2' ' A' ' 182' ' ' PHE . 18.2 mt -73.63 -28.48 61.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 75.099999999999994 110.926 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.487 ' O ' ' CD ' ' A' ' 170' ' ' PRO . 37.9 m-80 -71.38 -11.97 61.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 73.219999999999999 110.861 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.22 -18.33 39.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 110.938 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.9 pt -115.99 -24.54 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 62.549999999999997 111.163 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -55.97 -60.43 8.82 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.593 0.711 . . . . 73.510000000000005 110.908 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.487 ' CD ' ' O ' ' A' ' 166' ' ' ASN . 53.7 Cg_endo -69.81 -2.01 9.49 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 53.240000000000002 112.361 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.575 ' CD2' HD21 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -88.94 -42.89 11.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 72.420000000000002 110.899 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.575 HD21 ' CD2' ' A' ' 171' ' ' TYR . 5.4 mt -57.05 -45.79 82.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 73.120000000000005 110.929 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -45.43 107.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 64.299999999999997 111.134 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 133.5 -50.38 0.88 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.76 . . . . 61.020000000000003 112.487 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.9 t -133.23 22.34 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 73.519999999999996 111.092 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -153.6 -79.46 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 63.32 112.456 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 56.22 15.82 12.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.778 -0.725 . . . . 71.299999999999997 112.477 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.34 -93.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 64.140000000000001 112.507 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 193' ' ' ARG . . . 175.03 123.92 0.77 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 60.100000000000001 112.442 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.483 ' O ' ' C ' ' A' ' 181' ' ' GLN . 2.7 pp -135.27 -0.22 2.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 74.530000000000001 110.941 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -30.73 117.62 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.510000000000005 110.873 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.466 ' HB2' ' CD1' ' A' ' 165' ' ' LEU . 19.3 t80 -55.63 129.62 39.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.856 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.417 HD11 ' C ' ' A' ' 192' ' ' VAL . 43.0 mt -89.67 -74.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 72.200000000000003 110.889 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 16.6 ptp -167.45 -170.77 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 74.409999999999997 110.844 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 35.0 mt -138.36 133.46 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 111.097 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -130.91 59.8 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 73.129999999999995 110.925 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 99.12 -146.74 18.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.725 -0.75 . . . . 72.150000000000006 112.514 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 3.04 3.0 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.705 2.27 . . . . 70.209999999999994 112.335 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.4 mt -115.81 118.34 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.019999999999996 111.155 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 66.8 t -91.27 139.73 17.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 111.083 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.411 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 7.8 mtmt -107.49 145.83 32.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 75.120000000000005 110.901 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.459 ' CG1' ' N ' ' A' ' 193' ' ' ARG . 70.6 t -158.73 158.18 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 111.112 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.459 ' N ' ' CG1' ' A' ' 192' ' ' VAL . 5.8 ttt180 -99.5 137.81 37.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.120000000000005 110.903 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -130.46 84.47 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 74.209999999999994 110.926 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -112.32 170.09 8.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.319999999999993 111.145 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.42 ' N ' ' OG1' ' A' ' 195' ' ' THR . . . 84.06 -163.25 39.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 63.020000000000003 112.462 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -35.45 12.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.686 2.258 . . . . 74.319999999999993 112.338 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -84.59 32.29 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 111.063 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -72.19 -52.2 17.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 72.519999999999996 111.123 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 7.1 p -164.66 69.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 75.0 111.111 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 202' ' ' ARG . 56.1 t -88.83 -83.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 74.340000000000003 111.1 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.424 ' N ' HG13 ' A' ' 201' ' ' VAL . 0.0 OUTLIER 172.08 41.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 75.409999999999997 110.9 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.461 ' CA ' HD12 ' A' ' 206' ' ' ILE . 23.1 m -166.83 -57.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 71.510000000000005 111.186 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 31.9 t -60.11 -63.96 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 71.230000000000004 111.127 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -44.56 -29.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 73.420000000000002 110.855 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.461 HD12 ' CA ' ' A' ' 203' ' ' THR . 3.0 mt -79.8 -45.25 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 71.030000000000001 111.149 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.28 -15.07 31.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 111.113 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 209' ' ' SER . 54.1 t -80.25 -85.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.349999999999994 111.143 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.461 ' C ' ' O ' ' A' ' 208' ' ' VAL . 1.6 t -33.43 -41.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 74.030000000000001 110.854 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.44 -54.7 7.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 70.329999999999998 110.896 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -56.31 19.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 75.040000000000006 110.862 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.448 HD22 ' CG1' ' A' ' 208' ' ' VAL . 1.6 mm? -45.7 -74.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 71.530000000000001 110.881 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 212' ' ' LEU . 3.9 ttp180 -37.39 -52.49 1.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 74.049999999999997 110.874 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -46.36 -92.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.857 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.26 -54.26 1.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 70.129999999999995 110.883 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.455 ' CD1' HG12 ' A' ' 161' ' ' VAL . 11.2 pt -106.17 88.19 2.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.602 0.715 . . . . 74.430000000000007 111.122 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -23.21 31.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.648 2.232 . . . . 74.329999999999998 112.376 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.7 t -45.63 -28.54 1.0 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 72.549999999999997 110.862 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -55.65 157.15 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 75.420000000000002 111.1 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.498 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.5 OUTLIER -141.68 -37.84 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 73.299999999999997 110.964 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.411 HG13 ' C ' ' A' ' 220' ' ' GLN . 11.2 mt -140.93 85.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 73.109999999999999 111.128 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.04 115.9 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 111.094 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -95.76 152.77 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 73.510000000000005 110.889 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.4 mt -139.7 100.01 3.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 74.150000000000006 110.9 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 225' ' ' LEU . 0.3 OUTLIER -57.56 177.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.926 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 70.120000000000005 110.857 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 14.1 mtt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.824 0.345 . . . . 72.530000000000001 110.861 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.0 mp -123.52 -174.5 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 75.420000000000002 110.905 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.91 -18.05 14.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 70.519999999999996 110.911 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.487 ' C ' ' CG ' ' A' ' 157' ' ' ASN . 6.6 tp 61.92 106.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.977 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.487 ' CG ' ' C ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -176.25 166.76 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 75.019999999999996 110.853 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -42.22 -38.97 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 74.310000000000002 110.834 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -65.18 -56.26 13.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 73.109999999999999 110.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 162' ' ' GLU . 53.1 m-20 -76.52 -61.87 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 73.019999999999996 110.901 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.46 ' N ' ' O ' ' A' ' 157' ' ' ASN . 6.1 p -38.69 -28.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 111.113 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 160' ' ' ASN . 2.4 mm-40 -59.52 -59.96 4.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.25 110.843 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -36.71 23.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 74.140000000000001 110.894 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.47 HG12 ' CD2' ' A' ' 212' ' ' LEU . 41.9 t -70.64 -45.85 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 74.040000000000006 111.121 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.468 HD12 ' CD1' ' A' ' 182' ' ' PHE . 75.7 mt -61.09 -24.08 65.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.932 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.41 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 24.3 m-80 -74.57 -5.86 45.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 64.420000000000002 110.894 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.09 -8.06 40.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 75.549999999999997 110.85 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.3 pt -123.22 -43.68 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 75.319999999999993 111.14 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -44.22 -59.95 3.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.576 0.703 . . . . 74.310000000000002 110.914 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.79 -30.48 22.09 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 75.519999999999996 112.373 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.547 ' CD2' HD21 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -63.76 -14.51 53.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 110.948 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.547 HD21 ' CD2' ' A' ' 171' ' ' TYR . 4.5 mt -79.56 -55.62 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 74.120000000000005 110.917 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.51 -54.24 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 111.127 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -40.71 -60.33 2.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.747 . . . . 75.030000000000001 112.452 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 82.8 p -64.92 -50.38 66.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 75.209999999999994 111.164 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -169.54 -40.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 63.32 112.455 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 127.44 164.44 11.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 71.400000000000006 112.509 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.21 -178.74 41.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 74.430000000000007 112.524 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -140.42 99.98 0.26 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 71.019999999999996 112.494 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.5 OUTLIER -118.31 25.84 10.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.751 0.31 . . . . 74.519999999999996 110.89 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -35.77 119.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 110.944 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.468 ' CD1' HD12 ' A' ' 165' ' ' LEU . 19.5 t80 -48.5 116.2 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 73.140000000000001 110.862 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.26 -73.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 73.540000000000006 110.905 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 14.1 ptp -171.32 -171.05 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 110.912 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -131.78 131.12 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 73.140000000000001 111.132 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -135.43 74.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 62.32 110.931 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.33 -144.77 24.84 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 63.520000000000003 112.446 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 3.52 2.74 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.689 2.259 . . . . 72.400000000000006 112.314 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.453 HG21 ' N ' ' A' ' 190' ' ' VAL . 44.5 mt -109.63 149.72 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 73.129999999999995 111.128 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.453 ' N ' HG21 ' A' ' 189' ' ' ILE . 56.7 t -126.39 135.33 64.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 70.319999999999993 111.146 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.453 ' N ' HG13 ' A' ' 190' ' ' VAL . 13.6 mtmt -105.0 133.95 48.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 71.540000000000006 110.878 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 66.3 t -153.41 129.63 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 73.230000000000004 111.12 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 179.42 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 72.420000000000002 110.833 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.25 67.92 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 71.239999999999995 110.919 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 73.4 p -90.42 -179.8 5.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 75.439999999999998 111.187 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 91.76 173.64 42.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 72.049999999999997 112.482 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -16.84 37.52 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.25 . . . . 71.430000000000007 112.345 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.46 -18.92 59.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 53.520000000000003 111.104 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.62 -45.63 81.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 111.107 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 30.9 m -92.0 49.3 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 71.219999999999999 111.159 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 83.6 t -138.81 125.57 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 75.120000000000005 111.164 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -55.79 158.05 3.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 73.120000000000005 110.879 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.428 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 1.9 m 79.73 -55.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.479 . . . . 74.540000000000006 111.191 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 76.1 t -38.88 -60.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.049999999999997 111.121 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -43.97 39.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 74.230000000000004 110.87 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.64 -53.77 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 74.150000000000006 111.168 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -44.53 -27.74 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 75.239999999999995 111.12 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 2.6 t -73.05 -56.47 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 74.299999999999997 111.162 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.31 20.39 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 73.310000000000002 110.85 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -103.66 -40.26 6.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 75.530000000000001 110.895 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.38 -34.12 25.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 72.319999999999993 110.889 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.47 ' CD2' HG12 ' A' ' 164' ' ' VAL . 7.4 mt -68.32 -67.3 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 75.129999999999995 110.898 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.59 -24.16 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 71.230000000000004 110.904 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -78.7 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.904 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.29 -51.43 14.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 72.510000000000005 110.931 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 2.2 pt -107.02 91.96 7.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.593 0.711 . . . . 72.430000000000007 111.141 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -17.64 37.46 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.667 2.245 . . . . 74.129999999999995 112.329 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.6 t -54.46 -28.44 44.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 52.049999999999997 110.833 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.8 mt -57.64 153.12 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 75.510000000000005 111.127 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.429 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 2.0 mt-30 -133.12 -37.38 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.219999999999999 110.907 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.8 mp -145.74 102.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 74.329999999999998 111.088 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.72 107.58 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 74.140000000000001 111.113 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -93.2 94.51 8.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.889 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.9 117.22 24.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 73.439999999999998 110.916 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.68 170.93 15.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 71.430000000000007 110.889 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 73.430000000000007 110.893 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.821 0.343 . . . . 72.439999999999998 110.869 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.462 ' CB ' HG22 ' A' ' 216' ' ' ILE . 28.6 mt -88.14 176.92 7.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.946 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -110.69 -8.75 14.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 64.430000000000007 110.907 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.435 ' CD1' HD13 ' A' ' 216' ' ' ILE . 26.8 tp 58.19 97.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 73.049999999999997 110.9 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.06 164.27 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.922 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -46.58 -21.94 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.510000000000005 110.924 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -41.14 18.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 74.519999999999996 110.899 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.15 -57.13 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 74.420000000000002 110.873 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.452 HG22 ' CZ ' ' A' ' 182' ' ' PHE . 29.5 m -45.96 -26.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 71.420000000000002 111.093 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -61.08 -59.44 5.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.91 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -42.33 42.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 72.329999999999998 110.907 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.471 HG13 ' CD2' ' A' ' 212' ' ' LEU . 2.0 t -70.6 -42.1 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 65.329999999999998 111.144 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.555 HD12 ' CD1' ' A' ' 182' ' ' PHE . 31.0 mt -61.86 -32.93 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 75.530000000000001 110.948 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -69.95 -3.66 17.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 74.040000000000006 110.887 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -94.43 -2.01 52.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.875 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.452 ' CD1' HG11 ' A' ' 208' ' ' VAL . 4.1 pt -136.59 -35.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 72.219999999999999 111.159 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -45.95 -60.02 4.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.535 0.683 . . . . 75.230000000000004 110.836 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.0 Cg_endo -69.73 3.29 2.84 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.713 2.276 . . . . 72.340000000000003 112.349 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.517 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.4 OUTLIER -102.39 -23.56 13.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 70.409999999999997 110.927 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.487 HD23 ' CD2' ' A' ' 171' ' ' TYR . 2.5 mt -84.31 -36.95 22.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 70.409999999999997 110.889 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.27 -13.37 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 71.349999999999994 111.052 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.17 -40.96 8.25 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.71 -0.757 . . . . 74.120000000000005 112.425 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.0 t -105.16 4.49 31.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 75.439999999999998 111.108 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -179.24 -101.5 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 70.129999999999995 112.469 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.31 69.75 0.4 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.716 -0.754 . . . . 54.409999999999997 112.496 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.88 -123.31 1.89 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 53.229999999999997 112.477 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -138.14 112.47 0.89 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 73.510000000000005 112.455 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -122.11 6.65 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.729 0.299 . . . . 74.430000000000007 110.933 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 182' ' ' PHE . 0.0 OUTLIER -37.94 96.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 71.439999999999998 110.893 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.555 ' CD1' HD12 ' A' ' 165' ' ' LEU . 17.6 t80 -37.49 119.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 73.450000000000003 110.887 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.0 mt -77.54 -73.41 0.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 63.420000000000002 110.905 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 15.0 ptp -174.15 -174.36 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 73.349999999999994 110.891 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 11.3 mt -133.33 137.01 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 74.439999999999998 111.178 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.8 57.05 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.862 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 91.72 -135.24 12.67 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 73.420000000000002 112.451 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 2.4 3.52 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.716 2.277 . . . . 72.219999999999999 112.342 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.434 ' CD1' ' HB ' ' A' ' 221' ' ' ILE . 26.9 mm -125.41 124.46 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 71.349999999999994 111.13 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.466 HG22 ' N ' ' A' ' 191' ' ' LYS . 6.4 p -109.97 137.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 65.450000000000003 111.17 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.466 ' N ' HG22 ' A' ' 190' ' ' VAL . 15.0 mtmt -101.16 146.46 27.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.109999999999999 110.9 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 91.0 t -158.94 152.69 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 74.439999999999998 111.127 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.5 155.26 22.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 75.420000000000002 110.877 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 198' ' ' ALA . 0.1 OUTLIER -153.16 84.41 1.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.530000000000001 110.941 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 11.9 p -120.18 -170.94 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.439999999999998 111.143 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 73.13 -168.6 53.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 61.240000000000002 112.503 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -15.69 37.13 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.256 . . . . 74.239999999999995 112.348 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 194' ' ' LEU . . . -96.21 52.25 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 72.219999999999999 111.087 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.465 ' CB ' HD11 ' A' ' 194' ' ' LEU . . . -142.99 141.73 31.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 73.140000000000001 111.068 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.451 ' CB ' ' O ' ' A' ' 199' ' ' ALA . 2.7 t 81.45 -40.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 74.25 111.14 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 202' ' ' ARG . 87.9 t -47.46 139.24 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 74.409999999999997 111.129 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.465 ' N ' HG11 ' A' ' 201' ' ' VAL . 1.7 tpt85 -85.55 78.23 9.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 70.140000000000001 110.879 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.446 ' CG2' HG13 ' A' ' 201' ' ' VAL . 2.5 t 174.33 -42.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 74.0 111.117 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 45.7 t -70.08 -44.33 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 72.219999999999999 111.095 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -4.81 18.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 110.861 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.31 -66.88 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 111.107 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -45.71 -21.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 75.409999999999997 111.091 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.452 HG11 ' CD1' ' A' ' 168' ' ' ILE . 87.7 t -74.79 -75.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 71.430000000000007 111.136 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 33.7 t -57.43 -12.5 2.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 74.519999999999996 110.852 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -40.27 67.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 73.129999999999995 110.906 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.03 -32.92 51.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.852 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.471 ' CD2' HG13 ' A' ' 164' ' ' VAL . 9.2 mt -72.16 -60.37 2.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 73.010000000000005 110.945 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -46.33 -26.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 71.099999999999994 110.854 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.96 -74.27 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 75.120000000000005 110.88 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.422 ' C ' HD11 ' A' ' 154' ' ' LEU . 0.8 OUTLIER -53.21 -52.71 58.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 75.099999999999994 110.914 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.462 HG22 ' CB ' ' A' ' 154' ' ' LEU . 6.8 pt -106.2 87.75 2.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.722 . . . . 74.120000000000005 111.159 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -5.82 17.12 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.664 2.243 . . . . 75.219999999999999 112.332 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.9 t -69.22 -1.6 8.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 73.25 110.873 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -78.96 154.84 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 111.192 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -138.12 -35.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.898 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.434 ' HB ' ' CD1' ' A' ' 189' ' ' ILE . 47.2 mt -152.71 103.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 111.146 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 93.8 t -78.13 107.95 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 111.107 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -94.0 118.5 31.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.519999999999996 110.923 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -114.41 102.48 10.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 75.549999999999997 110.88 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.1 mp -69.9 162.77 27.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.947 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 75.239999999999995 110.834 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.762 0.315 . . . . 74.540000000000006 110.917 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.9 mp -139.05 -171.37 3.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 75.310000000000002 110.925 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -103.37 -12.74 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.230000000000004 110.885 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 11.2 tp 60.85 115.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 74.040000000000006 110.942 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 160' ' ' ASN . 16.8 p30 174.76 -173.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.898 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -37.4 87.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.150000000000006 110.847 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -72.92 -24.2 60.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 73.25 110.869 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 162' ' ' GLU . 91.7 m-20 -101.07 -67.74 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 72.239999999999995 110.877 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.486 HG13 ' CZ ' ' A' ' 182' ' ' PHE . 4.0 p -36.82 -29.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 71.030000000000001 111.166 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.6 mt-10 -55.01 -59.32 4.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.340000000000003 110.92 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -36.39 62.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 110.866 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.456 HG12 ' CD2' ' A' ' 212' ' ' LEU . 93.1 t -65.23 -42.01 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 74.219999999999999 111.145 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.409 HD11 ' CD1' ' A' ' 182' ' ' PHE . 62.0 mt -69.43 -21.81 63.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 73.5 110.887 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -72.88 -16.12 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 74.109999999999999 110.877 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -89.72 6.35 41.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 110.86 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.76 -34.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.319999999999993 111.122 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.7 -61.03 5.23 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.539 0.685 . . . . 75.450000000000003 110.889 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.78 -11.37 30.67 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.684 2.256 . . . . 74.299999999999997 112.335 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -84.86 -13.18 51.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 73.519999999999996 110.959 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.541 ' CD1' ' CD2' ' A' ' 180' ' ' LEU . 6.4 mt -80.39 -41.89 23.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.931 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -39.21 -48.59 1.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.409999999999997 111.119 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.3 -55.66 29.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 72.25 112.485 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.8 p -77.08 2.46 15.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.795 0.331 . . . . 71.349999999999994 111.12 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 151.1 -64.32 0.38 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.73 . . . . 72.510000000000005 112.496 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 124.44 32.41 0.83 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 75.349999999999994 112.482 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -46.35 174.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 72.510000000000005 112.483 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -126.69 117.57 2.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.752 -0.737 . . . . 64.319999999999993 112.487 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.541 ' CD2' ' CD1' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -118.14 25.23 10.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.788 0.328 . . . . 71.0 110.901 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 182' ' ' PHE . 0.0 OUTLIER -34.35 124.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 75.219999999999999 110.89 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.486 ' CZ ' HG13 ' A' ' 161' ' ' VAL . 17.8 t80 -52.5 135.61 33.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.912 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 53.8 mt -94.28 -71.51 0.66 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 75.340000000000003 110.884 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 6.8 ptp -176.06 -162.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 74.310000000000002 110.851 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 8.7 mt -146.41 127.42 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 75.540000000000006 111.12 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.13 48.66 1.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.310000000000002 110.875 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 106.73 -140.13 15.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 75.120000000000005 112.507 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 3.09 3.0 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.683 2.255 . . . . 65.299999999999997 112.357 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.49 135.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 111.126 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 76.5 t -109.83 137.03 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 111.106 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -107.75 140.62 40.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 75.239999999999995 110.906 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 90.8 t -152.48 144.8 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 75.549999999999997 111.159 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.14 166.96 17.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 73.129999999999995 110.842 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.91 84.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 74.150000000000006 110.864 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.6 p -99.97 158.42 15.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 111.126 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 90.36 -177.58 42.57 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.659 -0.781 . . . . 63.140000000000001 112.435 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 0.74 5.16 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.707 2.271 . . . . 72.439999999999998 112.352 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.404 ' CB ' HG13 ' A' ' 204' ' ' VAL . . . -87.93 16.87 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 44.329999999999998 111.104 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -120.52 49.39 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 71.319999999999993 111.075 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.3 p -177.56 -35.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 64.239999999999995 111.149 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 20.2 t -47.94 137.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 74.140000000000001 111.122 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.36 42.85 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 74.030000000000001 110.893 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.1 m -160.59 -46.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 74.109999999999999 111.14 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.404 HG13 ' CB ' ' A' ' 198' ' ' ALA . 43.4 t -61.55 -64.78 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 75.519999999999996 111.12 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -50.59 -30.23 12.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 74.310000000000002 110.839 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 18.5 mt -73.65 -35.69 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 72.439999999999998 111.113 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -58.32 -44.31 88.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 111.073 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 70.1 t -53.68 -80.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 71.25 111.157 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.4 t -42.84 -39.28 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 73.150000000000006 110.857 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.41 -40.31 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.934 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 212' ' ' LEU . 0.4 OUTLIER -85.11 -59.84 2.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 72.140000000000001 110.897 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 211' ' ' LYS . 2.3 mt -32.72 -69.9 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 75.25 110.956 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.421 ' NH2' ' HB ' ' A' ' 222' ' ' VAL . 0.0 OUTLIER -49.35 -40.92 37.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.88 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 211' ' ' LYS . 2.0 mt-10 -64.53 -80.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 75.099999999999994 110.943 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 12.2 mmtt -40.99 -58.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 73.5 110.869 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 9.4 pt -106.97 88.42 3.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.625 0.726 . . . . 73.310000000000002 111.148 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -9.26 25.68 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.714 2.276 . . . . 73.340000000000003 112.365 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.69 -14.13 62.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 74.129999999999995 110.877 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 mt -61.11 146.02 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 75.450000000000003 111.135 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 221' ' ' ILE . 13.0 mp0 -116.88 -38.28 3.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 73.219999999999999 110.873 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 220' ' ' GLN . 4.7 mp -153.27 103.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 72.230000000000004 111.11 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.421 ' HB ' ' NH2' ' A' ' 213' ' ' ARG . 0.9 OUTLIER -72.9 115.56 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 71.209999999999994 111.09 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -100.66 108.11 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 71.120000000000005 110.948 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mt -99.37 113.6 26.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 75.200000000000003 110.944 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.9 mp -93.93 176.06 6.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 110.917 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 72.340000000000003 110.834 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.8 tpt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.813 0.34 . . . . 70.329999999999998 110.887 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.7 mp -121.14 -171.92 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 74.319999999999993 110.91 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -102.22 -21.56 14.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.010000000000005 110.886 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.519 ' C ' ' CG ' ' A' ' 157' ' ' ASN . 5.5 tp 61.07 113.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 71.340000000000003 110.917 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.599 ' N ' ' ND2' ' A' ' 157' ' ' ASN . 0.0 OUTLIER 174.71 -178.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 72.299999999999997 110.847 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -6.64 4.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 74.439999999999998 110.892 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.46 -43.68 7.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 54.439999999999998 110.895 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 61.1 m-20 -94.62 -49.48 5.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 74.010000000000005 110.902 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.463 ' CG2' HD13 ' A' ' 156' ' ' LEU . 86.6 t -43.08 -44.02 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 72.129999999999995 111.155 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.49 -34.46 69.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 73.400000000000006 110.85 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -62.61 -45.13 94.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.919 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.48 HG12 ' CD2' ' A' ' 212' ' ' LEU . 23.1 t -70.4 -31.79 47.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 111.129 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.412 ' CD1' ' HB2' ' A' ' 182' ' ' PHE . 46.5 mt -70.03 -27.8 64.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 75.510000000000005 110.936 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 14.5 m-80 -69.9 -9.35 54.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 75.549999999999997 110.83 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -87.94 -15.6 36.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 110.869 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.422 HD11 ' CG2' ' A' ' 208' ' ' VAL . 1.5 pt -118.34 -30.04 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 75.510000000000005 111.154 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.51 -61.05 5.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.703 . . . . 73.200000000000003 110.877 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.5 Cg_endo -69.74 1.78 4.12 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.702 2.268 . . . . 73.209999999999994 112.33 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.53 ' CD2' HD22 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -94.12 -31.53 14.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 75.230000000000004 110.924 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.53 HD22 ' CD2' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -77.61 -60.39 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 74.340000000000003 110.972 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -38.27 -52.38 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 73.150000000000006 111.076 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -38.71 -44.16 1.79 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 74.219999999999999 112.512 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.2 p -99.91 -15.09 18.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.373 . . . . 74.400000000000006 111.162 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -176.05 -88.08 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 53.340000000000003 112.473 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 114.18 99.67 2.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.695 -0.764 . . . . 73.340000000000003 112.452 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -93.25 -92.36 1.53 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 52.310000000000002 112.515 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.72 119.75 0.56 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.715 -0.755 . . . . 74.030000000000001 112.483 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.4 OUTLIER -139.78 17.8 2.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.756 0.312 . . . . 75.439999999999998 110.934 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.4 OUTLIER -34.28 96.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 74.230000000000004 110.945 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' A' ' 180' ' ' LEU . 91.4 t80 -36.47 118.71 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 72.540000000000006 110.861 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 46.8 mt -82.02 -78.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 72.439999999999998 110.922 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.9 -166.19 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 72.510000000000005 110.898 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.466 HG12 ' CG2' ' A' ' 190' ' ' VAL . 32.5 mt -142.55 139.91 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 74.530000000000001 111.182 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -128.5 69.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 73.140000000000001 110.917 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 89.8 -139.7 15.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 71.530000000000001 112.445 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.417 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.6 Cg_endo -69.81 1.22 4.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.626 2.218 . . . . 75.329999999999998 112.333 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.5 127.55 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 73.540000000000006 111.141 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.466 ' CG2' HG12 ' A' ' 185' ' ' ILE . 6.2 p -105.17 144.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 73.5 111.169 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 10.7 mtmt -103.84 146.18 29.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 75.239999999999995 110.88 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 88.1 t -157.97 136.9 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 71.010000000000005 111.098 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.408 ' O ' ' CD2' ' A' ' 194' ' ' LEU . 11.3 ttt180 -73.69 161.35 30.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 73.439999999999998 110.848 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.449 ' CD1' ' HA ' ' A' ' 199' ' ' ALA . 0.2 OUTLIER -157.99 102.64 1.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.911 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.0 p -129.78 161.89 29.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 72.040000000000006 111.152 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.2 -177.78 38.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 74.439999999999998 112.519 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -43.8 2.46 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 74.420000000000002 112.326 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 199' ' ' ALA . . . -62.8 -25.76 68.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 64.120000000000005 111.127 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.449 ' HA ' ' CD1' ' A' ' 194' ' ' LEU . . . -34.06 -85.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 72.349999999999994 111.149 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.03 112.2 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 71.319999999999993 111.18 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 1.6 p -137.79 -61.49 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.17 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.476 ' CB ' ' O ' ' A' ' 201' ' ' VAL . 1.1 mtt-85 162.23 35.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 110.855 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.468 ' N ' ' CD1' ' A' ' 206' ' ' ILE . 43.7 m -168.29 -56.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 64.329999999999998 111.124 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.429 ' O ' ' N ' ' A' ' 207' ' ' ALA . 59.3 t -48.63 -70.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 73.400000000000006 111.098 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.49 -22.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.310000000000002 110.876 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 203' ' ' THR . 3.1 mp -89.89 -33.02 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 73.340000000000003 111.145 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -74.31 -11.67 60.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.519999999999996 111.066 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.422 ' CG2' HD11 ' A' ' 168' ' ' ILE . 64.1 t -85.53 -74.81 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 75.510000000000005 111.117 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 14.8 t -53.46 -15.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 72.030000000000001 110.872 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -64.65 -40.26 95.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.909 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.7 -41.23 12.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 75.209999999999994 110.911 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 164' ' ' VAL . 24.7 mt -52.63 -66.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 75.019999999999996 110.903 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -50.43 -24.23 2.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 74.400000000000006 110.908 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.33 -68.46 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.906 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -48.3 82.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 75.219999999999999 110.912 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 1.7 pt -109.6 93.76 14.9 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.645 0.736 . . . . 64.409999999999997 111.17 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -22.09 32.96 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 72.109999999999999 112.324 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 21.0 t -54.71 -15.42 1.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 72.329999999999998 110.877 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.7 mt -70.87 143.53 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 72.230000000000004 111.159 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -127.05 -42.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 75.340000000000003 110.881 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.1 mt -140.91 102.64 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 74.219999999999999 111.123 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.21 116.22 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 111.077 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.51 135.2 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 64.400000000000006 110.91 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 30.1 mt -121.97 103.03 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 63.039999999999999 110.906 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.4 171.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 73.25 110.939 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 63.130000000000003 110.84 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.783 0.325 . . . . 74.420000000000002 110.881 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.5 mt -148.41 -173.1 4.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 72.439999999999998 110.928 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.436 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 4.4 mt-10 -108.55 -6.23 16.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 72.010000000000005 110.925 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.466 ' CD1' ' CG2' ' A' ' 161' ' ' VAL . 3.2 tp 61.17 119.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.549999999999997 110.943 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.488 ' O ' ' N ' ' A' ' 161' ' ' VAL . 5.8 p30 169.37 179.53 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 74.450000000000003 110.891 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -26.5 65.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.857 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.407 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 11.6 pt-20 -84.24 -30.96 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.510000000000005 110.865 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 155' ' ' GLU . 89.5 m-20 -97.32 -62.29 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 71.340000000000003 110.922 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.57 HG13 ' CE1' ' A' ' 182' ' ' PHE . 50.0 t -38.78 -46.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 75.310000000000002 111.156 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.14 -56.02 5.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.854 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -43.07 30.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 72.430000000000007 110.902 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.459 HG21 ' CB ' ' A' ' 215' ' ' LYS . 33.6 t -70.14 -42.94 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 73.209999999999994 111.149 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.531 HD13 ' CD1' ' A' ' 182' ' ' PHE . 56.5 mt -63.84 -24.7 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 73.439999999999998 110.905 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -69.17 -10.84 59.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.299999999999997 110.876 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -84.73 -25.74 28.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 110.884 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 169' ' ' ARG . 1.7 pt -106.98 -45.33 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.147 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.508 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 2.8 mtt180 -34.48 -58.71 0.63 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.631 0.729 . . . . 74.450000000000003 110.877 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.76 -30.8 21.72 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 72.010000000000005 112.379 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.512 ' CD2' HD21 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -74.34 -15.0 60.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 73.219999999999999 110.915 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 171' ' ' TYR . 3.8 mt -76.5 -43.02 41.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 61.530000000000001 110.912 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.19 -22.62 48.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 60.219999999999999 111.118 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -46.32 -49.37 15.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 64.120000000000005 112.459 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.7 t -125.98 48.78 2.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 70.310000000000002 111.167 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.18 -97.65 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 73.319999999999993 112.489 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.03 125.46 4.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 73.219999999999999 112.511 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -128.81 -102.54 1.07 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 64.230000000000004 112.492 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -169.34 119.33 0.82 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.709 -0.758 . . . . 65.430000000000007 112.465 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -140.95 6.08 1.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 75.040000000000006 110.893 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -35.0 111.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 74.400000000000006 110.9 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.57 ' CE1' HG13 ' A' ' 161' ' ' VAL . 27.3 t80 -37.78 122.19 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 75.040000000000006 110.865 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 38.1 mt -81.01 -77.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 75.409999999999997 110.965 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.419 ' C ' HG13 ' A' ' 185' ' ' ILE . 12.5 ptm -169.99 -172.91 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 74.430000000000007 110.883 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.419 HG13 ' C ' ' A' ' 184' ' ' MET . 2.4 mt -133.73 130.52 56.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 75.209999999999994 111.134 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.09 75.83 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 71.25 110.954 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 87.19 -151.16 23.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 61.340000000000003 112.496 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 2.93 3.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.687 2.258 . . . . 75.140000000000001 112.303 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 24.0 mt -113.71 124.38 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 74.030000000000001 111.118 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.0 137.97 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 111.177 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.6 mtmm -104.94 142.16 35.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 73.5 110.901 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.431 HG11 ' N ' ' A' ' 193' ' ' ARG . 56.1 t -156.91 142.83 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 73.319999999999993 111.152 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.431 ' N ' HG11 ' A' ' 192' ' ' VAL . 1.0 OUTLIER -73.69 163.1 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 64.319999999999993 110.887 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -164.49 93.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 110.915 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 5.9 p -132.49 -168.84 2.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 61.219999999999999 111.094 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.79 -158.13 42.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 75.239999999999995 112.476 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.26 18.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.678 2.252 . . . . 74.439999999999998 112.364 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.475 ' HB3' ' CG1' ' A' ' 204' ' ' VAL . . . -90.22 -162.41 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 73.239999999999995 111.131 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 200' ' ' VAL . . . 74.01 144.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 111.062 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 199' ' ' ALA . 22.0 m 34.05 42.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 72.340000000000003 111.169 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 23.0 t -99.12 -16.63 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 111.16 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 70.47 40.17 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 75.120000000000005 110.859 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.83 -44.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 72.209999999999994 111.133 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 198' ' ' ALA . 53.6 t -72.64 -47.34 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 72.230000000000004 111.125 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -61.54 -40.89 96.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.340000000000003 110.893 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.72 -37.3 58.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.349999999999994 111.104 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.8 -29.95 69.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 111.107 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.438 HG11 ' CD1' ' A' ' 212' ' ' LEU . 67.3 t -65.04 -75.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 74.420000000000002 111.125 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.423 ' OG ' ' CZ ' ' A' ' 213' ' ' ARG . 1.9 t -55.33 -19.0 7.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 73.120000000000005 110.872 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.409 ' O ' ' OE1' ' A' ' 214' ' ' GLU . 3.8 mtpp -61.93 -40.32 95.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 72.129999999999995 110.855 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.86 -32.81 17.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 75.450000000000003 110.87 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.446 ' CD2' HG13 ' A' ' 164' ' ' VAL . 10.5 mt -69.29 -67.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 74.109999999999999 110.932 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . 0.423 ' CZ ' ' OG ' ' A' ' 209' ' ' SER . 0.7 OUTLIER -45.07 -27.95 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 75.409999999999997 110.862 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 210' ' ' LYS . 0.4 OUTLIER -81.68 -76.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 110.902 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.459 ' CB ' HG21 ' A' ' 164' ' ' VAL . 16.4 mmtt -42.24 -59.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 72.349999999999994 110.893 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 3.4 pt -103.94 95.42 7.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.659 0.743 . . . . 75.120000000000005 111.167 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -22.04 32.58 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.673 2.249 . . . . 75.209999999999994 112.33 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 17.0 t -49.06 -35.74 16.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 73.329999999999998 110.851 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -48.37 154.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.349999999999994 111.129 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.446 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.8 OUTLIER -134.94 -35.53 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 74.450000000000003 110.927 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 53.4 mt -146.76 91.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 72.200000000000003 111.147 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 39.8 t -65.05 109.82 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 73.030000000000001 111.096 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -100.9 130.58 46.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 110.856 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 14.2 mt -117.07 114.09 23.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 64.25 110.909 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.52 177.88 7.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 74.439999999999998 110.925 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.450000000000003 110.879 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.809 0.337 . . . . 74.439999999999998 110.891 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 12.4 mt -83.58 -176.3 6.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 71.219999999999999 110.897 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -104.13 -17.82 14.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.319999999999993 110.919 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.435 ' CD1' HD13 ' A' ' 216' ' ' ILE . 8.9 tp 59.71 111.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 73.420000000000002 110.95 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -175.99 171.96 2.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 71.530000000000001 110.867 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.18 -20.51 1.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 64.420000000000002 110.869 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.51 -35.22 25.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 73.150000000000006 110.903 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -90.0 -55.85 3.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 73.400000000000006 110.882 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.439 HG11 ' CD1' ' A' ' 216' ' ' ILE . 26.6 m -47.46 -26.72 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 63.32 111.092 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -62.79 -42.02 99.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.893 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -34.08 69.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 74.219999999999999 110.944 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 212' ' ' LEU . 30.4 t -73.37 -42.93 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 71.540000000000006 111.087 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.452 HD21 ' CD1' ' A' ' 180' ' ' LEU . 85.0 mt -65.89 -23.59 66.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 75.329999999999998 110.915 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -73.37 -8.64 56.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 71.450000000000003 110.861 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.19 1.59 49.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 74.120000000000005 110.916 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.465 ' CD1' HG12 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -132.91 -35.19 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 64.420000000000002 111.103 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.481 ' NH2' ' NE2' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -52.19 -60.56 5.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 75.129999999999995 110.874 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.4 Cg_endo -69.77 -4.73 14.63 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.691 2.261 . . . . 62.229999999999997 112.305 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.537 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.0 OUTLIER -90.53 -22.1 21.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 64.140000000000001 110.924 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.474 HD21 ' CD2' ' A' ' 171' ' ' TYR . 5.3 mt -76.37 -44.81 34.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 75.319999999999993 110.912 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.5 -38.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 71.109999999999999 111.13 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.69 152.1 19.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 52.119999999999997 112.501 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.0 t 40.14 56.26 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.33 . . . . 74.439999999999998 111.132 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 156.37 -86.72 0.12 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 63.399999999999999 112.46 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 89.34 89.24 1.23 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 73.510000000000005 112.526 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.33 -158.81 7.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 63.210000000000001 112.515 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.92 152.68 24.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 64.430000000000007 112.458 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.463 ' CD2' ' HG3' ' A' ' 169' ' ' ARG . 0.6 OUTLIER -140.9 25.7 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 74.439999999999998 110.919 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.481 ' NE2' ' NH2' ' A' ' 169' ' ' ARG . 2.5 tp60 -32.71 110.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.956 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -46.95 133.15 11.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 75.540000000000006 110.889 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.79 -69.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 72.310000000000002 110.905 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.1 ptp -178.13 -176.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 64.310000000000002 110.859 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.2 mt -131.29 125.27 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 111.145 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -124.9 56.41 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 71.239999999999995 110.913 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 95.71 -141.77 15.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.747 -0.74 . . . . 52.109999999999999 112.424 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.7 Cg_endo -69.72 3.28 2.84 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 72.010000000000005 112.358 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.02 118.3 58.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 111.127 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 191' ' ' LYS . 66.7 t -97.22 135.53 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 54.229999999999997 111.15 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.455 ' N ' HG13 ' A' ' 190' ' ' VAL . 10.9 mtmt -109.76 139.58 44.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 74.349999999999994 110.907 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.2 t -152.23 160.58 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 72.349999999999994 111.117 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.37 166.65 12.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 110.854 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -156.42 70.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 71.439999999999998 110.91 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 76.4 p -89.09 173.3 8.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 111.156 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 86.24 -179.49 49.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.761 . . . . 75.219999999999999 112.455 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -24.43 29.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.709 2.273 . . . . 73.239999999999995 112.342 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' A' ' 194' ' ' LEU . . . -79.85 103.43 9.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 73.409999999999997 111.074 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -165.0 -74.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 61.009999999999998 111.103 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 28.5 m -61.92 -11.01 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 111.146 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 13.2 t -64.02 128.82 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 111.131 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -77.58 58.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 73.209999999999994 110.871 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 96.6 m -163.65 -55.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 74.530000000000001 111.13 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 59.8 t -54.47 -61.44 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 64.129999999999995 111.112 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -53.73 -25.69 19.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.510000000000005 110.873 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.01 -28.73 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 111.114 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.93 -32.34 72.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 70.549999999999997 111.075 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.465 HG12 ' CD1' ' A' ' 168' ' ' ILE . 3.8 t -67.07 -70.26 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 65.120000000000005 111.114 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 7.8 t -50.35 -17.91 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 74.430000000000007 110.854 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -66.96 -41.09 87.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 73.239999999999995 110.918 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -88.49 -33.99 17.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 75.400000000000006 110.905 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.462 ' CD2' HG12 ' A' ' 164' ' ' VAL . 11.3 mt -63.88 -67.14 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.340000000000003 110.901 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -16.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 74.409999999999997 110.85 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.96 -78.45 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.239999999999995 110.871 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -47.09 -55.87 7.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 73.450000000000003 110.863 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.439 ' CD1' HG11 ' A' ' 161' ' ' VAL . 4.1 pt -108.05 91.53 8.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 75.349999999999994 111.152 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -16.06 37.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.63 2.22 . . . . 74.540000000000006 112.37 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.78 -23.94 7.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 71.510000000000005 110.821 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 5.2 mt -58.81 158.14 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 72.230000000000004 111.112 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.498 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -137.59 -35.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 75.340000000000003 110.903 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.408 HG13 ' C ' ' A' ' 220' ' ' GLN . 72.9 mt -150.71 96.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 75.430000000000007 111.143 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 28.7 m -67.89 121.52 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.129999999999995 111.134 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.63 119.18 38.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.91 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.48 119.16 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 110.959 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.31 168.87 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 110.928 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.230000000000004 110.852 -179.907 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.807 0.337 . . . . 75.019999999999996 110.849 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.31 -170.26 2.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 70.319999999999993 110.911 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -104.12 -17.05 15.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 75.319999999999993 110.894 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.493 ' C ' ' CG ' ' A' ' 157' ' ' ASN . 9.4 tp 58.15 113.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.896 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.493 ' CG ' ' C ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER 175.52 -177.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 110.875 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.89 -45.38 67.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 72.430000000000007 110.823 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -57.93 -56.17 25.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 72.030000000000001 110.927 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 162' ' ' GLU . 94.8 m-20 -74.52 -65.85 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.909 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.544 HG21 ' CE1' ' A' ' 182' ' ' PHE . 2.5 p -34.75 -33.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 71.430000000000007 111.147 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -56.22 -57.1 13.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.901 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.96 -43.71 77.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.908 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' A' ' 212' ' ' LEU . 17.8 t -63.81 -40.89 90.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 63.450000000000003 111.177 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.51 HD13 ' CD1' ' A' ' 182' ' ' PHE . 54.0 mt -66.35 -32.79 74.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 110.891 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 4.5 m-80 -63.97 -13.13 43.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.310000000000002 110.844 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.02 1.13 48.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 70.109999999999999 110.877 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.15 -34.61 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 73.5 111.157 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.42 -60.77 5.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 74.340000000000003 110.851 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' CG ' ' O ' ' A' ' 166' ' ' ASN . 53.8 Cg_endo -69.76 -0.39 6.83 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 72.040000000000006 112.34 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.504 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -92.99 -27.1 17.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 73.310000000000002 110.943 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.446 HD21 ' CD2' ' A' ' 171' ' ' TYR . 6.1 mt -75.63 -39.95 57.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 74.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -44.36 -50.33 9.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 75.209999999999994 111.157 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -45.3 -43.74 9.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 54.210000000000001 112.504 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.9 t -113.76 37.43 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 74.310000000000002 111.124 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.71 109.08 0.46 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 75.25 112.469 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -74.9 137.56 22.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.704 -0.76 . . . . 60.030000000000001 112.507 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.01 -106.44 2.9 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.718 -0.753 . . . . 74.030000000000001 112.474 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.08 113.81 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.752 . . . . 71.030000000000001 112.471 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.429 ' CD2' HD12 ' A' ' 172' ' ' LEU . 1.7 pp -142.55 6.68 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.736 0.303 . . . . 72.239999999999995 110.905 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 182' ' ' PHE . 2.2 tp60 -36.19 105.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 74.519999999999996 110.897 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.544 ' CE1' HG21 ' A' ' 161' ' ' VAL . 10.0 t80 -34.09 129.44 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 62.229999999999997 110.876 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 89.0 mt -95.6 -72.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 74.510000000000005 110.923 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.06 -173.31 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 72.109999999999999 110.861 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.1 mt -135.52 143.92 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 75.530000000000001 111.116 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.47 ' CG ' ' HB ' ' A' ' 189' ' ' ILE . 7.9 ptpt -121.4 38.43 4.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.872 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 93.35 -112.23 4.25 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 72.340000000000003 112.49 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -22.89 31.18 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.723 2.282 . . . . 74.439999999999998 112.314 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.47 ' HB ' ' CG ' ' A' ' 186' ' ' LYS . 2.6 mp -106.45 146.66 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 111.115 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.69 137.54 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 72.430000000000007 111.165 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -98.25 140.13 33.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 73.430000000000007 110.922 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.4 t -151.03 149.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 62.219999999999999 111.109 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.97 161.4 20.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 110.842 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.407 HD13 ' C ' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -173.12 61.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 74.340000000000003 110.983 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 22.6 p -80.42 -49.3 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 75.430000000000007 111.133 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -45.87 173.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.711 -0.757 . . . . 72.349999999999994 112.498 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.18 2.93 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 73.129999999999995 112.345 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.407 ' C ' HD13 ' A' ' 194' ' ' LEU . . . -78.42 6.9 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 74.0 111.102 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -91.76 -61.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 75.340000000000003 111.063 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.12 50.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 52.549999999999997 111.115 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 1.7 t -124.89 146.17 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.530000000000001 111.172 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -95.5 35.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 75.310000000000002 110.869 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.7 m -156.68 -66.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.439999999999998 111.144 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 57.9 t -44.78 -58.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 74.010000000000005 111.125 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -56.69 -21.86 30.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.230000000000004 110.896 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 15.6 mm -80.96 -52.22 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 73.409999999999997 111.158 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.98 -35.7 25.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 65.129999999999995 111.107 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.9 t -59.53 -83.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 71.010000000000005 111.117 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 48.0 t -49.22 -18.49 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 64.510000000000005 110.863 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -60.48 -40.23 90.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 61.420000000000002 110.909 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 214' ' ' GLU . 1.4 mmtt -86.59 -54.56 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.847 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.471 ' CD2' HG11 ' A' ' 164' ' ' VAL . 1.5 mt -37.07 -70.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 74.140000000000001 110.877 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -53.49 -22.46 8.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.86 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -77.39 -67.42 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 70.310000000000002 110.923 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -60.72 -46.39 90.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 75.129999999999995 110.916 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.401 ' CG1' ' O ' ' A' ' 212' ' ' LEU . 4.4 pt -111.68 86.26 6.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.657 0.742 . . . . 74.120000000000005 111.111 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 0.26 5.92 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.688 2.259 . . . . 73.439999999999998 112.319 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.6 t -76.6 1.68 16.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 74.120000000000005 110.857 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 6.3 mt -83.65 157.88 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 74.450000000000003 111.13 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.501 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.1 OUTLIER -132.43 -33.13 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 74.010000000000005 110.932 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.415 HG12 ' C ' ' A' ' 220' ' ' GLN . 33.6 mm -153.62 108.89 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 75.019999999999996 111.13 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.2 t -82.52 117.83 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 71.420000000000002 111.087 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -107.87 136.25 47.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 110.891 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.8 mt -124.05 104.32 8.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 70.340000000000003 110.944 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.18 168.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.140000000000001 110.915 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 110.862 -179.908 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.416 ' HE1' ' N ' ' A' ' 153' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.822 0.344 . . . . 73.510000000000005 110.839 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.451 ' CD1' HG23 ' A' ' 216' ' ' ILE . 11.4 mt -141.94 -175.74 4.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 74.200000000000003 110.895 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.85 -18.09 18.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 62.200000000000003 110.873 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.507 ' C ' ' CG ' ' A' ' 157' ' ' ASN . 5.6 tp 61.49 113.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 64.430000000000007 110.926 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.563 ' N ' ' ND2' ' A' ' 157' ' ' ASN . 0.0 OUTLIER 171.8 173.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 75.209999999999994 110.883 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 162' ' ' GLU . 3.6 mt-10 -49.49 -37.03 24.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 63.420000000000002 110.901 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.8 -54.12 25.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 63.420000000000002 110.924 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' A' ' 161' ' ' VAL . 86.6 m-20 -79.32 -62.82 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 72.409999999999997 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.561 HG12 ' CE1' ' A' ' 182' ' ' PHE . 72.7 t -34.56 -50.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 74.329999999999998 111.133 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 20.7 mm-40 -40.34 -60.2 1.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 75.030000000000001 110.865 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.28 -36.86 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 64.340000000000003 110.929 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.47 HG12 ' CD2' ' A' ' 212' ' ' LEU . 40.2 t -73.44 -34.39 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 71.549999999999997 111.082 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.467 ' CD1' ' HB2' ' A' ' 182' ' ' PHE . 27.8 mt -72.79 -30.93 64.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 73.230000000000004 110.927 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.82 -6.85 44.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.894 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -90.98 -12.87 34.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.319999999999993 110.871 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.51 -28.33 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 73.129999999999995 111.119 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.467 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -51.61 -60.87 5.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 74.409999999999997 110.844 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 169' ' ' ARG . 53.9 Cg_endo -69.73 2.62 3.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.675 2.25 . . . . 72.010000000000005 112.37 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.498 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -97.61 -28.44 13.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.927 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.498 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.3 mt -76.31 -43.08 42.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 110.925 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.17 38.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.200000000000003 111.062 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.53 -20.16 3.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 35.240000000000002 112.476 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.1 t -161.95 30.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 70.150000000000006 111.174 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -165.29 -69.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 73.140000000000001 112.507 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.98 127.34 3.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.698 -0.763 . . . . 72.239999999999995 112.493 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 158.86 176.16 30.6 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 74.209999999999994 112.475 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.23 -171.98 12.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 74.530000000000001 112.513 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.469 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.6 OUTLIER -163.66 30.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.816 0.341 . . . . 75.25 110.962 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 180' ' ' LEU . 9.3 tp60 -32.19 107.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 73.019999999999996 110.886 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.561 ' CE1' HG12 ' A' ' 161' ' ' VAL . 35.7 t80 -48.22 108.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 71.510000000000005 110.877 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 46.9 mt -64.92 -78.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 110.912 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 7.3 ptp -168.49 -174.64 2.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 73.099999999999994 110.885 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.1 mt -127.88 123.97 61.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 72.209999999999994 111.143 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.73 79.18 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 74.239999999999995 110.901 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 76.49 -146.56 33.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.724 . . . . 74.239999999999995 112.532 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 3.18 2.9 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.688 2.259 . . . . 73.25 112.363 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.9 mt -121.31 115.31 46.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.145 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.16 140.24 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 73.439999999999998 111.123 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.421 ' C ' HG23 ' A' ' 192' ' ' VAL . 11.5 mtmt -101.94 136.64 41.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 73.409999999999997 110.89 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.447 HG13 ' N ' ' A' ' 193' ' ' ARG . 82.5 t -140.42 156.46 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 75.019999999999996 111.162 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.447 ' N ' HG13 ' A' ' 192' ' ' VAL . 2.8 ttt180 -91.25 174.2 7.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 75.150000000000006 110.855 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -175.24 81.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 74.439999999999998 110.896 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 62.5 p -100.99 179.1 4.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 75.430000000000007 111.153 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.49 175.84 48.12 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.765 -0.731 . . . . 64.409999999999997 112.432 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -0.12 6.5 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.685 2.257 . . . . 73.430000000000007 112.305 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -86.39 5.39 35.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 73.099999999999994 111.089 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -94.28 170.07 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 63.43 111.127 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.443 ' O ' ' CG2' ' A' ' 200' ' ' VAL . 8.3 p 39.56 38.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 73.530000000000001 111.104 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.467 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 1.5 p -113.1 -15.3 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 62.100000000000001 111.155 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.482 ' O ' ' CG1' ' A' ' 206' ' ' ILE . 0.0 OUTLIER 80.7 -58.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 110.855 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.6 m -51.35 -63.24 1.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.010000000000005 111.111 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 42.9 t -49.47 -65.05 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 75.109999999999999 111.087 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.456 ' HB2' ' CD1' ' A' ' 224' ' ' LEU . 0.1 OUTLIER -51.74 -34.03 37.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.878 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 202' ' ' ARG . 14.1 mt -66.1 -56.72 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 70.329999999999998 111.163 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.78 -34.02 18.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 73.129999999999995 111.073 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.473 HG13 ' CD1' ' A' ' 212' ' ' LEU . 98.6 t -60.7 -69.23 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 72.010000000000005 111.094 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.3 -17.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 75.230000000000004 110.837 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -73.93 -39.74 63.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 74.510000000000005 110.89 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.92 -34.4 26.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 74.049999999999997 110.867 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.473 ' CD1' HG13 ' A' ' 208' ' ' VAL . 8.2 mt -68.59 -70.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.889 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -21.82 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 72.349999999999994 110.866 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.82 -81.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.329999999999998 110.898 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -46.4 -47.74 18.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 75.409999999999997 110.893 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.451 HG23 ' CD1' ' A' ' 154' ' ' LEU . 2.5 pt -112.95 91.49 18.24 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.631 0.729 . . . . 73.099999999999994 111.092 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -13.53 34.89 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.689 2.259 . . . . 74.109999999999999 112.354 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.18 -11.17 5.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 73.450000000000003 110.873 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 220' ' ' GLN . 1.1 mt -71.67 143.84 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.439999999999998 111.115 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 219' ' ' ILE . 2.9 mt-30 -126.19 -41.53 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 74.439999999999998 110.89 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.4 mp -141.93 104.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 73.239999999999995 111.164 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.73 121.47 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 111.14 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -114.79 129.07 56.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.450000000000003 110.908 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.456 ' CD1' ' HB2' ' A' ' 205' ' ' ARG . 10.2 mt -113.14 140.56 47.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 73.230000000000004 110.917 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.91 164.07 14.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 73.319999999999993 110.942 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 64.219999999999999 110.877 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.843 0.354 . . . . 73.310000000000002 110.875 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.48 -171.07 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 75.5 110.904 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.401 ' O ' ' O ' ' A' ' 156' ' ' LEU . 2.0 tp10 -91.0 -23.88 20.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 63.310000000000002 110.9 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.437 HD11 ' CG1' ' A' ' 219' ' ' ILE . 9.6 tt 53.99 107.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 73.409999999999997 110.913 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 185' ' ' ILE . 9.1 p30 -174.91 171.63 3.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 73.209999999999994 110.859 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -48.8 -22.84 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 73.420000000000002 110.805 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.96 -52.36 6.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 75.109999999999999 110.871 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -68.38 -53.78 21.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 74.040000000000006 110.937 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.6 m -49.5 -27.46 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 64.400000000000006 111.108 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.38 -48.23 73.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 71.549999999999997 110.862 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.06 -40.3 80.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 64.140000000000001 110.919 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.44 ' CG2' ' HB2' ' A' ' 215' ' ' LYS . 4.1 t -78.22 -35.69 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 111.166 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.425 HD13 ' CD1' ' A' ' 182' ' ' PHE . 32.5 mt -68.0 -25.3 65.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 70.319999999999993 110.941 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.416 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 19.9 m-20 -72.84 -9.5 58.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 75.439999999999998 110.847 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -94.38 -5.72 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 71.400000000000006 110.906 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.93 -40.19 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 72.299999999999997 111.155 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 1.8 mtt180 -48.01 -58.63 7.4 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.727 . . . . 71.420000000000002 110.829 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.69 -29.93 23.41 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.713 2.275 . . . . 74.439999999999998 112.355 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.557 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -58.91 -28.68 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 73.129999999999995 110.944 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.557 HD23 ' CD2' ' A' ' 171' ' ' TYR . 3.4 mt -68.57 -53.44 22.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 71.239999999999995 110.916 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -50.05 -26.53 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 73.319999999999993 111.137 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -47.78 -63.95 3.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 73.140000000000001 112.494 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.9 t -109.44 -1.76 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 72.040000000000006 111.164 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.35 101.02 0.2 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 55.009999999999998 112.483 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.462 ' HA2' ' CB ' ' A' ' 172' ' ' LEU . . . -82.1 164.02 43.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.76 -0.733 . . . . 70.209999999999994 112.518 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -136.03 -102.53 0.67 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.766 -0.73 . . . . 74.409999999999997 112.522 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -173.43 113.78 0.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.713 -0.756 . . . . 75.329999999999998 112.488 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 181' ' ' GLN . 0.7 OUTLIER -135.43 23.49 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 75.209999999999994 110.896 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 180' ' ' LEU . 1.1 tp60 -33.92 111.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 73.400000000000006 110.918 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.426 ' HB2' ' NH2' ' A' ' 169' ' ' ARG . 40.6 t80 -57.11 125.01 20.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 74.239999999999995 110.927 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.18 -77.01 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 72.540000000000006 110.915 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' MET . . . . . 0.416 ' C ' HG13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -169.9 -173.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 72.5 110.905 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.461 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 1.7 mt -132.63 132.11 59.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 73.209999999999994 111.154 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -124.21 66.26 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 74.540000000000006 110.915 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 90.78 -139.01 14.66 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.752 -0.737 . . . . 72.430000000000007 112.492 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 -4.99 15.2 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.68 2.253 . . . . 71.340000000000003 112.335 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.6 mt -114.63 120.86 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.439999999999998 111.143 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.41 HG11 ' N ' ' A' ' 191' ' ' LYS . 25.1 t -100.25 136.04 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 54.210000000000001 111.155 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.41 ' N ' HG11 ' A' ' 190' ' ' VAL . 19.5 mtmt -104.31 156.81 17.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.140000000000001 110.926 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 2.6 p 179.05 147.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 75.439999999999998 111.144 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -72.37 170.76 13.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 74.549999999999997 110.905 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.32 88.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 73.239999999999995 110.932 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.2 p -116.78 -174.49 2.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 54.520000000000003 111.13 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.54 179.14 51.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.784 -0.722 . . . . 75.019999999999996 112.507 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 2.26 3.71 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.7 2.266 . . . . 73.230000000000004 112.323 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -106.16 42.32 1.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 74.030000000000001 111.149 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -96.67 -53.93 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 74.340000000000003 111.151 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.5 p -142.15 86.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 75.040000000000006 111.151 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.485 ' O ' ' CG2' ' A' ' 201' ' ' VAL . 9.0 p -125.67 24.64 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 75.349999999999994 111.117 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.87 39.08 13.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 72.329999999999998 110.883 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.8 m -164.5 -66.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 70.109999999999999 111.175 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.434 HG22 ' CG1' ' A' ' 201' ' ' VAL . 97.7 t -53.16 -70.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 74.209999999999994 111.117 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -38.96 -30.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 72.120000000000005 110.875 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . 0.461 ' CG2' ' HE2' ' A' ' 210' ' ' LYS . 3.5 mt -80.66 -44.53 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 74.109999999999999 111.108 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -52.67 -29.8 28.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 74.140000000000001 111.096 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 210' ' ' LYS . 62.9 t -69.2 -85.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 71.040000000000006 111.13 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.474 ' N ' HG13 ' A' ' 208' ' ' VAL . 44.8 t -39.61 -25.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 75.400000000000006 110.844 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 208' ' ' VAL . 1.2 mttt -61.6 -46.45 89.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 74.319999999999993 110.878 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -49.54 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.409999999999997 110.888 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.457 HD21 ' CG1' ' A' ' 208' ' ' VAL . 2.2 mm? -52.05 -74.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 74.519999999999996 110.909 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.01 -29.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.869 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.41 -74.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 73.010000000000005 110.922 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.44 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 1.6 mptt -62.49 -48.27 80.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 75.530000000000001 110.892 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 11.6 pt -106.52 87.64 2.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.622 0.725 . . . . 74.329999999999998 111.152 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -21.44 33.84 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.232 . . . . 75.140000000000001 112.4 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.5 t -46.31 -40.03 11.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 62.32 110.862 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.478 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.8 mt -39.41 155.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 74.349999999999994 111.103 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.478 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -135.69 -34.4 0.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 110.947 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 33.2 mm -153.05 104.93 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 71.400000000000006 111.128 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.63 115.39 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 74.409999999999997 111.153 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -105.29 129.51 53.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 70.439999999999998 110.922 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.8 mt -119.07 109.11 15.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 110.926 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.35 165.41 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 73.510000000000005 110.897 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 110.864 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 7.8 mmt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.825 0.345 . . . . 71.549999999999997 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.9 mt -107.52 -174.64 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 75.329999999999998 110.956 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.498 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 1.6 mp0 -119.0 -2.58 10.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 110.893 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.48 ' O ' ' CB ' ' A' ' 157' ' ' ASN . 20.2 tp 60.81 126.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 74.439999999999998 110.937 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 156' ' ' LEU . 3.6 p30 162.19 179.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 74.129999999999995 110.884 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.05 -19.28 62.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 63.350000000000001 110.86 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.407 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 10.7 pt-20 -90.07 -34.69 15.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 75.019999999999996 110.847 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.498 ' ND2' ' H ' ' A' ' 155' ' ' GLU . 94.1 m-20 -93.29 -59.75 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 74.25 110.841 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.416 ' CG2' HD12 ' A' ' 156' ' ' LEU . 63.3 t -38.97 -43.35 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 73.219999999999999 111.115 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -45.82 -56.13 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 64.439999999999998 110.914 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -34.04 64.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 74.299999999999997 110.873 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.468 HG23 ' CB ' ' A' ' 215' ' ' LYS . 73.6 t -69.91 -50.89 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 53.420000000000002 111.128 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 22.1 mt -59.0 -22.92 61.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 74.140000000000001 110.893 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -72.32 -6.32 42.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 74.049999999999997 110.936 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -98.57 7.99 45.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 72.540000000000006 110.903 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -143.36 -35.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 72.319999999999993 111.188 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -50.37 -60.6 5.0 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.575 0.702 . . . . 75.530000000000001 110.845 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.79 0.87 5.04 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.678 2.252 . . . . 74.209999999999994 112.339 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.481 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.2 OUTLIER -97.15 -21.43 17.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 110.928 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 171' ' ' TYR . 6.4 mt -81.22 -43.95 18.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 72.239999999999995 110.935 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.58 -50.52 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 72.430000000000007 111.102 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.37 -45.0 97.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.801 -0.714 . . . . 74.140000000000001 112.501 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.0 p -88.41 21.88 2.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 74.25 111.109 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 177' ' ' GLY . . . 90.48 79.02 1.36 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 71.239999999999995 112.487 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 176' ' ' GLY . . . -37.05 156.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.789 -0.72 . . . . 51.340000000000003 112.489 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.67 -113.62 1.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 73.150000000000006 112.493 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -164.01 114.18 0.59 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.693 -0.765 . . . . 74.340000000000003 112.445 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.503 ' CD2' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -138.75 14.15 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 74.120000000000005 110.882 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -32.15 95.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 75.129999999999995 110.899 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.465 ' N ' ' O ' ' A' ' 180' ' ' LEU . 54.9 t80 -36.04 118.9 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 72.109999999999999 110.894 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 42.2 mt -78.3 -78.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 74.239999999999995 110.915 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -167.59 -159.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 74.030000000000001 110.867 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 74.8 mt -146.24 135.83 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.349999999999994 111.092 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -128.55 57.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 74.200000000000003 110.933 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.58 -140.34 14.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 63.409999999999997 112.488 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -3.35 11.84 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 73.010000000000005 112.349 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 21.8 mt -110.94 138.28 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 74.109999999999999 111.126 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 16.9 t -115.31 132.95 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 111.083 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.3 mtmt -98.25 142.55 29.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 73.519999999999996 110.873 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 193' ' ' ARG . 88.0 t -155.35 139.61 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 111.159 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.427 ' N ' HG13 ' A' ' 192' ' ' VAL . 3.1 ttt180 -73.92 169.75 16.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 110.932 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.401 ' CD1' ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -160.88 96.84 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 74.040000000000006 110.93 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.15 153.84 38.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 75.409999999999997 111.108 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 121.12 -172.56 15.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 65.239999999999995 112.497 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -8.69 24.24 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 72.430000000000007 112.313 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.65 8.49 11.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 73.450000000000003 111.105 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 194' ' ' LEU . . . -51.49 -61.59 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.030000000000001 111.099 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.07 107.96 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 74.200000000000003 111.142 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 42.4 t -146.81 -79.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 62.43 111.104 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.409 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -175.25 137.11 0.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.439999999999998 110.898 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 204' ' ' VAL . 0.2 OUTLIER 77.86 -60.86 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.443 . . . . 71.400000000000006 111.153 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 203' ' ' THR . 98.9 t -35.44 -71.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 111.11 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.55 -49.3 1.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 63.009999999999998 110.855 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.39 -58.3 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.140000000000001 111.125 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -40.51 -35.72 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 111.059 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.59 -76.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 75.25 111.109 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.4 t -54.97 -14.15 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.310000000000002 110.858 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -65.13 -39.93 93.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 74.530000000000001 110.86 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 214' ' ' GLU . 0.9 OUTLIER -87.03 -62.61 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.418 . . . . 75.420000000000002 110.958 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.467 ' C ' ' O ' ' A' ' 211' ' ' LYS . 9.8 mt -31.72 -69.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.109999999999999 110.946 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -38.0 32.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.874 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.3 OUTLIER -66.91 -79.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 74.430000000000007 110.898 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.468 ' CB ' HG23 ' A' ' 164' ' ' VAL . 11.8 mmtm -45.16 -52.75 8.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 71.530000000000001 110.916 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 212' ' ' LEU . 6.5 pt -110.57 93.68 17.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 75.239999999999995 111.136 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -23.24 31.23 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.714 2.276 . . . . 74.150000000000006 112.364 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.08 -26.28 2.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 73.329999999999998 110.838 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.9 mt -59.71 152.56 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 75.329999999999998 111.16 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLN . . . . . 0.415 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 2.2 mt-30 -131.19 -37.49 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 73.319999999999993 110.917 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.8 mt -141.72 112.38 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 74.340000000000003 111.086 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.09 114.29 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 72.439999999999998 111.074 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -103.91 129.54 51.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 72.409999999999997 110.94 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 14.2 mt -119.32 102.41 8.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 63.020000000000003 110.903 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.9 mp -82.18 160.23 23.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 75.209999999999994 110.931 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 72.120000000000005 110.842 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.562 ' CD2' ' ND2' ' A' ' 160' ' ' ASN . 3.2 mp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.769 0.319 . . . . 75.22 110.945 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.18 -11.41 14.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 73.31 110.882 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.573 ' CD1' HD12 ' A' ' 216' ' ' ILE . 29.2 tp 59.62 92.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 64.23 110.955 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.784 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -175.31 175.21 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.33 110.86 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.47 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 9.6 mt-10 -42.7 -55.39 3.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 74.1 110.895 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.405 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -51.01 -30.97 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 60.42 110.905 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.562 ' ND2' ' CD2' ' A' ' 154' ' ' LEU . 2.1 m120 -96.59 -72.53 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 72.24 110.932 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 157' ' ' ASN . 30.3 m -33.94 -34.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.54 111.13 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -55.16 -57.59 11.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.02 110.903 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -53.04 -54.45 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.14 110.898 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 211' ' ' LYS . 3.4 t -62.87 -29.57 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 61.4 111.088 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' A' ' 182' ' ' PHE . 15.1 mt -71.39 -32.49 68.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 63.2 110.919 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -72.38 -5.58 37.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 64.32 110.905 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -93.16 -9.53 39.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 64.43 110.873 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.85 -31.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 54.32 111.147 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.812 ' NE ' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -51.16 -60.67 5.2 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.535 0.683 . . . . 71.53 110.901 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.9 Cg_endo -69.78 2.54 3.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.668 2.245 . . . . 33.03 112.343 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.631 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -96.41 -28.72 14.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 70.4 110.959 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.631 HD23 ' CD2' ' A' ' 171' ' ' TYR . 9.2 mt -72.79 -34.46 66.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.868 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -85.77 -11.31 53.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.1 111.1 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -88.69 2.86 84.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 70.33 112.456 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.5 t -130.57 9.92 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 74.4 111.178 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.52 -56.8 0.58 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 72.23 112.487 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 169.09 162.03 20.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 60.3 112.475 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -173.58 -160.68 22.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.75 . . . . 72.33 112.486 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.97 110.02 0.24 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 72.34 112.499 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.812 HD11 ' NE ' ' A' ' 169' ' ' ARG . 3.7 pp -113.18 -31.73 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.745 0.307 . . . . 72.12 110.887 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.596 ' N ' HD12 ' A' ' 180' ' ' LEU . 0.4 OUTLIER 33.63 90.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 62.31 110.906 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.705 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 28.0 t80 -42.4 114.06 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 53.41 110.876 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.98 -79.61 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 44.45 110.897 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 27.5 ptm -167.67 -170.81 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 61.14 110.847 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 157' ' ' ASN . 7.3 mt -131.61 144.44 37.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 72.5 111.104 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.8 68.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 73.43 110.929 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 83.13 -141.87 21.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 64.42 112.502 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 54.0 Cg_endo -69.74 -1.18 8.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.231 . . . . 74.3 112.372 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 47.6 mt -117.92 124.25 72.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.33 111.138 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 191' ' ' LYS . 1.4 p -108.72 155.1 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 62.22 111.153 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.442 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 13.9 mtmt -116.26 141.04 48.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 72.13 110.915 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.467 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 43.7 t -151.53 155.46 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 71.32 111.134 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -94.81 172.06 8.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 63.11 110.886 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.913 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -167.67 86.21 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.51 110.929 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.1 p -123.83 177.95 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 54.24 111.14 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 87.13 -172.16 43.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 70.02 112.477 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -1.33 8.27 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.65 2.233 . . . . 62.21 112.382 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.03 57.51 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 50.31 111.14 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.913 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -99.89 -94.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 62.1 111.105 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.26 59.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 61.43 111.105 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 201' ' ' VAL . 4.9 t -101.12 30.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 60.41 111.123 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.0 OUTLIER 67.56 133.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 73.34 110.865 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.625 ' HA ' HD12 ' A' ' 206' ' ' ILE . 0.6 OUTLIER 78.54 -51.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 52.55 111.162 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 47.9 t -40.5 -51.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 54.32 111.113 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.17 -35.4 80.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.53 110.888 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 203' ' ' THR . 18.1 mt -64.1 -50.36 77.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 70.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.98 -36.77 29.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 73.21 111.103 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.501 ' O ' HD22 ' A' ' 212' ' ' LEU . 58.0 t -59.22 -83.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 63.42 111.157 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.472 ' N ' HG12 ' A' ' 208' ' ' VAL . 29.0 t -48.86 -20.54 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.14 110.837 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -58.55 -46.22 87.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 55.24 110.89 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.613 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -82.59 -46.62 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 44.14 110.937 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 208' ' ' VAL . 1.6 mm? -47.18 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.899 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.65 -52.2 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.34 110.9 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -41.21 -80.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 73.42 110.883 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 217' ' ' PRO . 0.9 OUTLIER -51.48 -51.41 55.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 63.13 110.865 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.573 HD12 ' CD1' ' A' ' 156' ' ' LEU . 5.2 pt -107.16 82.77 1.22 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.595 0.712 . . . . 73.42 111.096 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 53.7 Cg_endo -69.77 -5.69 16.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.667 2.244 . . . . 73.21 112.337 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 23.3 t -66.38 -22.95 66.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 72.21 110.862 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 7.3 mt -57.89 158.67 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 75.45 111.169 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.522 ' O ' HD13 ' A' ' 221' ' ' ILE . 1.1 mt-30 -134.84 -33.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 75.15 110.894 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.522 HD13 ' O ' ' A' ' 220' ' ' GLN . 37.5 mm -154.13 106.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 61.05 111.123 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 76.8 t -80.42 114.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 54.31 111.148 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -96.78 113.59 25.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 71.4 110.901 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.486 HD22 HD23 ' A' ' 194' ' ' LEU . 12.0 mt -100.53 102.72 13.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.893 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.91 -176.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 64.11 110.887 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.88 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.778 HD12 ' O ' ' A' ' 215' ' ' LYS . 5.9 mt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.797 0.332 . . . . 63.31 110.924 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -117.54 -0.82 11.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 65.41 110.873 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.706 HD13 HD12 ' A' ' 216' ' ' ILE . 20.4 tp 52.86 97.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 75.4 110.867 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.586 ' O ' HG22 ' A' ' 161' ' ' VAL . 3.6 p30 -159.14 164.43 35.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 75.51 110.876 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 16.8 mt-10 -45.15 -30.57 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 72.43 110.871 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.36 -44.45 52.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.945 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -80.51 -59.64 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 50.35 110.861 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.75 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 21.7 m -39.09 -33.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 71.44 111.107 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.34 -51.09 62.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 72.42 110.91 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -40.51 68.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 54.31 110.929 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.863 HG11 ' HA ' ' A' ' 212' ' ' LEU . 21.5 t -79.47 -34.79 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 70.11 111.083 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.487 HD23 HD11 ' A' ' 168' ' ' ILE . 27.9 mt -71.12 -21.31 62.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 73.15 110.912 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.415 ' O ' ' CD ' ' A' ' 170' ' ' PRO . 61.3 m-20 -74.5 -12.26 60.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 75.2 110.901 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -83.01 -14.16 54.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 71.32 110.876 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.763 HD13 ' HA ' ' A' ' 208' ' ' VAL . 3.2 pt -121.14 -31.16 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 72.35 111.09 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.731 ' HG2' HD13 ' A' ' 180' ' ' LEU . 1.1 mtt180 -49.04 -60.86 4.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.643 0.735 . . . . 73.31 110.871 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.0 Cg_endo -69.72 1.92 3.98 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.741 2.294 . . . . 74.53 112.341 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.518 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -105.66 -17.57 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 71.54 110.907 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.979 HD12 HD23 ' A' ' 180' ' ' LEU . 2.9 mt -77.84 -28.9 50.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 63.11 110.912 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.9 42.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 72.13 111.065 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -132.87 -33.59 0.37 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 53.45 112.499 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.9 t -144.59 9.51 1.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.787 0.327 . . . . 61.44 111.107 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 149.63 90.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.733 . . . . 63.43 112.488 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . -125.08 168.55 17.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 61.03 112.495 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 154.44 -14.07 0.53 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 71.11 112.502 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -134.42 116.89 1.7 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 74.43 112.553 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.979 HD23 HD12 ' A' ' 172' ' ' LEU . 0.3 OUTLIER -173.9 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 73.43 110.898 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 180' ' ' LEU . 8.3 tp60 -36.22 99.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 75.44 110.953 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.75 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 15.0 t80 -46.52 116.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 64.12 110.878 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 80.3 mt -76.0 -73.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 71.1 110.876 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.402 ' C ' HG13 ' A' ' 185' ' ' ILE . 28.0 ptm -173.4 -168.95 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 75.14 110.902 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.402 HG13 ' C ' ' A' ' 184' ' ' MET . 8.0 mt -136.25 129.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 74.01 111.137 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.37 56.14 1.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 73.35 110.911 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.91 -145.59 16.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.758 -0.734 . . . . 63.21 112.486 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 3.27 2.91 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.688 2.258 . . . . 72.13 112.322 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 221' ' ' ILE . 3.9 mp -115.21 130.49 69.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.54 111.123 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 84.0 t -104.6 148.59 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 75.42 111.087 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -116.79 140.88 48.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 71.03 110.887 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 193' ' ' ARG . 21.4 t -151.95 166.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 62.35 111.143 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.615 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.1 OUTLIER -92.87 143.11 26.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 74.23 110.909 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.666 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -143.61 87.31 1.92 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 71.42 110.888 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.05 -171.47 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 64.21 111.118 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.81 -169.85 55.01 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.723 -0.751 . . . . 44.31 112.506 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.53 ' O ' HG13 ' A' ' 201' ' ' VAL . 54.0 Cg_endo -69.67 0.43 5.59 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 35.11 112.397 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.684 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -103.68 -5.6 22.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 42.42 111.104 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.628 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -80.53 42.06 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.51 111.069 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.4 p 179.34 -29.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 74.34 111.093 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 198' ' ' ALA . 27.5 m -56.93 127.09 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 52.41 111.109 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -79.71 77.5 6.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 73.22 110.9 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 t 176.03 -44.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 63.23 111.155 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.684 HG11 ' HB1' ' A' ' 198' ' ' ALA . 41.0 t -72.21 -42.68 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 70.2 111.149 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -65.88 -7.13 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 72.43 110.838 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.55 -57.54 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 74.45 111.115 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.28 -20.48 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 73.51 111.093 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.763 ' HA ' HD13 ' A' ' 168' ' ' ILE . 88.9 t -72.29 -62.28 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 62.01 111.119 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 222' ' ' VAL . 32.1 t -80.59 14.5 2.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 71.03 110.853 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -39.86 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 74.2 110.932 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.62 -35.68 22.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 74.32 110.903 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.863 ' HA ' HG11 ' A' ' 164' ' ' VAL . 7.7 mt -68.72 -65.4 0.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 64.22 110.91 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.03 -21.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 74.21 110.878 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.409 ' N ' ' C ' ' A' ' 212' ' ' LEU . 20.9 tt0 -85.14 -72.49 0.48 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 74.44 110.881 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.778 ' O ' HD12 ' A' ' 154' ' ' LEU . 2.0 mptt -51.51 -54.04 31.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 74.32 110.92 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.715 HG23 HD13 ' A' ' 154' ' ' LEU . 2.0 pt -103.37 95.07 6.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.589 0.709 . . . . 54.25 111.15 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 -24.94 29.53 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.711 2.274 . . . . 64.13 112.358 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 46.0 t -47.37 -29.16 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 62.21 110.855 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.3 mt -59.37 153.3 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 73.22 111.122 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.431 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -139.66 -38.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.886 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 189' ' ' ILE . 21.8 mt -140.67 98.53 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 65.34 111.12 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.466 HG21 ' OG ' ' A' ' 209' ' ' SER . 67.1 t -74.89 109.15 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 72.53 111.135 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -97.68 138.89 34.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 74.24 110.966 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.666 HD22 HD23 ' A' ' 194' ' ' LEU . 8.2 mt -122.01 127.33 50.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 72.5 110.915 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 225' ' ' LEU . 2.1 mm? -96.63 172.16 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 75.31 110.888 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 43.23 110.8 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.535 HD23 ' CG ' ' A' ' 160' ' ' ASN . 4.8 mp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.779 0.323 . . . . 71.43 110.912 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -108.88 -13.23 14.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 63.44 110.875 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.728 HD13 HD12 ' A' ' 216' ' ' ILE . 15.7 tp 58.29 100.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 72.31 110.919 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.692 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -167.08 161.24 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 70.42 110.882 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.441 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -34.89 -35.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 75.21 110.869 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' ASN . 0.2 OUTLIER -71.82 -53.68 12.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.857 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.535 ' CG ' HD23 ' A' ' 154' ' ' LEU . 12.2 m-20 -67.78 -56.17 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 64.01 110.878 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.855 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 33.6 m -48.79 -27.87 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 62.23 111.147 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.46 -58.59 7.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 72.42 110.878 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -45.07 45.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 72.33 110.892 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.779 HG11 ' HA ' ' A' ' 212' ' ' LEU . 1.3 t -68.63 -42.31 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 65.32 111.134 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.514 HD11 ' CD1' ' A' ' 182' ' ' PHE . 49.7 mt -63.41 -20.64 65.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.941 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.485 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 16.3 m-20 -76.48 -9.48 58.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 51.31 110.862 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.65 1.75 56.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 74.24 110.847 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.753 HG21 ' HA ' ' A' ' 208' ' ' VAL . 1.1 pt -131.75 -45.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.04 111.148 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.49 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -46.23 -60.28 3.82 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.607 0.718 . . . . 74.4 110.858 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.79 -11.12 30.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.653 2.235 . . . . 63.33 112.397 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.55 ' CD1' ' O ' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -88.15 -12.4 44.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.885 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.509 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.3 mt -84.27 -53.57 5.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 74.35 110.961 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 175' ' ' THR . . . -58.12 -54.3 48.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 71.51 111.134 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -35.02 -31.59 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 54.2 112.44 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 173' ' ' ALA . 1.2 t -134.21 64.86 1.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 72.24 111.191 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.93 -69.71 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.744 . . . . 74.43 112.519 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . 120.34 175.75 15.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 72.52 112.443 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -158.56 -123.37 0.72 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.723 -0.751 . . . . 53.05 112.468 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 163.32 114.49 0.31 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.725 -0.75 . . . . 74.13 112.502 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.464 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 3.4 pp -133.56 -39.5 0.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.744 0.307 . . . . 63.35 110.919 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 180' ' ' LEU . 5.4 tp-100 34.3 90.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 73.41 110.904 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.855 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 25.9 t80 -36.96 107.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 73.21 110.89 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 36.0 mt -68.38 -79.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 74.51 110.935 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.2 ptp -165.3 -171.67 2.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 52.44 110.915 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.28 134.43 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 65.42 111.085 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.75 66.53 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 74.55 110.887 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 89.62 -146.0 18.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 52.22 112.452 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.8 Cg_endo -69.73 3.2 2.89 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.674 2.249 . . . . 72.33 112.36 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mt -123.23 110.46 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 74.0 111.18 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.6 p -96.25 132.3 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 75.43 111.132 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.441 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 14.8 mtmt -89.49 146.27 24.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 75.3 110.946 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 193' ' ' ARG . 97.4 t -158.93 156.56 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 75.42 111.17 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.477 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.1 OUTLIER -90.12 172.5 8.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 73.25 110.85 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.57 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -162.6 81.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 74.02 110.919 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.0 p -114.24 -169.66 1.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 75.42 111.15 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 74.11 -179.09 42.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 62.4 112.513 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -2.1 9.61 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.68 2.253 . . . . 55.23 112.342 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 1.025 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -82.57 -17.45 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.31 111.092 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -56.27 -62.68 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 72.1 111.118 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.32 97.76 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 75.04 111.153 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 7.3 p -159.79 -33.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.42 111.123 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 201' ' ' VAL . 9.9 ttp180 85.35 142.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.4 110.859 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.479 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 2.7 m 83.03 -32.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 61.4 111.156 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 1.025 HG11 ' HB1' ' A' ' 198' ' ' ALA . 33.3 t -70.14 -71.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.148 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -40.22 -43.39 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 72.11 110.912 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.556 HG22 ' CD ' ' A' ' 210' ' ' LYS . 3.1 mp -60.11 -44.13 94.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 55.11 111.116 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.39 -36.55 22.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 52.2 111.091 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.753 ' HA ' HG21 ' A' ' 168' ' ' ILE . 55.1 t -65.77 -85.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 74.21 111.149 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.697 ' HA ' HD23 ' A' ' 212' ' ' LEU . 40.9 m -34.01 -43.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 61.41 110.853 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.556 ' CD ' HG22 ' A' ' 206' ' ' ILE . 14.0 mtpt -47.84 -51.45 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.15 110.909 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.544 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -61.87 -66.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 75.13 110.899 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.82 ' H ' HD22 ' A' ' 212' ' ' LEU . 1.4 mm? -35.0 -73.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 73.02 110.956 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.34 -35.28 0.96 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 74.35 110.856 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 211' ' ' LYS . 2.6 tp10 -57.14 -72.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 71.04 110.883 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 217' ' ' PRO . 5.2 mttp -63.57 -48.73 76.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.13 110.911 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.728 HD12 HD13 ' A' ' 156' ' ' LEU . 7.1 pt -107.03 83.24 1.28 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.639 0.733 . . . . 73.43 111.104 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 53.5 Cg_endo -69.82 -5.35 16.03 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.701 2.267 . . . . 74.2 112.33 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.15 -11.7 43.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 72.14 110.897 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 5.1 mt -68.77 158.3 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 61.13 111.151 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.872 ' HB3' HD12 ' A' ' 221' ' ' ILE . 0.2 OUTLIER -136.89 -34.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 71.14 110.907 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.872 HD12 ' HB3' ' A' ' 220' ' ' GLN . 4.5 mp -150.61 108.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 62.54 111.123 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 79.1 t -86.57 112.69 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 62.13 111.116 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -100.59 115.59 30.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.21 110.916 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.57 HD22 HD23 ' A' ' 194' ' ' LEU . 4.0 mt -103.51 101.71 11.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 65.31 110.921 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.35 174.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 73.04 110.904 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 65.23 110.824 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 215' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.031 0 CA-C-O 120.769 0.318 . . . . 55.34 110.937 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -101.62 -2.79 29.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 64.11 110.894 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.725 HD13 HD12 ' A' ' 216' ' ' ILE . 10.9 tp 54.48 89.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 61.45 110.938 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.812 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -149.76 178.98 8.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.881 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.32 -48.93 77.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.857 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -58.84 -46.61 87.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 71.13 110.889 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.676 ' CG ' HD22 ' A' ' 154' ' ' LEU . 9.2 m120 -71.07 -69.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 65.22 110.925 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.856 HG21 ' CE2' ' A' ' 182' ' ' PHE . 20.7 m -36.95 -31.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 63.14 111.127 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.7 mt-10 -55.38 -58.08 9.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 70.42 110.951 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -39.59 56.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 64.43 110.93 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.963 HG11 ' HA ' ' A' ' 212' ' ' LEU . 21.4 t -64.3 -53.45 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.31 111.13 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 182' ' ' PHE . 16.2 mt -58.15 -24.56 59.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 62.33 110.897 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -72.23 -6.85 45.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 63.02 110.865 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.66 4.92 43.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 63.01 110.886 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.7 -34.54 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 75.4 111.099 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.717 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -54.71 -60.58 7.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 71.43 110.889 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.0 Cg_endo -69.82 -5.94 17.45 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.71 2.273 . . . . 50.13 112.286 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.584 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -86.42 -22.45 26.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 71.4 110.889 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.584 HD23 ' CD2' ' A' ' 171' ' ' TYR . 7.2 mt -78.21 -53.61 7.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.2 110.954 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -36.73 -51.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 72.14 111.078 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -39.41 -44.44 2.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.79 -0.719 . . . . 74.03 112.452 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 53.2 p -88.15 -33.38 18.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 54.12 111.126 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 170.38 -42.28 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.68 -0.771 . . . . 72.55 112.461 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.1 162.83 28.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 50.31 112.478 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -151.05 -94.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 64.15 112.446 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 169.99 122.34 0.63 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.69 -0.767 . . . . 64.44 112.459 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.717 HD11 ' HD2' ' A' ' 169' ' ' ARG . 1.1 pp -150.07 13.15 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 75.35 110.902 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 182' ' ' PHE . 0.5 OUTLIER -35.34 105.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 72.02 110.917 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.856 ' CE2' HG21 ' A' ' 161' ' ' VAL . 8.8 t80 -34.25 121.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 64.31 110.877 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.424 ' CD1' HD13 ' A' ' 225' ' ' LEU . 77.5 mt -80.82 -68.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 72.33 110.923 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 12.1 ptp -177.51 -175.65 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 74.02 110.897 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.2 mt -130.31 124.32 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 72.3 111.126 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.32 74.99 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.0 110.951 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 85.24 -149.04 23.51 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 73.22 112.495 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 3.53 2.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.704 2.269 . . . . 73.21 112.369 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.2 mt -117.06 123.48 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 71.55 111.101 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 41.0 t -99.09 143.69 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 71.22 111.136 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -107.56 142.33 37.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 74.5 110.887 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 193' ' ' ARG . 59.5 t -154.4 155.41 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 50.24 111.159 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.459 ' N ' HG12 ' A' ' 192' ' ' VAL . 7.5 tpt180 -94.26 154.74 17.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 63.21 110.849 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -149.91 76.84 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 75.33 110.922 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.5 p -108.17 -169.55 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.24 111.119 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.01 -178.15 33.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.766 -0.731 . . . . 63.34 112.48 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -0.78 7.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.699 2.266 . . . . 75.13 112.388 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -85.76 -6.39 59.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 54.21 111.116 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -72.03 -50.64 26.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.087 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 200' ' ' VAL . 2.7 p -93.0 71.85 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 63.3 111.131 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.941 HG12 HG22 ' A' ' 203' ' ' THR . 15.1 t -155.02 117.54 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 73.31 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 71.17 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.886 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.941 HG22 HG12 ' A' ' 201' ' ' VAL . 14.6 t -179.35 -33.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.11 111.146 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.479 HG21 ' HB1' ' A' ' 198' ' ' ALA . 20.0 t -67.69 -68.96 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.45 111.16 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -45.97 -33.14 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 72.14 110.868 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.7 mp -71.22 -42.84 75.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 65.44 111.134 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.74 -33.68 76.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 54.31 111.125 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.676 HG12 HD11 ' A' ' 212' ' ' LEU . 94.5 t -62.57 -75.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 75.21 111.125 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.587 ' HA ' HD12 ' A' ' 212' ' ' LEU . 5.6 t -53.55 -15.61 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 54.41 110.853 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -40.65 86.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 63.23 110.898 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -86.81 -35.04 19.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.01 110.909 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.963 ' HA ' HG11 ' A' ' 164' ' ' VAL . 8.5 mt -66.41 -64.45 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 61.51 110.927 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -22.19 1.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.886 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -83.95 -79.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 42.12 110.884 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.819 ' O ' HD12 ' A' ' 154' ' ' LEU . 14.8 mmtt -41.23 -55.9 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 75.11 110.927 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.725 HD12 HD13 ' A' ' 156' ' ' LEU . 4.4 pt -108.35 85.58 2.89 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 71.12 111.161 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.8 9.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.638 2.225 . . . . 71.34 112.316 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' SER . . . . . 0.412 ' HB3' ' CB ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -71.79 -6.29 40.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 63.11 110.857 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 220' ' ' GLN . 3.2 mt -73.36 154.69 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 62.14 111.146 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.565 ' O ' HD13 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -126.3 -33.7 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 71.04 110.882 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 220' ' ' GLN . 30.1 mm -151.74 107.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 73.04 111.147 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.8 t -78.77 109.07 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 73.3 111.073 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -99.44 119.69 38.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 70.34 110.907 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.7 mt -110.86 105.7 14.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 64.55 110.887 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.424 HD13 ' CD1' ' A' ' 183' ' ' LEU . 4.9 mp -81.45 162.98 23.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.9 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 63.41 110.881 -179.95 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.636 HD22 ' N ' ' A' ' 154' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.734 0.302 . . . . 74.1 110.931 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -112.01 -0.32 15.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.43 110.912 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.732 ' CD1' HD12 ' A' ' 216' ' ' ILE . 8.0 tp 61.73 110.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 75.42 110.896 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.931 ' H ' HG23 ' A' ' 161' ' ' VAL . 0.1 OUTLIER 169.64 164.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.876 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -33.97 -60.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 73.0 110.887 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -44.92 -60.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 161' ' ' VAL . 9.5 m120 -73.86 -67.39 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.1 110.912 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.931 HG23 ' H ' ' A' ' 157' ' ' ASN . 90.0 t -33.29 -46.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 65.24 111.137 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 30.0 mm-40 -47.39 -56.78 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.15 110.885 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.79 -49.8 19.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 73.52 110.89 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 212' ' ' LEU . 1.9 t -63.44 -42.72 97.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 50.35 111.137 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.59 HD22 HD12 ' A' ' 180' ' ' LEU . 75.9 mt -61.18 -28.9 69.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 74.34 110.924 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -71.25 -6.06 36.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 74.33 110.902 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.67 -12.08 24.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 70.44 110.864 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.75 -34.19 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 62.4 111.12 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.519 ' HG3' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.05 -60.96 5.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 75.24 110.925 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.4 Cg_endo -69.75 1.36 4.5 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.66 2.24 . . . . 62.24 112.363 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.627 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -94.89 -23.43 17.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 43.24 110.932 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.627 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.9 mt -80.98 -36.28 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 75.21 110.887 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.69 60.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 73.32 111.078 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.72 -44.78 80.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 71.44 112.481 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 175' ' ' THR . 5.8 t -143.2 99.99 3.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.895 0.379 . . . . 65.44 111.15 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.43 63.59 3.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.778 -0.725 . . . . 54.04 112.497 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 172' ' ' LEU . . . -62.56 100.31 0.31 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 63.24 112.454 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -79.96 -153.34 8.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.753 -0.737 . . . . 72.34 112.477 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -136.67 115.0 1.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 70.04 112.435 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.59 HD12 HD22 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -121.24 21.03 11.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 53.22 110.95 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -34.57 107.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.939 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.911 ' CE1' HG11 ' A' ' 161' ' ' VAL . 24.5 t80 -50.42 104.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 64.32 110.852 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.82 -74.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 72.53 110.91 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.46 ' CG ' ' HE3' ' A' ' 191' ' ' LYS . 1.8 ptt? -169.24 -171.37 1.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 72.42 110.898 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 157' ' ' ASN . 1.8 mt -132.61 125.94 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 43.44 111.139 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.63 77.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 74.45 110.885 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.423 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 75.75 -142.37 28.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.772 -0.728 . . . . 62.04 112.446 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.423 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.5 Cg_endo -69.78 3.3 2.86 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.711 2.274 . . . . 75.44 112.328 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.6 mt -120.55 122.9 69.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 73.03 111.128 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.2 p -106.25 135.2 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 72.54 111.125 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.46 ' HE3' ' CG ' ' A' ' 184' ' ' MET . 15.7 mtmt -93.77 142.47 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 70.55 110.877 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 85.9 t -156.65 130.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 74.22 111.137 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.61 167.43 18.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 73.12 110.842 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.473 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -157.26 85.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 60.35 110.883 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.1 p -114.15 -177.22 3.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 44.43 111.161 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.41 -177.54 51.6 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 61.22 112.471 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -12.84 33.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.661 2.24 . . . . 71.52 112.358 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.448 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -100.92 60.18 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 51.3 111.125 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -124.83 3.71 8.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 51.04 111.06 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 200' ' ' VAL . 9.5 p -169.0 76.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 72.42 111.138 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 201' ' ' VAL . 7.1 p -137.19 7.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 75.14 111.142 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.37 47.74 19.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 75.24 110.873 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.9 m -163.91 -64.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 75.05 111.14 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.621 HG23 HG11 ' A' ' 201' ' ' VAL . 77.3 t -47.75 -59.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 73.22 111.104 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.8 -22.99 6.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 75.11 110.877 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.9 mm -77.52 -47.16 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 75.44 111.139 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.25 -18.8 17.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 65.44 111.135 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.554 ' O ' HD22 ' A' ' 212' ' ' LEU . 59.9 t -73.81 -83.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 65.31 111.118 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.461 ' N ' HG12 ' A' ' 208' ' ' VAL . 2.7 t -42.28 -23.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.84 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 208' ' ' VAL . 19.5 mttt -58.8 -59.45 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.897 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.463 ' HB3' HG12 ' A' ' 164' ' ' VAL . 7.6 mmtt -65.34 -45.25 84.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 74.13 110.899 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 208' ' ' VAL . 1.5 mm? -54.03 -65.93 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 72.35 110.942 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -49.54 -32.35 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 74.15 110.897 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.4 -71.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.03 110.896 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.539 ' O ' HD22 ' A' ' 154' ' ' LEU . 7.5 mptt -56.65 -52.34 65.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 71.03 110.942 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.732 HD12 ' CD1' ' A' ' 156' ' ' LEU . 8.4 pt -106.48 86.24 2.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.593 0.711 . . . . 73.33 111.144 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -7.05 20.09 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.726 2.284 . . . . 54.12 112.296 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.76 -3.91 10.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 54.45 110.883 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.4 mt -74.19 152.59 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 63.3 111.152 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.879 ' HB3' HD12 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -132.02 -37.1 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.2 110.904 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 220' ' ' GLN . 4.6 mp -150.81 104.89 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 74.53 111.122 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.97 114.74 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 73.43 111.133 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.09 129.85 51.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.22 110.877 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.473 HD22 HD23 ' A' ' 194' ' ' LEU . 7.2 mt -118.76 126.83 52.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 71.05 110.899 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 225' ' ' LEU . 4.1 mp -94.42 168.32 10.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 72.12 110.923 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.4 110.859 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.486 HD22 ' CG ' ' A' ' 160' ' ' ASN . 16.3 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.764 0.316 . . . . 74.43 110.931 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.49 -13.53 16.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.894 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.654 ' HA ' HG21 ' A' ' 216' ' ' ILE . 6.7 tp 58.24 109.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 65.23 110.928 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.672 ' HA ' HD13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -177.52 -171.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.925 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -69.86 -4.35 19.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.865 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.484 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 7.2 mm-40 -102.15 -41.59 6.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 71.54 110.849 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.486 ' CG ' HD22 ' A' ' 154' ' ' LEU . 11.2 m120 -88.13 -41.9 12.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 65.15 110.841 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 182' ' ' PHE . 2.8 p -58.99 -30.34 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 73.21 111.175 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.77 -57.34 12.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 73.11 110.875 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.34 -44.37 23.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.21 110.868 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.979 HG11 ' HA ' ' A' ' 212' ' ' LEU . 20.6 t -68.04 -45.84 82.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.31 111.18 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.488 HD23 HD11 ' A' ' 168' ' ' ILE . 48.3 mt -61.03 -24.91 66.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 55.12 110.891 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -76.81 -2.01 31.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 70.31 110.893 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -102.62 8.7 39.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 63.1 110.919 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.746 HD13 ' HA ' ' A' ' 208' ' ' VAL . 0.7 OUTLIER -142.96 -37.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.23 111.178 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.485 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -48.7 -60.7 4.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.596 0.713 . . . . 75.53 110.868 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.78 2.86 3.17 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.715 2.276 . . . . 54.44 112.301 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.657 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -98.3 -21.41 16.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 63.31 110.923 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.657 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.9 mt -82.51 -45.88 14.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 75.15 110.87 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -50.1 -20.67 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 64.35 111.149 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -92.56 42.69 2.67 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 74.5 112.521 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 176.73 -50.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 75.53 111.113 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -178.63 70.58 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 74.13 112.498 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -57.05 163.13 6.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.714 -0.755 . . . . 63.42 112.496 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -144.84 -102.58 0.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 61.44 112.481 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.58 112.53 0.53 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.741 . . . . 74.15 112.477 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.528 ' C ' ' CD2' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -136.62 6.26 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 61.34 110.912 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.479 ' N ' HD22 ' A' ' 180' ' ' LEU . 2.5 tp60 -35.12 109.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 75.2 110.886 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.668 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 22.7 t80 -43.81 121.51 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 70.32 110.879 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 225' ' ' LEU . 19.4 mt -83.7 -73.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 65.21 110.875 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.6 -170.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 65.02 110.86 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.672 HD13 ' HA ' ' A' ' 157' ' ' ASN . 7.6 mt -136.22 138.27 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.44 111.13 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -130.25 48.37 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 64.55 110.872 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.409 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 100.54 -138.67 13.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 72.35 112.46 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.409 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.6 Cg_endo -69.82 0.35 5.81 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.635 2.223 . . . . 74.1 112.326 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.84 101.35 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 73.44 111.13 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.91 142.11 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 50.42 111.134 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.456 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 5.5 mtmt -100.42 146.31 27.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.944 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 98.5 t -159.13 147.48 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 73.54 111.117 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.5 165.34 23.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.892 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.746 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -161.77 71.5 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 52.44 110.92 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 17.1 p -113.89 176.53 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 63.44 111.081 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.19 -163.22 26.44 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 52.31 112.486 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -38.21 8.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.691 2.26 . . . . 73.34 112.358 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.754 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -83.26 49.39 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 71.52 111.087 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.746 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -105.93 -62.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 63.21 111.115 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.1 m -95.15 28.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 71.22 111.122 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.66 136.7 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 64.52 111.14 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.413 ' C ' HG22 ' A' ' 203' ' ' THR . 5.2 mmt180 -89.96 84.76 6.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 65.24 110.872 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.474 ' HA ' HD12 ' A' ' 206' ' ' ILE . 0.7 OUTLIER 168.54 -45.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 74.33 111.135 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.754 HG11 ' HB1' ' A' ' 198' ' ' ALA . 75.4 t -73.12 -55.35 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 74.44 111.155 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -51.14 -34.41 30.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 75.54 110.895 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.731 HG22 ' HG3' ' A' ' 210' ' ' LYS . 6.1 mt -68.78 -58.63 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 64.44 111.133 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -39.36 -50.25 2.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.42 111.106 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.746 ' HA ' HD13 ' A' ' 168' ' ' ILE . 40.5 t -45.34 -84.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 62.44 111.1 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.6 ' N ' HG12 ' A' ' 208' ' ' VAL . 48.8 m -47.85 -34.57 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 62.51 110.834 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.731 ' HG3' HG22 ' A' ' 206' ' ' ILE . 0.0 OUTLIER -49.88 -40.19 42.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 74.42 110.889 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -86.35 -38.64 17.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 61.21 110.874 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.979 ' HA ' HG11 ' A' ' 164' ' ' VAL . 15.1 mt -62.6 -67.65 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 72.22 110.887 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.1 -31.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 71.32 110.867 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.86 -73.24 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.842 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.615 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.7 OUTLIER -51.69 -51.2 57.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 72.0 110.913 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.654 HG21 ' HA ' ' A' ' 156' ' ' LEU . 1.7 pt -105.53 89.79 3.61 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.595 0.712 . . . . 63.33 111.12 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 54.0 Cg_endo -69.72 -16.33 37.67 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.702 2.268 . . . . 52.45 112.374 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 47.4 m -58.27 -19.85 37.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 72.13 110.836 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.468 HG21 ' CG2' ' A' ' 222' ' ' VAL . 3.3 mt -67.99 152.28 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 73.24 111.121 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.443 ' C ' HG13 ' A' ' 221' ' ' ILE . 0.2 OUTLIER -133.42 -37.92 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 54.5 110.904 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.443 HG13 ' C ' ' A' ' 220' ' ' GLN . 50.9 mt -145.38 96.26 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.42 111.111 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.468 ' CG2' HG21 ' A' ' 219' ' ' ILE . 58.1 t -74.13 104.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.144 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.4 113.98 24.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.889 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.462 ' HB3' HD23 ' A' ' 194' ' ' LEU . 1.3 mt -110.26 100.82 9.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.42 . . . . 70.35 110.934 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.445 HD13 HD12 ' A' ' 183' ' ' LEU . 4.3 mp -65.76 159.5 25.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 74.01 110.917 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 52.11 110.84 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.0 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.744 0.307 . . . . 62.14 110.96 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -96.46 -9.4 29.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 70.22 110.903 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.84 HD13 HD12 ' A' ' 216' ' ' ILE . 13.3 tp 51.77 100.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 73.01 110.915 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -171.07 167.28 7.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 70.34 110.849 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.458 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 4.5 mt-10 -37.64 -54.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 61.54 110.898 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -48.79 -52.5 23.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.869 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 163' ' ' LYS . 4.2 m120 -73.87 -70.32 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.51 110.883 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.571 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 13.3 m -33.78 -37.74 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 62.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -60.08 -50.01 75.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 52.42 110.879 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.0 OUTLIER -55.83 -54.19 47.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 71.42 110.895 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' A' ' 211' ' ' LYS . 3.5 t -61.86 -41.11 89.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 75.1 111.144 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 37.4 mt -61.2 -27.78 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 43.54 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 13.6 m120 -71.07 -8.67 55.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 74.04 110.881 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -88.57 -15.73 34.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 72.21 110.929 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.473 HG21 ' HA ' ' A' ' 208' ' ' VAL . 1.2 pt -117.72 -33.13 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.53 111.098 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.723 ' HG3' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -50.42 -60.29 5.61 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.596 0.712 . . . . 64.31 110.849 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.79 -3.42 11.99 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.643 2.229 . . . . 62.24 112.34 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.762 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -92.29 -16.81 25.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.908 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.762 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.8 mt -83.44 -28.94 28.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 72.24 110.897 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 175' ' ' THR . . . -79.81 -39.29 31.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 71.43 111.115 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -36.87 -33.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.744 -0.741 . . . . 60.54 112.485 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 173' ' ' ALA . 1.7 t -154.42 74.46 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.802 0.334 . . . . 74.22 111.158 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 146.93 -106.95 0.38 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 63.02 112.523 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -145.54 -98.39 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 73.32 112.483 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 129.85 123.12 2.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 74.05 112.542 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.45 107.37 0.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 71.34 112.504 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.723 HD21 ' HG3' ' A' ' 169' ' ' ARG . 4.3 pp -144.11 -40.16 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.776 0.322 . . . . 61.34 110.93 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.591 ' N ' HD12 ' A' ' 180' ' ' LEU . 13.5 tp60 34.24 90.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 75.15 110.923 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.571 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 31.5 t80 -34.49 113.76 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 74.0 110.919 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 191' ' ' LYS . 14.2 mt -66.78 -79.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 75.12 110.923 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 18.5 ptp -171.88 -174.59 1.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 62.04 110.852 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.47 143.55 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 74.34 111.122 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.88 39.19 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 73.31 110.931 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 112.7 -139.3 15.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.687 -0.768 . . . . 72.14 112.503 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.8 Cg_endo -69.73 0.27 5.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.668 2.245 . . . . 64.14 112.347 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.78 127.72 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 62.53 111.122 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.78 145.25 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 51.32 111.095 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.439 ' HB3' HD12 ' A' ' 183' ' ' LEU . 22.2 mtmt -112.81 145.49 40.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 75.23 110.869 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 21.7 t -158.23 154.12 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 74.23 111.089 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.568 ' O ' HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -91.67 169.84 10.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.847 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.568 HD22 ' O ' ' A' ' 193' ' ' ARG . 0.2 OUTLIER -163.33 92.31 0.73 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 63.14 110.929 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.13 167.92 19.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 73.1 111.134 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 100.19 -160.96 19.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 74.43 112.473 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.94 7.65 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.665 2.243 . . . . 70.21 112.33 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.545 ' O ' HG11 ' A' ' 204' ' ' VAL . . . -137.88 50.14 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 50.23 111.103 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.541 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -74.88 -27.32 60.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 63.51 111.09 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 200' ' ' VAL . 1.1 p 166.14 92.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 74.53 111.132 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 8.5 p -116.76 -36.94 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 73.23 111.148 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.53 ' C ' HD12 ' A' ' 206' ' ' ILE . 0.6 OUTLIER 162.96 -85.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 70.12 110.899 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 37.0 p -59.63 -25.7 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 70.02 111.161 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 208' ' ' VAL . 53.9 t -58.23 -56.21 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 64.34 111.141 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -32.03 60.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 54.44 110.874 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.537 HG22 ' HE3' ' A' ' 210' ' ' LYS . 36.3 mt -64.01 -56.78 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 74.34 111.186 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.01 -32.45 54.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 72.41 111.12 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 204' ' ' VAL . 55.3 t -63.12 -86.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 54.43 111.166 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.652 ' HA ' HD23 ' A' ' 212' ' ' LEU . 24.5 m -33.94 -45.4 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 61.12 110.844 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' A' ' 206' ' ' ILE . 3.2 mtmt -44.46 -50.3 9.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 72.11 110.906 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.536 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -64.93 -66.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 61.22 110.889 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.82 ' H ' HD22 ' A' ' 212' ' ' LEU . 1.0 OUTLIER -37.4 -67.36 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.912 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -29.54 3.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 74.33 110.835 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.9 OUTLIER -68.25 -75.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 64.31 110.938 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -56.63 -52.88 63.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 60.11 110.878 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.84 HD12 HD13 ' A' ' 156' ' ' LEU . 5.6 pt -107.16 84.46 1.68 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.661 0.743 . . . . 61.31 111.152 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -11.3 30.53 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.665 2.243 . . . . 50.51 112.32 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 45.5 t -58.26 -22.09 51.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 72.43 110.875 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.7 mt -57.7 155.51 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 70.43 111.118 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.448 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 1.1 tt0 -132.48 -34.57 1.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 71.0 110.875 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 27.9 mm -149.25 106.56 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 61.44 111.157 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.473 HG12 ' HG ' ' A' ' 224' ' ' LEU . 95.1 t -74.71 110.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 70.04 111.161 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -96.41 104.24 16.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 71.31 110.919 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.473 ' HG ' HG12 ' A' ' 222' ' ' VAL . 1.1 mt -105.54 115.39 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.895 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.0 mp -98.66 159.83 14.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 62.34 110.953 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 72.53 110.833 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.544 HD22 ' OD1' ' A' ' 160' ' ' ASN . 10.4 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.8 0.333 . . . . 75.1 110.911 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -102.54 -1.29 30.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.887 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 216' ' ' ILE . 12.4 tp 60.1 108.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 65.04 110.877 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.873 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -168.22 -178.98 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 72.24 110.891 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.11 -49.07 79.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 74.1 110.899 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -59.58 -32.53 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 62.02 110.901 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.544 ' OD1' HD22 ' A' ' 154' ' ' LEU . 4.9 m120 -83.48 -70.28 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 74.33 110.914 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 157' ' ' ASN . 29.5 m -35.63 -30.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 65.14 111.084 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 160' ' ' ASN . 2.8 mt-10 -55.31 -58.85 6.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.55 110.868 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -51.06 56.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 52.35 110.903 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.74 HG11 ' HA ' ' A' ' 212' ' ' LEU . 1.4 t -65.25 -31.03 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 63.23 111.121 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 165' ' ' LEU . 14.1 mt -72.6 -32.14 65.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.48 . . . . 71.34 110.895 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 60.7 m-20 -67.39 -14.29 62.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 63.22 110.921 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -89.53 4.98 47.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 71.4 110.871 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 169' ' ' ARG . 0.3 OUTLIER -139.91 -55.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 52.41 111.148 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -35.34 -58.89 0.73 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.709 . . . . 73.25 110.879 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.69 -27.87 26.26 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.281 . . . . 64.54 112.366 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.622 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -73.08 -16.03 61.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 71.32 110.91 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.6 mt -75.61 -46.37 32.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 72.03 110.909 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 174' ' ' GLY . . . -58.03 -42.56 85.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 45.43 111.101 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -34.82 -78.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 63.3 112.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.1 t -94.97 40.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 73.1 111.152 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . 96.67 94.93 1.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 73.4 112.542 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . -82.98 171.48 50.74 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 64.34 112.47 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -126.22 -87.36 0.64 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 22.44 112.468 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 157.63 109.72 0.29 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.757 -0.735 . . . . 55.23 112.453 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 2.9 pp -112.1 -34.15 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 75.04 110.879 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER 33.85 89.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 75.42 110.919 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 28.6 t80 -38.52 107.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.881 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 191' ' ' LYS . 14.4 mt -66.22 -80.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.42 110.948 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -166.08 -168.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 75.3 110.896 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 157' ' ' ASN . 7.6 mt -135.53 124.79 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 75.44 111.166 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.76 72.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.887 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.421 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 82.87 -140.71 20.39 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 72.52 112.488 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.421 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 54.0 Cg_endo -69.75 0.01 6.25 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 73.02 112.36 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 25.5 mt -117.76 136.16 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 71.12 111.099 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.51 130.86 73.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 52.12 111.131 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.506 ' HB3' HD12 ' A' ' 183' ' ' LEU . 14.5 mtmt -90.54 142.58 27.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 52.34 110.946 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 55.7 t -153.67 151.43 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 75.43 111.156 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.866 ' O ' HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -86.73 163.55 17.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 74.1 110.914 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 193' ' ' ARG . 0.3 OUTLIER -158.21 79.63 0.83 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 75.23 110.944 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 p -113.32 171.34 7.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.483 . . . . 61.24 111.115 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 86.83 -169.56 40.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.707 -0.759 . . . . 64.12 112.498 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -19.29 36.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.69 2.26 . . . . 65.52 112.34 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.916 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -97.83 42.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 64.25 111.14 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -96.14 92.03 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 62.32 111.089 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.457 HG13 ' HE ' ' A' ' 205' ' ' ARG . 76.8 t 45.06 90.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 62.24 111.151 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 202' ' ' ARG . 43.5 t -125.66 -82.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 72.44 111.127 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.77 ' O ' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -176.21 47.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.44 110.869 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 202' ' ' ARG . 0.7 OUTLIER -174.57 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 72.13 111.13 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.916 HG21 ' HB1' ' A' ' 198' ' ' ALA . 93.4 t -58.75 -70.89 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 43.23 111.136 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.457 ' HE ' HG13 ' A' ' 200' ' ' VAL . 0.0 OUTLIER -35.33 -44.22 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.53 110.872 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.444 HD12 ' N ' ' A' ' 203' ' ' THR . 2.9 mt -54.11 -50.42 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.114 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -62.71 -32.86 74.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.24 111.1 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.678 ' C ' HD23 ' A' ' 212' ' ' LEU . 40.8 t -80.38 0.99 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 72.44 111.164 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -134.57 7.38 3.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.897 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.59 -40.64 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 74.41 110.887 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -80.64 -27.32 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 53.01 110.878 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.74 ' HA ' HG11 ' A' ' 164' ' ' VAL . 2.4 mm? -69.08 -71.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 72.34 110.894 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -45.18 -21.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.869 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 212' ' ' LEU . 1.2 tp10 -70.77 -66.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 74.5 110.867 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.491 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.4 OUTLIER -67.22 -44.3 79.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.12 110.926 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.633 HD12 HD13 ' A' ' 156' ' ' LEU . 4.8 pt -111.57 89.18 10.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 73.11 111.101 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -20.68 34.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 71.42 112.354 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.06 -22.88 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 70.11 110.815 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.6 mt -58.51 148.14 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.12 111.156 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.465 ' O ' HD13 ' A' ' 221' ' ' ILE . 0.9 OUTLIER -129.44 -39.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 74.42 110.92 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 220' ' ' GLN . 27.3 mm -150.67 114.43 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 64.53 111.087 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 85.6 t -86.81 121.49 37.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.02 111.103 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -108.5 122.87 47.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.34 110.961 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.752 ' HB3' HD23 ' A' ' 194' ' ' LEU . 24.8 mt -115.27 102.2 9.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.921 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.2 mt -72.71 173.35 9.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 72.4 110.897 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.6 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 64.04 110.896 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 215' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.79 0.329 . . . . 61.21 110.892 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.547 ' HB3' HD22 ' A' ' 157' ' ' ASN . 1.3 tp10 -97.77 -13.2 21.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 62.41 110.884 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.694 ' CD1' HD12 ' A' ' 216' ' ' ILE . 5.3 tp 58.56 113.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.13 110.915 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.753 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 174.7 166.43 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 63.11 110.934 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.36 -26.32 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 73.24 110.853 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 160' ' ' ASN . 11.5 pm0 -78.58 -33.28 47.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 62.54 110.886 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 162' ' ' GLU . 24.9 m-20 -100.87 -60.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.912 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 157' ' ' ASN . 9.3 p -42.18 -23.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 72.24 111.122 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.596 ' HA ' HD12 ' A' ' 165' ' ' LEU . 4.3 mt-10 -64.67 -55.01 22.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 50.12 110.891 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -40.78 45.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 74.54 110.889 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.662 HG11 ' HA ' ' A' ' 212' ' ' LEU . 25.2 t -71.38 -33.41 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 54.13 111.144 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 162' ' ' GLU . 9.1 mt -71.02 -28.78 64.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 70.21 110.931 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.486 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 29.4 m-80 -71.02 -8.21 51.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 62.5 110.898 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.94 -3.88 50.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 74.41 110.849 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.88 -36.9 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 72.24 111.127 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.499 ' HA ' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.99 -59.93 7.86 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 73.12 110.876 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.7 Cg_endo -69.79 -20.79 34.22 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.717 2.278 . . . . 74.11 112.331 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.661 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -69.2 -19.77 63.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.927 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.661 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.8 mt -79.51 -55.36 5.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 65.32 110.935 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -43.43 -28.66 0.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 53.1 111.086 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.57 -39.38 93.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 43.31 112.504 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 43.3 p -107.18 1.74 24.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 71.01 111.185 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 149.38 -56.09 0.48 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 63.22 112.46 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 110.5 173.78 20.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 61.15 112.476 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -161.04 -111.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 43.34 112.532 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -178.73 119.83 0.67 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.757 -0.735 . . . . 73.1 112.506 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 169' ' ' ARG . 0.5 OUTLIER -149.55 11.99 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.754 0.311 . . . . 64.22 110.91 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 182' ' ' PHE . 29.6 tp60 -35.02 104.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 53.31 110.907 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.731 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 22.0 t80 -34.69 125.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.31 110.858 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 89.8 mt -86.66 -74.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.919 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 22.8 ptp -165.11 -173.66 2.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 74.05 110.895 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 157' ' ' ASN . 5.9 mt -130.84 136.94 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 63.42 111.163 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -136.15 71.98 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 70.35 110.855 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 81.89 -145.3 24.61 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 73.22 112.527 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.516 ' HG2' HD12 ' A' ' 189' ' ' ILE . 53.9 Cg_endo -69.76 3.27 2.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 72.34 112.347 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.516 HD12 ' HG2' ' A' ' 188' ' ' PRO . 4.2 mp -122.83 112.09 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 70.14 111.156 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.409 HG21 ' HE1' ' A' ' 182' ' ' PHE . 7.4 p -92.16 142.1 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 61.22 111.098 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -99.87 141.56 32.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 70.24 110.933 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.7 t -154.51 147.87 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 71.2 111.122 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.779 ' O ' HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -87.93 166.82 14.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 62.53 110.869 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.78 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -159.16 96.63 1.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.938 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 15.7 p -125.5 179.94 4.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 63.3 111.157 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.96 -177.91 54.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 51.13 112.517 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -20.53 34.79 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.732 2.288 . . . . 74.43 112.349 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.24 -24.24 47.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 33.42 111.101 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.78 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -49.94 -63.03 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.15 111.145 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 200' ' ' VAL . 1.0 OUTLIER -119.99 96.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.4 111.116 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 201' ' ' VAL . 10.2 p -162.85 22.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 73.41 111.092 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.7 OUTLIER 59.46 152.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 75.24 110.862 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 2.5 m 81.15 -68.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.0 111.151 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 205' ' ' ARG . 92.7 t -44.39 -67.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 63.02 111.158 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 204' ' ' VAL . 6.8 ptm180 -36.72 -36.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 71.15 110.871 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.555 HG22 ' CD ' ' A' ' 210' ' ' LYS . 3.8 mp -77.26 -51.17 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 72.33 111.136 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -51.94 -16.43 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 65.42 111.152 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 86.3 t -89.51 -52.52 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 54.51 111.152 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.3 t -84.14 24.48 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.2 110.808 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.555 ' CD ' HG22 ' A' ' 206' ' ' ILE . 0.3 OUTLIER -111.24 -40.21 4.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 74.1 110.916 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -31.73 33.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.882 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.662 ' HA ' HG11 ' A' ' 164' ' ' VAL . 6.6 mt -69.54 -65.21 0.74 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.925 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -28.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 70.43 110.921 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -75.51 -68.19 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 64.43 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.456 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.7 OUTLIER -56.32 -56.61 18.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 75.52 110.896 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.694 HD12 ' CD1' ' A' ' 156' ' ' LEU . 3.5 pt -104.77 92.22 4.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.654 0.74 . . . . 72.34 111.095 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 53.5 Cg_endo -69.81 -22.53 31.72 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.655 2.237 . . . . 62.35 112.359 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' SER . . . . . 0.407 ' HB3' HD22 ' A' ' 156' ' ' LEU . 0.3 OUTLIER -50.22 -20.45 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 73.44 110.842 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.6 mt -62.54 154.02 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 75.42 111.109 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.443 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -136.29 -37.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 63.11 110.928 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 189' ' ' ILE . 29.6 mm -152.09 105.31 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 74.2 111.151 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 74.3 t -81.29 118.77 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 52.44 111.124 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -101.91 108.03 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 72.31 110.913 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.766 ' HB3' HD23 ' A' ' 194' ' ' LEU . 3.3 mt -96.65 102.35 14.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 75.34 110.918 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 226' ' ' SER . 9.1 mp -70.94 173.42 7.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 64.2 110.904 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 225' ' ' LEU . 44.4 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.842 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 154' ' ' LEU . 10.5 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.782 0.325 . . . . 72.41 110.898 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.87 -7.99 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 73.01 110.858 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.841 HD13 HD12 ' A' ' 216' ' ' ILE . 6.8 tp 50.89 98.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 71.22 110.887 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.681 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -166.17 169.85 13.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.52 110.884 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.466 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 3.7 mt-10 -44.53 -29.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 54.14 110.876 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.459 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 3.7 pt-20 -70.66 -42.88 70.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 54.42 110.884 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 162' ' ' GLU . 7.7 m120 -86.53 -63.5 1.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 63.13 110.864 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.758 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 33.8 m -37.51 -30.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 64.21 111.123 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.4 mt-10 -64.85 -51.93 59.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 74.2 110.883 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -58.57 -50.43 73.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 75.34 110.904 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.422 HG13 ' HD3' ' A' ' 215' ' ' LYS . 1.7 t -62.24 -30.2 48.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 74.14 111.085 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.575 HD11 ' CD1' ' A' ' 182' ' ' PHE . 18.2 mt -73.63 -28.48 61.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 75.1 110.926 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.487 ' O ' ' CD ' ' A' ' 170' ' ' PRO . 37.9 m-80 -71.38 -11.97 61.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.861 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.22 -18.33 39.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 75.42 110.938 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.494 HD11 HD23 ' A' ' 165' ' ' LEU . 2.9 pt -115.99 -24.54 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 52.15 111.163 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.58 ' HG3' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -55.97 -60.43 8.82 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.593 0.711 . . . . 73.51 110.908 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.487 ' CD ' ' O ' ' A' ' 166' ' ' ASN . 53.7 Cg_endo -69.81 -2.01 9.49 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 53.24 112.361 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.717 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -88.94 -42.89 11.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 71.14 110.899 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.717 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.4 mt -57.05 -45.79 82.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 63.12 110.929 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -45.43 107.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 53.05 111.134 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 133.5 -50.38 0.88 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.76 . . . . 23.43 112.487 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.9 t -133.23 22.34 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 52.03 111.092 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -153.6 -79.46 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 53.11 112.456 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 56.22 15.82 12.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.778 -0.725 . . . . 71.11 112.477 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.34 -93.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 64.14 112.507 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 193' ' ' ARG . . . 175.03 123.92 0.77 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 60.1 112.442 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.699 ' C ' HD12 ' A' ' 180' ' ' LEU . 2.7 pp -135.27 -0.22 2.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 70.34 110.941 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 180' ' ' LEU . 1.4 pp0? -30.73 117.62 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.51 110.873 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.758 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 19.3 t80 -55.63 129.62 39.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 70.33 110.856 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.67 -74.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 72.2 110.889 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 16.6 ptp -167.45 -170.77 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 63.53 110.844 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 157' ' ' ASN . 35.0 mt -138.36 133.46 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 72.12 111.097 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -130.91 59.8 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.925 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 99.12 -146.74 18.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.725 -0.75 . . . . 71.21 112.514 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 3.04 3.0 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.705 2.27 . . . . 70.21 112.335 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.4 mt -115.81 118.34 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 70.35 111.155 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 66.8 t -91.27 139.73 17.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.44 111.083 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 192' ' ' VAL . 7.8 mtmt -107.49 145.83 32.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 61.3 110.901 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 193' ' ' ARG . 70.6 t -158.73 158.18 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 61.53 111.112 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.541 ' O ' HD22 ' A' ' 194' ' ' LEU . 5.8 ttt180 -99.5 137.81 37.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.903 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.541 HD22 ' O ' ' A' ' 193' ' ' ARG . 1.8 mm? -130.46 84.47 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 71.23 110.926 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -112.32 170.09 8.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.32 111.145 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.42 ' N ' ' OG1' ' A' ' 195' ' ' THR . . . 84.06 -163.25 39.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 61.15 112.462 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -35.45 12.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.686 2.258 . . . . 64.02 112.338 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.724 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -84.59 32.29 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 71.34 111.063 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.48 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -72.19 -52.2 17.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 61.42 111.123 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.579 ' O ' HG13 ' A' ' 200' ' ' VAL . 7.1 p -164.66 69.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 70.12 111.111 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 202' ' ' ARG . 56.1 t -88.83 -83.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 74.34 111.1 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.504 ' N ' HG12 ' A' ' 201' ' ' VAL . 0.0 OUTLIER 172.08 41.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 75.41 110.9 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.492 ' N ' HD12 ' A' ' 206' ' ' ILE . 23.1 m -166.83 -57.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 63.33 111.186 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.724 HG11 ' HB1' ' A' ' 198' ' ' ALA . 31.9 t -60.11 -63.96 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 71.03 111.127 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -44.56 -29.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 71.43 110.855 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 203' ' ' THR . 3.0 mt -79.8 -45.25 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 71.03 111.149 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.28 -15.07 31.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.113 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 209' ' ' SER . 54.1 t -80.25 -85.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 70.31 111.143 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.593 ' HA ' HD23 ' A' ' 212' ' ' LEU . 1.6 t -33.43 -41.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 72.41 110.854 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.44 -54.7 7.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 52.21 110.896 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -56.31 19.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 75.04 110.862 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.695 ' H ' HD22 ' A' ' 212' ' ' LEU . 1.6 mm? -45.7 -74.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 70.13 110.881 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 212' ' ' LEU . 3.9 ttp180 -37.39 -52.49 1.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 74.05 110.874 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -46.36 -92.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.857 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.422 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -38.26 -54.26 1.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 63.23 110.883 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.841 HD12 HD13 ' A' ' 156' ' ' LEU . 11.2 pt -106.17 88.19 2.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.602 0.715 . . . . 74.43 111.122 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -23.21 31.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.648 2.232 . . . . 74.33 112.376 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.7 t -45.63 -28.54 1.0 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 72.55 110.862 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -55.65 157.15 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 75.42 111.1 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.498 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.5 OUTLIER -141.68 -37.84 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 62.52 110.964 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 220' ' ' GLN . 11.2 mt -140.93 85.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 54.14 111.128 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.04 115.9 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.52 111.094 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.491 ' O ' HD23 ' A' ' 224' ' ' LEU . 8.2 mm-40 -95.76 152.77 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 34.13 110.889 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 223' ' ' GLN . 20.4 mt -139.7 100.01 3.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 74.15 110.9 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 225' ' ' LEU . 0.3 OUTLIER -57.56 177.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 72.14 110.926 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 61.02 110.857 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' A' ' 160' ' ' ASN . 7.0 mp . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.815 0.34 . . . . 71.45 110.905 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.91 -18.05 14.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 70.52 110.911 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.751 HD13 HD12 ' A' ' 216' ' ' ILE . 6.6 tp 61.92 106.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 73.51 110.977 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.731 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -176.25 166.76 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 55.12 110.853 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -42.22 -38.97 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 70.03 110.834 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -65.18 -56.26 13.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 64.25 110.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.578 ' HB3' HD23 ' A' ' 154' ' ' LEU . 53.1 m-20 -76.52 -61.87 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 72.13 110.901 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 157' ' ' ASN . 6.1 p -38.69 -28.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 54.3 111.113 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 160' ' ' ASN . 2.4 mm-40 -59.52 -59.96 4.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 62.3 110.843 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -36.71 23.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 74.14 110.894 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.899 HG11 ' HA ' ' A' ' 212' ' ' LEU . 41.9 t -70.64 -45.85 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 54.14 111.121 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.582 HD22 HD12 ' A' ' 180' ' ' LEU . 75.7 mt -61.09 -24.08 65.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.932 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.41 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 24.3 m-80 -74.57 -5.86 45.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 63.4 110.894 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.09 -8.06 40.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 64.2 110.85 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.425 HD11 HD23 ' A' ' 165' ' ' LEU . 1.3 pt -123.22 -43.68 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 75.32 111.14 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -44.22 -59.95 3.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.576 0.703 . . . . 62.51 110.914 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.79 -30.48 22.09 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 75.52 112.373 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.616 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -63.76 -14.51 53.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 73.03 110.948 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.616 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.5 mt -79.56 -55.62 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 74.12 110.917 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.51 -54.24 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.23 111.127 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -40.71 -60.33 2.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.747 . . . . 75.03 112.452 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 82.8 p -64.92 -50.38 66.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 75.21 111.164 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -169.54 -40.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 52.52 112.455 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 127.44 164.44 11.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.509 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.21 -178.74 41.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 74.43 112.524 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -140.42 99.98 0.26 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 71.02 112.494 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.582 HD12 HD22 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -118.31 25.84 10.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.751 0.31 . . . . 74.52 110.89 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 180' ' ' LEU . 1.4 pp0? -35.77 119.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 74.34 110.944 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.603 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 19.5 t80 -48.5 116.2 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 71.42 110.862 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.26 -73.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.905 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 14.1 ptp -171.32 -171.05 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 74.2 110.912 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -131.78 131.12 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 73.14 111.132 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -135.43 74.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 61.22 110.931 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.33 -144.77 24.84 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 63.43 112.446 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 3.52 2.74 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.689 2.259 . . . . 72.4 112.314 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 44.5 mt -109.63 149.72 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 52.22 111.128 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.7 t -126.39 135.33 64.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 70.32 111.146 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -105.0 133.95 48.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 71.54 110.878 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 180' ' ' LEU . 66.3 t -153.41 129.63 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 53.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 179.42 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 72.42 110.833 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.25 67.92 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 71.24 110.919 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 73.4 p -90.42 -179.8 5.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 64.31 111.187 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 91.76 173.64 42.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 72.05 112.482 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -16.84 37.52 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.25 . . . . 45.04 112.345 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.46 -18.92 59.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 53.52 111.104 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.62 -45.63 81.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 74.11 111.107 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 30.9 m -92.0 49.3 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 61.53 111.159 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 83.6 t -138.81 125.57 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 75.12 111.164 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -55.79 158.05 3.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 73.11 110.879 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.428 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 1.9 m 79.73 -55.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.479 . . . . 74.31 111.191 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 208' ' ' VAL . 76.1 t -38.88 -60.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.05 111.121 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -43.97 39.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 74.23 110.87 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.53 HG22 ' HG3' ' A' ' 210' ' ' LYS . 70.1 mt -64.64 -53.77 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 71.02 111.168 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -44.53 -27.74 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 75.24 111.12 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 204' ' ' VAL . 2.6 t -73.05 -56.47 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 74.3 111.162 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.683 ' HB3' HG21 ' A' ' 222' ' ' VAL . 0.7 OUTLIER -83.31 20.39 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 73.31 110.85 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.53 ' HG3' HG22 ' A' ' 206' ' ' ILE . 3.7 mtpp -103.66 -40.26 6.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 75.53 110.895 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.38 -34.12 25.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 65.52 110.889 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.899 ' HA ' HG11 ' A' ' 164' ' ' VAL . 7.4 mt -68.32 -67.3 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.898 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.59 -24.16 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 60.54 110.904 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -78.7 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 74.33 110.904 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.423 ' O ' HD13 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -46.29 -51.43 14.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 72.51 110.931 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.751 HD12 HD13 ' A' ' 156' ' ' LEU . 2.2 pt -107.02 91.96 7.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.593 0.711 . . . . 72.43 111.141 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 216' ' ' ILE . 53.6 Cg_endo -69.76 -17.64 37.46 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.667 2.245 . . . . 74.13 112.329 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.6 t -54.46 -28.44 44.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 34.3 110.833 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.8 mt -57.64 153.12 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 72.33 111.127 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.75 ' HB3' HD12 ' A' ' 221' ' ' ILE . 2.0 mt-30 -133.12 -37.38 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.22 110.907 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 220' ' ' GLN . 3.8 mp -145.74 102.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 72.43 111.088 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.683 HG21 ' HB3' ' A' ' 209' ' ' SER . 0.4 OUTLIER -70.72 107.58 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 71.11 111.113 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -93.2 94.51 8.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.889 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.9 117.22 24.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.916 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.68 170.93 15.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 71.43 110.889 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 73.43 110.893 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.65 HD12 HG23 ' A' ' 216' ' ' ILE . 28.6 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.728 0.299 . . . . 75.41 110.946 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -110.69 -8.75 14.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 63.2 110.907 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.708 HD13 HD12 ' A' ' 216' ' ' ILE . 26.8 tp 58.19 97.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 64.41 110.9 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.639 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -159.06 164.27 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.922 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -46.58 -21.94 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.51 110.924 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -41.14 18.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 74.52 110.899 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.15 -57.13 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 74.4 110.873 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.863 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 29.5 m -45.96 -26.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 64.23 111.093 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -61.08 -59.44 5.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.91 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -42.33 42.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 72.33 110.907 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.887 HG11 ' HA ' ' A' ' 212' ' ' LEU . 2.0 t -70.6 -42.1 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 65.33 111.144 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.571 HD11 ' CD1' ' A' ' 182' ' ' PHE . 31.0 mt -61.86 -32.93 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 74.04 110.948 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -69.95 -3.66 17.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.42 110.887 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -94.43 -2.01 52.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.875 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.75 ' CD1' HG13 ' A' ' 208' ' ' VAL . 4.1 pt -136.59 -35.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 72.22 111.159 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.489 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -45.95 -60.02 4.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.535 0.683 . . . . 75.23 110.836 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.0 Cg_endo -69.73 3.29 2.84 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.713 2.276 . . . . 63.34 112.349 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.614 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -102.39 -23.56 13.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 70.41 110.927 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.614 HD23 ' CD2' ' A' ' 171' ' ' TYR . 2.5 mt -84.31 -36.95 22.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 65.21 110.889 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.27 -13.37 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 70.31 111.052 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.17 -40.96 8.25 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.71 -0.757 . . . . 74.12 112.425 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.0 t -105.16 4.49 31.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 75.44 111.108 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -179.24 -101.5 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 44.4 112.469 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.31 69.75 0.4 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.716 -0.754 . . . . 42.54 112.496 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.88 -123.31 1.89 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 53.23 112.477 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -138.14 112.47 0.89 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 64.41 112.455 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.857 ' H ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -122.11 6.65 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.729 0.299 . . . . 74.33 110.933 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 182' ' ' PHE . 0.2 OUTLIER -37.94 96.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 64.22 110.893 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.863 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 17.6 t80 -37.49 119.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 73.45 110.887 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.0 mt -77.54 -73.41 0.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 61.35 110.905 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 15.0 ptp -174.15 -174.36 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 61.41 110.891 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 157' ' ' ASN . 11.3 mt -133.33 137.01 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 54.35 111.178 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.8 57.05 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 72.12 110.862 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 91.72 -135.24 12.67 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 41.22 112.451 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.634 ' O ' HD13 ' A' ' 189' ' ' ILE . 53.7 Cg_endo -69.66 2.4 3.52 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.716 2.277 . . . . 72.14 112.342 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.872 HD12 ' HB ' ' A' ' 221' ' ' ILE . 26.9 mm -125.41 124.46 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 63.03 111.13 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 6.4 p -109.97 137.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 64.3 111.17 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 15.0 mtmt -101.16 146.46 27.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 72.13 110.9 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 91.0 t -158.94 152.69 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 72.24 111.127 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.528 ' NH1' HG21 ' A' ' 195' ' ' THR . 0.0 OUTLIER -84.5 155.26 22.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 74.42 110.877 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -153.16 84.41 1.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 70.32 110.941 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.528 HG21 ' NH1' ' A' ' 193' ' ' ARG . 11.9 p -120.18 -170.94 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.33 111.143 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 73.13 -168.6 53.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 41.32 112.503 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -15.69 37.13 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.256 . . . . 72.42 112.348 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 194' ' ' LEU . . . -96.21 52.25 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 51.5 111.087 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.673 ' C ' HG23 ' A' ' 200' ' ' VAL . . . -142.99 141.73 31.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 73.12 111.068 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.673 HG23 ' C ' ' A' ' 199' ' ' ALA . 2.7 t 81.45 -40.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.22 111.14 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 1.009 HG12 HG22 ' A' ' 203' ' ' THR . 87.9 t -47.46 139.24 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 52.04 111.129 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 1.7 tpt85 -85.55 78.23 9.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 70.14 110.879 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . 1.009 HG22 HG12 ' A' ' 201' ' ' VAL . 2.5 t 174.33 -42.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 61.02 111.117 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.673 ' O ' HG23 ' A' ' 208' ' ' VAL . 45.7 t -70.08 -44.33 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.25 111.095 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -4.81 18.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 75.12 110.861 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.404 HG22 ' HG3' ' A' ' 210' ' ' LYS . 10.6 mm -91.31 -66.88 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 71.21 111.107 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -45.71 -21.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 75.41 111.091 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.75 HG13 ' CD1' ' A' ' 168' ' ' ILE . 87.7 t -74.79 -75.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 63.35 111.136 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.515 ' HA ' HD12 ' A' ' 212' ' ' LEU . 33.7 t -57.43 -12.5 2.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 74.52 110.852 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 206' ' ' ILE . 0.0 OUTLIER -72.22 -40.27 67.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 72.41 110.906 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.541 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -78.03 -32.92 51.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.852 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.887 ' HA ' HG11 ' A' ' 164' ' ' VAL . 9.2 mt -72.16 -60.37 2.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 73.01 110.945 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -46.33 -26.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 62.33 110.854 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.96 -74.27 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 75.12 110.88 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.51 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.8 OUTLIER -53.21 -52.71 58.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 75.1 110.914 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.708 HD12 HD13 ' A' ' 156' ' ' LEU . 6.8 pt -106.2 87.75 2.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.722 . . . . 74.12 111.159 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -5.82 17.12 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.664 2.243 . . . . 71.03 112.332 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.9 t -69.22 -1.6 8.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.44 110.873 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -78.96 154.84 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 65.15 111.192 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -138.12 -35.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.34 110.898 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.872 ' HB ' HD12 ' A' ' 189' ' ' ILE . 47.2 mt -152.71 103.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 73.35 111.146 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.463 HG21 ' OG ' ' A' ' 209' ' ' SER . 93.8 t -78.13 107.95 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 35.14 111.107 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -94.0 118.5 31.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.923 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -114.41 102.48 10.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.35 110.88 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.593 ' H ' HD12 ' A' ' 225' ' ' LEU . 5.1 mp -69.9 162.77 27.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 65.15 110.947 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 75.24 110.834 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.435 HD23 ' HB3' ' A' ' 160' ' ' ASN . 6.9 mp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.775 0.321 . . . . 72.35 110.925 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -103.37 -12.74 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.23 110.885 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.755 HD13 HD12 ' A' ' 216' ' ' ILE . 11.2 tp 60.85 115.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 71.02 110.942 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.676 ' O ' HG12 ' A' ' 161' ' ' VAL . 16.8 p30 174.76 -173.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 70.31 110.898 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -37.4 87.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.15 110.847 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.413 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 11.3 pt-20 -72.92 -24.2 60.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 73.25 110.869 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 162' ' ' GLU . 91.7 m-20 -101.07 -67.74 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 72.24 110.877 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.755 HG11 ' CZ ' ' A' ' 182' ' ' PHE . 4.0 p -36.82 -29.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 71.03 111.166 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.6 mt-10 -55.01 -59.32 4.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.92 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -36.39 62.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 64.31 110.866 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.915 HG11 ' HA ' ' A' ' 212' ' ' LEU . 93.1 t -65.23 -42.01 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 62.44 111.145 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.478 HD11 ' CD1' ' A' ' 182' ' ' PHE . 62.0 mt -69.43 -21.81 63.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 64.11 110.887 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -72.88 -16.12 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 64.53 110.877 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -89.72 6.35 41.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.33 110.86 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.692 HG21 ' HA ' ' A' ' 208' ' ' VAL . 0.9 OUTLIER -137.76 -34.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.22 111.122 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.7 -61.03 5.23 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.539 0.685 . . . . 75.45 110.889 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.78 -11.37 30.67 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.684 2.256 . . . . 71.12 112.335 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.543 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -84.86 -13.18 51.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 73.3 110.959 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.847 HD11 ' CD2' ' A' ' 180' ' ' LEU . 6.4 mt -80.39 -41.89 23.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.931 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -39.21 -48.59 1.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.12 111.119 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.3 -55.66 29.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 72.25 112.485 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.8 p -77.08 2.46 15.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.795 0.331 . . . . 71.35 111.12 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 151.1 -64.32 0.38 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.73 . . . . 72.51 112.496 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 124.44 32.41 0.83 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 42.31 112.482 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -46.35 174.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 72.51 112.483 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -126.69 117.57 2.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.752 -0.737 . . . . 64.32 112.487 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.847 ' CD2' HD11 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -118.14 25.23 10.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.788 0.328 . . . . 45.31 110.901 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 180' ' ' LEU . 1.4 pp0? -34.35 124.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 75.22 110.89 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.755 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 17.8 t80 -52.5 135.61 33.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.912 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 53.8 mt -94.28 -71.51 0.66 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 75.34 110.884 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.418 ' C ' HG13 ' A' ' 185' ' ' ILE . 6.8 ptp -176.06 -162.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 74.31 110.851 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.418 HG13 ' C ' ' A' ' 184' ' ' MET . 8.7 mt -146.41 127.42 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 51.03 111.12 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.13 48.66 1.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 51.01 110.875 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 106.73 -140.13 15.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 75.12 112.507 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 3.09 3.0 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.683 2.255 . . . . 62.13 112.357 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.49 135.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 73.35 111.126 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 156' ' ' LEU . 76.5 t -109.83 137.03 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 64.13 111.106 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -107.75 140.62 40.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 73.24 110.906 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 90.8 t -152.48 144.8 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 75.55 111.159 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.14 166.96 17.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.842 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -160.91 84.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 62.53 110.864 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.6 p -99.97 158.42 15.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 42.44 111.126 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 90.36 -177.58 42.57 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.659 -0.781 . . . . 54.44 112.435 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' PRO . . . . . 0.459 ' O ' HG23 ' A' ' 201' ' ' VAL . 53.9 Cg_endo -69.71 0.74 5.16 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.707 2.271 . . . . 72.34 112.352 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.934 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -87.93 16.87 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 32.22 111.104 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -120.52 49.39 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 61.02 111.075 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.3 p -177.56 -35.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 64.24 111.149 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 197' ' ' PRO . 20.2 t -47.94 137.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 71.15 111.122 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.421 ' C ' HD12 ' A' ' 206' ' ' ILE . 0.0 OUTLIER -80.36 42.85 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 73.45 110.893 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.1 m -160.59 -46.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 74.11 111.14 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.934 HG11 ' HB1' ' A' ' 198' ' ' ALA . 43.4 t -61.55 -64.78 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 75.52 111.12 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -50.59 -30.23 12.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 72.04 110.839 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 202' ' ' ARG . 18.5 mt -73.65 -35.69 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 72.44 111.113 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -58.32 -44.31 88.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.21 111.073 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.791 HG12 HD11 ' A' ' 212' ' ' LEU . 70.1 t -53.68 -80.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 71.25 111.157 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.4 t -42.84 -39.28 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 52.24 110.857 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.41 -40.31 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 44.24 110.934 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 212' ' ' LEU . 0.4 OUTLIER -85.11 -59.84 2.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 54.51 110.897 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.915 ' HA ' HG11 ' A' ' 164' ' ' VAL . 2.3 mt -32.72 -69.9 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 75.25 110.956 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.5 HH22 HG11 ' A' ' 222' ' ' VAL . 0.0 OUTLIER -49.35 -40.92 37.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 64.31 110.88 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 211' ' ' LYS . 2.0 mt-10 -64.53 -80.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 75.1 110.943 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.674 ' CB ' HG22 ' A' ' 164' ' ' VAL . 12.2 mmtt -40.99 -58.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 71.01 110.869 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.755 HD12 HD13 ' A' ' 156' ' ' LEU . 9.4 pt -106.97 88.42 3.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.625 0.726 . . . . 54.25 111.148 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -9.26 25.68 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.714 2.276 . . . . 73.34 112.365 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.69 -14.13 62.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 74.13 110.877 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 mt -61.11 146.02 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 74.12 111.135 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.788 ' HB3' HD12 ' A' ' 221' ' ' ILE . 13.0 mp0 -116.88 -38.28 3.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 73.13 110.873 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.788 HD12 ' HB3' ' A' ' 220' ' ' GLN . 4.7 mp -153.27 103.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 70.03 111.11 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.5 HG11 HH22 ' A' ' 213' ' ' ARG . 0.9 OUTLIER -72.9 115.56 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 55.25 111.09 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -100.66 108.11 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 71.12 110.948 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mt -99.37 113.6 26.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 75.2 110.944 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.9 mp -93.93 176.06 6.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 74.45 110.917 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 72.34 110.834 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.762 HD13 ' O ' ' A' ' 215' ' ' LYS . 6.7 mp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.753 0.311 . . . . 72.24 110.91 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -102.22 -21.56 14.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.01 110.886 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.619 HD12 HG22 ' A' ' 161' ' ' VAL . 5.5 tp 61.07 113.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 61.43 110.917 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.929 ' H ' HG23 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 174.71 -178.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 72.3 110.847 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -6.64 4.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 70.52 110.892 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.46 -43.68 7.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 54.44 110.895 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.523 ' HB3' HD23 ' A' ' 154' ' ' LEU . 61.1 m-20 -94.62 -49.48 5.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 61.04 110.902 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.929 HG23 ' H ' ' A' ' 157' ' ' ASN . 86.6 t -43.08 -44.02 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 72.13 111.155 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -57.49 -34.46 69.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 73.4 110.85 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -62.61 -45.13 94.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.919 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.958 HG11 ' HA ' ' A' ' 212' ' ' LEU . 23.1 t -70.4 -31.79 47.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 71.23 111.129 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 162' ' ' GLU . 46.5 mt -70.03 -27.8 64.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 73.04 110.936 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 14.5 m-80 -69.9 -9.35 54.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 75.34 110.83 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -87.94 -15.6 36.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 65.3 110.869 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.778 HD13 ' HA ' ' A' ' 208' ' ' VAL . 1.5 pt -118.34 -30.04 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 71.21 111.154 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.555 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.51 -61.05 5.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.703 . . . . 73.2 110.877 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.5 Cg_endo -69.74 1.78 4.12 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.702 2.268 . . . . 73.21 112.33 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.688 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -94.12 -31.53 14.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 75.14 110.924 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.688 HD23 ' CD2' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -77.61 -60.39 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 71.15 110.972 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -38.27 -52.38 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 54.1 111.076 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -38.71 -44.16 1.79 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 74.22 112.512 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.2 p -99.91 -15.09 18.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.373 . . . . 73.21 111.162 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -176.05 -88.08 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 53.34 112.473 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 114.18 99.67 2.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.695 -0.764 . . . . 73.34 112.452 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -93.25 -92.36 1.53 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 52.31 112.515 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.72 119.75 0.56 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.715 -0.755 . . . . 74.03 112.483 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.555 HD11 ' HD2' ' A' ' 169' ' ' ARG . 0.4 OUTLIER -139.78 17.8 2.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.756 0.312 . . . . 73.44 110.934 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.6 OUTLIER -34.28 96.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 72.32 110.945 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.626 ' CE1' HG11 ' A' ' 161' ' ' VAL . 91.4 t80 -36.47 118.71 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.861 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 46.8 mt -82.02 -78.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 72.44 110.922 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.9 -166.19 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 71.22 110.898 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.788 HD11 HG21 ' A' ' 161' ' ' VAL . 32.5 mt -142.55 139.91 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 52.4 111.182 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -128.5 69.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 62.12 110.917 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 89.8 -139.7 15.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 55.14 112.445 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 1.22 4.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.626 2.218 . . . . 75.33 112.333 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.5 127.55 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 70.11 111.141 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.689 HG23 HG12 ' A' ' 185' ' ' ILE . 6.2 p -105.17 144.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 73.5 111.169 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 10.7 mtmt -103.84 146.18 29.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 72.41 110.88 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 88.1 t -157.97 136.9 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 64.04 111.098 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.874 ' O ' HD22 ' A' ' 194' ' ' LEU . 11.3 ttt180 -73.69 161.35 30.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 71.54 110.848 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.879 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.2 OUTLIER -157.99 102.64 1.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 73.55 110.911 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.0 p -129.78 161.89 29.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 61.45 111.152 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.2 -177.78 38.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 71.45 112.519 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -43.8 2.46 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 74.42 112.326 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.565 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -62.8 -25.76 68.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 64.04 111.127 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.879 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -34.06 -85.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 55.31 111.149 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.03 112.2 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 71.32 111.18 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.7 HG13 ' H ' ' A' ' 202' ' ' ARG . 1.6 p -137.79 -61.49 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 74.22 111.17 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.7 ' H ' HG13 ' A' ' 201' ' ' VAL . 1.1 mtt-85 162.23 35.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 73.14 110.855 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.468 ' N ' ' CD1' ' A' ' 206' ' ' ILE . 43.7 m -168.29 -56.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 64.33 111.124 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.565 HG21 ' HB1' ' A' ' 198' ' ' ALA . 59.3 t -48.63 -70.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 60.44 111.098 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.49 -22.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.31 110.876 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 203' ' ' THR . 3.1 mp -89.89 -33.02 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 73.34 111.145 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -74.31 -11.67 60.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.52 111.066 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.778 ' HA ' HD13 ' A' ' 168' ' ' ILE . 64.1 t -85.53 -74.81 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 75.51 111.117 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.424 ' HA ' HD12 ' A' ' 212' ' ' LEU . 14.8 t -53.46 -15.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 63.41 110.872 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -64.65 -40.26 95.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.909 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.7 -41.23 12.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 75.21 110.911 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.958 ' HA ' HG11 ' A' ' 164' ' ' VAL . 24.7 mt -52.63 -66.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 72.24 110.903 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -50.43 -24.23 2.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 74.4 110.908 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.33 -68.46 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.906 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.762 ' O ' HD13 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -59.25 -48.3 82.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.912 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.497 HG23 HD22 ' A' ' 154' ' ' LEU . 1.7 pt -109.6 93.76 14.9 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.645 0.736 . . . . 64.41 111.17 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -22.09 32.96 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 65.04 112.324 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 21.0 t -54.71 -15.42 1.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 72.33 110.877 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.7 mt -70.87 143.53 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 71.23 111.159 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -127.05 -42.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 75.34 110.881 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.1 mt -140.91 102.64 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 74.22 111.123 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.21 116.22 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.077 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.51 135.2 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 64.4 110.91 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.515 ' HB3' HD23 ' A' ' 194' ' ' LEU . 30.1 mt -121.97 103.03 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 63.04 110.906 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.4 171.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.939 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 45.14 110.84 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.781 HD22 ' CG ' ' A' ' 160' ' ' ASN . 6.5 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.793 0.33 . . . . 72.44 110.928 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -108.55 -6.23 16.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 61.32 110.925 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.708 HD12 ' CG2' ' A' ' 161' ' ' VAL . 3.2 tp 61.17 119.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.55 110.943 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.93 ' H ' HG23 ' A' ' 161' ' ' VAL . 5.8 p30 169.37 179.53 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.891 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -26.5 65.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.857 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.429 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 11.6 pt-20 -84.24 -30.96 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.11 110.865 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.781 ' CG ' HD22 ' A' ' 154' ' ' LEU . 9.5 m120 -97.32 -62.29 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 63.44 110.922 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.93 HG23 ' H ' ' A' ' 157' ' ' ASN . 50.0 t -38.78 -46.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 75.31 111.156 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.14 -56.02 5.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.854 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -43.07 30.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 65.25 110.902 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.77 HG11 ' HA ' ' A' ' 212' ' ' LEU . 33.6 t -70.14 -42.94 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 65.31 111.149 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.629 HD11 ' CD1' ' A' ' 182' ' ' PHE . 56.5 mt -63.84 -24.7 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 71.13 110.905 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -69.17 -10.84 59.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.3 110.876 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -84.73 -25.74 28.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 72.14 110.884 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 169' ' ' ARG . 1.7 pt -106.98 -45.33 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 73.21 111.147 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.837 ' HG3' HD21 ' A' ' 180' ' ' LEU . 2.8 mtt180 -34.48 -58.71 0.63 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.631 0.729 . . . . 74.22 110.877 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.76 -30.8 21.72 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 72.01 112.379 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.57 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -74.34 -15.0 60.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 73.22 110.915 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.57 HD23 ' CD2' ' A' ' 171' ' ' TYR . 3.8 mt -76.5 -43.02 41.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 54.11 110.912 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.19 -22.62 48.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 60.22 111.118 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -46.32 -49.37 15.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 62.03 112.459 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.7 t -125.98 48.78 2.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 63.35 111.167 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.18 -97.65 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 72.53 112.489 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.03 125.46 4.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 63.53 112.511 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -128.81 -102.54 1.07 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 64.23 112.492 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -169.34 119.33 0.82 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.709 -0.758 . . . . 65.43 112.465 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.837 HD21 ' HG3' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -140.95 6.08 1.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 72.32 110.893 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.449 ' N ' HD13 ' A' ' 180' ' ' LEU . 0.9 OUTLIER -35.0 111.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 74.4 110.9 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.774 ' CE1' HG11 ' A' ' 161' ' ' VAL . 27.3 t80 -37.78 122.19 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 75.04 110.865 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 38.1 mt -81.01 -77.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 75.41 110.965 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.423 ' C ' HG13 ' A' ' 185' ' ' ILE . 12.5 ptm -169.99 -172.91 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 74.34 110.883 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.423 HG13 ' C ' ' A' ' 184' ' ' MET . 2.4 mt -133.73 130.52 56.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 75.21 111.134 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.09 75.83 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 71.25 110.954 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 87.19 -151.16 23.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 24.21 112.496 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 2.93 3.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.687 2.258 . . . . 75.14 112.303 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 24.0 mt -113.71 124.38 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 62.14 111.118 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.0 137.97 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.41 111.177 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.404 ' C ' HG23 ' A' ' 192' ' ' VAL . 4.6 mtmm -104.94 142.16 35.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 73.14 110.901 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.404 HG23 ' C ' ' A' ' 191' ' ' LYS . 56.1 t -156.91 142.83 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 71.4 111.152 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.468 ' NH2' HG21 ' A' ' 195' ' ' THR . 1.0 OUTLIER -73.69 163.1 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 64.31 110.887 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.72 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -164.49 93.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.41 110.915 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.468 HG21 ' NH2' ' A' ' 193' ' ' ARG . 5.9 p -132.49 -168.84 2.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 54.2 111.094 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.79 -158.13 42.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 54.22 112.476 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.26 18.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.678 2.252 . . . . 74.44 112.364 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.614 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -90.22 -162.41 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 73.24 111.131 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.716 ' HB2' HD12 ' A' ' 194' ' ' LEU . . . 74.01 144.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.062 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 200' ' ' VAL . 22.0 m 34.05 42.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 72.34 111.169 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 199' ' ' ALA . 23.0 t -99.12 -16.63 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.33 111.16 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 70.47 40.17 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 75.12 110.859 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.83 -44.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 72.21 111.133 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.614 HG11 ' HB1' ' A' ' 198' ' ' ALA . 53.6 t -72.64 -47.34 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 72.23 111.125 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -61.54 -40.89 96.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 63.21 110.893 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.72 -37.3 58.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 60.51 111.104 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.8 -29.95 69.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.01 111.107 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 212' ' ' LEU . 67.3 t -65.04 -75.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 52.52 111.125 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.527 ' HA ' HD12 ' A' ' 212' ' ' LEU . 1.9 t -55.33 -19.0 7.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 60.44 110.872 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.409 ' O ' ' OE1' ' A' ' 214' ' ' GLU . 3.8 mtpp -61.93 -40.32 95.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 71.52 110.855 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.86 -32.81 17.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 75.45 110.87 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.77 ' HA ' HG11 ' A' ' 164' ' ' VAL . 10.5 mt -69.29 -67.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 74.11 110.932 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ARG . . . . . 0.423 ' CZ ' ' OG ' ' A' ' 209' ' ' SER . 0.7 OUTLIER -45.07 -27.95 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.52 110.862 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 210' ' ' LYS . 0.4 OUTLIER -81.68 -76.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 71.13 110.902 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.509 ' CB ' HG22 ' A' ' 164' ' ' VAL . 16.4 mmtt -42.24 -59.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 65.15 110.893 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.523 HD13 HG22 ' A' ' 161' ' ' VAL . 3.4 pt -103.94 95.42 7.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.659 0.743 . . . . 71.41 111.167 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -22.04 32.58 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.673 2.249 . . . . 74.01 112.33 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 17.0 t -49.06 -35.74 16.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 63.31 110.851 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.457 HG21 HG22 ' A' ' 222' ' ' VAL . 4.5 mt -48.37 154.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.35 111.129 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.446 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.8 OUTLIER -134.94 -35.53 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 54.22 110.927 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.41 HG13 ' C ' ' A' ' 220' ' ' GLN . 53.4 mt -146.76 91.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 64.24 111.147 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 219' ' ' ILE . 39.8 t -65.05 109.82 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 73.03 111.096 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -100.9 130.58 46.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 64.55 110.856 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.72 HD22 HD23 ' A' ' 194' ' ' LEU . 14.2 mt -117.07 114.09 23.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 50.1 110.909 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.52 177.88 7.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 72.03 110.925 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 72.21 110.879 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 215' ' ' LYS . 12.4 mt . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.811 0.338 . . . . 71.22 110.897 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -104.13 -17.82 14.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.919 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.885 HD13 HD12 ' A' ' 216' ' ' ILE . 8.9 tp 59.71 111.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 73.42 110.95 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.629 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -175.99 171.96 2.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 53.42 110.867 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.18 -20.51 1.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 64.42 110.869 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.51 -35.22 25.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 73.15 110.903 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.636 ' ND2' HD22 ' A' ' 154' ' ' LEU . 4.2 m-20 -90.0 -55.85 3.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 73.02 110.882 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 157' ' ' ASN . 26.6 m -47.46 -26.72 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 63.32 111.092 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -62.79 -42.02 99.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.893 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -34.08 69.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.944 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.828 HG11 ' HA ' ' A' ' 212' ' ' LEU . 30.4 t -73.37 -42.93 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 71.54 111.087 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.944 HD22 ' CD1' ' A' ' 180' ' ' LEU . 85.0 mt -65.89 -23.59 66.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 74.32 110.915 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -73.37 -8.64 56.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 64.31 110.861 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.19 1.59 49.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.916 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.972 HD12 HG13 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -132.91 -35.19 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 64.42 111.103 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.717 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.19 -60.56 5.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 75.13 110.874 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.4 Cg_endo -69.77 -4.73 14.63 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.691 2.261 . . . . 60.22 112.305 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.596 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -90.53 -22.1 21.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 64.14 110.924 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.596 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.3 mt -76.37 -44.81 34.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 50.24 110.912 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.5 -38.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 62.25 111.13 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.69 152.1 19.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 45.12 112.501 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.0 t 40.14 56.26 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.33 . . . . 74.44 111.132 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 156.37 -86.72 0.12 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 25.05 112.46 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 89.34 89.24 1.23 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 73.51 112.526 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.33 -158.81 7.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 63.21 112.515 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.92 152.68 24.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 64.32 112.458 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.944 ' CD1' HD22 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -140.9 25.7 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 65.21 110.919 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.1 OUTLIER -32.71 110.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.956 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.569 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 5.7 t80 -46.95 133.15 11.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 75.54 110.889 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.79 -69.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 52.22 110.905 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.1 ptp -178.13 -176.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 64.31 110.859 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.2 mt -131.29 125.27 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 75.14 111.145 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -124.9 56.41 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 70.11 110.913 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 95.71 -141.77 15.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.747 -0.74 . . . . 40.34 112.424 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.422 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.7 Cg_endo -69.72 3.28 2.84 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 52.44 112.358 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.02 118.3 58.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 75.52 111.127 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 66.7 t -97.22 135.53 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 54.23 111.15 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -109.76 139.58 44.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 74.35 110.907 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 193' ' ' ARG . 40.2 t -152.23 160.58 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 63.14 111.117 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.536 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.0 OUTLIER -92.37 166.65 12.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.854 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -156.42 70.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 71.44 110.91 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 76.4 p -89.09 173.3 8.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 74.52 111.156 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 86.24 -179.49 49.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.761 . . . . 75.22 112.455 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -24.43 29.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.709 2.273 . . . . 73.24 112.342 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.674 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -79.85 103.43 9.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 73.41 111.074 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -165.0 -74.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 45.4 111.103 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 28.5 m -61.92 -11.01 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.146 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 13.2 t -64.02 128.82 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.44 111.131 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -77.58 58.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 61.43 110.871 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 96.6 m -163.65 -55.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 74.53 111.13 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.674 HG21 ' HB1' ' A' ' 198' ' ' ALA . 59.8 t -54.47 -61.44 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 64.13 111.112 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -53.73 -25.69 19.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.51 110.873 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.01 -28.73 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 71.04 111.114 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.93 -32.34 72.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 70.55 111.075 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 1.021 HG12 HD11 ' A' ' 212' ' ' LEU . 3.8 t -67.07 -70.26 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 63.43 111.114 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.617 ' HA ' HD12 ' A' ' 212' ' ' LEU . 7.8 t -50.35 -17.91 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.854 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -66.96 -41.09 87.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 73.24 110.918 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -88.49 -33.99 17.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.1 110.905 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 1.021 HD11 HG12 ' A' ' 208' ' ' VAL . 11.3 mt -63.88 -67.14 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -16.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 72.2 110.85 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.96 -78.45 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.13 110.871 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.681 ' O ' HD12 ' A' ' 154' ' ' LEU . 1.2 mttp -47.09 -55.87 7.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 72.43 110.863 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.885 HD12 HD13 ' A' ' 156' ' ' LEU . 4.1 pt -108.05 91.53 8.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 75.13 111.152 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -16.06 37.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.63 2.22 . . . . 74.54 112.37 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.78 -23.94 7.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 71.51 110.821 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 5.2 mt -58.81 158.14 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 72.23 111.112 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.498 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -137.59 -35.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 75.34 110.903 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 220' ' ' GLN . 72.9 mt -150.71 96.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 71.35 111.143 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 222' ' ' VAL . 28.7 m -67.89 121.52 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.13 111.134 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.63 119.18 38.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.91 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.48 119.16 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 72.13 110.959 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.31 168.87 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 70.04 110.928 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.23 110.852 -179.907 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.737 HD23 ' CG ' ' A' ' 160' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.747 0.308 . . . . 64.34 110.911 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -104.12 -17.05 15.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 75.32 110.894 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.721 ' CD1' HD12 ' A' ' 216' ' ' ILE . 9.4 tp 58.15 113.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.2 110.896 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.621 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 175.52 -177.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.875 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.421 ' HA ' HG12 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -52.89 -45.38 67.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 72.43 110.823 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -57.93 -56.17 25.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 72.03 110.927 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.737 ' CG ' HD23 ' A' ' 154' ' ' LEU . 10.2 m120 -74.52 -65.85 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 71.42 110.909 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 157' ' ' ASN . 2.5 p -34.75 -33.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 54.34 111.147 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -56.22 -57.1 13.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.901 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.96 -43.71 77.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.908 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.882 HG11 ' HA ' ' A' ' 212' ' ' LEU . 17.8 t -63.81 -40.89 90.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 63.45 111.177 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 182' ' ' PHE . 54.0 mt -66.35 -32.79 74.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 74.41 110.891 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 4.5 m-80 -63.97 -13.13 43.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.31 110.844 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.02 1.13 48.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 63.21 110.877 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.702 HG21 ' HA ' ' A' ' 208' ' ' VAL . 0.6 OUTLIER -135.15 -34.61 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 62.22 111.157 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.42 -60.77 5.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 71.51 110.851 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' CG ' ' O ' ' A' ' 166' ' ' ASN . 53.8 Cg_endo -69.76 -0.39 6.83 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 63.33 112.34 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.639 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -92.99 -27.1 17.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 72.21 110.943 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.639 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.1 mt -75.63 -39.95 57.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 74.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -44.36 -50.33 9.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 75.21 111.157 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -45.3 -43.74 9.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 50.21 112.504 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.9 t -113.76 37.43 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 74.31 111.124 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.71 109.08 0.46 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 65.14 112.469 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -74.9 137.56 22.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.704 -0.76 . . . . 42.1 112.507 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.01 -106.44 2.9 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.718 -0.753 . . . . 61.04 112.474 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.08 113.81 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.752 . . . . 71.03 112.471 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 181' ' ' GLN . 1.7 pp -142.55 6.68 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.736 0.303 . . . . 71.53 110.905 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 182' ' ' PHE . 2.2 tp60 -36.19 105.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 74.52 110.897 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.604 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 10.0 t80 -34.09 129.44 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 62.2 110.876 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 89.0 mt -95.6 -72.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.51 110.923 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.404 ' C ' HG13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -166.06 -173.31 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 72.11 110.861 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 187' ' ' GLY . 4.1 mt -135.52 143.92 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 75.53 111.116 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LYS . . . . . 0.475 ' CG ' ' HB ' ' A' ' 189' ' ' ILE . 7.9 ptpt -121.4 38.43 4.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 73.12 110.872 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.584 ' H ' HG22 ' A' ' 185' ' ' ILE . . . 93.35 -112.23 4.25 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 70.41 112.49 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.519 ' HG2' HD12 ' A' ' 189' ' ' ILE . 53.4 Cg_endo -69.82 -22.89 31.18 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.723 2.282 . . . . 70.5 112.314 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.519 HD12 ' HG2' ' A' ' 188' ' ' PRO . 2.6 mp -106.45 146.66 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 65.25 111.115 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.69 137.54 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 63.42 111.165 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -98.25 140.13 33.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 62.43 110.922 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 193' ' ' ARG . 41.4 t -151.03 149.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 62.22 111.109 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.441 ' O ' HG12 ' A' ' 192' ' ' VAL . 0.0 OUTLIER -83.97 161.4 20.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.842 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -173.12 61.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 65.15 110.983 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 22.6 p -80.42 -49.3 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.34 111.133 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -45.87 173.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.711 -0.757 . . . . 43.13 112.498 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.18 2.93 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 71.43 112.345 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 1.153 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -78.42 6.9 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 61.41 111.102 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 194' ' ' LEU . . . -91.76 -61.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 62.11 111.063 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 200' ' ' VAL . 21.3 t -76.12 50.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 31.02 111.115 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 198' ' ' ALA . 1.7 t -124.89 146.17 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.53 111.172 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -95.5 35.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 62.01 110.869 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.7 m -156.68 -66.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.31 111.144 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 1.153 HG11 ' HB1' ' A' ' 198' ' ' ALA . 57.9 t -44.78 -58.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 73.21 111.125 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -56.69 -21.86 30.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.11 110.896 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.437 HG22 ' HG3' ' A' ' 210' ' ' LYS . 15.6 mm -80.96 -52.22 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 65.41 111.158 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.98 -35.7 25.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 64.54 111.107 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.702 ' HA ' HG21 ' A' ' 168' ' ' ILE . 38.9 t -59.53 -83.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 64.2 111.117 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.588 ' N ' HG12 ' A' ' 208' ' ' VAL . 48.0 t -49.22 -18.49 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 64.51 110.863 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.437 ' HG3' HG22 ' A' ' 206' ' ' ILE . 3.0 mttm -60.48 -40.23 90.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 54.12 110.909 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 214' ' ' GLU . 1.4 mmtt -86.59 -54.56 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 70.12 110.847 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.882 ' HA ' HG11 ' A' ' 164' ' ' VAL . 1.5 mt -37.07 -70.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 65.3 110.877 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -53.49 -22.46 8.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 72.31 110.86 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -77.39 -67.42 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 70.31 110.923 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.67 ' O ' HD13 ' A' ' 154' ' ' LEU . 1.9 mptt -60.72 -46.39 90.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 64.51 110.916 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.721 HD12 ' CD1' ' A' ' 156' ' ' LEU . 4.4 pt -111.68 86.26 6.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.657 0.742 . . . . 72.31 111.111 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 0.26 5.92 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.688 2.259 . . . . 73.44 112.319 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.6 t -76.6 1.68 16.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 72.33 110.857 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 6.3 mt -83.65 157.88 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 74.45 111.13 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.501 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.1 OUTLIER -132.43 -33.13 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 74.01 110.932 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 189' ' ' ILE . 33.6 mm -153.62 108.89 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 70.51 111.13 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.2 t -82.52 117.83 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 71.42 111.087 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -107.87 136.25 47.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 72.23 110.891 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.8 mt -124.05 104.32 8.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 63.41 110.944 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.18 168.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 62.12 110.915 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 61.13 110.862 -179.908 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.501 ' CB ' HG22 ' A' ' 216' ' ' ILE . 11.4 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.815 0.341 . . . . 74.11 110.895 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.66 ' HB3' HD22 ' A' ' 157' ' ' ASN . 0.7 OUTLIER -97.85 -18.09 18.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 62.2 110.873 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.623 HD12 HD12 ' A' ' 216' ' ' ILE . 5.6 tp 61.49 113.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 64.42 110.926 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.962 ' H ' HG23 ' A' ' 161' ' ' VAL . 0.1 OUTLIER 171.8 173.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.883 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 162' ' ' GLU . 3.6 mt-10 -49.49 -37.03 24.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 63.42 110.901 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.8 -54.12 25.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 63.42 110.924 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.438 ' HB3' HD13 ' A' ' 154' ' ' LEU . 8.5 m120 -79.32 -62.82 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 64.42 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.962 HG23 ' H ' ' A' ' 157' ' ' ASN . 72.7 t -34.56 -50.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 73.54 111.133 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 20.7 mm-40 -40.34 -60.2 1.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.865 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.28 -36.86 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 64.24 110.929 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.815 HG11 ' HA ' ' A' ' 212' ' ' LEU . 40.2 t -73.44 -34.39 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.082 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' A' ' 182' ' ' PHE . 27.8 mt -72.79 -30.93 64.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 71.34 110.927 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.82 -6.85 44.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.894 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -90.98 -12.87 34.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.32 110.871 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.514 HD13 HG22 ' A' ' 208' ' ' VAL . 0.8 OUTLIER -123.51 -28.33 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 72.4 111.119 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.652 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -51.61 -60.87 5.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 74.41 110.844 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.9 Cg_endo -69.73 2.62 3.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.675 2.25 . . . . 62.31 112.37 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.634 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -97.61 -28.44 13.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.927 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.634 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.3 mt -76.31 -43.08 42.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 72.14 110.925 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.17 38.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 65.33 111.062 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.53 -20.16 3.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 35.24 112.476 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.1 t -161.95 30.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 64.23 111.174 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -165.29 -69.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 54.43 112.507 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.98 127.34 3.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.698 -0.763 . . . . 70.12 112.493 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 158.86 176.16 30.6 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 74.21 112.475 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.23 -171.98 12.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 74.53 112.513 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.652 HD11 ' HD2' ' A' ' 169' ' ' ARG . 0.6 OUTLIER -163.66 30.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.816 0.341 . . . . 72.13 110.962 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 180' ' ' LEU . 9.3 tp60 -32.19 107.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 73.02 110.886 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.826 ' CE1' HG11 ' A' ' 161' ' ' VAL . 35.7 t80 -48.22 108.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 71.51 110.877 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.728 HD12 HD13 ' A' ' 225' ' ' LEU . 46.9 mt -64.92 -78.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.14 110.912 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 7.3 ptp -168.49 -174.64 2.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 71.54 110.885 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.1 mt -127.88 123.97 61.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 51.51 111.143 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.73 79.18 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 74.11 110.901 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 76.49 -146.56 33.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.724 . . . . 74.24 112.532 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 3.18 2.9 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.688 2.259 . . . . 73.25 112.363 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.9 mt -121.31 115.31 46.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 72.31 111.145 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.16 140.24 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 53.14 111.123 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.573 ' HG2' HD11 ' A' ' 225' ' ' LEU . 11.5 mtmt -101.94 136.64 41.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 54.21 110.89 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 193' ' ' ARG . 82.5 t -140.42 156.46 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 75.02 111.162 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.476 ' N ' HG12 ' A' ' 192' ' ' VAL . 2.8 ttt180 -91.25 174.2 7.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.11 110.855 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 199' ' ' ALA . 0.2 OUTLIER -175.24 81.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 74.44 110.896 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 62.5 p -100.99 179.1 4.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 75.43 111.153 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.49 175.84 48.12 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.765 -0.731 . . . . 64.33 112.432 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -0.12 6.5 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.685 2.257 . . . . 73.43 112.305 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.86 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -86.39 5.39 35.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 73.1 111.089 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.489 ' HB2' HD12 ' A' ' 194' ' ' LEU . . . -94.28 170.07 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 63.43 111.127 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 200' ' ' VAL . 8.3 p 39.56 38.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 73.53 111.104 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.467 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 1.5 p -113.1 -15.3 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 62.1 111.155 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.778 ' HD3' HD11 ' A' ' 206' ' ' ILE . 0.0 OUTLIER 80.7 -58.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.32 110.855 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.6 m -51.35 -63.24 1.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.01 111.111 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.86 HG21 ' HB1' ' A' ' 198' ' ' ALA . 42.9 t -49.47 -65.05 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 61.2 111.087 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ARG . . . . . 0.473 ' HB2' ' CD1' ' A' ' 224' ' ' LEU . 0.1 OUTLIER -51.74 -34.03 37.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.878 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.778 HD11 ' HD3' ' A' ' 202' ' ' ARG . 14.1 mt -66.1 -56.72 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 70.33 111.163 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.78 -34.02 18.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 73.13 111.073 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.869 HG12 HD11 ' A' ' 212' ' ' LEU . 98.6 t -60.7 -69.23 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 61.54 111.094 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.582 ' HA ' HD12 ' A' ' 212' ' ' LEU . 0.9 OUTLIER -51.3 -17.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 75.23 110.837 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -73.93 -39.74 63.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.89 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.92 -34.4 26.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 74.05 110.867 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.869 HD11 HG12 ' A' ' 208' ' ' VAL . 8.2 mt -68.59 -70.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 71.43 110.889 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -21.82 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 71.22 110.866 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.82 -81.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 52.23 110.898 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -46.4 -47.74 18.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 75.41 110.893 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.623 HD12 HD12 ' A' ' 156' ' ' LEU . 2.5 pt -112.95 91.49 18.24 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.631 0.729 . . . . 73.1 111.092 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -13.53 34.89 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.689 2.259 . . . . 74.11 112.354 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.18 -11.17 5.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.873 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.576 HG12 HD13 ' A' ' 156' ' ' LEU . 1.1 mt -71.67 143.84 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.44 111.115 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -126.19 -41.53 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 74.44 110.89 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.4 mp -141.93 104.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 71.42 111.164 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.73 121.47 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.11 111.14 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -114.79 129.07 56.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.908 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.473 ' CD1' ' HB2' ' A' ' 205' ' ' ARG . 10.2 mt -113.14 140.56 47.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 60.01 110.917 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.728 HD13 HD12 ' A' ' 183' ' ' LEU . 5.7 mp -115.91 164.07 14.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 63.21 110.942 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 64.22 110.877 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 154' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.77 0.319 . . . . 75.5 110.904 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.401 ' O ' ' O ' ' A' ' 156' ' ' LEU . 2.0 tp10 -91.0 -23.88 20.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 63.31 110.9 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.589 HD11 ' CG1' ' A' ' 219' ' ' ILE . 9.6 tt 53.99 107.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 73.41 110.913 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.807 ' HA ' HD13 ' A' ' 185' ' ' ILE . 9.1 p30 -174.91 171.63 3.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 71.33 110.859 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -48.8 -22.84 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 65.13 110.805 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.96 -52.36 6.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 74.3 110.871 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -68.38 -53.78 21.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 74.04 110.937 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 157' ' ' ASN . 18.6 m -49.5 -27.46 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 64.4 111.108 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.38 -48.23 73.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 71.55 110.862 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.06 -40.3 80.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 54.31 110.919 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.644 HG12 ' HB3' ' A' ' 211' ' ' LYS . 4.1 t -78.22 -35.69 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 71.24 111.166 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 182' ' ' PHE . 32.5 mt -68.0 -25.3 65.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 70.32 110.941 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.416 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 19.9 m-20 -72.84 -9.5 58.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.847 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -94.38 -5.72 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 61.45 110.906 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.93 -40.19 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 65.23 111.155 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.558 ' HA ' HD21 ' A' ' 180' ' ' LEU . 1.8 mtt180 -48.01 -58.63 7.4 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.727 . . . . 65.34 110.829 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.69 -29.93 23.41 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.713 2.275 . . . . 71.2 112.355 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.73 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -58.91 -28.68 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 73.13 110.944 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.73 HD23 ' CD2' ' A' ' 171' ' ' TYR . 3.4 mt -68.57 -53.44 22.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 71.24 110.916 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -50.05 -26.53 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 73.03 111.137 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -47.78 -63.95 3.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 64.53 112.494 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.9 t -109.44 -1.76 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 72.04 111.164 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.35 101.02 0.2 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 55.01 112.483 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.476 ' HA2' ' CB ' ' A' ' 172' ' ' LEU . . . -82.1 164.02 43.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.76 -0.733 . . . . 51.15 112.518 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -136.03 -102.53 0.67 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.766 -0.73 . . . . 70.04 112.522 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -173.43 113.78 0.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.713 -0.756 . . . . 75.33 112.488 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 169' ' ' ARG . 0.7 OUTLIER -135.43 23.49 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 73.12 110.896 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 180' ' ' LEU . 1.1 tp60 -33.92 111.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 71.04 110.918 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 40.6 t80 -57.11 125.01 20.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 73.24 110.927 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.18 -77.01 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 72.54 110.915 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' MET . . . . . 0.425 ' C ' HG13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -169.9 -173.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 72.5 110.905 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.807 HD13 ' HA ' ' A' ' 157' ' ' ASN . 1.7 mt -132.63 132.11 59.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 64.12 111.154 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -124.21 66.26 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.52 110.915 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 90.78 -139.01 14.66 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.752 -0.737 . . . . 72.43 112.492 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.408 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.1 Cg_endo -69.83 -4.99 15.2 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.68 2.253 . . . . 71.34 112.335 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.6 mt -114.63 120.86 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.44 111.143 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.74 HG22 HG23 ' A' ' 185' ' ' ILE . 25.1 t -100.25 136.04 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 54.21 111.155 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -104.31 156.81 17.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.14 110.926 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 193' ' ' ARG . 2.6 p 179.05 147.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 75.32 111.144 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ARG . . . . . 0.412 ' O ' HG22 ' A' ' 192' ' ' VAL . 0.3 OUTLIER -72.37 170.76 13.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 52.43 110.905 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.667 HD23 HD22 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -168.32 88.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.4 110.932 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.2 p -116.78 -174.49 2.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 54.22 111.13 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.54 179.14 51.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.784 -0.722 . . . . 75.02 112.507 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 2.26 3.71 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.7 2.266 . . . . 73.23 112.323 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.979 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -106.16 42.32 1.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 74.03 111.149 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -96.67 -53.93 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 74.34 111.151 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 200' ' ' VAL . 3.5 p -142.15 86.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 75.04 111.151 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 201' ' ' VAL . 9.0 p -125.67 24.64 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 75.35 111.117 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.87 39.08 13.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 71.52 110.883 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.598 ' N ' HD12 ' A' ' 206' ' ' ILE . 55.8 m -164.5 -66.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 70.11 111.175 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.979 HG11 ' HB1' ' A' ' 198' ' ' ALA . 97.7 t -53.16 -70.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 42.35 111.117 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -38.96 -30.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 72.12 110.875 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ILE . . . . . 0.598 HD12 ' N ' ' A' ' 203' ' ' THR . 3.5 mt -80.66 -44.53 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 71.31 111.108 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -52.67 -29.8 28.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 73.14 111.096 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 209' ' ' SER . 62.9 t -69.2 -85.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 55.03 111.13 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.483 ' N ' HG12 ' A' ' 208' ' ' VAL . 44.8 t -39.61 -25.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 70.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.544 ' CE ' HG22 ' A' ' 206' ' ' ILE . 1.2 mttt -61.6 -46.45 89.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 63.34 110.878 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.644 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -71.97 -49.54 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.22 110.888 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.714 ' H ' HD22 ' A' ' 212' ' ' LEU . 2.2 mm? -52.05 -74.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 74.52 110.909 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.01 -29.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 71.22 110.869 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.41 -74.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 73.01 110.922 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.455 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 1.6 mptt -62.49 -48.27 80.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 64.3 110.892 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.623 HD13 HG12 ' A' ' 161' ' ' VAL . 11.6 pt -106.52 87.64 2.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.622 0.725 . . . . 74.33 111.152 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -21.44 33.84 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.232 . . . . 74.22 112.4 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.5 t -46.31 -40.03 11.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 61.1 110.862 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.589 ' CG1' HD11 ' A' ' 156' ' ' LEU . 4.8 mt -39.41 155.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 74.01 111.103 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.478 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -135.69 -34.4 0.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 73.34 110.947 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 33.2 mm -153.05 104.93 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 64.22 111.128 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.63 115.39 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 73.54 111.153 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -105.29 129.51 53.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 70.44 110.922 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.667 HD22 HD23 ' A' ' 194' ' ' LEU . 5.8 mt -119.07 109.11 15.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 64.35 110.926 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.35 165.41 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 63.54 110.897 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.864 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.557 HD22 ' HB3' ' A' ' 160' ' ' ASN . 7.9 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.759 0.314 . . . . 75.33 110.956 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.0 -2.58 10.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.893 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.788 HD13 HD12 ' A' ' 216' ' ' ILE . 20.2 tp 60.81 126.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 73.21 110.937 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.929 ' H ' HG23 ' A' ' 161' ' ' VAL . 3.6 p30 162.19 179.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 74.13 110.884 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.05 -19.28 62.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 60.02 110.86 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.431 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 10.7 pt-20 -90.07 -34.69 15.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 75.02 110.847 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.557 ' HB3' HD22 ' A' ' 154' ' ' LEU . 11.6 m120 -93.29 -59.75 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 61.54 110.841 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.929 HG23 ' H ' ' A' ' 157' ' ' ASN . 63.3 t -38.97 -43.35 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 73.22 111.115 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -45.82 -56.13 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 64.41 110.914 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -34.04 64.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 74.3 110.873 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.897 HG11 ' HA ' ' A' ' 212' ' ' LEU . 73.6 t -69.91 -50.89 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 53.42 111.128 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 22.1 mt -59.0 -22.92 61.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 53.42 110.893 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -72.32 -6.32 42.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 62.54 110.936 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -98.57 7.99 45.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 72.54 110.903 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -143.36 -35.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 72.22 111.188 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -50.37 -60.6 5.0 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.575 0.702 . . . . 75.53 110.845 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.79 0.87 5.04 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.678 2.252 . . . . 74.21 112.339 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.59 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -97.15 -21.43 17.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.3 110.928 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.59 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.4 mt -81.22 -43.95 18.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 52.33 110.935 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.58 -50.52 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 51.23 111.102 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.37 -45.0 97.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.801 -0.714 . . . . 74.14 112.501 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.0 p -88.41 21.88 2.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 74.25 111.109 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 177' ' ' GLY . . . 90.48 79.02 1.36 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 71.24 112.487 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 176' ' ' GLY . . . -37.05 156.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.789 -0.72 . . . . 51.34 112.489 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.67 -113.62 1.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 73.15 112.493 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -164.01 114.18 0.59 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.693 -0.765 . . . . 74.34 112.445 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.88 ' O ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -138.75 14.15 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 73.44 110.882 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -32.15 95.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 63.04 110.899 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.749 ' CE1' HG11 ' A' ' 161' ' ' VAL . 54.9 t80 -36.04 118.9 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 72.1 110.894 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.501 HD12 HD13 ' A' ' 225' ' ' LEU . 42.2 mt -78.3 -78.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 73.43 110.915 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -167.59 -159.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 74.03 110.867 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 74.8 mt -146.24 135.83 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.35 111.092 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -128.55 57.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 60.42 110.933 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.58 -140.34 14.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 61.32 112.488 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -3.35 11.84 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 61.13 112.349 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 21.8 mt -110.94 138.28 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 63.33 111.126 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 185' ' ' ILE . 16.9 t -115.31 132.95 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 75.41 111.083 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.555 ' HG2' HD11 ' A' ' 225' ' ' LEU . 19.3 mtmt -98.25 142.55 29.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 65.32 110.873 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 88.0 t -155.35 139.61 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 72.42 111.159 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -73.92 169.75 16.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.932 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.775 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -160.88 96.84 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 74.04 110.93 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.15 153.84 38.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 70.51 111.108 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 121.12 -172.56 15.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 65.24 112.497 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -8.69 24.24 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 65.1 112.313 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.65 8.49 11.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 63.34 111.105 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.775 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -51.49 -61.59 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 60.53 111.099 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.07 107.96 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 73.45 111.142 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 202' ' ' ARG . 42.4 t -146.81 -79.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 62.43 111.104 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ARG . . . . . 0.473 ' N ' HG12 ' A' ' 201' ' ' VAL . 0.1 OUTLIER -175.25 137.11 0.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.44 110.898 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 204' ' ' VAL . 0.2 OUTLIER 77.86 -60.86 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.443 . . . . 71.4 111.153 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 203' ' ' THR . 98.9 t -35.44 -71.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 50.33 111.11 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.55 -49.3 1.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 63.01 110.855 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.39 -58.3 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.14 111.125 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -40.51 -35.72 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 64.23 111.059 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.59 -76.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 53.53 111.109 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.4 t -54.97 -14.15 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 62.53 110.858 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -65.13 -39.93 93.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 74.24 110.86 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 214' ' ' GLU . 0.9 OUTLIER -87.03 -62.61 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.418 . . . . 75.23 110.958 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.897 ' HA ' HG11 ' A' ' 164' ' ' VAL . 9.8 mt -31.72 -69.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.11 110.946 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -38.0 32.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 74.24 110.874 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.3 OUTLIER -66.91 -79.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 73.14 110.898 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.71 ' CB ' HG22 ' A' ' 164' ' ' VAL . 11.8 mmtm -45.16 -52.75 8.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 63.01 110.916 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.788 HD12 HD13 ' A' ' 156' ' ' LEU . 6.5 pt -110.57 93.68 17.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 73.04 111.136 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -23.24 31.23 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.714 2.276 . . . . 51.54 112.364 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.08 -26.28 2.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 60.14 110.838 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.9 mt -59.71 152.56 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 75.33 111.16 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLN . . . . . 0.415 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 2.2 mt-30 -131.19 -37.49 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 60.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.8 mt -141.72 112.38 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 43.22 111.086 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.09 114.29 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 72.44 111.074 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -103.91 129.54 51.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 63.11 110.94 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.678 ' HB3' HD23 ' A' ' 194' ' ' LEU . 14.2 mt -119.32 102.41 8.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 61.12 110.903 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LEU . . . . . 0.555 HD11 ' HG2' ' A' ' 191' ' ' LYS . 4.9 mp -82.18 160.23 23.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 75.21 110.931 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 64.31 110.842 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.792 0.329 . . . . 54.44 110.91 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.562 ' CD2' ' ND2' ' A' ' 160' ' ' ASN . 3.2 mp -90.28 -170.91 2.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 75.22 110.945 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.18 -11.41 14.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 73.31 110.882 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.573 ' CD1' HD12 ' A' ' 216' ' ' ILE . 29.2 tp 59.62 92.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 64.23 110.955 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.784 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -175.31 175.21 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.33 110.86 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.47 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 9.6 mt-10 -42.7 -55.39 3.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 74.1 110.895 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.405 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -51.01 -30.97 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 60.42 110.905 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.562 ' ND2' ' CD2' ' A' ' 154' ' ' LEU . 2.1 m120 -96.59 -72.53 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 72.24 110.932 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 157' ' ' ASN . 30.3 m -33.94 -34.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.54 111.13 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -55.16 -57.59 11.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.02 110.903 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -53.04 -54.45 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.14 110.898 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 211' ' ' LYS . 3.4 t -62.87 -29.57 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 61.4 111.088 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' A' ' 182' ' ' PHE . 15.1 mt -71.39 -32.49 68.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 63.2 110.919 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -72.38 -5.58 37.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 64.32 110.905 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -93.16 -9.53 39.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 64.43 110.873 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.85 -31.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 54.32 111.147 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.812 ' NE ' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -51.16 -60.67 5.2 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.535 0.683 . . . . 71.53 110.901 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.9 Cg_endo -69.78 2.54 3.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.668 2.245 . . . . 33.03 112.343 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.631 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -96.41 -28.72 14.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 70.4 110.959 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.631 HD23 ' CD2' ' A' ' 171' ' ' TYR . 9.2 mt -72.79 -34.46 66.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.868 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -85.77 -11.31 53.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.1 111.1 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -88.69 2.86 84.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 70.33 112.456 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.5 t -130.57 9.92 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 74.4 111.178 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.52 -56.8 0.58 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 72.23 112.487 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 169.09 162.03 20.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 60.3 112.475 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -173.58 -160.68 22.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.75 . . . . 72.33 112.486 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.97 110.02 0.24 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 72.34 112.499 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.812 HD11 ' NE ' ' A' ' 169' ' ' ARG . 3.7 pp -113.18 -31.73 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.745 0.307 . . . . 72.12 110.887 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.596 ' N ' HD12 ' A' ' 180' ' ' LEU . 0.4 OUTLIER 33.63 90.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 62.31 110.906 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.705 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 28.0 t80 -42.4 114.06 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 53.41 110.876 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.98 -79.61 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 44.45 110.897 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 27.5 ptm -167.67 -170.81 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 61.14 110.847 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 157' ' ' ASN . 7.3 mt -131.61 144.44 37.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 72.5 111.104 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.8 68.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 73.43 110.929 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 83.13 -141.87 21.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 64.42 112.502 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 54.0 Cg_endo -69.74 -1.18 8.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.231 . . . . 74.3 112.372 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 47.6 mt -117.92 124.25 72.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.33 111.138 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 191' ' ' LYS . 1.4 p -108.72 155.1 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 62.22 111.153 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.442 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 13.9 mtmt -116.26 141.04 48.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 72.13 110.915 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.467 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 43.7 t -151.53 155.46 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 71.32 111.134 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -94.81 172.06 8.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 63.11 110.886 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.913 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -167.67 86.21 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.51 110.929 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.1 p -123.83 177.95 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 54.24 111.14 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 87.13 -172.16 43.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 70.02 112.477 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -1.33 8.27 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.65 2.233 . . . . 62.21 112.382 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.03 57.51 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 50.31 111.14 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.913 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -99.89 -94.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 62.1 111.105 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.26 59.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 61.43 111.105 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 201' ' ' VAL . 4.9 t -101.12 30.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 60.41 111.123 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.0 OUTLIER 67.56 133.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 73.34 110.865 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.625 ' HA ' HD12 ' A' ' 206' ' ' ILE . 0.6 OUTLIER 78.54 -51.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 52.55 111.162 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 47.9 t -40.5 -51.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 54.32 111.113 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.17 -35.4 80.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.53 110.888 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 203' ' ' THR . 18.1 mt -64.1 -50.36 77.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 70.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.98 -36.77 29.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 73.21 111.103 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.501 ' O ' HD22 ' A' ' 212' ' ' LEU . 58.0 t -59.22 -83.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 63.42 111.157 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.472 ' N ' HG12 ' A' ' 208' ' ' VAL . 29.0 t -48.86 -20.54 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.14 110.837 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -58.55 -46.22 87.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 55.24 110.89 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.613 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -82.59 -46.62 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 44.14 110.937 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 208' ' ' VAL . 1.6 mm? -47.18 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.899 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.65 -52.2 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.34 110.9 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -41.21 -80.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 73.42 110.883 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 217' ' ' PRO . 0.9 OUTLIER -51.48 -51.41 55.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 63.13 110.865 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.573 HD12 ' CD1' ' A' ' 156' ' ' LEU . 5.2 pt -107.16 82.77 1.22 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.595 0.712 . . . . 73.42 111.096 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 53.7 Cg_endo -69.77 -5.69 16.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.667 2.244 . . . . 73.21 112.337 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 23.3 t -66.38 -22.95 66.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 72.21 110.862 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 7.3 mt -57.89 158.67 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 75.45 111.169 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.522 ' O ' HD13 ' A' ' 221' ' ' ILE . 1.1 mt-30 -134.84 -33.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 75.15 110.894 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.522 HD13 ' O ' ' A' ' 220' ' ' GLN . 37.5 mm -154.13 106.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 61.05 111.123 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 76.8 t -80.42 114.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 54.31 111.148 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -96.78 113.59 25.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 71.4 110.901 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.486 HD22 HD23 ' A' ' 194' ' ' LEU . 12.0 mt -100.53 102.72 13.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.893 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.91 -176.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 64.11 110.887 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.88 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.818 0.342 . . . . 74.53 110.868 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.778 HD12 ' O ' ' A' ' 215' ' ' LYS . 5.9 mt -117.65 -175.75 2.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 63.31 110.924 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -117.54 -0.82 11.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 65.41 110.873 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.706 HD13 HD12 ' A' ' 216' ' ' ILE . 20.4 tp 52.86 97.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 75.4 110.867 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.586 ' O ' HG22 ' A' ' 161' ' ' VAL . 3.6 p30 -159.14 164.43 35.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 75.51 110.876 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 16.8 mt-10 -45.15 -30.57 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 72.43 110.871 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.36 -44.45 52.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.945 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -80.51 -59.64 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 50.35 110.861 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.75 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 21.7 m -39.09 -33.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 71.44 111.107 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.34 -51.09 62.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 72.42 110.91 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -40.51 68.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 54.31 110.929 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.863 HG11 ' HA ' ' A' ' 212' ' ' LEU . 21.5 t -79.47 -34.79 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 70.11 111.083 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.487 HD23 HD11 ' A' ' 168' ' ' ILE . 27.9 mt -71.12 -21.31 62.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 73.15 110.912 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.415 ' O ' ' CD ' ' A' ' 170' ' ' PRO . 61.3 m-20 -74.5 -12.26 60.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 75.2 110.901 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -83.01 -14.16 54.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 71.32 110.876 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.763 HD13 ' HA ' ' A' ' 208' ' ' VAL . 3.2 pt -121.14 -31.16 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 72.35 111.09 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.731 ' HG2' HD13 ' A' ' 180' ' ' LEU . 1.1 mtt180 -49.04 -60.86 4.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.643 0.735 . . . . 73.31 110.871 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.0 Cg_endo -69.72 1.92 3.98 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.741 2.294 . . . . 74.53 112.341 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.518 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -105.66 -17.57 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 71.54 110.907 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.979 HD12 HD23 ' A' ' 180' ' ' LEU . 2.9 mt -77.84 -28.9 50.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 63.11 110.912 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.9 42.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 72.13 111.065 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -132.87 -33.59 0.37 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 53.45 112.499 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.9 t -144.59 9.51 1.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.787 0.327 . . . . 61.44 111.107 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 149.63 90.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.733 . . . . 63.43 112.488 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . -125.08 168.55 17.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 61.03 112.495 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 154.44 -14.07 0.53 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 71.11 112.502 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -134.42 116.89 1.7 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 74.43 112.553 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.979 HD23 HD12 ' A' ' 172' ' ' LEU . 0.3 OUTLIER -173.9 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 73.43 110.898 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 180' ' ' LEU . 8.3 tp60 -36.22 99.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 75.44 110.953 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.75 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 15.0 t80 -46.52 116.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 64.12 110.878 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 80.3 mt -76.0 -73.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 71.1 110.876 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.402 ' C ' HG13 ' A' ' 185' ' ' ILE . 28.0 ptm -173.4 -168.95 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 75.14 110.902 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.402 HG13 ' C ' ' A' ' 184' ' ' MET . 8.0 mt -136.25 129.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 74.01 111.137 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.37 56.14 1.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 73.35 110.911 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.91 -145.59 16.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.758 -0.734 . . . . 63.21 112.486 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 3.27 2.91 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.688 2.258 . . . . 72.13 112.322 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 221' ' ' ILE . 3.9 mp -115.21 130.49 69.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.54 111.123 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 84.0 t -104.6 148.59 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 75.42 111.087 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -116.79 140.88 48.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 71.03 110.887 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 193' ' ' ARG . 21.4 t -151.95 166.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 62.35 111.143 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.615 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.1 OUTLIER -92.87 143.11 26.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 74.23 110.909 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.666 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -143.61 87.31 1.92 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 71.42 110.888 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.05 -171.47 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 64.21 111.118 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.81 -169.85 55.01 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.723 -0.751 . . . . 44.31 112.506 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.53 ' O ' HG13 ' A' ' 201' ' ' VAL . 54.0 Cg_endo -69.67 0.43 5.59 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 35.11 112.397 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.684 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -103.68 -5.6 22.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 42.42 111.104 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.628 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -80.53 42.06 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.51 111.069 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.4 p 179.34 -29.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 74.34 111.093 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 198' ' ' ALA . 27.5 m -56.93 127.09 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 52.41 111.109 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -79.71 77.5 6.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 73.22 110.9 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 t 176.03 -44.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 63.23 111.155 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.684 HG11 ' HB1' ' A' ' 198' ' ' ALA . 41.0 t -72.21 -42.68 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 70.2 111.149 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -65.88 -7.13 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 72.43 110.838 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.55 -57.54 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 74.45 111.115 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.28 -20.48 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 73.51 111.093 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.763 ' HA ' HD13 ' A' ' 168' ' ' ILE . 88.9 t -72.29 -62.28 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 62.01 111.119 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 222' ' ' VAL . 32.1 t -80.59 14.5 2.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 71.03 110.853 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -39.86 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 74.2 110.932 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.62 -35.68 22.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 74.32 110.903 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.863 ' HA ' HG11 ' A' ' 164' ' ' VAL . 7.7 mt -68.72 -65.4 0.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 64.22 110.91 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.03 -21.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 74.21 110.878 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.409 ' N ' ' C ' ' A' ' 212' ' ' LEU . 20.9 tt0 -85.14 -72.49 0.48 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 74.44 110.881 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.778 ' O ' HD12 ' A' ' 154' ' ' LEU . 2.0 mptt -51.51 -54.04 31.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 74.32 110.92 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.715 HG23 HD13 ' A' ' 154' ' ' LEU . 2.0 pt -103.37 95.07 6.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.589 0.709 . . . . 54.25 111.15 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 -24.94 29.53 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.711 2.274 . . . . 64.13 112.358 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 46.0 t -47.37 -29.16 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 62.21 110.855 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.3 mt -59.37 153.3 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 73.22 111.122 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.431 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -139.66 -38.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 73.14 110.886 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 189' ' ' ILE . 21.8 mt -140.67 98.53 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 65.34 111.12 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.466 HG21 ' OG ' ' A' ' 209' ' ' SER . 67.1 t -74.89 109.15 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 72.53 111.135 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -97.68 138.89 34.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 74.24 110.966 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.666 HD22 HD23 ' A' ' 194' ' ' LEU . 8.2 mt -122.01 127.33 50.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 72.5 110.915 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 225' ' ' LEU . 2.1 mm? -96.63 172.16 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 75.31 110.888 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 43.23 110.8 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.785 0.326 . . . . 75.34 110.902 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.535 HD23 ' CG ' ' A' ' 160' ' ' ASN . 4.8 mp -86.01 -176.31 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 71.43 110.912 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -108.88 -13.23 14.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 63.44 110.875 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.728 HD13 HD12 ' A' ' 216' ' ' ILE . 15.7 tp 58.29 100.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 72.31 110.919 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.692 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -167.08 161.24 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 70.42 110.882 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.441 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -34.89 -35.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 75.21 110.869 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' ASN . 0.2 OUTLIER -71.82 -53.68 12.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.857 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.535 ' CG ' HD23 ' A' ' 154' ' ' LEU . 12.2 m-20 -67.78 -56.17 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 64.01 110.878 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.855 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 33.6 m -48.79 -27.87 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 62.23 111.147 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.46 -58.59 7.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 72.42 110.878 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -45.07 45.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 72.33 110.892 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.779 HG11 ' HA ' ' A' ' 212' ' ' LEU . 1.3 t -68.63 -42.31 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 65.32 111.134 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.514 HD11 ' CD1' ' A' ' 182' ' ' PHE . 49.7 mt -63.41 -20.64 65.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 73.51 110.941 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.485 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 16.3 m-20 -76.48 -9.48 58.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 51.31 110.862 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.65 1.75 56.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 74.24 110.847 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.753 HG21 ' HA ' ' A' ' 208' ' ' VAL . 1.1 pt -131.75 -45.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.04 111.148 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.49 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -46.23 -60.28 3.82 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.607 0.718 . . . . 74.4 110.858 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.79 -11.12 30.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.653 2.235 . . . . 63.33 112.397 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.55 ' CD1' ' O ' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -88.15 -12.4 44.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 72.23 110.885 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.509 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.3 mt -84.27 -53.57 5.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 74.35 110.961 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 175' ' ' THR . . . -58.12 -54.3 48.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 71.51 111.134 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -35.02 -31.59 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 54.2 112.44 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 173' ' ' ALA . 1.2 t -134.21 64.86 1.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 72.24 111.191 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.93 -69.71 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.744 . . . . 74.43 112.519 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . 120.34 175.75 15.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 72.52 112.443 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -158.56 -123.37 0.72 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.723 -0.751 . . . . 53.05 112.468 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 163.32 114.49 0.31 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.725 -0.75 . . . . 74.13 112.502 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.464 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 3.4 pp -133.56 -39.5 0.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.744 0.307 . . . . 63.35 110.919 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 180' ' ' LEU . 5.4 tp-100 34.3 90.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 73.41 110.904 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.855 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 25.9 t80 -36.96 107.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 73.21 110.89 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 36.0 mt -68.38 -79.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 74.51 110.935 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.2 ptp -165.3 -171.67 2.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 52.44 110.915 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.28 134.43 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 65.42 111.085 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.75 66.53 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 74.55 110.887 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 89.62 -146.0 18.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 52.22 112.452 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.8 Cg_endo -69.73 3.2 2.89 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.674 2.249 . . . . 72.33 112.36 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mt -123.23 110.46 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 74.0 111.18 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.6 p -96.25 132.3 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 75.43 111.132 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.441 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 14.8 mtmt -89.49 146.27 24.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 75.3 110.946 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 193' ' ' ARG . 97.4 t -158.93 156.56 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 75.42 111.17 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.477 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.1 OUTLIER -90.12 172.5 8.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 73.25 110.85 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.57 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -162.6 81.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 74.02 110.919 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.0 p -114.24 -169.66 1.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 75.42 111.15 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 74.11 -179.09 42.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 62.4 112.513 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -2.1 9.61 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.68 2.253 . . . . 55.23 112.342 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 1.025 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -82.57 -17.45 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.31 111.092 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -56.27 -62.68 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 72.1 111.118 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.32 97.76 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 75.04 111.153 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 7.3 p -159.79 -33.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.42 111.123 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 201' ' ' VAL . 9.9 ttp180 85.35 142.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.4 110.859 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.479 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 2.7 m 83.03 -32.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 61.4 111.156 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 1.025 HG11 ' HB1' ' A' ' 198' ' ' ALA . 33.3 t -70.14 -71.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.148 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -40.22 -43.39 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 72.11 110.912 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.556 HG22 ' CD ' ' A' ' 210' ' ' LYS . 3.1 mp -60.11 -44.13 94.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 55.11 111.116 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.39 -36.55 22.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 52.2 111.091 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.753 ' HA ' HG21 ' A' ' 168' ' ' ILE . 55.1 t -65.77 -85.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 74.21 111.149 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.697 ' HA ' HD23 ' A' ' 212' ' ' LEU . 40.9 m -34.01 -43.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 61.41 110.853 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.556 ' CD ' HG22 ' A' ' 206' ' ' ILE . 14.0 mtpt -47.84 -51.45 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.15 110.909 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.544 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -61.87 -66.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 75.13 110.899 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.82 ' H ' HD22 ' A' ' 212' ' ' LEU . 1.4 mm? -35.0 -73.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 73.02 110.956 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.34 -35.28 0.96 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 74.35 110.856 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 211' ' ' LYS . 2.6 tp10 -57.14 -72.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 71.04 110.883 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 217' ' ' PRO . 5.2 mttp -63.57 -48.73 76.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.13 110.911 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.728 HD12 HD13 ' A' ' 156' ' ' LEU . 7.1 pt -107.03 83.24 1.28 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.639 0.733 . . . . 73.43 111.104 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 53.5 Cg_endo -69.82 -5.35 16.03 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.701 2.267 . . . . 74.2 112.33 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.15 -11.7 43.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 72.14 110.897 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 5.1 mt -68.77 158.3 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 61.13 111.151 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.872 ' HB3' HD12 ' A' ' 221' ' ' ILE . 0.2 OUTLIER -136.89 -34.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 71.14 110.907 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.872 HD12 ' HB3' ' A' ' 220' ' ' GLN . 4.5 mp -150.61 108.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 62.54 111.123 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 79.1 t -86.57 112.69 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 62.13 111.116 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -100.59 115.59 30.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.21 110.916 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.57 HD22 HD23 ' A' ' 194' ' ' LEU . 4.0 mt -103.51 101.71 11.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 65.31 110.921 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.35 174.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 73.04 110.904 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 65.23 110.824 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.846 0.355 . . . . 54.34 110.838 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 215' ' ' LYS . 1.0 OUTLIER -96.72 -175.08 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 55.34 110.937 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -101.62 -2.79 29.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 64.11 110.894 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.725 HD13 HD12 ' A' ' 216' ' ' ILE . 10.9 tp 54.48 89.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 61.45 110.938 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.812 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -149.76 178.98 8.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.34 110.881 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.32 -48.93 77.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.34 110.857 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -58.84 -46.61 87.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 71.13 110.889 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.676 ' CG ' HD22 ' A' ' 154' ' ' LEU . 9.2 m120 -71.07 -69.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 65.22 110.925 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.856 HG21 ' CE2' ' A' ' 182' ' ' PHE . 20.7 m -36.95 -31.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 63.14 111.127 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.7 mt-10 -55.38 -58.08 9.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 70.42 110.951 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -39.59 56.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 64.43 110.93 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.963 HG11 ' HA ' ' A' ' 212' ' ' LEU . 21.4 t -64.3 -53.45 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.31 111.13 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 182' ' ' PHE . 16.2 mt -58.15 -24.56 59.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 62.33 110.897 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -72.23 -6.85 45.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 63.02 110.865 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.66 4.92 43.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 63.01 110.886 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.7 -34.54 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 75.4 111.099 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.717 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -54.71 -60.58 7.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 71.43 110.889 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.0 Cg_endo -69.82 -5.94 17.45 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.71 2.273 . . . . 50.13 112.286 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.584 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -86.42 -22.45 26.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 71.4 110.889 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.584 HD23 ' CD2' ' A' ' 171' ' ' TYR . 7.2 mt -78.21 -53.61 7.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.2 110.954 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -36.73 -51.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 72.14 111.078 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -39.41 -44.44 2.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.79 -0.719 . . . . 74.03 112.452 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 53.2 p -88.15 -33.38 18.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 54.12 111.126 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 170.38 -42.28 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.68 -0.771 . . . . 72.55 112.461 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.1 162.83 28.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 50.31 112.478 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -151.05 -94.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 64.15 112.446 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 169.99 122.34 0.63 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.69 -0.767 . . . . 64.44 112.459 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.717 HD11 ' HD2' ' A' ' 169' ' ' ARG . 1.1 pp -150.07 13.15 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 75.35 110.902 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 182' ' ' PHE . 0.5 OUTLIER -35.34 105.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 72.02 110.917 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.856 ' CE2' HG21 ' A' ' 161' ' ' VAL . 8.8 t80 -34.25 121.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 64.31 110.877 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.424 ' CD1' HD13 ' A' ' 225' ' ' LEU . 77.5 mt -80.82 -68.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 72.33 110.923 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 12.1 ptp -177.51 -175.65 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 74.02 110.897 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.2 mt -130.31 124.32 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 72.3 111.126 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.32 74.99 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.0 110.951 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 85.24 -149.04 23.51 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 73.22 112.495 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 3.53 2.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.704 2.269 . . . . 73.21 112.369 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.2 mt -117.06 123.48 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 71.55 111.101 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 41.0 t -99.09 143.69 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 71.22 111.136 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -107.56 142.33 37.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 74.5 110.887 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 193' ' ' ARG . 59.5 t -154.4 155.41 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 50.24 111.159 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.459 ' N ' HG12 ' A' ' 192' ' ' VAL . 7.5 tpt180 -94.26 154.74 17.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 63.21 110.849 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -149.91 76.84 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 75.33 110.922 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.5 p -108.17 -169.55 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.24 111.119 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.01 -178.15 33.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.766 -0.731 . . . . 63.34 112.48 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -0.78 7.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.699 2.266 . . . . 75.13 112.388 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -85.76 -6.39 59.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 54.21 111.116 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -72.03 -50.64 26.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.087 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 200' ' ' VAL . 2.7 p -93.0 71.85 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 63.3 111.131 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.941 HG12 HG22 ' A' ' 203' ' ' THR . 15.1 t -155.02 117.54 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 73.31 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 71.17 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.886 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.941 HG22 HG12 ' A' ' 201' ' ' VAL . 14.6 t -179.35 -33.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.11 111.146 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.479 HG21 ' HB1' ' A' ' 198' ' ' ALA . 20.0 t -67.69 -68.96 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.45 111.16 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -45.97 -33.14 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 72.14 110.868 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.7 mp -71.22 -42.84 75.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 65.44 111.134 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.74 -33.68 76.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 54.31 111.125 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.676 HG12 HD11 ' A' ' 212' ' ' LEU . 94.5 t -62.57 -75.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 75.21 111.125 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.587 ' HA ' HD12 ' A' ' 212' ' ' LEU . 5.6 t -53.55 -15.61 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 54.41 110.853 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -40.65 86.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 63.23 110.898 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -86.81 -35.04 19.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.01 110.909 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.963 ' HA ' HG11 ' A' ' 164' ' ' VAL . 8.5 mt -66.41 -64.45 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 61.51 110.927 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -22.19 1.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.886 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -83.95 -79.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 42.12 110.884 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.819 ' O ' HD12 ' A' ' 154' ' ' LEU . 14.8 mmtt -41.23 -55.9 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 75.11 110.927 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.725 HD12 HD13 ' A' ' 156' ' ' LEU . 4.4 pt -108.35 85.58 2.89 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 71.12 111.161 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.8 9.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.638 2.225 . . . . 71.34 112.316 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.412 ' HB3' ' CB ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -71.79 -6.29 40.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 63.11 110.857 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 220' ' ' GLN . 3.2 mt -73.36 154.69 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 62.14 111.146 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.565 ' O ' HD13 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -126.3 -33.7 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 71.04 110.882 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 220' ' ' GLN . 30.1 mm -151.74 107.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 73.04 111.147 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.8 t -78.77 109.07 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 73.3 111.073 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -99.44 119.69 38.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 70.34 110.907 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.7 mt -110.86 105.7 14.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 64.55 110.887 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.424 HD13 ' CD1' ' A' ' 183' ' ' LEU . 4.9 mp -81.45 162.98 23.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.34 110.9 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 63.41 110.881 -179.95 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.499 ' C ' HD13 ' A' ' 154' ' ' LEU . 4.7 mtp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.844 0.354 . . . . 74.15 110.904 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.636 HD22 ' N ' ' A' ' 154' ' ' LEU . 0.2 OUTLIER -115.43 -149.58 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 74.1 110.931 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -112.01 -0.32 15.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.43 110.912 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.732 ' CD1' HD12 ' A' ' 216' ' ' ILE . 8.0 tp 61.73 110.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 75.42 110.896 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.931 ' H ' HG23 ' A' ' 161' ' ' VAL . 0.1 OUTLIER 169.64 164.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.13 110.876 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -33.97 -60.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 73.0 110.887 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -44.92 -60.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.41 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 161' ' ' VAL . 9.5 m120 -73.86 -67.39 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.1 110.912 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.931 HG23 ' H ' ' A' ' 157' ' ' ASN . 90.0 t -33.29 -46.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 65.24 111.137 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 30.0 mm-40 -47.39 -56.78 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.15 110.885 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.79 -49.8 19.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 73.52 110.89 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 212' ' ' LEU . 1.9 t -63.44 -42.72 97.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 50.35 111.137 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.59 HD22 HD12 ' A' ' 180' ' ' LEU . 75.9 mt -61.18 -28.9 69.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 74.34 110.924 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -71.25 -6.06 36.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 74.33 110.902 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.67 -12.08 24.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 70.44 110.864 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.75 -34.19 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 62.4 111.12 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.519 ' HG3' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.05 -60.96 5.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 75.24 110.925 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.4 Cg_endo -69.75 1.36 4.5 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.66 2.24 . . . . 62.24 112.363 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.627 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -94.89 -23.43 17.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 43.24 110.932 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.627 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.9 mt -80.98 -36.28 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 75.21 110.887 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.69 60.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 73.32 111.078 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.72 -44.78 80.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 71.44 112.481 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.576 ' O ' HG23 ' A' ' 175' ' ' THR . 5.8 t -143.2 99.99 3.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.895 0.379 . . . . 65.44 111.15 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.43 63.59 3.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.778 -0.725 . . . . 54.04 112.497 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 172' ' ' LEU . . . -62.56 100.31 0.31 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 63.24 112.454 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -79.96 -153.34 8.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.753 -0.737 . . . . 72.34 112.477 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -136.67 115.0 1.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 70.04 112.435 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.59 HD12 HD22 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -121.24 21.03 11.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 53.22 110.95 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -34.57 107.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.939 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.911 ' CE1' HG11 ' A' ' 161' ' ' VAL . 24.5 t80 -50.42 104.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 64.32 110.852 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.82 -74.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 72.53 110.91 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.46 ' CG ' ' HE3' ' A' ' 191' ' ' LYS . 1.8 ptt? -169.24 -171.37 1.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 72.42 110.898 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 157' ' ' ASN . 1.8 mt -132.61 125.94 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 43.44 111.139 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.63 77.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 74.45 110.885 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.423 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 75.75 -142.37 28.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.772 -0.728 . . . . 62.04 112.446 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.423 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.5 Cg_endo -69.78 3.3 2.86 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.711 2.274 . . . . 75.44 112.328 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.6 mt -120.55 122.9 69.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 73.03 111.128 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.2 p -106.25 135.2 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 72.54 111.125 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.46 ' HE3' ' CG ' ' A' ' 184' ' ' MET . 15.7 mtmt -93.77 142.47 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 70.55 110.877 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 85.9 t -156.65 130.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 74.22 111.137 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.61 167.43 18.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 73.12 110.842 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.473 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -157.26 85.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 60.35 110.883 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.1 p -114.15 -177.22 3.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 44.43 111.161 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.41 -177.54 51.6 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 61.22 112.471 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -12.84 33.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.661 2.24 . . . . 71.52 112.358 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.448 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -100.92 60.18 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 51.3 111.125 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -124.83 3.71 8.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 51.04 111.06 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 200' ' ' VAL . 9.5 p -169.0 76.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 72.42 111.138 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 201' ' ' VAL . 7.1 p -137.19 7.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 75.14 111.142 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.37 47.74 19.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 75.24 110.873 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.9 m -163.91 -64.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 75.05 111.14 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.621 HG23 HG11 ' A' ' 201' ' ' VAL . 77.3 t -47.75 -59.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 73.22 111.104 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.8 -22.99 6.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 75.11 110.877 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.9 mm -77.52 -47.16 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 75.44 111.139 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.25 -18.8 17.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 65.44 111.135 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.554 ' O ' HD22 ' A' ' 212' ' ' LEU . 59.9 t -73.81 -83.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 65.31 111.118 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.461 ' N ' HG12 ' A' ' 208' ' ' VAL . 2.7 t -42.28 -23.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.84 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 208' ' ' VAL . 19.5 mttt -58.8 -59.45 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 74.42 110.897 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.463 ' HB3' HG12 ' A' ' 164' ' ' VAL . 7.6 mmtt -65.34 -45.25 84.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 74.13 110.899 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 208' ' ' VAL . 1.5 mm? -54.03 -65.93 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 72.35 110.942 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -49.54 -32.35 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 74.15 110.897 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.4 -71.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.03 110.896 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.539 ' O ' HD22 ' A' ' 154' ' ' LEU . 7.5 mptt -56.65 -52.34 65.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 71.03 110.942 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.732 HD12 ' CD1' ' A' ' 156' ' ' LEU . 8.4 pt -106.48 86.24 2.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.593 0.711 . . . . 73.33 111.144 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -7.05 20.09 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.726 2.284 . . . . 54.12 112.296 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.76 -3.91 10.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 54.45 110.883 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.4 mt -74.19 152.59 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 63.3 111.152 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.879 ' HB3' HD12 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -132.02 -37.1 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.2 110.904 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 220' ' ' GLN . 4.6 mp -150.81 104.89 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 74.53 111.122 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.97 114.74 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 73.43 111.133 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.09 129.85 51.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.22 110.877 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.473 HD22 HD23 ' A' ' 194' ' ' LEU . 7.2 mt -118.76 126.83 52.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 71.05 110.899 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 225' ' ' LEU . 4.1 mp -94.42 168.32 10.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 72.12 110.923 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.4 110.859 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 5.1 mmt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.805 0.336 . . . . 73.34 110.874 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.486 HD22 ' CG ' ' A' ' 160' ' ' ASN . 16.3 mt -123.13 -174.46 2.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 74.43 110.931 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.49 -13.53 16.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.894 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.654 ' HA ' HG21 ' A' ' 216' ' ' ILE . 6.7 tp 58.24 109.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 65.23 110.928 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.672 ' HA ' HD13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -177.52 -171.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.925 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -69.86 -4.35 19.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.865 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.484 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 7.2 mm-40 -102.15 -41.59 6.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 71.54 110.849 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.486 ' CG ' HD22 ' A' ' 154' ' ' LEU . 11.2 m120 -88.13 -41.9 12.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 65.15 110.841 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 182' ' ' PHE . 2.8 p -58.99 -30.34 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 73.21 111.175 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.77 -57.34 12.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 73.11 110.875 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.34 -44.37 23.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.21 110.868 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.979 HG11 ' HA ' ' A' ' 212' ' ' LEU . 20.6 t -68.04 -45.84 82.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.31 111.18 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.488 HD23 HD11 ' A' ' 168' ' ' ILE . 48.3 mt -61.03 -24.91 66.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 55.12 110.891 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -76.81 -2.01 31.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 70.31 110.893 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -102.62 8.7 39.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 63.1 110.919 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.746 HD13 ' HA ' ' A' ' 208' ' ' VAL . 0.7 OUTLIER -142.96 -37.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.23 111.178 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.485 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -48.7 -60.7 4.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.596 0.713 . . . . 75.53 110.868 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.78 2.86 3.17 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.715 2.276 . . . . 54.44 112.301 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.657 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -98.3 -21.41 16.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 63.31 110.923 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.657 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.9 mt -82.51 -45.88 14.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 75.15 110.87 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -50.1 -20.67 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 64.35 111.149 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -92.56 42.69 2.67 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 74.5 112.521 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 176.73 -50.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 75.53 111.113 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -178.63 70.58 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 74.13 112.498 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -57.05 163.13 6.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.714 -0.755 . . . . 63.42 112.496 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -144.84 -102.58 0.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 61.44 112.481 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.58 112.53 0.53 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.741 . . . . 74.15 112.477 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.528 ' C ' ' CD2' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -136.62 6.26 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 61.34 110.912 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.479 ' N ' HD22 ' A' ' 180' ' ' LEU . 2.5 tp60 -35.12 109.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 75.2 110.886 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.668 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 22.7 t80 -43.81 121.51 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 70.32 110.879 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 225' ' ' LEU . 19.4 mt -83.7 -73.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 65.21 110.875 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.6 -170.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 65.02 110.86 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.672 HD13 ' HA ' ' A' ' 157' ' ' ASN . 7.6 mt -136.22 138.27 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.44 111.13 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -130.25 48.37 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 64.55 110.872 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.409 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 100.54 -138.67 13.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 72.35 112.46 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.409 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.6 Cg_endo -69.82 0.35 5.81 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.635 2.223 . . . . 74.1 112.326 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.84 101.35 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 73.44 111.13 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.91 142.11 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 50.42 111.134 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.456 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 5.5 mtmt -100.42 146.31 27.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.944 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 98.5 t -159.13 147.48 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 73.54 111.117 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.5 165.34 23.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.892 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.746 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -161.77 71.5 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 52.44 110.92 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 17.1 p -113.89 176.53 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 63.44 111.081 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.19 -163.22 26.44 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 52.31 112.486 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -38.21 8.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.691 2.26 . . . . 73.34 112.358 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.754 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -83.26 49.39 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 71.52 111.087 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.746 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -105.93 -62.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 63.21 111.115 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.1 m -95.15 28.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 71.22 111.122 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.66 136.7 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 64.52 111.14 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.413 ' C ' HG22 ' A' ' 203' ' ' THR . 5.2 mmt180 -89.96 84.76 6.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 65.24 110.872 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.474 ' HA ' HD12 ' A' ' 206' ' ' ILE . 0.7 OUTLIER 168.54 -45.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 74.33 111.135 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.754 HG11 ' HB1' ' A' ' 198' ' ' ALA . 75.4 t -73.12 -55.35 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 74.44 111.155 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -51.14 -34.41 30.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 75.54 110.895 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.731 HG22 ' HG3' ' A' ' 210' ' ' LYS . 6.1 mt -68.78 -58.63 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 64.44 111.133 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -39.36 -50.25 2.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.42 111.106 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.746 ' HA ' HD13 ' A' ' 168' ' ' ILE . 40.5 t -45.34 -84.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 62.44 111.1 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.6 ' N ' HG12 ' A' ' 208' ' ' VAL . 48.8 m -47.85 -34.57 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 62.51 110.834 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.731 ' HG3' HG22 ' A' ' 206' ' ' ILE . 0.0 OUTLIER -49.88 -40.19 42.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 74.42 110.889 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -86.35 -38.64 17.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 61.21 110.874 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.979 ' HA ' HG11 ' A' ' 164' ' ' VAL . 15.1 mt -62.6 -67.65 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 72.22 110.887 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.1 -31.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 71.32 110.867 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.86 -73.24 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.842 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.615 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.7 OUTLIER -51.69 -51.2 57.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 72.0 110.913 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.654 HG21 ' HA ' ' A' ' 156' ' ' LEU . 1.7 pt -105.53 89.79 3.61 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.595 0.712 . . . . 63.33 111.12 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 54.0 Cg_endo -69.72 -16.33 37.67 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.702 2.268 . . . . 52.45 112.374 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 47.4 m -58.27 -19.85 37.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 72.13 110.836 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.468 HG21 ' CG2' ' A' ' 222' ' ' VAL . 3.3 mt -67.99 152.28 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 73.24 111.121 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.443 ' C ' HG13 ' A' ' 221' ' ' ILE . 0.2 OUTLIER -133.42 -37.92 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 54.5 110.904 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.443 HG13 ' C ' ' A' ' 220' ' ' GLN . 50.9 mt -145.38 96.26 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.42 111.111 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.468 ' CG2' HG21 ' A' ' 219' ' ' ILE . 58.1 t -74.13 104.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 73.13 111.144 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.4 113.98 24.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 74.32 110.889 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.462 ' HB3' HD23 ' A' ' 194' ' ' LEU . 1.3 mt -110.26 100.82 9.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.42 . . . . 70.35 110.934 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.445 HD13 HD12 ' A' ' 183' ' ' LEU . 4.3 mp -65.76 159.5 25.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 74.01 110.917 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 52.11 110.84 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.846 0.355 . . . . 62.12 110.855 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.0 mt -96.15 -171.55 2.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 62.14 110.96 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -96.46 -9.4 29.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 70.22 110.903 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.84 HD13 HD12 ' A' ' 216' ' ' ILE . 13.3 tp 51.77 100.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 73.01 110.915 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -171.07 167.28 7.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 70.34 110.849 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.458 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 4.5 mt-10 -37.64 -54.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 61.54 110.898 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -48.79 -52.5 23.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 72.44 110.869 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 163' ' ' LYS . 4.2 m120 -73.87 -70.32 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.51 110.883 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.571 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 13.3 m -33.78 -37.74 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 62.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -60.08 -50.01 75.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 52.42 110.879 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.0 OUTLIER -55.83 -54.19 47.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 71.42 110.895 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' A' ' 211' ' ' LYS . 3.5 t -61.86 -41.11 89.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 75.1 111.144 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 37.4 mt -61.2 -27.78 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 43.54 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.447 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 13.6 m120 -71.07 -8.67 55.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 74.04 110.881 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -88.57 -15.73 34.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 72.21 110.929 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.473 HG21 ' HA ' ' A' ' 208' ' ' VAL . 1.2 pt -117.72 -33.13 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.53 111.098 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.723 ' HG3' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -50.42 -60.29 5.61 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.596 0.712 . . . . 64.31 110.849 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.79 -3.42 11.99 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.643 2.229 . . . . 62.24 112.34 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.762 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -92.29 -16.81 25.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.908 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.762 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.8 mt -83.44 -28.94 28.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 72.24 110.897 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 175' ' ' THR . . . -79.81 -39.29 31.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 71.43 111.115 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -36.87 -33.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.744 -0.741 . . . . 60.54 112.485 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 173' ' ' ALA . 1.7 t -154.42 74.46 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.802 0.334 . . . . 74.22 111.158 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 146.93 -106.95 0.38 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 63.02 112.523 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -145.54 -98.39 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 73.32 112.483 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 129.85 123.12 2.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 74.05 112.542 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.45 107.37 0.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 71.34 112.504 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.723 HD21 ' HG3' ' A' ' 169' ' ' ARG . 4.3 pp -144.11 -40.16 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.776 0.322 . . . . 61.34 110.93 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.591 ' N ' HD12 ' A' ' 180' ' ' LEU . 13.5 tp60 34.24 90.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 75.15 110.923 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.571 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 31.5 t80 -34.49 113.76 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 74.0 110.919 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 191' ' ' LYS . 14.2 mt -66.78 -79.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 75.12 110.923 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 18.5 ptp -171.88 -174.59 1.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 62.04 110.852 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.47 143.55 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 74.34 111.122 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.88 39.19 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 73.31 110.931 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 112.7 -139.3 15.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.687 -0.768 . . . . 72.14 112.503 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.8 Cg_endo -69.73 0.27 5.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.668 2.245 . . . . 64.14 112.347 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.78 127.72 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 62.53 111.122 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.78 145.25 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 51.32 111.095 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.439 ' HB3' HD12 ' A' ' 183' ' ' LEU . 22.2 mtmt -112.81 145.49 40.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 75.23 110.869 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 21.7 t -158.23 154.12 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 74.23 111.089 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.568 ' O ' HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -91.67 169.84 10.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.847 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.568 HD22 ' O ' ' A' ' 193' ' ' ARG . 0.2 OUTLIER -163.33 92.31 0.73 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 63.14 110.929 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.13 167.92 19.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 73.1 111.134 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 100.19 -160.96 19.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 74.43 112.473 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.94 7.65 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.665 2.243 . . . . 70.21 112.33 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.545 ' O ' HG11 ' A' ' 204' ' ' VAL . . . -137.88 50.14 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 50.23 111.103 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.541 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -74.88 -27.32 60.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 63.51 111.09 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 200' ' ' VAL . 1.1 p 166.14 92.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 74.53 111.132 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 8.5 p -116.76 -36.94 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 73.23 111.148 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.53 ' C ' HD12 ' A' ' 206' ' ' ILE . 0.6 OUTLIER 162.96 -85.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 70.12 110.899 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 37.0 p -59.63 -25.7 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 70.02 111.161 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 208' ' ' VAL . 53.9 t -58.23 -56.21 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 64.34 111.141 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -32.03 60.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 54.44 110.874 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.537 HG22 ' HE3' ' A' ' 210' ' ' LYS . 36.3 mt -64.01 -56.78 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 74.34 111.186 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.01 -32.45 54.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 72.41 111.12 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 204' ' ' VAL . 55.3 t -63.12 -86.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 54.43 111.166 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.652 ' HA ' HD23 ' A' ' 212' ' ' LEU . 24.5 m -33.94 -45.4 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 61.12 110.844 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' A' ' 206' ' ' ILE . 3.2 mtmt -44.46 -50.3 9.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 72.11 110.906 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.536 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -64.93 -66.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 61.22 110.889 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.82 ' H ' HD22 ' A' ' 212' ' ' LEU . 1.0 OUTLIER -37.4 -67.36 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.912 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -29.54 3.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 74.33 110.835 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.9 OUTLIER -68.25 -75.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 64.31 110.938 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -56.63 -52.88 63.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 60.11 110.878 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.84 HD12 HD13 ' A' ' 156' ' ' LEU . 5.6 pt -107.16 84.46 1.68 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.661 0.743 . . . . 61.31 111.152 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -11.3 30.53 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.665 2.243 . . . . 50.51 112.32 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 45.5 t -58.26 -22.09 51.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 72.43 110.875 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.7 mt -57.7 155.51 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 70.43 111.118 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.448 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 1.1 tt0 -132.48 -34.57 1.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 71.0 110.875 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 27.9 mm -149.25 106.56 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 61.44 111.157 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.473 HG12 ' HG ' ' A' ' 224' ' ' LEU . 95.1 t -74.71 110.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 70.04 111.161 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -96.41 104.24 16.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 71.31 110.919 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.473 ' HG ' HG12 ' A' ' 222' ' ' VAL . 1.1 mt -105.54 115.39 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.895 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.0 mp -98.66 159.83 14.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 62.34 110.953 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 72.53 110.833 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.798 0.332 . . . . 70.3 110.876 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.544 HD22 ' OD1' ' A' ' 160' ' ' ASN . 10.4 mt -159.36 -177.2 6.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 75.1 110.911 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -102.54 -1.29 30.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.887 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 216' ' ' ILE . 12.4 tp 60.1 108.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 65.04 110.877 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.873 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -168.22 -178.98 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 72.24 110.891 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.11 -49.07 79.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 74.1 110.899 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -59.58 -32.53 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 62.02 110.901 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.544 ' OD1' HD22 ' A' ' 154' ' ' LEU . 4.9 m120 -83.48 -70.28 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 74.33 110.914 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 157' ' ' ASN . 29.5 m -35.63 -30.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 65.14 111.084 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 160' ' ' ASN . 2.8 mt-10 -55.31 -58.85 6.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.55 110.868 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -51.06 56.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 52.35 110.903 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.74 HG11 ' HA ' ' A' ' 212' ' ' LEU . 1.4 t -65.25 -31.03 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 63.23 111.121 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 165' ' ' LEU . 14.1 mt -72.6 -32.14 65.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.48 . . . . 71.34 110.895 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 60.7 m-20 -67.39 -14.29 62.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 63.22 110.921 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -89.53 4.98 47.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 71.4 110.871 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 169' ' ' ARG . 0.3 OUTLIER -139.91 -55.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 52.41 111.148 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -35.34 -58.89 0.73 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.709 . . . . 73.25 110.879 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.69 -27.87 26.26 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.281 . . . . 64.54 112.366 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.622 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -73.08 -16.03 61.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 71.32 110.91 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.6 mt -75.61 -46.37 32.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 72.03 110.909 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 174' ' ' GLY . . . -58.03 -42.56 85.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 45.43 111.101 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -34.82 -78.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 63.3 112.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.1 t -94.97 40.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 73.1 111.152 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . 96.67 94.93 1.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 73.4 112.542 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . -82.98 171.48 50.74 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 64.34 112.47 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -126.22 -87.36 0.64 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 22.44 112.468 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 157.63 109.72 0.29 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.757 -0.735 . . . . 55.23 112.453 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 2.9 pp -112.1 -34.15 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 75.04 110.879 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER 33.85 89.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 75.42 110.919 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 28.6 t80 -38.52 107.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.881 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 191' ' ' LYS . 14.4 mt -66.22 -80.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.42 110.948 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -166.08 -168.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 75.3 110.896 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 157' ' ' ASN . 7.6 mt -135.53 124.79 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 75.44 111.166 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.76 72.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.887 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.421 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 82.87 -140.71 20.39 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 72.52 112.488 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.421 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 54.0 Cg_endo -69.75 0.01 6.25 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 73.02 112.36 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 25.5 mt -117.76 136.16 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 71.12 111.099 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.51 130.86 73.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 52.12 111.131 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.506 ' HB3' HD12 ' A' ' 183' ' ' LEU . 14.5 mtmt -90.54 142.58 27.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 52.34 110.946 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 55.7 t -153.67 151.43 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 75.43 111.156 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.866 ' O ' HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -86.73 163.55 17.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 74.1 110.914 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 193' ' ' ARG . 0.3 OUTLIER -158.21 79.63 0.83 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 75.23 110.944 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 p -113.32 171.34 7.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.483 . . . . 61.24 111.115 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 86.83 -169.56 40.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.707 -0.759 . . . . 64.12 112.498 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -19.29 36.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.69 2.26 . . . . 65.52 112.34 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.916 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -97.83 42.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 64.25 111.14 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -96.14 92.03 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 62.32 111.089 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.457 HG13 ' HE ' ' A' ' 205' ' ' ARG . 76.8 t 45.06 90.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 62.24 111.151 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 202' ' ' ARG . 43.5 t -125.66 -82.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 72.44 111.127 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.77 ' O ' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -176.21 47.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.44 110.869 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 202' ' ' ARG . 0.7 OUTLIER -174.57 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 72.13 111.13 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.916 HG21 ' HB1' ' A' ' 198' ' ' ALA . 93.4 t -58.75 -70.89 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 43.23 111.136 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.457 ' HE ' HG13 ' A' ' 200' ' ' VAL . 0.0 OUTLIER -35.33 -44.22 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.53 110.872 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.444 HD12 ' N ' ' A' ' 203' ' ' THR . 2.9 mt -54.11 -50.42 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.114 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -62.71 -32.86 74.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.24 111.1 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.678 ' C ' HD23 ' A' ' 212' ' ' LEU . 40.8 t -80.38 0.99 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 72.44 111.164 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -134.57 7.38 3.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.897 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.59 -40.64 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 74.41 110.887 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -80.64 -27.32 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 53.01 110.878 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.74 ' HA ' HG11 ' A' ' 164' ' ' VAL . 2.4 mm? -69.08 -71.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 72.34 110.894 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -45.18 -21.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.869 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 212' ' ' LEU . 1.2 tp10 -70.77 -66.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 74.5 110.867 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.491 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.4 OUTLIER -67.22 -44.3 79.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.12 110.926 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.633 HD12 HD13 ' A' ' 156' ' ' LEU . 4.8 pt -111.57 89.18 10.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 73.11 111.101 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -20.68 34.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 71.42 112.354 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.06 -22.88 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 70.11 110.815 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.6 mt -58.51 148.14 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.12 111.156 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.465 ' O ' HD13 ' A' ' 221' ' ' ILE . 0.9 OUTLIER -129.44 -39.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 74.42 110.92 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 220' ' ' GLN . 27.3 mm -150.67 114.43 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 64.53 111.087 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 85.6 t -86.81 121.49 37.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.02 111.103 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -108.5 122.87 47.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.34 110.961 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.752 ' HB3' HD23 ' A' ' 194' ' ' LEU . 24.8 mt -115.27 102.2 9.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.921 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.2 mt -72.71 173.35 9.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 72.4 110.897 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.6 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 64.04 110.896 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.456 ' HB2' ' CG ' ' A' ' 217' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.764 0.316 . . . . 75.34 110.922 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 215' ' ' LYS . 0.5 OUTLIER -144.85 -174.07 4.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 61.21 110.892 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.547 ' HB3' HD22 ' A' ' 157' ' ' ASN . 1.3 tp10 -97.77 -13.2 21.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 62.41 110.884 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.694 ' CD1' HD12 ' A' ' 216' ' ' ILE . 5.3 tp 58.56 113.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.13 110.915 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.753 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 174.7 166.43 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 63.11 110.934 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.36 -26.32 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 73.24 110.853 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 160' ' ' ASN . 11.5 pm0 -78.58 -33.28 47.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 62.54 110.886 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 162' ' ' GLU . 24.9 m-20 -100.87 -60.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 75.52 110.912 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 157' ' ' ASN . 9.3 p -42.18 -23.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 72.24 111.122 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.596 ' HA ' HD12 ' A' ' 165' ' ' LEU . 4.3 mt-10 -64.67 -55.01 22.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 50.12 110.891 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -40.78 45.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 74.54 110.889 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.662 HG11 ' HA ' ' A' ' 212' ' ' LEU . 25.2 t -71.38 -33.41 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 54.13 111.144 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 162' ' ' GLU . 9.1 mt -71.02 -28.78 64.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 70.21 110.931 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.486 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 29.4 m-80 -71.02 -8.21 51.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 62.5 110.898 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.94 -3.88 50.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 74.41 110.849 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.88 -36.9 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 72.24 111.127 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.499 ' HA ' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.99 -59.93 7.86 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 73.12 110.876 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.7 Cg_endo -69.79 -20.79 34.22 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.717 2.278 . . . . 74.11 112.331 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.661 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -69.2 -19.77 63.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 73.43 110.927 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.661 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.8 mt -79.51 -55.36 5.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 65.32 110.935 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -43.43 -28.66 0.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 53.1 111.086 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.57 -39.38 93.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 43.31 112.504 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 43.3 p -107.18 1.74 24.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 71.01 111.185 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 149.38 -56.09 0.48 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 63.22 112.46 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 110.5 173.78 20.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 61.15 112.476 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -161.04 -111.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 43.34 112.532 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -178.73 119.83 0.67 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.757 -0.735 . . . . 73.1 112.506 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 169' ' ' ARG . 0.5 OUTLIER -149.55 11.99 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.754 0.311 . . . . 64.22 110.91 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 182' ' ' PHE . 29.6 tp60 -35.02 104.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 53.31 110.907 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.731 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 22.0 t80 -34.69 125.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.31 110.858 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 89.8 mt -86.66 -74.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.919 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 22.8 ptp -165.11 -173.66 2.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 74.05 110.895 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 157' ' ' ASN . 5.9 mt -130.84 136.94 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 63.42 111.163 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -136.15 71.98 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 70.35 110.855 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 81.89 -145.3 24.61 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 73.22 112.527 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.516 ' HG2' HD12 ' A' ' 189' ' ' ILE . 53.9 Cg_endo -69.76 3.27 2.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 72.34 112.347 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.516 HD12 ' HG2' ' A' ' 188' ' ' PRO . 4.2 mp -122.83 112.09 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 70.14 111.156 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.409 HG21 ' HE1' ' A' ' 182' ' ' PHE . 7.4 p -92.16 142.1 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 61.22 111.098 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -99.87 141.56 32.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 70.24 110.933 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.7 t -154.51 147.87 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 71.2 111.122 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.779 ' O ' HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -87.93 166.82 14.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 62.53 110.869 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.78 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -159.16 96.63 1.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.938 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 15.7 p -125.5 179.94 4.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 63.3 111.157 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.96 -177.91 54.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 51.13 112.517 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -20.53 34.79 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.732 2.288 . . . . 74.43 112.349 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.24 -24.24 47.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 33.42 111.101 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.78 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -49.94 -63.03 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.15 111.145 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 200' ' ' VAL . 1.0 OUTLIER -119.99 96.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.4 111.116 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 201' ' ' VAL . 10.2 p -162.85 22.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 73.41 111.092 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.7 OUTLIER 59.46 152.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 75.24 110.862 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 2.5 m 81.15 -68.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.0 111.151 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 205' ' ' ARG . 92.7 t -44.39 -67.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 63.02 111.158 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 204' ' ' VAL . 6.8 ptm180 -36.72 -36.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 71.15 110.871 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.555 HG22 ' CD ' ' A' ' 210' ' ' LYS . 3.8 mp -77.26 -51.17 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 72.33 111.136 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -51.94 -16.43 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 65.42 111.152 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 86.3 t -89.51 -52.52 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 54.51 111.152 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.3 t -84.14 24.48 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.2 110.808 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.555 ' CD ' HG22 ' A' ' 206' ' ' ILE . 0.3 OUTLIER -111.24 -40.21 4.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 74.1 110.916 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -31.73 33.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.882 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.662 ' HA ' HG11 ' A' ' 164' ' ' VAL . 6.6 mt -69.54 -65.21 0.74 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.925 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -28.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 70.43 110.921 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -75.51 -68.19 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 64.43 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.456 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.7 OUTLIER -56.32 -56.61 18.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 75.52 110.896 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.694 HD12 ' CD1' ' A' ' 156' ' ' LEU . 3.5 pt -104.77 92.22 4.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.654 0.74 . . . . 72.34 111.095 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.456 ' CG ' ' HB2' ' A' ' 153' ' ' MET . 53.5 Cg_endo -69.81 -22.53 31.72 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.655 2.237 . . . . 62.35 112.359 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' SER . . . . . 0.407 ' HB3' HD22 ' A' ' 156' ' ' LEU . 0.3 OUTLIER -50.22 -20.45 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 73.44 110.842 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.6 mt -62.54 154.02 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 75.42 111.109 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.443 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -136.29 -37.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 63.11 110.928 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 189' ' ' ILE . 29.6 mm -152.09 105.31 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 74.2 111.151 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 74.3 t -81.29 118.77 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 52.44 111.124 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -101.91 108.03 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 72.31 110.913 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.766 ' HB3' HD23 ' A' ' 194' ' ' LEU . 3.3 mt -96.65 102.35 14.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 75.34 110.918 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 226' ' ' SER . 9.1 mp -70.94 173.42 7.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 64.2 110.904 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 225' ' ' LEU . 44.4 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.842 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 49.2 mtt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.85 0.357 . . . . 73.33 110.916 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 154' ' ' LEU . 10.5 mt -119.99 -174.71 2.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 72.41 110.898 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.87 -7.99 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 73.01 110.858 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.841 HD13 HD12 ' A' ' 216' ' ' ILE . 6.8 tp 50.89 98.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 71.22 110.887 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.681 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -166.17 169.85 13.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.52 110.884 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.466 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 3.7 mt-10 -44.53 -29.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 54.14 110.876 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.459 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 3.7 pt-20 -70.66 -42.88 70.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 54.42 110.884 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 162' ' ' GLU . 7.7 m120 -86.53 -63.5 1.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 63.13 110.864 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.758 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 33.8 m -37.51 -30.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 64.21 111.123 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.4 mt-10 -64.85 -51.93 59.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 74.2 110.883 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -58.57 -50.43 73.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 75.34 110.904 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.422 HG13 ' HD3' ' A' ' 215' ' ' LYS . 1.7 t -62.24 -30.2 48.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 74.14 111.085 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.575 HD11 ' CD1' ' A' ' 182' ' ' PHE . 18.2 mt -73.63 -28.48 61.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 75.1 110.926 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.487 ' O ' ' CD ' ' A' ' 170' ' ' PRO . 37.9 m-80 -71.38 -11.97 61.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 73.22 110.861 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.22 -18.33 39.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 75.42 110.938 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.494 HD11 HD23 ' A' ' 165' ' ' LEU . 2.9 pt -115.99 -24.54 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 52.15 111.163 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.58 ' HG3' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -55.97 -60.43 8.82 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.593 0.711 . . . . 73.51 110.908 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.487 ' CD ' ' O ' ' A' ' 166' ' ' ASN . 53.7 Cg_endo -69.81 -2.01 9.49 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 53.24 112.361 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.717 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -88.94 -42.89 11.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 71.14 110.899 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.717 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.4 mt -57.05 -45.79 82.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 63.12 110.929 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -45.43 107.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 53.05 111.134 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 133.5 -50.38 0.88 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.76 . . . . 23.43 112.487 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.9 t -133.23 22.34 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 52.03 111.092 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -153.6 -79.46 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 53.11 112.456 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 56.22 15.82 12.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.778 -0.725 . . . . 71.11 112.477 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.34 -93.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 64.14 112.507 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 193' ' ' ARG . . . 175.03 123.92 0.77 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 60.1 112.442 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.699 ' C ' HD12 ' A' ' 180' ' ' LEU . 2.7 pp -135.27 -0.22 2.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 70.34 110.941 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 180' ' ' LEU . 1.4 pp0? -30.73 117.62 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.51 110.873 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.758 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 19.3 t80 -55.63 129.62 39.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 70.33 110.856 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.67 -74.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 72.2 110.889 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 16.6 ptp -167.45 -170.77 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 63.53 110.844 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 157' ' ' ASN . 35.0 mt -138.36 133.46 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 72.12 111.097 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -130.91 59.8 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.925 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 99.12 -146.74 18.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.725 -0.75 . . . . 71.21 112.514 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 3.04 3.0 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.705 2.27 . . . . 70.21 112.335 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.4 mt -115.81 118.34 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 70.35 111.155 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 66.8 t -91.27 139.73 17.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.44 111.083 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 192' ' ' VAL . 7.8 mtmt -107.49 145.83 32.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 61.3 110.901 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 193' ' ' ARG . 70.6 t -158.73 158.18 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 61.53 111.112 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.541 ' O ' HD22 ' A' ' 194' ' ' LEU . 5.8 ttt180 -99.5 137.81 37.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.903 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.541 HD22 ' O ' ' A' ' 193' ' ' ARG . 1.8 mm? -130.46 84.47 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 71.23 110.926 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -112.32 170.09 8.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.32 111.145 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.42 ' N ' ' OG1' ' A' ' 195' ' ' THR . . . 84.06 -163.25 39.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 61.15 112.462 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -35.45 12.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.686 2.258 . . . . 64.02 112.338 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.724 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -84.59 32.29 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 71.34 111.063 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.48 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -72.19 -52.2 17.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 61.42 111.123 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.579 ' O ' HG13 ' A' ' 200' ' ' VAL . 7.1 p -164.66 69.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 70.12 111.111 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 202' ' ' ARG . 56.1 t -88.83 -83.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 74.34 111.1 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.504 ' N ' HG12 ' A' ' 201' ' ' VAL . 0.0 OUTLIER 172.08 41.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 75.41 110.9 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.492 ' N ' HD12 ' A' ' 206' ' ' ILE . 23.1 m -166.83 -57.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 63.33 111.186 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.724 HG11 ' HB1' ' A' ' 198' ' ' ALA . 31.9 t -60.11 -63.96 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 71.03 111.127 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -44.56 -29.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 71.43 110.855 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 203' ' ' THR . 3.0 mt -79.8 -45.25 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 71.03 111.149 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.28 -15.07 31.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 73.23 111.113 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 209' ' ' SER . 54.1 t -80.25 -85.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 70.31 111.143 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.593 ' HA ' HD23 ' A' ' 212' ' ' LEU . 1.6 t -33.43 -41.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 72.41 110.854 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.44 -54.7 7.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 52.21 110.896 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -56.31 19.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 75.04 110.862 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.695 ' H ' HD22 ' A' ' 212' ' ' LEU . 1.6 mm? -45.7 -74.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 70.13 110.881 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 212' ' ' LEU . 3.9 ttp180 -37.39 -52.49 1.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 74.05 110.874 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -46.36 -92.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.857 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.422 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -38.26 -54.26 1.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 63.23 110.883 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.841 HD12 HD13 ' A' ' 156' ' ' LEU . 11.2 pt -106.17 88.19 2.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.602 0.715 . . . . 74.43 111.122 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -23.21 31.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.648 2.232 . . . . 74.33 112.376 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.7 t -45.63 -28.54 1.0 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 72.55 110.862 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -55.65 157.15 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 75.42 111.1 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.498 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.5 OUTLIER -141.68 -37.84 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 62.52 110.964 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 220' ' ' GLN . 11.2 mt -140.93 85.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 54.14 111.128 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.04 115.9 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.52 111.094 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.491 ' O ' HD23 ' A' ' 224' ' ' LEU . 8.2 mm-40 -95.76 152.77 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 34.13 110.889 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 223' ' ' GLN . 20.4 mt -139.7 100.01 3.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 74.15 110.9 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 225' ' ' LEU . 0.3 OUTLIER -57.56 177.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 72.14 110.926 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 61.02 110.857 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 14.1 mtt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.824 0.345 . . . . 63.22 110.861 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' A' ' 160' ' ' ASN . 7.0 mp -123.52 -174.5 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 71.45 110.905 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.91 -18.05 14.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 70.52 110.911 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.751 HD13 HD12 ' A' ' 216' ' ' ILE . 6.6 tp 61.92 106.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 73.51 110.977 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.731 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -176.25 166.76 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 55.12 110.853 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -42.22 -38.97 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 70.03 110.834 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -65.18 -56.26 13.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 64.25 110.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.578 ' HB3' HD23 ' A' ' 154' ' ' LEU . 53.1 m-20 -76.52 -61.87 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 72.13 110.901 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 157' ' ' ASN . 6.1 p -38.69 -28.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 54.3 111.113 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 160' ' ' ASN . 2.4 mm-40 -59.52 -59.96 4.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 62.3 110.843 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -36.71 23.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 74.14 110.894 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.899 HG11 ' HA ' ' A' ' 212' ' ' LEU . 41.9 t -70.64 -45.85 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 54.14 111.121 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.582 HD22 HD12 ' A' ' 180' ' ' LEU . 75.7 mt -61.09 -24.08 65.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 73.32 110.932 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.41 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 24.3 m-80 -74.57 -5.86 45.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 63.4 110.894 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.09 -8.06 40.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 64.2 110.85 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.425 HD11 HD23 ' A' ' 165' ' ' LEU . 1.3 pt -123.22 -43.68 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 75.32 111.14 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -44.22 -59.95 3.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.576 0.703 . . . . 62.51 110.914 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.79 -30.48 22.09 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 75.52 112.373 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.616 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -63.76 -14.51 53.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 73.03 110.948 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.616 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.5 mt -79.56 -55.62 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 74.12 110.917 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.51 -54.24 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.23 111.127 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -40.71 -60.33 2.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.747 . . . . 75.03 112.452 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 82.8 p -64.92 -50.38 66.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 75.21 111.164 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -169.54 -40.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 52.52 112.455 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 127.44 164.44 11.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.509 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.21 -178.74 41.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 74.43 112.524 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -140.42 99.98 0.26 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 71.02 112.494 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.582 HD12 HD22 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -118.31 25.84 10.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.751 0.31 . . . . 74.52 110.89 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 180' ' ' LEU . 1.4 pp0? -35.77 119.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 74.34 110.944 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.603 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 19.5 t80 -48.5 116.2 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 71.42 110.862 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.26 -73.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.905 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 14.1 ptp -171.32 -171.05 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 74.2 110.912 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -131.78 131.12 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 73.14 111.132 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -135.43 74.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 61.22 110.931 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.33 -144.77 24.84 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 63.43 112.446 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 3.52 2.74 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.689 2.259 . . . . 72.4 112.314 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 44.5 mt -109.63 149.72 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 52.22 111.128 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.7 t -126.39 135.33 64.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 70.32 111.146 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -105.0 133.95 48.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 71.54 110.878 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 180' ' ' LEU . 66.3 t -153.41 129.63 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 53.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 179.42 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 72.42 110.833 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.25 67.92 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 71.24 110.919 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 73.4 p -90.42 -179.8 5.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 64.31 111.187 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 91.76 173.64 42.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 72.05 112.482 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -16.84 37.52 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.25 . . . . 45.04 112.345 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.46 -18.92 59.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 53.52 111.104 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.62 -45.63 81.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 74.11 111.107 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 30.9 m -92.0 49.3 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 61.53 111.159 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 83.6 t -138.81 125.57 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 75.12 111.164 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -55.79 158.05 3.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 73.11 110.879 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.428 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 1.9 m 79.73 -55.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.479 . . . . 74.31 111.191 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 208' ' ' VAL . 76.1 t -38.88 -60.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.05 111.121 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -43.97 39.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 74.23 110.87 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.53 HG22 ' HG3' ' A' ' 210' ' ' LYS . 70.1 mt -64.64 -53.77 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 71.02 111.168 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -44.53 -27.74 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 75.24 111.12 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 204' ' ' VAL . 2.6 t -73.05 -56.47 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 74.3 111.162 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.683 ' HB3' HG21 ' A' ' 222' ' ' VAL . 0.7 OUTLIER -83.31 20.39 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 73.31 110.85 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.53 ' HG3' HG22 ' A' ' 206' ' ' ILE . 3.7 mtpp -103.66 -40.26 6.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 75.53 110.895 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.38 -34.12 25.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 65.52 110.889 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.899 ' HA ' HG11 ' A' ' 164' ' ' VAL . 7.4 mt -68.32 -67.3 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.898 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.59 -24.16 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 60.54 110.904 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -78.7 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 74.33 110.904 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.423 ' O ' HD13 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -46.29 -51.43 14.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 72.51 110.931 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.751 HD12 HD13 ' A' ' 156' ' ' LEU . 2.2 pt -107.02 91.96 7.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.593 0.711 . . . . 72.43 111.141 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 216' ' ' ILE . 53.6 Cg_endo -69.76 -17.64 37.46 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.667 2.245 . . . . 74.13 112.329 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.6 t -54.46 -28.44 44.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 34.3 110.833 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.8 mt -57.64 153.12 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 72.33 111.127 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.75 ' HB3' HD12 ' A' ' 221' ' ' ILE . 2.0 mt-30 -133.12 -37.38 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.22 110.907 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 220' ' ' GLN . 3.8 mp -145.74 102.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 72.43 111.088 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.683 HG21 ' HB3' ' A' ' 209' ' ' SER . 0.4 OUTLIER -70.72 107.58 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 71.11 111.113 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -93.2 94.51 8.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 74.33 110.889 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.9 117.22 24.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 73.44 110.916 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.68 170.93 15.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 71.43 110.889 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 73.43 110.893 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.821 0.343 . . . . 63.02 110.869 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.65 HD12 HG23 ' A' ' 216' ' ' ILE . 28.6 mt -88.14 176.92 7.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 75.41 110.946 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -110.69 -8.75 14.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 63.2 110.907 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.708 HD13 HD12 ' A' ' 216' ' ' ILE . 26.8 tp 58.19 97.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 64.41 110.9 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.639 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -159.06 164.27 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.922 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -46.58 -21.94 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.51 110.924 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -41.14 18.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 74.52 110.899 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.15 -57.13 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 74.4 110.873 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.863 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 29.5 m -45.96 -26.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 64.23 111.093 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -61.08 -59.44 5.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.91 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -42.33 42.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 72.33 110.907 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.887 HG11 ' HA ' ' A' ' 212' ' ' LEU . 2.0 t -70.6 -42.1 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 65.33 111.144 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.571 HD11 ' CD1' ' A' ' 182' ' ' PHE . 31.0 mt -61.86 -32.93 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 74.04 110.948 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -69.95 -3.66 17.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.42 110.887 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -94.43 -2.01 52.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.875 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.75 ' CD1' HG13 ' A' ' 208' ' ' VAL . 4.1 pt -136.59 -35.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 72.22 111.159 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.489 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -45.95 -60.02 4.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.535 0.683 . . . . 75.23 110.836 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.0 Cg_endo -69.73 3.29 2.84 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.713 2.276 . . . . 63.34 112.349 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.614 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -102.39 -23.56 13.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 70.41 110.927 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.614 HD23 ' CD2' ' A' ' 171' ' ' TYR . 2.5 mt -84.31 -36.95 22.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 65.21 110.889 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.27 -13.37 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 70.31 111.052 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.17 -40.96 8.25 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.71 -0.757 . . . . 74.12 112.425 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.0 t -105.16 4.49 31.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 75.44 111.108 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -179.24 -101.5 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 44.4 112.469 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.31 69.75 0.4 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.716 -0.754 . . . . 42.54 112.496 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.88 -123.31 1.89 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 53.23 112.477 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -138.14 112.47 0.89 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 64.41 112.455 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.857 ' H ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -122.11 6.65 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.729 0.299 . . . . 74.33 110.933 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 182' ' ' PHE . 0.2 OUTLIER -37.94 96.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 64.22 110.893 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.863 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 17.6 t80 -37.49 119.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 73.45 110.887 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.0 mt -77.54 -73.41 0.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 61.35 110.905 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 15.0 ptp -174.15 -174.36 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 61.41 110.891 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 157' ' ' ASN . 11.3 mt -133.33 137.01 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 54.35 111.178 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.8 57.05 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 72.12 110.862 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 91.72 -135.24 12.67 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 41.22 112.451 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.634 ' O ' HD13 ' A' ' 189' ' ' ILE . 53.7 Cg_endo -69.66 2.4 3.52 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.716 2.277 . . . . 72.14 112.342 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.872 HD12 ' HB ' ' A' ' 221' ' ' ILE . 26.9 mm -125.41 124.46 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 63.03 111.13 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 6.4 p -109.97 137.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 64.3 111.17 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 15.0 mtmt -101.16 146.46 27.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 72.13 110.9 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 91.0 t -158.94 152.69 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 72.24 111.127 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.528 ' NH1' HG21 ' A' ' 195' ' ' THR . 0.0 OUTLIER -84.5 155.26 22.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 74.42 110.877 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -153.16 84.41 1.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 70.32 110.941 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.528 HG21 ' NH1' ' A' ' 193' ' ' ARG . 11.9 p -120.18 -170.94 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.33 111.143 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 73.13 -168.6 53.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 41.32 112.503 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -15.69 37.13 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.256 . . . . 72.42 112.348 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 194' ' ' LEU . . . -96.21 52.25 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 51.5 111.087 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.673 ' C ' HG23 ' A' ' 200' ' ' VAL . . . -142.99 141.73 31.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 73.12 111.068 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.673 HG23 ' C ' ' A' ' 199' ' ' ALA . 2.7 t 81.45 -40.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.22 111.14 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 1.009 HG12 HG22 ' A' ' 203' ' ' THR . 87.9 t -47.46 139.24 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 52.04 111.129 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 1.7 tpt85 -85.55 78.23 9.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 70.14 110.879 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . 1.009 HG22 HG12 ' A' ' 201' ' ' VAL . 2.5 t 174.33 -42.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 61.02 111.117 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.673 ' O ' HG23 ' A' ' 208' ' ' VAL . 45.7 t -70.08 -44.33 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.25 111.095 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -4.81 18.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 75.12 110.861 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.404 HG22 ' HG3' ' A' ' 210' ' ' LYS . 10.6 mm -91.31 -66.88 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 71.21 111.107 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -45.71 -21.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 75.41 111.091 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.75 HG13 ' CD1' ' A' ' 168' ' ' ILE . 87.7 t -74.79 -75.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 63.35 111.136 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.515 ' HA ' HD12 ' A' ' 212' ' ' LEU . 33.7 t -57.43 -12.5 2.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 74.52 110.852 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 206' ' ' ILE . 0.0 OUTLIER -72.22 -40.27 67.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 72.41 110.906 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.541 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -78.03 -32.92 51.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.852 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.887 ' HA ' HG11 ' A' ' 164' ' ' VAL . 9.2 mt -72.16 -60.37 2.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 73.01 110.945 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -46.33 -26.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 62.33 110.854 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.96 -74.27 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 75.12 110.88 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.51 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.8 OUTLIER -53.21 -52.71 58.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 75.1 110.914 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.708 HD12 HD13 ' A' ' 156' ' ' LEU . 6.8 pt -106.2 87.75 2.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.722 . . . . 74.12 111.159 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -5.82 17.12 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.664 2.243 . . . . 71.03 112.332 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.9 t -69.22 -1.6 8.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.44 110.873 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -78.96 154.84 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 65.15 111.192 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -138.12 -35.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.34 110.898 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.872 ' HB ' HD12 ' A' ' 189' ' ' ILE . 47.2 mt -152.71 103.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 73.35 111.146 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.463 HG21 ' OG ' ' A' ' 209' ' ' SER . 93.8 t -78.13 107.95 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 35.14 111.107 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -94.0 118.5 31.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 73.42 110.923 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -114.41 102.48 10.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.35 110.88 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.593 ' H ' HD12 ' A' ' 225' ' ' LEU . 5.1 mp -69.9 162.77 27.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 65.15 110.947 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 75.24 110.834 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.856 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.762 0.315 . . . . 74.54 110.917 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 153' ' ' MET . 6.9 mp -139.05 -171.37 3.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 72.35 110.925 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -103.37 -12.74 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.23 110.885 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.755 HD13 HD12 ' A' ' 216' ' ' ILE . 11.2 tp 60.85 115.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 71.02 110.942 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.676 ' O ' HG12 ' A' ' 161' ' ' VAL . 16.8 p30 174.76 -173.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 70.31 110.898 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -37.4 87.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.15 110.847 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.413 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 11.3 pt-20 -72.92 -24.2 60.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 73.25 110.869 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 162' ' ' GLU . 91.7 m-20 -101.07 -67.74 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 72.24 110.877 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.755 HG11 ' CZ ' ' A' ' 182' ' ' PHE . 4.0 p -36.82 -29.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 71.03 111.166 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.6 mt-10 -55.01 -59.32 4.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.92 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -36.39 62.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 64.31 110.866 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.915 HG11 ' HA ' ' A' ' 212' ' ' LEU . 93.1 t -65.23 -42.01 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 62.44 111.145 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.478 HD11 ' CD1' ' A' ' 182' ' ' PHE . 62.0 mt -69.43 -21.81 63.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 64.11 110.887 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -72.88 -16.12 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 64.53 110.877 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -89.72 6.35 41.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.33 110.86 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.692 HG21 ' HA ' ' A' ' 208' ' ' VAL . 0.9 OUTLIER -137.76 -34.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.22 111.122 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.7 -61.03 5.23 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.539 0.685 . . . . 75.45 110.889 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.78 -11.37 30.67 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.684 2.256 . . . . 71.12 112.335 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.543 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -84.86 -13.18 51.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 73.3 110.959 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.847 HD11 ' CD2' ' A' ' 180' ' ' LEU . 6.4 mt -80.39 -41.89 23.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.931 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -39.21 -48.59 1.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.12 111.119 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.3 -55.66 29.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 72.25 112.485 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.8 p -77.08 2.46 15.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.795 0.331 . . . . 71.35 111.12 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 151.1 -64.32 0.38 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.73 . . . . 72.51 112.496 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 124.44 32.41 0.83 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 42.31 112.482 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -46.35 174.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 72.51 112.483 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -126.69 117.57 2.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.752 -0.737 . . . . 64.32 112.487 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.847 ' CD2' HD11 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -118.14 25.23 10.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.788 0.328 . . . . 45.31 110.901 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 180' ' ' LEU . 1.4 pp0? -34.35 124.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 75.22 110.89 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.755 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 17.8 t80 -52.5 135.61 33.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.912 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 53.8 mt -94.28 -71.51 0.66 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 75.34 110.884 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.418 ' C ' HG13 ' A' ' 185' ' ' ILE . 6.8 ptp -176.06 -162.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 74.31 110.851 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.418 HG13 ' C ' ' A' ' 184' ' ' MET . 8.7 mt -146.41 127.42 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 51.03 111.12 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.13 48.66 1.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 51.01 110.875 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 106.73 -140.13 15.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 75.12 112.507 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 3.09 3.0 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.683 2.255 . . . . 62.13 112.357 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.49 135.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 73.35 111.126 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 156' ' ' LEU . 76.5 t -109.83 137.03 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 64.13 111.106 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -107.75 140.62 40.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 73.24 110.906 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 90.8 t -152.48 144.8 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 75.55 111.159 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.14 166.96 17.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 73.13 110.842 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -160.91 84.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 62.53 110.864 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.6 p -99.97 158.42 15.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 42.44 111.126 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 90.36 -177.58 42.57 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.659 -0.781 . . . . 54.44 112.435 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PRO . . . . . 0.459 ' O ' HG23 ' A' ' 201' ' ' VAL . 53.9 Cg_endo -69.71 0.74 5.16 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.707 2.271 . . . . 72.34 112.352 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.934 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -87.93 16.87 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 32.22 111.104 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -120.52 49.39 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 61.02 111.075 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.3 p -177.56 -35.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 64.24 111.149 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 197' ' ' PRO . 20.2 t -47.94 137.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 71.15 111.122 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.421 ' C ' HD12 ' A' ' 206' ' ' ILE . 0.0 OUTLIER -80.36 42.85 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 73.45 110.893 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.1 m -160.59 -46.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 74.11 111.14 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.934 HG11 ' HB1' ' A' ' 198' ' ' ALA . 43.4 t -61.55 -64.78 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 75.52 111.12 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -50.59 -30.23 12.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 72.04 110.839 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 202' ' ' ARG . 18.5 mt -73.65 -35.69 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 72.44 111.113 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -58.32 -44.31 88.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.21 111.073 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.791 HG12 HD11 ' A' ' 212' ' ' LEU . 70.1 t -53.68 -80.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 71.25 111.157 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.4 t -42.84 -39.28 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 52.24 110.857 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.41 -40.31 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 44.24 110.934 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 212' ' ' LEU . 0.4 OUTLIER -85.11 -59.84 2.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 54.51 110.897 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.915 ' HA ' HG11 ' A' ' 164' ' ' VAL . 2.3 mt -32.72 -69.9 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 75.25 110.956 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.5 HH22 HG11 ' A' ' 222' ' ' VAL . 0.0 OUTLIER -49.35 -40.92 37.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 64.31 110.88 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 211' ' ' LYS . 2.0 mt-10 -64.53 -80.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 75.1 110.943 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.674 ' CB ' HG22 ' A' ' 164' ' ' VAL . 12.2 mmtt -40.99 -58.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 71.01 110.869 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.755 HD12 HD13 ' A' ' 156' ' ' LEU . 9.4 pt -106.97 88.42 3.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.625 0.726 . . . . 54.25 111.148 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -9.26 25.68 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.714 2.276 . . . . 73.34 112.365 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.69 -14.13 62.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 74.13 110.877 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 mt -61.11 146.02 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 74.12 111.135 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.788 ' HB3' HD12 ' A' ' 221' ' ' ILE . 13.0 mp0 -116.88 -38.28 3.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 73.13 110.873 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.788 HD12 ' HB3' ' A' ' 220' ' ' GLN . 4.7 mp -153.27 103.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 70.03 111.11 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.5 HG11 HH22 ' A' ' 213' ' ' ARG . 0.9 OUTLIER -72.9 115.56 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 55.25 111.09 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -100.66 108.11 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 71.12 110.948 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mt -99.37 113.6 26.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 75.2 110.944 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.9 mp -93.93 176.06 6.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 74.45 110.917 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 72.34 110.834 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.8 tpt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.813 0.34 . . . . 70.14 110.887 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.762 HD13 ' O ' ' A' ' 215' ' ' LYS . 6.7 mp -121.14 -171.92 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 72.24 110.91 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -102.22 -21.56 14.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.01 110.886 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.619 HD12 HG22 ' A' ' 161' ' ' VAL . 5.5 tp 61.07 113.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 61.43 110.917 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.929 ' H ' HG23 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 174.71 -178.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 72.3 110.847 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -6.64 4.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 70.52 110.892 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.46 -43.68 7.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 54.44 110.895 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.523 ' HB3' HD23 ' A' ' 154' ' ' LEU . 61.1 m-20 -94.62 -49.48 5.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 61.04 110.902 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.929 HG23 ' H ' ' A' ' 157' ' ' ASN . 86.6 t -43.08 -44.02 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 72.13 111.155 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -57.49 -34.46 69.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 73.4 110.85 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -62.61 -45.13 94.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.919 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.958 HG11 ' HA ' ' A' ' 212' ' ' LEU . 23.1 t -70.4 -31.79 47.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 71.23 111.129 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 162' ' ' GLU . 46.5 mt -70.03 -27.8 64.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 73.04 110.936 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 14.5 m-80 -69.9 -9.35 54.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 75.34 110.83 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -87.94 -15.6 36.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 65.3 110.869 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.778 HD13 ' HA ' ' A' ' 208' ' ' VAL . 1.5 pt -118.34 -30.04 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 71.21 111.154 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.555 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.51 -61.05 5.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.703 . . . . 73.2 110.877 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.5 Cg_endo -69.74 1.78 4.12 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.702 2.268 . . . . 73.21 112.33 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.688 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -94.12 -31.53 14.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 75.14 110.924 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.688 HD23 ' CD2' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -77.61 -60.39 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 71.15 110.972 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -38.27 -52.38 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 54.1 111.076 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -38.71 -44.16 1.79 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 74.22 112.512 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.2 p -99.91 -15.09 18.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.373 . . . . 73.21 111.162 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -176.05 -88.08 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 53.34 112.473 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 114.18 99.67 2.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.695 -0.764 . . . . 73.34 112.452 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -93.25 -92.36 1.53 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 52.31 112.515 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.72 119.75 0.56 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.715 -0.755 . . . . 74.03 112.483 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.555 HD11 ' HD2' ' A' ' 169' ' ' ARG . 0.4 OUTLIER -139.78 17.8 2.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.756 0.312 . . . . 73.44 110.934 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.6 OUTLIER -34.28 96.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 72.32 110.945 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.626 ' CE1' HG11 ' A' ' 161' ' ' VAL . 91.4 t80 -36.47 118.71 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.861 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 46.8 mt -82.02 -78.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 72.44 110.922 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.9 -166.19 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 71.22 110.898 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.788 HD11 HG21 ' A' ' 161' ' ' VAL . 32.5 mt -142.55 139.91 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 52.4 111.182 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -128.5 69.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 62.12 110.917 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 89.8 -139.7 15.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 55.14 112.445 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 1.22 4.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.626 2.218 . . . . 75.33 112.333 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.5 127.55 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 70.11 111.141 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.689 HG23 HG12 ' A' ' 185' ' ' ILE . 6.2 p -105.17 144.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 73.5 111.169 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 10.7 mtmt -103.84 146.18 29.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 72.41 110.88 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 88.1 t -157.97 136.9 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 64.04 111.098 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.874 ' O ' HD22 ' A' ' 194' ' ' LEU . 11.3 ttt180 -73.69 161.35 30.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 71.54 110.848 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.879 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.2 OUTLIER -157.99 102.64 1.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 73.55 110.911 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.0 p -129.78 161.89 29.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 61.45 111.152 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.2 -177.78 38.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 71.45 112.519 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -43.8 2.46 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 74.42 112.326 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.565 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -62.8 -25.76 68.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 64.04 111.127 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.879 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -34.06 -85.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 55.31 111.149 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.03 112.2 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 71.32 111.18 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.7 HG13 ' H ' ' A' ' 202' ' ' ARG . 1.6 p -137.79 -61.49 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 74.22 111.17 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.7 ' H ' HG13 ' A' ' 201' ' ' VAL . 1.1 mtt-85 162.23 35.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 73.14 110.855 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.468 ' N ' ' CD1' ' A' ' 206' ' ' ILE . 43.7 m -168.29 -56.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 64.33 111.124 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.565 HG21 ' HB1' ' A' ' 198' ' ' ALA . 59.3 t -48.63 -70.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 60.44 111.098 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.49 -22.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.31 110.876 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 203' ' ' THR . 3.1 mp -89.89 -33.02 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 73.34 111.145 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -74.31 -11.67 60.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.52 111.066 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.778 ' HA ' HD13 ' A' ' 168' ' ' ILE . 64.1 t -85.53 -74.81 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 75.51 111.117 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.424 ' HA ' HD12 ' A' ' 212' ' ' LEU . 14.8 t -53.46 -15.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 63.41 110.872 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -64.65 -40.26 95.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 74.31 110.909 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.7 -41.23 12.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 75.21 110.911 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.958 ' HA ' HG11 ' A' ' 164' ' ' VAL . 24.7 mt -52.63 -66.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 72.24 110.903 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -50.43 -24.23 2.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 74.4 110.908 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.33 -68.46 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.906 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.762 ' O ' HD13 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -59.25 -48.3 82.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.912 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.497 HG23 HD22 ' A' ' 154' ' ' LEU . 1.7 pt -109.6 93.76 14.9 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.645 0.736 . . . . 64.41 111.17 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -22.09 32.96 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 65.04 112.324 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 21.0 t -54.71 -15.42 1.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 72.33 110.877 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.7 mt -70.87 143.53 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 71.23 111.159 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -127.05 -42.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 75.34 110.881 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.1 mt -140.91 102.64 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 74.22 111.123 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.21 116.22 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 74.45 111.077 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.51 135.2 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 64.4 110.91 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.515 ' HB3' HD23 ' A' ' 194' ' ' LEU . 30.1 mt -121.97 103.03 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 63.04 110.906 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.4 171.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 73.24 110.939 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 45.14 110.84 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.783 0.325 . . . . 72.34 110.881 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.781 HD22 ' CG ' ' A' ' 160' ' ' ASN . 6.5 mt -148.41 -173.1 4.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 72.44 110.928 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -108.55 -6.23 16.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 61.32 110.925 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.708 HD12 ' CG2' ' A' ' 161' ' ' VAL . 3.2 tp 61.17 119.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.55 110.943 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.93 ' H ' HG23 ' A' ' 161' ' ' VAL . 5.8 p30 169.37 179.53 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 74.44 110.891 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -26.5 65.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.857 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.429 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 11.6 pt-20 -84.24 -30.96 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.11 110.865 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.781 ' CG ' HD22 ' A' ' 154' ' ' LEU . 9.5 m120 -97.32 -62.29 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 63.44 110.922 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.93 HG23 ' H ' ' A' ' 157' ' ' ASN . 50.0 t -38.78 -46.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 75.31 111.156 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.14 -56.02 5.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.32 110.854 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -43.07 30.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 65.25 110.902 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.77 HG11 ' HA ' ' A' ' 212' ' ' LEU . 33.6 t -70.14 -42.94 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 65.31 111.149 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.629 HD11 ' CD1' ' A' ' 182' ' ' PHE . 56.5 mt -63.84 -24.7 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 71.13 110.905 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -69.17 -10.84 59.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.3 110.876 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -84.73 -25.74 28.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 72.14 110.884 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 169' ' ' ARG . 1.7 pt -106.98 -45.33 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 73.21 111.147 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.837 ' HG3' HD21 ' A' ' 180' ' ' LEU . 2.8 mtt180 -34.48 -58.71 0.63 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.631 0.729 . . . . 74.22 110.877 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.76 -30.8 21.72 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 72.01 112.379 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.57 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -74.34 -15.0 60.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 73.22 110.915 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.57 HD23 ' CD2' ' A' ' 171' ' ' TYR . 3.8 mt -76.5 -43.02 41.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 54.11 110.912 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.19 -22.62 48.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 60.22 111.118 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -46.32 -49.37 15.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 62.03 112.459 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.7 t -125.98 48.78 2.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 63.35 111.167 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.18 -97.65 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 72.53 112.489 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.03 125.46 4.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 63.53 112.511 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -128.81 -102.54 1.07 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 64.23 112.492 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -169.34 119.33 0.82 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.709 -0.758 . . . . 65.43 112.465 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.837 HD21 ' HG3' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -140.95 6.08 1.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 72.32 110.893 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.449 ' N ' HD13 ' A' ' 180' ' ' LEU . 0.9 OUTLIER -35.0 111.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 74.4 110.9 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.774 ' CE1' HG11 ' A' ' 161' ' ' VAL . 27.3 t80 -37.78 122.19 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 75.04 110.865 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 38.1 mt -81.01 -77.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 75.41 110.965 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.423 ' C ' HG13 ' A' ' 185' ' ' ILE . 12.5 ptm -169.99 -172.91 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 74.34 110.883 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.423 HG13 ' C ' ' A' ' 184' ' ' MET . 2.4 mt -133.73 130.52 56.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 75.21 111.134 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.09 75.83 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 71.25 110.954 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 87.19 -151.16 23.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 24.21 112.496 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 2.93 3.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.687 2.258 . . . . 75.14 112.303 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 24.0 mt -113.71 124.38 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 62.14 111.118 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.0 137.97 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.41 111.177 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.404 ' C ' HG23 ' A' ' 192' ' ' VAL . 4.6 mtmm -104.94 142.16 35.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 73.14 110.901 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.404 HG23 ' C ' ' A' ' 191' ' ' LYS . 56.1 t -156.91 142.83 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 71.4 111.152 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.468 ' NH2' HG21 ' A' ' 195' ' ' THR . 1.0 OUTLIER -73.69 163.1 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 64.31 110.887 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.72 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -164.49 93.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.41 110.915 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.468 HG21 ' NH2' ' A' ' 193' ' ' ARG . 5.9 p -132.49 -168.84 2.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 54.2 111.094 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.79 -158.13 42.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 54.22 112.476 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.26 18.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.678 2.252 . . . . 74.44 112.364 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.614 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -90.22 -162.41 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 73.24 111.131 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.716 ' HB2' HD12 ' A' ' 194' ' ' LEU . . . 74.01 144.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.062 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.452 ' O ' HG23 ' A' ' 200' ' ' VAL . 22.0 m 34.05 42.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 72.34 111.169 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 199' ' ' ALA . 23.0 t -99.12 -16.63 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.33 111.16 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 70.47 40.17 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 75.12 110.859 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.83 -44.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 72.21 111.133 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.614 HG11 ' HB1' ' A' ' 198' ' ' ALA . 53.6 t -72.64 -47.34 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 72.23 111.125 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -61.54 -40.89 96.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 63.21 110.893 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.72 -37.3 58.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 60.51 111.104 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.8 -29.95 69.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.01 111.107 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 212' ' ' LEU . 67.3 t -65.04 -75.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 52.52 111.125 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.527 ' HA ' HD12 ' A' ' 212' ' ' LEU . 1.9 t -55.33 -19.0 7.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 60.44 110.872 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.409 ' O ' ' OE1' ' A' ' 214' ' ' GLU . 3.8 mtpp -61.93 -40.32 95.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 71.52 110.855 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.86 -32.81 17.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 75.45 110.87 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.77 ' HA ' HG11 ' A' ' 164' ' ' VAL . 10.5 mt -69.29 -67.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 74.11 110.932 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ARG . . . . . 0.423 ' CZ ' ' OG ' ' A' ' 209' ' ' SER . 0.7 OUTLIER -45.07 -27.95 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.52 110.862 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 210' ' ' LYS . 0.4 OUTLIER -81.68 -76.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 71.13 110.902 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.509 ' CB ' HG22 ' A' ' 164' ' ' VAL . 16.4 mmtt -42.24 -59.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 65.15 110.893 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.523 HD13 HG22 ' A' ' 161' ' ' VAL . 3.4 pt -103.94 95.42 7.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.659 0.743 . . . . 71.41 111.167 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -22.04 32.58 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.673 2.249 . . . . 74.01 112.33 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 17.0 t -49.06 -35.74 16.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 63.31 110.851 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.457 HG21 HG22 ' A' ' 222' ' ' VAL . 4.5 mt -48.37 154.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.35 111.129 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.446 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.8 OUTLIER -134.94 -35.53 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 54.22 110.927 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.41 HG13 ' C ' ' A' ' 220' ' ' GLN . 53.4 mt -146.76 91.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 64.24 111.147 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 219' ' ' ILE . 39.8 t -65.05 109.82 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 73.03 111.096 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -100.9 130.58 46.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 64.55 110.856 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.72 HD22 HD23 ' A' ' 194' ' ' LEU . 14.2 mt -117.07 114.09 23.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 50.1 110.909 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.52 177.88 7.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 72.03 110.925 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 72.21 110.879 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.809 0.337 . . . . 62.12 110.891 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 215' ' ' LYS . 12.4 mt -83.58 -176.3 6.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 71.22 110.897 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -104.13 -17.82 14.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.11 110.919 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.885 HD13 HD12 ' A' ' 216' ' ' ILE . 8.9 tp 59.71 111.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 73.42 110.95 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.629 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -175.99 171.96 2.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 53.42 110.867 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.18 -20.51 1.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 64.42 110.869 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.51 -35.22 25.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 73.15 110.903 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.636 ' ND2' HD22 ' A' ' 154' ' ' LEU . 4.2 m-20 -90.0 -55.85 3.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 73.02 110.882 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 157' ' ' ASN . 26.6 m -47.46 -26.72 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 63.32 111.092 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -62.79 -42.02 99.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.893 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -34.08 69.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 74.22 110.944 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.828 HG11 ' HA ' ' A' ' 212' ' ' LEU . 30.4 t -73.37 -42.93 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 71.54 111.087 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.944 HD22 ' CD1' ' A' ' 180' ' ' LEU . 85.0 mt -65.89 -23.59 66.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 74.32 110.915 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -73.37 -8.64 56.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 64.31 110.861 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.19 1.59 49.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 74.12 110.916 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.972 HD12 HG13 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -132.91 -35.19 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 64.42 111.103 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.717 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.19 -60.56 5.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 75.13 110.874 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.4 Cg_endo -69.77 -4.73 14.63 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.691 2.261 . . . . 60.22 112.305 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.596 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -90.53 -22.1 21.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 64.14 110.924 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.596 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.3 mt -76.37 -44.81 34.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 50.24 110.912 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.5 -38.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 62.25 111.13 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.69 152.1 19.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 45.12 112.501 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.0 t 40.14 56.26 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.33 . . . . 74.44 111.132 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 156.37 -86.72 0.12 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 25.05 112.46 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 89.34 89.24 1.23 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 73.51 112.526 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.33 -158.81 7.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 63.21 112.515 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.92 152.68 24.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 64.32 112.458 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.944 ' CD1' HD22 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -140.9 25.7 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 65.21 110.919 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.461 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.1 OUTLIER -32.71 110.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 74.24 110.956 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.569 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 5.7 t80 -46.95 133.15 11.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 75.54 110.889 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.79 -69.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 52.22 110.905 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.1 ptp -178.13 -176.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 64.31 110.859 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.2 mt -131.29 125.27 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 75.14 111.145 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -124.9 56.41 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 70.11 110.913 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 95.71 -141.77 15.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.747 -0.74 . . . . 40.34 112.424 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.422 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.7 Cg_endo -69.72 3.28 2.84 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 52.44 112.358 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.02 118.3 58.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 75.52 111.127 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 66.7 t -97.22 135.53 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 54.23 111.15 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -109.76 139.58 44.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 74.35 110.907 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 193' ' ' ARG . 40.2 t -152.23 160.58 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 63.14 111.117 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.536 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.0 OUTLIER -92.37 166.65 12.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 73.32 110.854 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -156.42 70.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 71.44 110.91 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 76.4 p -89.09 173.3 8.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 74.52 111.156 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 86.24 -179.49 49.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.761 . . . . 75.22 112.455 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -24.43 29.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.709 2.273 . . . . 73.24 112.342 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.674 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -79.85 103.43 9.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 73.41 111.074 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -165.0 -74.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 45.4 111.103 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 28.5 m -61.92 -11.01 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 74.14 111.146 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 13.2 t -64.02 128.82 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.44 111.131 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -77.58 58.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 61.43 110.871 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 96.6 m -163.65 -55.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 74.53 111.13 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.674 HG21 ' HB1' ' A' ' 198' ' ' ALA . 59.8 t -54.47 -61.44 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 64.13 111.112 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -53.73 -25.69 19.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.51 110.873 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.01 -28.73 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 71.04 111.114 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.93 -32.34 72.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 70.55 111.075 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 1.021 HG12 HD11 ' A' ' 212' ' ' LEU . 3.8 t -67.07 -70.26 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 63.43 111.114 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.617 ' HA ' HD12 ' A' ' 212' ' ' LEU . 7.8 t -50.35 -17.91 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 74.43 110.854 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -66.96 -41.09 87.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 73.24 110.918 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -88.49 -33.99 17.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.1 110.905 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 1.021 HD11 HG12 ' A' ' 208' ' ' VAL . 11.3 mt -63.88 -67.14 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -16.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 72.2 110.85 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.96 -78.45 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.13 110.871 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.681 ' O ' HD12 ' A' ' 154' ' ' LEU . 1.2 mttp -47.09 -55.87 7.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 72.43 110.863 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.885 HD12 HD13 ' A' ' 156' ' ' LEU . 4.1 pt -108.05 91.53 8.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 75.13 111.152 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -16.06 37.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.63 2.22 . . . . 74.54 112.37 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.78 -23.94 7.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 71.51 110.821 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 5.2 mt -58.81 158.14 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 72.23 111.112 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.498 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -137.59 -35.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 75.34 110.903 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 220' ' ' GLN . 72.9 mt -150.71 96.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 71.35 111.143 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 222' ' ' VAL . 28.7 m -67.89 121.52 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.13 111.134 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.63 119.18 38.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 73.32 110.91 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.48 119.16 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 72.13 110.959 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.31 168.87 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 70.04 110.928 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.23 110.852 -179.907 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.807 0.337 . . . . 75.02 110.849 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.737 HD23 ' CG ' ' A' ' 160' ' ' ASN . 0.5 OUTLIER -138.31 -170.26 2.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 64.34 110.911 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -104.12 -17.05 15.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 75.32 110.894 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.721 ' CD1' HD12 ' A' ' 216' ' ' ILE . 9.4 tp 58.15 113.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.2 110.896 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.621 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 175.52 -177.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.24 110.875 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.421 ' HA ' HG12 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -52.89 -45.38 67.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 72.43 110.823 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -57.93 -56.17 25.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 72.03 110.927 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.737 ' CG ' HD23 ' A' ' 154' ' ' LEU . 10.2 m120 -74.52 -65.85 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 71.42 110.909 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 157' ' ' ASN . 2.5 p -34.75 -33.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 54.34 111.147 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -56.22 -57.1 13.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.901 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.96 -43.71 77.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.908 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.882 HG11 ' HA ' ' A' ' 212' ' ' LEU . 17.8 t -63.81 -40.89 90.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 63.45 111.177 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 182' ' ' PHE . 54.0 mt -66.35 -32.79 74.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 74.41 110.891 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 4.5 m-80 -63.97 -13.13 43.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.31 110.844 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.02 1.13 48.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 63.21 110.877 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.702 HG21 ' HA ' ' A' ' 208' ' ' VAL . 0.6 OUTLIER -135.15 -34.61 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 62.22 111.157 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.42 -60.77 5.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 71.51 110.851 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' CG ' ' O ' ' A' ' 166' ' ' ASN . 53.8 Cg_endo -69.76 -0.39 6.83 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 63.33 112.34 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.639 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -92.99 -27.1 17.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 72.21 110.943 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.639 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.1 mt -75.63 -39.95 57.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 74.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -44.36 -50.33 9.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 75.21 111.157 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -45.3 -43.74 9.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 50.21 112.504 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.9 t -113.76 37.43 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 74.31 111.124 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.71 109.08 0.46 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 65.14 112.469 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -74.9 137.56 22.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.704 -0.76 . . . . 42.1 112.507 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.01 -106.44 2.9 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.718 -0.753 . . . . 61.04 112.474 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.08 113.81 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.752 . . . . 71.03 112.471 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 181' ' ' GLN . 1.7 pp -142.55 6.68 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.736 0.303 . . . . 71.53 110.905 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 182' ' ' PHE . 2.2 tp60 -36.19 105.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 74.52 110.897 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.604 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 10.0 t80 -34.09 129.44 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 62.2 110.876 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 89.0 mt -95.6 -72.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.51 110.923 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.404 ' C ' HG13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -166.06 -173.31 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 72.11 110.861 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 187' ' ' GLY . 4.1 mt -135.52 143.92 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 75.53 111.116 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.475 ' CG ' ' HB ' ' A' ' 189' ' ' ILE . 7.9 ptpt -121.4 38.43 4.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 73.12 110.872 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.584 ' H ' HG22 ' A' ' 185' ' ' ILE . . . 93.35 -112.23 4.25 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 70.41 112.49 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.519 ' HG2' HD12 ' A' ' 189' ' ' ILE . 53.4 Cg_endo -69.82 -22.89 31.18 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.723 2.282 . . . . 70.5 112.314 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.519 HD12 ' HG2' ' A' ' 188' ' ' PRO . 2.6 mp -106.45 146.66 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 65.25 111.115 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.69 137.54 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 63.42 111.165 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -98.25 140.13 33.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 62.43 110.922 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 193' ' ' ARG . 41.4 t -151.03 149.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 62.22 111.109 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.441 ' O ' HG12 ' A' ' 192' ' ' VAL . 0.0 OUTLIER -83.97 161.4 20.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.842 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -173.12 61.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 65.15 110.983 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 22.6 p -80.42 -49.3 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.34 111.133 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -45.87 173.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.711 -0.757 . . . . 43.13 112.498 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.18 2.93 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 71.43 112.345 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 1.153 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -78.42 6.9 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 61.41 111.102 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 194' ' ' LEU . . . -91.76 -61.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 62.11 111.063 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 200' ' ' VAL . 21.3 t -76.12 50.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 31.02 111.115 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 198' ' ' ALA . 1.7 t -124.89 146.17 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.53 111.172 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -95.5 35.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 62.01 110.869 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.7 m -156.68 -66.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.31 111.144 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 1.153 HG11 ' HB1' ' A' ' 198' ' ' ALA . 57.9 t -44.78 -58.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 73.21 111.125 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -56.69 -21.86 30.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.11 110.896 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.437 HG22 ' HG3' ' A' ' 210' ' ' LYS . 15.6 mm -80.96 -52.22 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 65.41 111.158 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.98 -35.7 25.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 64.54 111.107 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.702 ' HA ' HG21 ' A' ' 168' ' ' ILE . 38.9 t -59.53 -83.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 64.2 111.117 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.588 ' N ' HG12 ' A' ' 208' ' ' VAL . 48.0 t -49.22 -18.49 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 64.51 110.863 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.437 ' HG3' HG22 ' A' ' 206' ' ' ILE . 3.0 mttm -60.48 -40.23 90.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 54.12 110.909 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 214' ' ' GLU . 1.4 mmtt -86.59 -54.56 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 70.12 110.847 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.882 ' HA ' HG11 ' A' ' 164' ' ' VAL . 1.5 mt -37.07 -70.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 65.3 110.877 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -53.49 -22.46 8.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 72.31 110.86 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -77.39 -67.42 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 70.31 110.923 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.67 ' O ' HD13 ' A' ' 154' ' ' LEU . 1.9 mptt -60.72 -46.39 90.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 64.51 110.916 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.721 HD12 ' CD1' ' A' ' 156' ' ' LEU . 4.4 pt -111.68 86.26 6.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.657 0.742 . . . . 72.31 111.111 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 0.26 5.92 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.688 2.259 . . . . 73.44 112.319 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.6 t -76.6 1.68 16.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 72.33 110.857 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 6.3 mt -83.65 157.88 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 74.45 111.13 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.501 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.1 OUTLIER -132.43 -33.13 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 74.01 110.932 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 189' ' ' ILE . 33.6 mm -153.62 108.89 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 70.51 111.13 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.2 t -82.52 117.83 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 71.42 111.087 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -107.87 136.25 47.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 72.23 110.891 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.8 mt -124.05 104.32 8.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 63.41 110.944 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.18 168.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 62.12 110.915 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 61.13 110.862 -179.908 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.822 0.344 . . . . 73.51 110.839 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.501 ' CB ' HG22 ' A' ' 216' ' ' ILE . 11.4 mt -141.94 -175.74 4.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.895 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.66 ' HB3' HD22 ' A' ' 157' ' ' ASN . 0.7 OUTLIER -97.85 -18.09 18.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 62.2 110.873 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.623 HD12 HD12 ' A' ' 216' ' ' ILE . 5.6 tp 61.49 113.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 64.42 110.926 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.962 ' H ' HG23 ' A' ' 161' ' ' VAL . 0.1 OUTLIER 171.8 173.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.883 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 162' ' ' GLU . 3.6 mt-10 -49.49 -37.03 24.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 63.42 110.901 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.8 -54.12 25.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 63.42 110.924 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.438 ' HB3' HD13 ' A' ' 154' ' ' LEU . 8.5 m120 -79.32 -62.82 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 64.42 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.962 HG23 ' H ' ' A' ' 157' ' ' ASN . 72.7 t -34.56 -50.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 73.54 111.133 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 20.7 mm-40 -40.34 -60.2 1.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.865 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.28 -36.86 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 64.24 110.929 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.815 HG11 ' HA ' ' A' ' 212' ' ' LEU . 40.2 t -73.44 -34.39 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 71.42 111.082 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' A' ' 182' ' ' PHE . 27.8 mt -72.79 -30.93 64.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 71.34 110.927 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.82 -6.85 44.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.894 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -90.98 -12.87 34.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.32 110.871 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.514 HD13 HG22 ' A' ' 208' ' ' VAL . 0.8 OUTLIER -123.51 -28.33 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 72.4 111.119 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.652 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -51.61 -60.87 5.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 74.41 110.844 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.9 Cg_endo -69.73 2.62 3.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.675 2.25 . . . . 62.31 112.37 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.634 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -97.61 -28.44 13.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.927 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.634 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.3 mt -76.31 -43.08 42.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 72.14 110.925 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.17 38.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 65.33 111.062 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.53 -20.16 3.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 35.24 112.476 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.1 t -161.95 30.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 64.23 111.174 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -165.29 -69.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 54.43 112.507 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.98 127.34 3.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.698 -0.763 . . . . 70.12 112.493 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 158.86 176.16 30.6 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 74.21 112.475 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.23 -171.98 12.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 74.53 112.513 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.652 HD11 ' HD2' ' A' ' 169' ' ' ARG . 0.6 OUTLIER -163.66 30.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.816 0.341 . . . . 72.13 110.962 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 180' ' ' LEU . 9.3 tp60 -32.19 107.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 73.02 110.886 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.826 ' CE1' HG11 ' A' ' 161' ' ' VAL . 35.7 t80 -48.22 108.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 71.51 110.877 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.728 HD12 HD13 ' A' ' 225' ' ' LEU . 46.9 mt -64.92 -78.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.14 110.912 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 7.3 ptp -168.49 -174.64 2.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 71.54 110.885 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.1 mt -127.88 123.97 61.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 51.51 111.143 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.73 79.18 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 74.11 110.901 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 76.49 -146.56 33.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.724 . . . . 74.24 112.532 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 3.18 2.9 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.688 2.259 . . . . 73.25 112.363 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.9 mt -121.31 115.31 46.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 72.31 111.145 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.16 140.24 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 53.14 111.123 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.573 ' HG2' HD11 ' A' ' 225' ' ' LEU . 11.5 mtmt -101.94 136.64 41.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 54.21 110.89 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 193' ' ' ARG . 82.5 t -140.42 156.46 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 75.02 111.162 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.476 ' N ' HG12 ' A' ' 192' ' ' VAL . 2.8 ttt180 -91.25 174.2 7.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.11 110.855 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 199' ' ' ALA . 0.2 OUTLIER -175.24 81.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 74.44 110.896 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 62.5 p -100.99 179.1 4.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 75.43 111.153 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.49 175.84 48.12 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.765 -0.731 . . . . 64.33 112.432 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -0.12 6.5 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.685 2.257 . . . . 73.43 112.305 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.86 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -86.39 5.39 35.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 73.1 111.089 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.489 ' HB2' HD12 ' A' ' 194' ' ' LEU . . . -94.28 170.07 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 63.43 111.127 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 200' ' ' VAL . 8.3 p 39.56 38.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 73.53 111.104 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.467 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 1.5 p -113.1 -15.3 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 62.1 111.155 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.778 ' HD3' HD11 ' A' ' 206' ' ' ILE . 0.0 OUTLIER 80.7 -58.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.32 110.855 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.6 m -51.35 -63.24 1.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.01 111.111 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.86 HG21 ' HB1' ' A' ' 198' ' ' ALA . 42.9 t -49.47 -65.05 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 61.2 111.087 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.473 ' HB2' ' CD1' ' A' ' 224' ' ' LEU . 0.1 OUTLIER -51.74 -34.03 37.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.878 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.778 HD11 ' HD3' ' A' ' 202' ' ' ARG . 14.1 mt -66.1 -56.72 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 70.33 111.163 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.78 -34.02 18.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 73.13 111.073 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.869 HG12 HD11 ' A' ' 212' ' ' LEU . 98.6 t -60.7 -69.23 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 61.54 111.094 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.582 ' HA ' HD12 ' A' ' 212' ' ' LEU . 0.9 OUTLIER -51.3 -17.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 75.23 110.837 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -73.93 -39.74 63.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 64.33 110.89 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.92 -34.4 26.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 74.05 110.867 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.869 HD11 HG12 ' A' ' 208' ' ' VAL . 8.2 mt -68.59 -70.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 71.43 110.889 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -21.82 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 71.22 110.866 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.82 -81.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 52.23 110.898 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -46.4 -47.74 18.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 75.41 110.893 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.623 HD12 HD12 ' A' ' 156' ' ' LEU . 2.5 pt -112.95 91.49 18.24 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.631 0.729 . . . . 73.1 111.092 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -13.53 34.89 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.689 2.259 . . . . 74.11 112.354 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.18 -11.17 5.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.873 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.576 HG12 HD13 ' A' ' 156' ' ' LEU . 1.1 mt -71.67 143.84 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.44 111.115 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -126.19 -41.53 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 74.44 110.89 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.4 mp -141.93 104.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 71.42 111.164 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.73 121.47 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.11 111.14 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -114.79 129.07 56.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.908 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.473 ' CD1' ' HB2' ' A' ' 205' ' ' ARG . 10.2 mt -113.14 140.56 47.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 60.01 110.917 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.728 HD13 HD12 ' A' ' 183' ' ' LEU . 5.7 mp -115.91 164.07 14.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 63.21 110.942 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 64.22 110.877 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.843 0.354 . . . . 71.14 110.875 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 154' ' ' LEU . 0.8 OUTLIER -95.48 -171.07 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 75.5 110.904 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.401 ' O ' ' O ' ' A' ' 156' ' ' LEU . 2.0 tp10 -91.0 -23.88 20.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 63.31 110.9 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.589 HD11 ' CG1' ' A' ' 219' ' ' ILE . 9.6 tt 53.99 107.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 73.41 110.913 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.807 ' HA ' HD13 ' A' ' 185' ' ' ILE . 9.1 p30 -174.91 171.63 3.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 71.33 110.859 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -48.8 -22.84 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 65.13 110.805 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.96 -52.36 6.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 74.3 110.871 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -68.38 -53.78 21.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 74.04 110.937 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 157' ' ' ASN . 18.6 m -49.5 -27.46 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 64.4 111.108 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.38 -48.23 73.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 71.55 110.862 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.06 -40.3 80.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 54.31 110.919 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.644 HG12 ' HB3' ' A' ' 211' ' ' LYS . 4.1 t -78.22 -35.69 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 71.24 111.166 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 182' ' ' PHE . 32.5 mt -68.0 -25.3 65.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 70.32 110.941 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.416 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 19.9 m-20 -72.84 -9.5 58.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.847 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -94.38 -5.72 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 61.45 110.906 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.93 -40.19 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 65.23 111.155 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.558 ' HA ' HD21 ' A' ' 180' ' ' LEU . 1.8 mtt180 -48.01 -58.63 7.4 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.727 . . . . 65.34 110.829 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.69 -29.93 23.41 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.713 2.275 . . . . 71.2 112.355 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.73 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -58.91 -28.68 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 73.13 110.944 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.73 HD23 ' CD2' ' A' ' 171' ' ' TYR . 3.4 mt -68.57 -53.44 22.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 71.24 110.916 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -50.05 -26.53 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 73.03 111.137 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -47.78 -63.95 3.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 64.53 112.494 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.9 t -109.44 -1.76 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 72.04 111.164 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.35 101.02 0.2 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 55.01 112.483 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.476 ' HA2' ' CB ' ' A' ' 172' ' ' LEU . . . -82.1 164.02 43.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.76 -0.733 . . . . 51.15 112.518 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -136.03 -102.53 0.67 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.766 -0.73 . . . . 70.04 112.522 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -173.43 113.78 0.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.713 -0.756 . . . . 75.33 112.488 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 169' ' ' ARG . 0.7 OUTLIER -135.43 23.49 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 73.12 110.896 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 180' ' ' LEU . 1.1 tp60 -33.92 111.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 71.04 110.918 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 40.6 t80 -57.11 125.01 20.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 73.24 110.927 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.18 -77.01 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 72.54 110.915 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' MET . . . . . 0.425 ' C ' HG13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -169.9 -173.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 72.5 110.905 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.807 HD13 ' HA ' ' A' ' 157' ' ' ASN . 1.7 mt -132.63 132.11 59.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 64.12 111.154 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -124.21 66.26 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.52 110.915 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 90.78 -139.01 14.66 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.752 -0.737 . . . . 72.43 112.492 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.408 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.1 Cg_endo -69.83 -4.99 15.2 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.68 2.253 . . . . 71.34 112.335 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.6 mt -114.63 120.86 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.44 111.143 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.74 HG22 HG23 ' A' ' 185' ' ' ILE . 25.1 t -100.25 136.04 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 54.21 111.155 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -104.31 156.81 17.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.14 110.926 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 193' ' ' ARG . 2.6 p 179.05 147.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 75.32 111.144 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.412 ' O ' HG22 ' A' ' 192' ' ' VAL . 0.3 OUTLIER -72.37 170.76 13.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 52.43 110.905 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.667 HD23 HD22 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -168.32 88.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.4 110.932 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.2 p -116.78 -174.49 2.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 54.22 111.13 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.54 179.14 51.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.784 -0.722 . . . . 75.02 112.507 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 2.26 3.71 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.7 2.266 . . . . 73.23 112.323 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.979 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -106.16 42.32 1.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 74.03 111.149 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -96.67 -53.93 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 74.34 111.151 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 200' ' ' VAL . 3.5 p -142.15 86.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 75.04 111.151 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 201' ' ' VAL . 9.0 p -125.67 24.64 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 75.35 111.117 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.87 39.08 13.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 71.52 110.883 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.598 ' N ' HD12 ' A' ' 206' ' ' ILE . 55.8 m -164.5 -66.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 70.11 111.175 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.979 HG11 ' HB1' ' A' ' 198' ' ' ALA . 97.7 t -53.16 -70.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 42.35 111.117 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -38.96 -30.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 72.12 110.875 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ILE . . . . . 0.598 HD12 ' N ' ' A' ' 203' ' ' THR . 3.5 mt -80.66 -44.53 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 71.31 111.108 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -52.67 -29.8 28.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 73.14 111.096 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 209' ' ' SER . 62.9 t -69.2 -85.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 55.03 111.13 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.483 ' N ' HG12 ' A' ' 208' ' ' VAL . 44.8 t -39.61 -25.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 70.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.544 ' CE ' HG22 ' A' ' 206' ' ' ILE . 1.2 mttt -61.6 -46.45 89.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 63.34 110.878 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.644 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -71.97 -49.54 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.22 110.888 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.714 ' H ' HD22 ' A' ' 212' ' ' LEU . 2.2 mm? -52.05 -74.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 74.52 110.909 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.01 -29.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 71.22 110.869 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.41 -74.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 73.01 110.922 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.455 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 1.6 mptt -62.49 -48.27 80.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 64.3 110.892 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.623 HD13 HG12 ' A' ' 161' ' ' VAL . 11.6 pt -106.52 87.64 2.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.622 0.725 . . . . 74.33 111.152 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -21.44 33.84 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.232 . . . . 74.22 112.4 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.5 t -46.31 -40.03 11.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 61.1 110.862 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.589 ' CG1' HD11 ' A' ' 156' ' ' LEU . 4.8 mt -39.41 155.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 74.01 111.103 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.478 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -135.69 -34.4 0.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 73.34 110.947 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 33.2 mm -153.05 104.93 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 64.22 111.128 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.63 115.39 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 73.54 111.153 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -105.29 129.51 53.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 70.44 110.922 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.667 HD22 HD23 ' A' ' 194' ' ' LEU . 5.8 mt -119.07 109.11 15.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 64.35 110.926 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.35 165.41 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 63.54 110.897 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.24 110.864 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 7.8 mmt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.825 0.345 . . . . 64.22 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.557 HD22 ' HB3' ' A' ' 160' ' ' ASN . 7.9 mt -107.52 -174.64 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.956 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -119.0 -2.58 10.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.893 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.788 HD13 HD12 ' A' ' 216' ' ' ILE . 20.2 tp 60.81 126.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 73.21 110.937 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.929 ' H ' HG23 ' A' ' 161' ' ' VAL . 3.6 p30 162.19 179.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 74.13 110.884 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.05 -19.28 62.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 60.02 110.86 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.431 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 10.7 pt-20 -90.07 -34.69 15.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 75.02 110.847 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.557 ' HB3' HD22 ' A' ' 154' ' ' LEU . 11.6 m120 -93.29 -59.75 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 61.54 110.841 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.929 HG23 ' H ' ' A' ' 157' ' ' ASN . 63.3 t -38.97 -43.35 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 73.22 111.115 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -45.82 -56.13 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 64.41 110.914 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -34.04 64.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 74.3 110.873 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.897 HG11 ' HA ' ' A' ' 212' ' ' LEU . 73.6 t -69.91 -50.89 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 53.42 111.128 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 22.1 mt -59.0 -22.92 61.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 53.42 110.893 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -72.32 -6.32 42.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 62.54 110.936 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -98.57 7.99 45.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 72.54 110.903 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -143.36 -35.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 72.22 111.188 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -50.37 -60.6 5.0 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.575 0.702 . . . . 75.53 110.845 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.79 0.87 5.04 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.678 2.252 . . . . 74.21 112.339 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.59 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -97.15 -21.43 17.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.3 110.928 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.59 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.4 mt -81.22 -43.95 18.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 52.33 110.935 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.58 -50.52 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 51.23 111.102 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.37 -45.0 97.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.801 -0.714 . . . . 74.14 112.501 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.0 p -88.41 21.88 2.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 74.25 111.109 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 177' ' ' GLY . . . 90.48 79.02 1.36 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 71.24 112.487 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 176' ' ' GLY . . . -37.05 156.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.789 -0.72 . . . . 51.34 112.489 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.67 -113.62 1.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 73.15 112.493 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -164.01 114.18 0.59 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.693 -0.765 . . . . 74.34 112.445 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.88 ' O ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -138.75 14.15 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 73.44 110.882 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -32.15 95.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 63.04 110.899 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.749 ' CE1' HG11 ' A' ' 161' ' ' VAL . 54.9 t80 -36.04 118.9 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 72.1 110.894 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.501 HD12 HD13 ' A' ' 225' ' ' LEU . 42.2 mt -78.3 -78.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 73.43 110.915 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -167.59 -159.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 74.03 110.867 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 74.8 mt -146.24 135.83 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.35 111.092 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -128.55 57.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 60.42 110.933 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.58 -140.34 14.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 61.32 112.488 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -3.35 11.84 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 61.13 112.349 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 21.8 mt -110.94 138.28 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 63.33 111.126 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 185' ' ' ILE . 16.9 t -115.31 132.95 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 75.41 111.083 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.555 ' HG2' HD11 ' A' ' 225' ' ' LEU . 19.3 mtmt -98.25 142.55 29.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 65.32 110.873 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 88.0 t -155.35 139.61 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 72.42 111.159 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -73.92 169.75 16.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.932 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.775 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -160.88 96.84 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 74.04 110.93 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.15 153.84 38.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 70.51 111.108 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 121.12 -172.56 15.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 65.24 112.497 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -8.69 24.24 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 65.1 112.313 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.65 8.49 11.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 63.34 111.105 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.775 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -51.49 -61.59 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 60.53 111.099 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.07 107.96 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 73.45 111.142 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 202' ' ' ARG . 42.4 t -146.81 -79.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 62.43 111.104 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.473 ' N ' HG12 ' A' ' 201' ' ' VAL . 0.1 OUTLIER -175.25 137.11 0.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.44 110.898 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 204' ' ' VAL . 0.2 OUTLIER 77.86 -60.86 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.443 . . . . 71.4 111.153 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 203' ' ' THR . 98.9 t -35.44 -71.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 50.33 111.11 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.55 -49.3 1.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 63.01 110.855 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.39 -58.3 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.14 111.125 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -40.51 -35.72 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 64.23 111.059 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.59 -76.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 53.53 111.109 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.4 t -54.97 -14.15 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 62.53 110.858 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -65.13 -39.93 93.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 74.24 110.86 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 214' ' ' GLU . 0.9 OUTLIER -87.03 -62.61 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.418 . . . . 75.23 110.958 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.897 ' HA ' HG11 ' A' ' 164' ' ' VAL . 9.8 mt -31.72 -69.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.11 110.946 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -38.0 32.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 74.24 110.874 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.3 OUTLIER -66.91 -79.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 73.14 110.898 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.71 ' CB ' HG22 ' A' ' 164' ' ' VAL . 11.8 mmtm -45.16 -52.75 8.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 63.01 110.916 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.788 HD12 HD13 ' A' ' 156' ' ' LEU . 6.5 pt -110.57 93.68 17.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 73.04 111.136 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -23.24 31.23 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.714 2.276 . . . . 51.54 112.364 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.08 -26.28 2.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 60.14 110.838 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.9 mt -59.71 152.56 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 75.33 111.16 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLN . . . . . 0.415 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 2.2 mt-30 -131.19 -37.49 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 60.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.8 mt -141.72 112.38 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 43.22 111.086 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.09 114.29 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 72.44 111.074 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -103.91 129.54 51.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 63.11 110.94 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.678 ' HB3' HD23 ' A' ' 194' ' ' LEU . 14.2 mt -119.32 102.41 8.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 61.12 110.903 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LEU . . . . . 0.555 HD11 ' HG2' ' A' ' 191' ' ' LYS . 4.9 mp -82.18 160.23 23.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 75.21 110.931 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 64.31 110.842 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.416 HD23 ' CG ' ' A' ' 160' ' ' ASN . 3.2 mp . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.769 0.319 . . . . 75.219999999999999 110.945 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.481 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 0.7 OUTLIER -109.18 -11.41 14.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 73.310000000000002 110.882 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.573 ' CD1' HD12 ' A' ' 216' ' ' ILE . 29.2 tp 59.62 92.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 64.230000000000004 110.955 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.784 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -175.31 175.21 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 110.86 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.47 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 9.6 mt-10 -42.7 -55.39 3.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 74.099999999999994 110.895 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.405 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -51.01 -30.97 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 60.420000000000002 110.905 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 155' ' ' GLU . 21.1 m-20 -96.59 -72.53 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 110.932 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 157' ' ' ASN . 30.3 m -33.94 -34.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.540000000000006 111.13 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -55.16 -57.59 11.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.019999999999996 110.903 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -53.04 -54.45 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.140000000000001 110.898 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 211' ' ' LYS . 3.4 t -62.87 -29.57 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 61.399999999999999 111.088 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' A' ' 182' ' ' PHE . 15.1 mt -71.39 -32.49 68.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 63.200000000000003 110.919 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -72.38 -5.58 37.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 64.319999999999993 110.905 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -93.16 -9.53 39.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 64.430000000000007 110.873 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.85 -31.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 54.32 111.147 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.812 ' NE ' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -51.16 -60.67 5.2 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.535 0.683 . . . . 71.530000000000001 110.901 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.9 Cg_endo -69.78 2.54 3.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.668 2.245 . . . . 33.030000000000001 112.343 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.631 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -96.41 -28.72 14.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 70.400000000000006 110.959 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.631 HD23 ' CD2' ' A' ' 171' ' ' TYR . 9.2 mt -72.79 -34.46 66.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.868 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -85.77 -11.31 53.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.099999999999994 111.1 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -88.69 2.86 84.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 70.329999999999998 112.456 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.5 t -130.57 9.92 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 74.400000000000006 111.178 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.52 -56.8 0.58 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 72.230000000000004 112.487 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 169.09 162.03 20.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 60.299999999999997 112.475 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -173.58 -160.68 22.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.75 . . . . 72.329999999999998 112.486 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.97 110.02 0.24 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 72.340000000000003 112.499 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.812 HD11 ' NE ' ' A' ' 169' ' ' ARG . 3.7 pp -113.18 -31.73 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.745 0.307 . . . . 72.120000000000005 110.887 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.596 ' N ' HD12 ' A' ' 180' ' ' LEU . 0.4 OUTLIER 33.63 90.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 62.310000000000002 110.906 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.705 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 28.0 t80 -42.4 114.06 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 53.409999999999997 110.876 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.98 -79.61 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 44.450000000000003 110.897 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 27.5 ptm -167.67 -170.81 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 61.140000000000001 110.847 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 157' ' ' ASN . 7.3 mt -131.61 144.44 37.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 72.5 111.104 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.8 68.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 73.430000000000007 110.929 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 83.13 -141.87 21.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 64.420000000000002 112.502 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 54.0 Cg_endo -69.74 -1.18 8.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.231 . . . . 74.299999999999997 112.372 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 47.6 mt -117.92 124.25 72.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.329999999999998 111.138 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 191' ' ' LYS . 1.4 p -108.72 155.1 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 62.219999999999999 111.153 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.442 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 13.9 mtmt -116.26 141.04 48.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 72.129999999999995 110.915 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.467 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 43.7 t -151.53 155.46 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 71.319999999999993 111.134 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -94.81 172.06 8.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 63.109999999999999 110.886 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.913 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -167.67 86.21 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.510000000000005 110.929 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.1 p -123.83 177.95 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 54.240000000000002 111.14 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 87.13 -172.16 43.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 70.019999999999996 112.477 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -1.33 8.27 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.65 2.233 . . . . 62.210000000000001 112.382 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.03 57.51 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 50.310000000000002 111.14 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.913 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -99.89 -94.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 62.100000000000001 111.105 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.26 59.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 61.43 111.105 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 201' ' ' VAL . 4.9 t -101.12 30.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 60.409999999999997 111.123 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.0 OUTLIER 67.56 133.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 73.340000000000003 110.865 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.625 ' HA ' HD12 ' A' ' 206' ' ' ILE . 0.6 OUTLIER 78.54 -51.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 52.549999999999997 111.162 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 47.9 t -40.5 -51.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 54.32 111.113 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.17 -35.4 80.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.530000000000001 110.888 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 203' ' ' THR . 18.1 mt -64.1 -50.36 77.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 70.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.98 -36.77 29.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 111.103 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.501 ' O ' HD22 ' A' ' 212' ' ' LEU . 58.0 t -59.22 -83.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 63.420000000000002 111.157 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.472 ' N ' HG12 ' A' ' 208' ' ' VAL . 29.0 t -48.86 -20.54 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.140000000000001 110.837 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -58.55 -46.22 87.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 55.240000000000002 110.89 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.613 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -82.59 -46.62 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 44.140000000000001 110.937 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 208' ' ' VAL . 1.6 mm? -47.18 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 73.329999999999998 110.899 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.65 -52.2 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 110.9 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -41.21 -80.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.883 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 217' ' ' PRO . 0.9 OUTLIER -51.48 -51.41 55.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 63.130000000000003 110.865 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.573 HD12 ' CD1' ' A' ' 156' ' ' LEU . 5.2 pt -107.16 82.77 1.22 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.595 0.712 . . . . 73.420000000000002 111.096 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 53.7 Cg_endo -69.77 -5.69 16.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.667 2.244 . . . . 73.209999999999994 112.337 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 23.3 t -66.38 -22.95 66.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 72.209999999999994 110.862 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 7.3 mt -57.89 158.67 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 75.450000000000003 111.169 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.522 ' O ' HD13 ' A' ' 221' ' ' ILE . 1.1 mt-30 -134.84 -33.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.894 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.522 HD13 ' O ' ' A' ' 220' ' ' GLN . 37.5 mm -154.13 106.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 61.049999999999997 111.123 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 76.8 t -80.42 114.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 54.310000000000002 111.148 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -96.78 113.59 25.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 71.400000000000006 110.901 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.486 HD22 HD23 ' A' ' 194' ' ' LEU . 12.0 mt -100.53 102.72 13.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 110.893 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.91 -176.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 64.109999999999999 110.887 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.439999999999998 110.88 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.778 HD12 ' O ' ' A' ' 215' ' ' LYS . 5.9 mt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.797 0.332 . . . . 63.310000000000002 110.924 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -117.54 -0.82 11.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 65.409999999999997 110.873 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.706 HD13 HD12 ' A' ' 216' ' ' ILE . 20.4 tp 52.86 97.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 75.400000000000006 110.867 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.586 ' O ' HG22 ' A' ' 161' ' ' VAL . 3.6 p30 -159.14 164.43 35.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 75.510000000000005 110.876 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 16.8 mt-10 -45.15 -30.57 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 72.430000000000007 110.871 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.36 -44.45 52.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.945 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -80.51 -59.64 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 50.350000000000001 110.861 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.75 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 21.7 m -39.09 -33.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.107 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.34 -51.09 62.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.91 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -40.51 68.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 54.310000000000002 110.929 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.863 HG11 ' HA ' ' A' ' 212' ' ' LEU . 21.5 t -79.47 -34.79 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 70.109999999999999 111.083 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.487 HD23 HD11 ' A' ' 168' ' ' ILE . 27.9 mt -71.12 -21.31 62.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 110.912 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.415 ' O ' ' CD ' ' A' ' 170' ' ' PRO . 61.3 m-20 -74.5 -12.26 60.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 75.200000000000003 110.901 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -83.01 -14.16 54.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 71.319999999999993 110.876 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.763 HD13 ' HA ' ' A' ' 208' ' ' VAL . 3.2 pt -121.14 -31.16 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 72.349999999999994 111.09 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.731 ' HG2' HD13 ' A' ' 180' ' ' LEU . 1.1 mtt180 -49.04 -60.86 4.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.643 0.735 . . . . 73.310000000000002 110.871 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.0 Cg_endo -69.72 1.92 3.98 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.741 2.294 . . . . 74.530000000000001 112.341 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.518 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -105.66 -17.57 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 71.540000000000006 110.907 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.979 HD12 HD23 ' A' ' 180' ' ' LEU . 2.9 mt -77.84 -28.9 50.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 63.109999999999999 110.912 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.9 42.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 72.129999999999995 111.065 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -132.87 -33.59 0.37 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 53.450000000000003 112.499 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.9 t -144.59 9.51 1.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.787 0.327 . . . . 61.439999999999998 111.107 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 149.63 90.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.733 . . . . 63.43 112.488 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . -125.08 168.55 17.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 61.030000000000001 112.495 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 154.44 -14.07 0.53 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 71.109999999999999 112.502 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -134.42 116.89 1.7 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 74.430000000000007 112.553 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.979 HD23 HD12 ' A' ' 172' ' ' LEU . 0.3 OUTLIER -173.9 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 73.430000000000007 110.898 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 180' ' ' LEU . 8.3 tp60 -36.22 99.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 75.439999999999998 110.953 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.75 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 15.0 t80 -46.52 116.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 64.120000000000005 110.878 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 80.3 mt -76.0 -73.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 71.099999999999994 110.876 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.402 ' C ' HG13 ' A' ' 185' ' ' ILE . 28.0 ptm -173.4 -168.95 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 75.140000000000001 110.902 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.402 HG13 ' C ' ' A' ' 184' ' ' MET . 8.0 mt -136.25 129.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 74.010000000000005 111.137 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.37 56.14 1.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 73.349999999999994 110.911 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.91 -145.59 16.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.758 -0.734 . . . . 63.210000000000001 112.486 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 3.27 2.91 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.688 2.258 . . . . 72.129999999999995 112.322 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 221' ' ' ILE . 3.9 mp -115.21 130.49 69.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.539999999999999 111.123 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 84.0 t -104.6 148.59 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 75.420000000000002 111.087 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -116.79 140.88 48.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 71.030000000000001 110.887 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 193' ' ' ARG . 21.4 t -151.95 166.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 62.350000000000001 111.143 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.615 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.1 OUTLIER -92.87 143.11 26.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 74.230000000000004 110.909 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.666 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -143.61 87.31 1.92 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.888 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.05 -171.47 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 64.209999999999994 111.118 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.81 -169.85 55.01 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.723 -0.751 . . . . 44.310000000000002 112.506 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.53 ' O ' HG13 ' A' ' 201' ' ' VAL . 54.0 Cg_endo -69.67 0.43 5.59 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 35.109999999999999 112.397 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.684 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -103.68 -5.6 22.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 42.420000000000002 111.104 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.628 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -80.53 42.06 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.510000000000005 111.069 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.4 p 179.34 -29.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 111.093 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 198' ' ' ALA . 27.5 m -56.93 127.09 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 52.409999999999997 111.109 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -79.71 77.5 6.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 73.219999999999999 110.9 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 t 176.03 -44.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 63.229999999999997 111.155 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.684 HG11 ' HB1' ' A' ' 198' ' ' ALA . 41.0 t -72.21 -42.68 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 70.200000000000003 111.149 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -65.88 -7.13 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.838 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.55 -57.54 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 111.115 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.28 -20.48 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 73.510000000000005 111.093 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.763 ' HA ' HD13 ' A' ' 168' ' ' ILE . 88.9 t -72.29 -62.28 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 62.009999999999998 111.119 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 222' ' ' VAL . 32.1 t -80.59 14.5 2.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 71.030000000000001 110.853 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -39.86 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 74.200000000000003 110.932 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.62 -35.68 22.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 74.319999999999993 110.903 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.863 ' HA ' HG11 ' A' ' 164' ' ' VAL . 7.7 mt -68.72 -65.4 0.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 64.219999999999999 110.91 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.03 -21.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 110.878 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.409 ' N ' ' C ' ' A' ' 212' ' ' LEU . 20.9 tt0 -85.14 -72.49 0.48 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 74.439999999999998 110.881 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.778 ' O ' HD12 ' A' ' 154' ' ' LEU . 2.0 mptt -51.51 -54.04 31.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 74.319999999999993 110.92 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.715 HG23 HD13 ' A' ' 154' ' ' LEU . 2.0 pt -103.37 95.07 6.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.589 0.709 . . . . 54.25 111.15 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 -24.94 29.53 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.711 2.274 . . . . 64.129999999999995 112.358 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 46.0 t -47.37 -29.16 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 62.210000000000001 110.855 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.3 mt -59.37 153.3 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 73.219999999999999 111.122 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.431 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -139.66 -38.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 110.886 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 189' ' ' ILE . 21.8 mt -140.67 98.53 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 65.340000000000003 111.12 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.466 HG21 ' OG ' ' A' ' 209' ' ' SER . 67.1 t -74.89 109.15 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 72.530000000000001 111.135 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -97.68 138.89 34.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.966 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.666 HD22 HD23 ' A' ' 194' ' ' LEU . 8.2 mt -122.01 127.33 50.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 72.5 110.915 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 225' ' ' LEU . 2.1 mm? -96.63 172.16 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 75.310000000000002 110.888 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 43.229999999999997 110.8 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.535 HD23 ' CG ' ' A' ' 160' ' ' ASN . 4.8 mp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.779 0.323 . . . . 71.430000000000007 110.912 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -108.88 -13.23 14.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 63.439999999999998 110.875 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.728 HD13 HD12 ' A' ' 216' ' ' ILE . 15.7 tp 58.29 100.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 72.310000000000002 110.919 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.692 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -167.08 161.24 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 70.420000000000002 110.882 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.441 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -34.89 -35.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 75.209999999999994 110.869 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' ASN . 0.2 OUTLIER -71.82 -53.68 12.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.857 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.535 ' CG ' HD23 ' A' ' 154' ' ' LEU . 12.2 m-20 -67.78 -56.17 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 64.010000000000005 110.878 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.855 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 33.6 m -48.79 -27.87 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 62.229999999999997 111.147 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.46 -58.59 7.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 72.420000000000002 110.878 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -45.07 45.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 72.329999999999998 110.892 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.779 HG11 ' HA ' ' A' ' 212' ' ' LEU . 1.3 t -68.63 -42.31 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 65.319999999999993 111.134 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.514 HD11 ' CD1' ' A' ' 182' ' ' PHE . 49.7 mt -63.41 -20.64 65.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 110.941 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.485 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 16.3 m-20 -76.48 -9.48 58.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 51.310000000000002 110.862 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.65 1.75 56.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 74.239999999999995 110.847 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.753 HG21 ' HA ' ' A' ' 208' ' ' VAL . 1.1 pt -131.75 -45.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.040000000000006 111.148 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.49 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -46.23 -60.28 3.82 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.607 0.718 . . . . 74.400000000000006 110.858 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.79 -11.12 30.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.653 2.235 . . . . 63.329999999999998 112.397 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.55 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -88.15 -12.4 44.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 72.230000000000004 110.885 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.509 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.3 mt -84.27 -53.57 5.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 74.349999999999994 110.961 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 175' ' ' THR . . . -58.12 -54.3 48.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 71.510000000000005 111.134 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -35.02 -31.59 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 54.200000000000003 112.44 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 173' ' ' ALA . 1.2 t -134.21 64.86 1.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 72.239999999999995 111.191 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.93 -69.71 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.744 . . . . 74.430000000000007 112.519 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . 120.34 175.75 15.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 72.519999999999996 112.443 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -158.56 -123.37 0.72 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.723 -0.751 . . . . 53.049999999999997 112.468 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 163.32 114.49 0.31 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.725 -0.75 . . . . 74.129999999999995 112.502 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.464 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 3.4 pp -133.56 -39.5 0.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.744 0.307 . . . . 63.350000000000001 110.919 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 180' ' ' LEU . 20.9 tp60 34.3 90.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 73.409999999999997 110.904 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.855 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 25.9 t80 -36.96 107.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 73.209999999999994 110.89 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 36.0 mt -68.38 -79.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 74.510000000000005 110.935 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.2 ptp -165.3 -171.67 2.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 52.439999999999998 110.915 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.28 134.43 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 65.420000000000002 111.085 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.75 66.53 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 74.549999999999997 110.887 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 89.62 -146.0 18.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 52.219999999999999 112.452 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.8 Cg_endo -69.73 3.2 2.89 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.674 2.249 . . . . 72.329999999999998 112.36 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mt -123.23 110.46 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 74.0 111.18 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.6 p -96.25 132.3 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 111.132 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.441 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 14.8 mtmt -89.49 146.27 24.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 75.299999999999997 110.946 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 193' ' ' ARG . 97.4 t -158.93 156.56 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 75.420000000000002 111.17 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.477 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.1 OUTLIER -90.12 172.5 8.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 73.25 110.85 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.57 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -162.6 81.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 74.019999999999996 110.919 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.0 p -114.24 -169.66 1.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 75.420000000000002 111.15 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 74.11 -179.09 42.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 62.399999999999999 112.513 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -2.1 9.61 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.68 2.253 . . . . 55.229999999999997 112.342 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 1.025 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -82.57 -17.45 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.310000000000002 111.092 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -56.27 -62.68 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 72.099999999999994 111.118 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.32 97.76 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 75.040000000000006 111.153 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 7.3 p -159.79 -33.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.420000000000002 111.123 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 201' ' ' VAL . 9.9 ttp180 85.35 142.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.400000000000006 110.859 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.479 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 2.7 m 83.03 -32.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 61.399999999999999 111.156 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 1.025 HG11 ' HB1' ' A' ' 198' ' ' ALA . 33.3 t -70.14 -71.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 111.148 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -40.22 -43.39 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 72.109999999999999 110.912 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.556 HG22 ' CD ' ' A' ' 210' ' ' LYS . 3.1 mp -60.11 -44.13 94.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 55.109999999999999 111.116 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.39 -36.55 22.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 52.200000000000003 111.091 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.753 ' HA ' HG21 ' A' ' 168' ' ' ILE . 55.1 t -65.77 -85.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 74.209999999999994 111.149 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.697 ' HA ' HD23 ' A' ' 212' ' ' LEU . 40.9 m -34.01 -43.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 61.409999999999997 110.853 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.556 ' CD ' HG22 ' A' ' 206' ' ' ILE . 14.0 mtpt -47.84 -51.45 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.150000000000006 110.909 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.544 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -61.87 -66.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 75.129999999999995 110.899 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.82 ' H ' HD22 ' A' ' 212' ' ' LEU . 1.4 mm? -35.0 -73.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 73.019999999999996 110.956 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.34 -35.28 0.96 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 74.349999999999994 110.856 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 211' ' ' LYS . 2.6 tp10 -57.14 -72.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 71.040000000000006 110.883 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 217' ' ' PRO . 5.2 mttp -63.57 -48.73 76.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.911 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.728 HD12 HD13 ' A' ' 156' ' ' LEU . 7.1 pt -107.03 83.24 1.28 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.639 0.733 . . . . 73.430000000000007 111.104 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 53.5 Cg_endo -69.82 -5.35 16.03 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.701 2.267 . . . . 74.200000000000003 112.33 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.15 -11.7 43.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 72.140000000000001 110.897 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 5.1 mt -68.77 158.3 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 61.130000000000003 111.151 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.872 ' HB3' HD12 ' A' ' 221' ' ' ILE . 0.2 OUTLIER -136.89 -34.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 71.140000000000001 110.907 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.872 HD12 ' HB3' ' A' ' 220' ' ' GLN . 4.5 mp -150.61 108.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 62.539999999999999 111.123 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 79.1 t -86.57 112.69 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 62.130000000000003 111.116 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -100.59 115.59 30.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.209999999999994 110.916 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.57 HD22 HD23 ' A' ' 194' ' ' LEU . 4.0 mt -103.51 101.71 11.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 65.310000000000002 110.921 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.35 174.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 73.040000000000006 110.904 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 65.230000000000004 110.824 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 215' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.031 0 CA-C-O 120.769 0.318 . . . . 55.340000000000003 110.937 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -101.62 -2.79 29.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 64.109999999999999 110.894 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.725 HD13 HD12 ' A' ' 216' ' ' ILE . 10.9 tp 54.48 89.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 61.450000000000003 110.938 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.812 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -149.76 178.98 8.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.881 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.32 -48.93 77.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 110.857 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -58.84 -46.61 87.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 71.129999999999995 110.889 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.676 ' CG ' HD22 ' A' ' 154' ' ' LEU . 98.1 m-20 -71.07 -69.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 65.219999999999999 110.925 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.856 HG21 ' CE2' ' A' ' 182' ' ' PHE . 20.7 m -36.95 -31.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 63.140000000000001 111.127 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.7 mt-10 -55.38 -58.08 9.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 70.420000000000002 110.951 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -39.59 56.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 64.430000000000007 110.93 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.963 HG11 ' HA ' ' A' ' 212' ' ' LEU . 21.4 t -64.3 -53.45 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 111.13 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 182' ' ' PHE . 16.2 mt -58.15 -24.56 59.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 62.329999999999998 110.897 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -72.23 -6.85 45.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 63.020000000000003 110.865 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.66 4.92 43.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 63.009999999999998 110.886 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.7 -34.54 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 75.400000000000006 111.099 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.717 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -54.71 -60.58 7.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 71.430000000000007 110.889 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.0 Cg_endo -69.82 -5.94 17.45 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.71 2.273 . . . . 50.130000000000003 112.286 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.584 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -86.42 -22.45 26.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 71.400000000000006 110.889 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.584 HD23 ' CD2' ' A' ' 171' ' ' TYR . 7.2 mt -78.21 -53.61 7.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.200000000000003 110.954 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -36.73 -51.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 111.078 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -39.41 -44.44 2.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.79 -0.719 . . . . 74.030000000000001 112.452 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 53.2 p -88.15 -33.38 18.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 54.119999999999997 111.126 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 170.38 -42.28 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.68 -0.771 . . . . 72.549999999999997 112.461 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.1 162.83 28.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 50.310000000000002 112.478 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -151.05 -94.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 64.150000000000006 112.446 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 169.99 122.34 0.63 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.69 -0.767 . . . . 64.439999999999998 112.459 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.717 HD11 ' HD2' ' A' ' 169' ' ' ARG . 1.1 pp -150.07 13.15 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 75.349999999999994 110.902 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 182' ' ' PHE . 0.5 OUTLIER -35.34 105.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 72.019999999999996 110.917 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.856 ' CE2' HG21 ' A' ' 161' ' ' VAL . 8.8 t80 -34.25 121.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 110.877 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.424 ' CD1' HD13 ' A' ' 225' ' ' LEU . 77.5 mt -80.82 -68.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 110.923 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 12.1 ptp -177.51 -175.65 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 74.019999999999996 110.897 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.2 mt -130.31 124.32 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 72.299999999999997 111.126 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.32 74.99 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.0 110.951 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 85.24 -149.04 23.51 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 73.219999999999999 112.495 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 3.53 2.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.704 2.269 . . . . 73.209999999999994 112.369 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.2 mt -117.06 123.48 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 71.549999999999997 111.101 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 41.0 t -99.09 143.69 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 71.219999999999999 111.136 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -107.56 142.33 37.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 74.5 110.887 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 193' ' ' ARG . 59.5 t -154.4 155.41 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 50.240000000000002 111.159 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.459 ' N ' HG12 ' A' ' 192' ' ' VAL . 7.5 tpt180 -94.26 154.74 17.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 110.849 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -149.91 76.84 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 75.329999999999998 110.922 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.5 p -108.17 -169.55 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 111.119 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.01 -178.15 33.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.766 -0.731 . . . . 63.340000000000003 112.48 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -0.78 7.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.699 2.266 . . . . 75.129999999999995 112.388 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -85.76 -6.39 59.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 54.210000000000001 111.116 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -72.03 -50.64 26.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 111.087 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 200' ' ' VAL . 2.7 p -93.0 71.85 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 63.299999999999997 111.131 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.941 HG12 HG22 ' A' ' 203' ' ' THR . 15.1 t -155.02 117.54 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 73.310000000000002 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 71.17 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.886 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.941 HG22 HG12 ' A' ' 201' ' ' VAL . 14.6 t -179.35 -33.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.109999999999999 111.146 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.479 HG21 ' HB1' ' A' ' 198' ' ' ALA . 20.0 t -67.69 -68.96 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.450000000000003 111.16 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -45.97 -33.14 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 72.140000000000001 110.868 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.7 mp -71.22 -42.84 75.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 65.439999999999998 111.134 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.74 -33.68 76.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 54.310000000000002 111.125 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.676 HG12 HD11 ' A' ' 212' ' ' LEU . 94.5 t -62.57 -75.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 75.209999999999994 111.125 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.587 ' HA ' HD12 ' A' ' 212' ' ' LEU . 5.6 t -53.55 -15.61 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 54.409999999999997 110.853 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -40.65 86.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 63.229999999999997 110.898 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -86.81 -35.04 19.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.010000000000005 110.909 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.963 ' HA ' HG11 ' A' ' 164' ' ' VAL . 8.5 mt -66.41 -64.45 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 61.509999999999998 110.927 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -22.19 1.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.886 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -83.95 -79.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 42.119999999999997 110.884 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.819 ' O ' HD12 ' A' ' 154' ' ' LEU . 14.8 mmtt -41.23 -55.9 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 75.109999999999999 110.927 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.725 HD12 HD13 ' A' ' 156' ' ' LEU . 4.4 pt -108.35 85.58 2.89 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 111.161 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.8 9.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.638 2.225 . . . . 71.340000000000003 112.316 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . 0.412 ' HB3' ' CB ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -71.79 -6.29 40.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 63.109999999999999 110.857 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 220' ' ' GLN . 3.2 mt -73.36 154.69 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 62.140000000000001 111.146 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.565 ' O ' HD13 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -126.3 -33.7 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 71.040000000000006 110.882 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 220' ' ' GLN . 30.1 mm -151.74 107.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 73.040000000000006 111.147 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.8 t -78.77 109.07 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.073 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -99.44 119.69 38.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 70.340000000000003 110.907 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.7 mt -110.86 105.7 14.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 64.549999999999997 110.887 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.424 HD13 ' CD1' ' A' ' 183' ' ' LEU . 4.9 mp -81.45 162.98 23.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.340000000000003 110.9 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 63.409999999999997 110.881 -179.95 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.636 ' N ' HD22 ' A' ' 154' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.734 0.302 . . . . 74.099999999999994 110.931 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.531 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 17.7 tt0 -112.01 -0.32 15.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.430000000000007 110.912 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.732 ' CD1' HD12 ' A' ' 216' ' ' ILE . 8.0 tp 61.73 110.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 75.420000000000002 110.896 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.931 ' H ' HG23 ' A' ' 161' ' ' VAL . 0.1 OUTLIER 169.64 164.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.129999999999995 110.876 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -33.97 -60.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 73.0 110.887 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -44.92 -60.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.409999999999997 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.796 ' ND2' HD21 ' A' ' 157' ' ' ASN . 53.1 m-20 -73.86 -67.39 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.912 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.931 HG23 ' H ' ' A' ' 157' ' ' ASN . 90.0 t -33.29 -46.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 65.239999999999995 111.137 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 30.0 mm-40 -47.39 -56.78 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 110.885 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.79 -49.8 19.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 73.519999999999996 110.89 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 212' ' ' LEU . 1.9 t -63.44 -42.72 97.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 50.350000000000001 111.137 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.59 HD22 HD12 ' A' ' 180' ' ' LEU . 75.9 mt -61.18 -28.9 69.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 110.924 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -71.25 -6.06 36.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.902 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.67 -12.08 24.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 70.439999999999998 110.864 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.75 -34.19 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 62.399999999999999 111.12 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.519 ' HG3' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.05 -60.96 5.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 75.239999999999995 110.925 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.4 Cg_endo -69.75 1.36 4.5 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.66 2.24 . . . . 62.240000000000002 112.363 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.627 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -94.89 -23.43 17.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 43.240000000000002 110.932 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.627 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.9 mt -80.98 -36.28 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 75.209999999999994 110.887 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.69 60.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 111.078 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.72 -44.78 80.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 71.439999999999998 112.481 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 175' ' ' THR . 5.8 t -143.2 99.99 3.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.895 0.379 . . . . 65.439999999999998 111.15 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.43 63.59 3.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.778 -0.725 . . . . 54.039999999999999 112.497 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 172' ' ' LEU . . . -62.56 100.31 0.31 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 63.240000000000002 112.454 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -79.96 -153.34 8.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.753 -0.737 . . . . 72.340000000000003 112.477 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -136.67 115.0 1.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 70.040000000000006 112.435 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.59 HD12 HD22 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -121.24 21.03 11.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 53.219999999999999 110.95 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -34.57 107.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 110.939 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.911 ' CE1' HG11 ' A' ' 161' ' ' VAL . 24.5 t80 -50.42 104.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 64.319999999999993 110.852 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.82 -74.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 72.530000000000001 110.91 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.46 ' CG ' ' HE3' ' A' ' 191' ' ' LYS . 1.8 ptt? -169.24 -171.37 1.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 72.420000000000002 110.898 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 157' ' ' ASN . 1.8 mt -132.61 125.94 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 43.439999999999998 111.139 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.63 77.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 74.450000000000003 110.885 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.423 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 75.75 -142.37 28.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.772 -0.728 . . . . 62.039999999999999 112.446 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.423 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.5 Cg_endo -69.78 3.3 2.86 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.711 2.274 . . . . 75.439999999999998 112.328 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.6 mt -120.55 122.9 69.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 73.030000000000001 111.128 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.2 p -106.25 135.2 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 72.540000000000006 111.125 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.46 ' HE3' ' CG ' ' A' ' 184' ' ' MET . 15.7 mtmt -93.77 142.47 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 70.549999999999997 110.877 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 85.9 t -156.65 130.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 74.219999999999999 111.137 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.61 167.43 18.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 110.842 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.473 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -157.26 85.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 60.350000000000001 110.883 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.1 p -114.15 -177.22 3.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 44.43 111.161 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.41 -177.54 51.6 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 61.219999999999999 112.471 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -12.84 33.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.661 2.24 . . . . 71.519999999999996 112.358 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.448 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -100.92 60.18 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 51.299999999999997 111.125 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -124.83 3.71 8.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 51.039999999999999 111.06 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 200' ' ' VAL . 9.5 p -169.0 76.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 72.420000000000002 111.138 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 201' ' ' VAL . 7.1 p -137.19 7.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 75.140000000000001 111.142 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.37 47.74 19.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 75.239999999999995 110.873 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.9 m -163.91 -64.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 75.049999999999997 111.14 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.621 HG23 HG11 ' A' ' 201' ' ' VAL . 77.3 t -47.75 -59.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 73.219999999999999 111.104 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.8 -22.99 6.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 75.109999999999999 110.877 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.9 mm -77.52 -47.16 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 75.439999999999998 111.139 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.25 -18.8 17.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 65.439999999999998 111.135 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.554 ' O ' HD22 ' A' ' 212' ' ' LEU . 59.9 t -73.81 -83.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 65.310000000000002 111.118 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.461 ' N ' HG12 ' A' ' 208' ' ' VAL . 2.7 t -42.28 -23.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.84 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 208' ' ' VAL . 19.5 mttt -58.8 -59.45 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 110.897 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.463 ' HB3' HG12 ' A' ' 164' ' ' VAL . 7.6 mmtt -65.34 -45.25 84.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 74.129999999999995 110.899 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 208' ' ' VAL . 1.5 mm? -54.03 -65.93 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 72.349999999999994 110.942 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -49.54 -32.35 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 74.150000000000006 110.897 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.4 -71.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.030000000000001 110.896 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.539 ' O ' HD22 ' A' ' 154' ' ' LEU . 7.5 mptt -56.65 -52.34 65.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 71.030000000000001 110.942 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.732 HD12 ' CD1' ' A' ' 156' ' ' LEU . 8.4 pt -106.48 86.24 2.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.593 0.711 . . . . 73.329999999999998 111.144 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -7.05 20.09 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.726 2.284 . . . . 54.119999999999997 112.296 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.76 -3.91 10.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 54.450000000000003 110.883 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.4 mt -74.19 152.59 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 63.299999999999997 111.152 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.879 ' HB3' HD12 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -132.02 -37.1 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.200000000000003 110.904 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 220' ' ' GLN . 4.6 mp -150.81 104.89 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 74.530000000000001 111.122 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.97 114.74 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 73.430000000000007 111.133 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.09 129.85 51.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.877 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.473 HD22 HD23 ' A' ' 194' ' ' LEU . 7.2 mt -118.76 126.83 52.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 71.049999999999997 110.899 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 225' ' ' LEU . 4.1 mp -94.42 168.32 10.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 72.120000000000005 110.923 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 110.859 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.486 HD22 ' CG ' ' A' ' 160' ' ' ASN . 16.3 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.764 0.316 . . . . 74.430000000000007 110.931 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.471 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 2.0 tt0 -103.49 -13.53 16.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.894 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.654 ' HA ' HG21 ' A' ' 216' ' ' ILE . 6.7 tp 58.24 109.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 65.230000000000004 110.928 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.672 ' HA ' HD13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -177.52 -171.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.925 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -69.86 -4.35 19.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.865 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.484 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 7.2 mm-40 -102.15 -41.59 6.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 71.540000000000006 110.849 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.486 ' CG ' HD22 ' A' ' 154' ' ' LEU . 95.7 m-20 -88.13 -41.9 12.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 65.150000000000006 110.841 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 182' ' ' PHE . 2.8 p -58.99 -30.34 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 111.175 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.77 -57.34 12.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 73.109999999999999 110.875 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.34 -44.37 23.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.209999999999994 110.868 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.979 HG11 ' HA ' ' A' ' 212' ' ' LEU . 20.6 t -68.04 -45.84 82.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 111.18 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.488 HD23 HD11 ' A' ' 168' ' ' ILE . 48.3 mt -61.03 -24.91 66.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 55.119999999999997 110.891 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -76.81 -2.01 31.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 70.310000000000002 110.893 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -102.62 8.7 39.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 63.100000000000001 110.919 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.746 HD13 ' HA ' ' A' ' 208' ' ' VAL . 0.7 OUTLIER -142.96 -37.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.230000000000004 111.178 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.485 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -48.7 -60.7 4.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.596 0.713 . . . . 75.530000000000001 110.868 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.78 2.86 3.17 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.715 2.276 . . . . 54.439999999999998 112.301 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.657 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -98.3 -21.41 16.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 63.310000000000002 110.923 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.657 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.9 mt -82.51 -45.88 14.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 75.150000000000006 110.87 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -50.1 -20.67 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 64.349999999999994 111.149 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -92.56 42.69 2.67 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 74.5 112.521 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 176.73 -50.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 75.530000000000001 111.113 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -178.63 70.58 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 74.129999999999995 112.498 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -57.05 163.13 6.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.714 -0.755 . . . . 63.420000000000002 112.496 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -144.84 -102.58 0.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 61.439999999999998 112.481 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.58 112.53 0.53 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.741 . . . . 74.150000000000006 112.477 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.528 ' CD2' ' C ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -136.62 6.26 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 61.340000000000003 110.912 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.479 ' N ' HD22 ' A' ' 180' ' ' LEU . 2.5 tp60 -35.12 109.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 75.200000000000003 110.886 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.668 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 22.7 t80 -43.81 121.51 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 70.319999999999993 110.879 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 225' ' ' LEU . 19.4 mt -83.7 -73.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 65.209999999999994 110.875 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.6 -170.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 65.019999999999996 110.86 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.672 HD13 ' HA ' ' A' ' 157' ' ' ASN . 7.6 mt -136.22 138.27 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 111.13 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -130.25 48.37 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 64.549999999999997 110.872 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.409 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 100.54 -138.67 13.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 72.349999999999994 112.46 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.409 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.6 Cg_endo -69.82 0.35 5.81 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.635 2.223 . . . . 74.099999999999994 112.326 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.84 101.35 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 73.439999999999998 111.13 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.91 142.11 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 50.420000000000002 111.134 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.456 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 5.5 mtmt -100.42 146.31 27.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.944 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 98.5 t -159.13 147.48 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 73.540000000000006 111.117 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.5 165.34 23.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.892 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.746 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -161.77 71.5 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 52.439999999999998 110.92 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 17.1 p -113.89 176.53 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 63.439999999999998 111.081 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.19 -163.22 26.44 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 52.310000000000002 112.486 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -38.21 8.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.691 2.26 . . . . 73.340000000000003 112.358 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.754 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -83.26 49.39 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 71.519999999999996 111.087 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.746 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -105.93 -62.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 63.210000000000001 111.115 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.1 m -95.15 28.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 71.219999999999999 111.122 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.66 136.7 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 64.519999999999996 111.14 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.413 ' C ' HG22 ' A' ' 203' ' ' THR . 5.2 mmt180 -89.96 84.76 6.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 65.239999999999995 110.872 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.474 ' HA ' HD12 ' A' ' 206' ' ' ILE . 0.7 OUTLIER 168.54 -45.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 74.329999999999998 111.135 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.754 HG11 ' HB1' ' A' ' 198' ' ' ALA . 75.4 t -73.12 -55.35 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 74.439999999999998 111.155 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -51.14 -34.41 30.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 75.540000000000006 110.895 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.731 HG22 ' HG3' ' A' ' 210' ' ' LYS . 6.1 mt -68.78 -58.63 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 64.439999999999998 111.133 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -39.36 -50.25 2.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.420000000000002 111.106 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.746 ' HA ' HD13 ' A' ' 168' ' ' ILE . 40.5 t -45.34 -84.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 62.439999999999998 111.1 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.6 ' N ' HG12 ' A' ' 208' ' ' VAL . 48.8 m -47.85 -34.57 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 62.509999999999998 110.834 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.731 ' HG3' HG22 ' A' ' 206' ' ' ILE . 0.0 OUTLIER -49.88 -40.19 42.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 74.420000000000002 110.889 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -86.35 -38.64 17.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 61.210000000000001 110.874 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.979 ' HA ' HG11 ' A' ' 164' ' ' VAL . 15.1 mt -62.6 -67.65 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 72.219999999999999 110.887 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.1 -31.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 71.319999999999993 110.867 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.86 -73.24 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.120000000000005 110.842 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.615 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.7 OUTLIER -51.69 -51.2 57.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 72.0 110.913 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.654 HG21 ' HA ' ' A' ' 156' ' ' LEU . 1.7 pt -105.53 89.79 3.61 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.595 0.712 . . . . 63.329999999999998 111.12 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 54.0 Cg_endo -69.72 -16.33 37.67 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.702 2.268 . . . . 52.450000000000003 112.374 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 47.4 m -58.27 -19.85 37.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.836 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.468 HG21 ' CG2' ' A' ' 222' ' ' VAL . 3.3 mt -67.99 152.28 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 111.121 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.443 ' C ' HG13 ' A' ' 221' ' ' ILE . 0.2 OUTLIER -133.42 -37.92 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 54.5 110.904 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.443 HG13 ' C ' ' A' ' 220' ' ' GLN . 50.9 mt -145.38 96.26 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.111 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.468 ' CG2' HG21 ' A' ' 219' ' ' ILE . 58.1 t -74.13 104.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 111.144 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.4 113.98 24.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.889 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.462 ' HB3' HD23 ' A' ' 194' ' ' LEU . 1.3 mt -110.26 100.82 9.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.42 . . . . 70.349999999999994 110.934 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.445 HD13 HD12 ' A' ' 183' ' ' LEU . 4.3 mp -65.76 159.5 25.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 74.010000000000005 110.917 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 52.109999999999999 110.84 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.0 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.744 0.307 . . . . 62.140000000000001 110.96 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -96.46 -9.4 29.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 70.219999999999999 110.903 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.84 HD13 HD12 ' A' ' 216' ' ' ILE . 13.3 tp 51.77 100.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 73.010000000000005 110.915 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -171.07 167.28 7.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 70.340000000000003 110.849 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.458 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 4.5 mt-10 -37.64 -54.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 61.539999999999999 110.898 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -48.79 -52.5 23.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 72.439999999999998 110.869 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 163' ' ' LYS . 37.0 m-20 -73.87 -70.32 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.510000000000005 110.883 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.571 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 13.3 m -33.78 -37.74 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 62.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 166' ' ' ASN . 0.8 OUTLIER -60.08 -50.01 75.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 52.420000000000002 110.879 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.0 OUTLIER -55.83 -54.19 47.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 71.420000000000002 110.895 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' A' ' 211' ' ' LYS . 3.5 t -61.86 -41.11 89.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 75.099999999999994 111.144 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 37.4 mt -61.2 -27.78 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 43.539999999999999 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 162' ' ' GLU . 45.1 m-80 -71.07 -8.67 55.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 74.040000000000006 110.881 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -88.57 -15.73 34.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 72.209999999999994 110.929 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.473 HG21 ' HA ' ' A' ' 208' ' ' VAL . 1.2 pt -117.72 -33.13 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.530000000000001 111.098 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.723 ' HG3' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -50.42 -60.29 5.61 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.596 0.712 . . . . 64.310000000000002 110.849 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.79 -3.42 11.99 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.643 2.229 . . . . 62.240000000000002 112.34 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.762 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -92.29 -16.81 25.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.310000000000002 110.908 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.762 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.8 mt -83.44 -28.94 28.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 72.239999999999995 110.897 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 175' ' ' THR . . . -79.81 -39.29 31.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 111.115 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -36.87 -33.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.744 -0.741 . . . . 60.539999999999999 112.485 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 173' ' ' ALA . 1.7 t -154.42 74.46 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.802 0.334 . . . . 74.219999999999999 111.158 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 146.93 -106.95 0.38 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 63.020000000000003 112.523 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -145.54 -98.39 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 73.319999999999993 112.483 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 129.85 123.12 2.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 74.049999999999997 112.542 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.45 107.37 0.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 71.340000000000003 112.504 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.723 HD21 ' HG3' ' A' ' 169' ' ' ARG . 4.3 pp -144.11 -40.16 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.776 0.322 . . . . 61.340000000000003 110.93 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.591 ' N ' HD12 ' A' ' 180' ' ' LEU . 13.5 tp60 34.24 90.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 75.150000000000006 110.923 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.571 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 31.5 t80 -34.49 113.76 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 74.0 110.919 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 191' ' ' LYS . 14.2 mt -66.78 -79.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 110.923 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 18.5 ptp -171.88 -174.59 1.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 62.039999999999999 110.852 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.47 143.55 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 74.340000000000003 111.122 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.88 39.19 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 73.310000000000002 110.931 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 112.7 -139.3 15.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.687 -0.768 . . . . 72.140000000000001 112.503 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.8 Cg_endo -69.73 0.27 5.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.668 2.245 . . . . 64.140000000000001 112.347 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.78 127.72 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 62.530000000000001 111.122 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.78 145.25 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 51.32 111.095 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.439 ' HB3' HD12 ' A' ' 183' ' ' LEU . 22.2 mtmt -112.81 145.49 40.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 75.230000000000004 110.869 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 21.7 t -158.23 154.12 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 111.089 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.568 ' O ' HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -91.67 169.84 10.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.847 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.568 HD22 ' O ' ' A' ' 193' ' ' ARG . 0.2 OUTLIER -163.33 92.31 0.73 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 63.140000000000001 110.929 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.13 167.92 19.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 73.099999999999994 111.134 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 100.19 -160.96 19.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 74.430000000000007 112.473 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.94 7.65 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.665 2.243 . . . . 70.209999999999994 112.33 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.545 ' O ' HG11 ' A' ' 204' ' ' VAL . . . -137.88 50.14 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 50.229999999999997 111.103 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.541 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -74.88 -27.32 60.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 63.509999999999998 111.09 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 200' ' ' VAL . 1.1 p 166.14 92.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 74.530000000000001 111.132 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 8.5 p -116.76 -36.94 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 111.148 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.53 ' C ' HD12 ' A' ' 206' ' ' ILE . 0.6 OUTLIER 162.96 -85.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 70.120000000000005 110.899 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 37.0 p -59.63 -25.7 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 70.019999999999996 111.161 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 208' ' ' VAL . 53.9 t -58.23 -56.21 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 64.340000000000003 111.141 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -32.03 60.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 54.439999999999998 110.874 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.537 HG22 ' HE3' ' A' ' 210' ' ' LYS . 36.3 mt -64.01 -56.78 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 111.186 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.01 -32.45 54.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 72.409999999999997 111.12 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 204' ' ' VAL . 55.3 t -63.12 -86.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 54.43 111.166 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.652 ' HA ' HD23 ' A' ' 212' ' ' LEU . 24.5 m -33.94 -45.4 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 61.119999999999997 110.844 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' A' ' 206' ' ' ILE . 3.2 mtmt -44.46 -50.3 9.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 72.109999999999999 110.906 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.536 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -64.93 -66.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 61.219999999999999 110.889 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.82 ' H ' HD22 ' A' ' 212' ' ' LEU . 1.0 OUTLIER -37.4 -67.36 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.912 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -29.54 3.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 74.329999999999998 110.835 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.9 OUTLIER -68.25 -75.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 110.938 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -56.63 -52.88 63.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 60.109999999999999 110.878 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.84 HD12 HD13 ' A' ' 156' ' ' LEU . 5.6 pt -107.16 84.46 1.68 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.661 0.743 . . . . 61.310000000000002 111.152 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -11.3 30.53 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.665 2.243 . . . . 50.509999999999998 112.32 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 45.5 t -58.26 -22.09 51.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 72.430000000000007 110.875 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.7 mt -57.7 155.51 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 70.430000000000007 111.118 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.448 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 1.1 tt0 -132.48 -34.57 1.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 71.0 110.875 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 27.9 mm -149.25 106.56 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 61.439999999999998 111.157 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.473 HG12 ' HG ' ' A' ' 224' ' ' LEU . 95.1 t -74.71 110.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 70.040000000000006 111.161 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -96.41 104.24 16.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 71.310000000000002 110.919 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.473 ' HG ' HG12 ' A' ' 222' ' ' VAL . 1.1 mt -105.54 115.39 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.895 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.0 mp -98.66 159.83 14.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 62.340000000000003 110.953 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 72.530000000000001 110.833 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.694 HD22 ' ND2' ' A' ' 160' ' ' ASN . 10.4 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.8 0.333 . . . . 75.099999999999994 110.911 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -102.54 -1.29 30.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.129999999999995 110.887 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 216' ' ' ILE . 12.4 tp 60.1 108.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 65.040000000000006 110.877 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.873 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -168.22 -178.98 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.891 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.11 -49.07 79.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 74.099999999999994 110.899 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -59.58 -32.53 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 62.020000000000003 110.901 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.694 ' ND2' HD22 ' A' ' 154' ' ' LEU . 77.4 m-20 -83.48 -70.28 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.914 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 157' ' ' ASN . 29.5 m -35.63 -30.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 65.140000000000001 111.084 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 160' ' ' ASN . 2.8 mt-10 -55.31 -58.85 6.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 110.868 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -51.06 56.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 52.350000000000001 110.903 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.74 HG11 ' HA ' ' A' ' 212' ' ' LEU . 1.4 t -65.25 -31.03 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 63.229999999999997 111.121 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 165' ' ' LEU . 14.1 mt -72.6 -32.14 65.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.48 . . . . 71.340000000000003 110.895 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 60.7 m-20 -67.39 -14.29 62.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 63.219999999999999 110.921 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -89.53 4.98 47.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 71.400000000000006 110.871 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 169' ' ' ARG . 0.3 OUTLIER -139.91 -55.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 52.409999999999997 111.148 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -35.34 -58.89 0.73 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.709 . . . . 73.25 110.879 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.69 -27.87 26.26 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.281 . . . . 64.540000000000006 112.366 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.622 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -73.08 -16.03 61.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 71.319999999999993 110.91 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.6 mt -75.61 -46.37 32.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 72.030000000000001 110.909 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 174' ' ' GLY . . . -58.03 -42.56 85.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 45.43 111.101 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -34.82 -78.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 63.299999999999997 112.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.1 t -94.97 40.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 73.099999999999994 111.152 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . 96.67 94.93 1.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 73.400000000000006 112.542 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . -82.98 171.48 50.74 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 64.340000000000003 112.47 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -126.22 -87.36 0.64 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 22.440000000000001 112.468 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 157.63 109.72 0.29 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.757 -0.735 . . . . 55.229999999999997 112.453 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 2.9 pp -112.1 -34.15 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 75.040000000000006 110.879 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.5 OUTLIER 33.85 89.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 75.420000000000002 110.919 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 28.6 t80 -38.52 107.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.881 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 191' ' ' LYS . 14.4 mt -66.22 -80.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.420000000000002 110.948 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -166.08 -168.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 75.299999999999997 110.896 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 157' ' ' ASN . 7.6 mt -135.53 124.79 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 75.439999999999998 111.166 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.76 72.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 73.310000000000002 110.887 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.421 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 82.87 -140.71 20.39 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 72.519999999999996 112.488 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.421 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 54.0 Cg_endo -69.75 0.01 6.25 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 73.019999999999996 112.36 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 25.5 mt -117.76 136.16 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 71.120000000000005 111.099 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.51 130.86 73.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 52.119999999999997 111.131 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.506 ' HB3' HD12 ' A' ' 183' ' ' LEU . 14.5 mtmt -90.54 142.58 27.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 52.340000000000003 110.946 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 55.7 t -153.67 151.43 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 75.430000000000007 111.156 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.866 ' O ' HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -86.73 163.55 17.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 74.099999999999994 110.914 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 193' ' ' ARG . 0.3 OUTLIER -158.21 79.63 0.83 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 75.230000000000004 110.944 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 p -113.32 171.34 7.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.483 . . . . 61.240000000000002 111.115 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 86.83 -169.56 40.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.707 -0.759 . . . . 64.120000000000005 112.498 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -19.29 36.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.69 2.26 . . . . 65.519999999999996 112.34 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.916 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -97.83 42.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 64.25 111.14 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -96.14 92.03 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 62.32 111.089 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.457 HG13 ' HE ' ' A' ' 205' ' ' ARG . 76.8 t 45.06 90.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 62.240000000000002 111.151 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 202' ' ' ARG . 43.5 t -125.66 -82.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 72.439999999999998 111.127 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.77 ' O ' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -176.21 47.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.439999999999998 110.869 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 202' ' ' ARG . 0.7 OUTLIER -174.57 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 72.129999999999995 111.13 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.916 HG21 ' HB1' ' A' ' 198' ' ' ALA . 93.4 t -58.75 -70.89 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 43.229999999999997 111.136 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.457 ' HE ' HG13 ' A' ' 200' ' ' VAL . 0.0 OUTLIER -35.33 -44.22 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.530000000000001 110.872 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.444 HD12 ' N ' ' A' ' 203' ' ' THR . 2.9 mt -54.11 -50.42 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.114 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -62.71 -32.86 74.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.239999999999995 111.1 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.678 ' C ' HD23 ' A' ' 212' ' ' LEU . 40.8 t -80.38 0.99 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 72.439999999999998 111.164 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -134.57 7.38 3.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 75.329999999999998 110.897 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.59 -40.64 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 74.409999999999997 110.887 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -80.64 -27.32 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 53.009999999999998 110.878 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.74 ' HA ' HG11 ' A' ' 164' ' ' VAL . 2.4 mm? -69.08 -71.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 72.340000000000003 110.894 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -45.18 -21.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.869 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 212' ' ' LEU . 1.2 tp10 -70.77 -66.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 74.5 110.867 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.491 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.4 OUTLIER -67.22 -44.3 79.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.120000000000005 110.926 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.633 HD12 HD13 ' A' ' 156' ' ' LEU . 4.8 pt -111.57 89.18 10.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 73.109999999999999 111.101 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -20.68 34.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 71.420000000000002 112.354 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.06 -22.88 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 70.109999999999999 110.815 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.6 mt -58.51 148.14 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.120000000000005 111.156 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.465 ' O ' HD13 ' A' ' 221' ' ' ILE . 0.9 OUTLIER -129.44 -39.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.92 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 220' ' ' GLN . 27.3 mm -150.67 114.43 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 64.530000000000001 111.087 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 85.6 t -86.81 121.49 37.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.019999999999996 111.103 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -108.5 122.87 47.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.340000000000003 110.961 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.752 ' HB3' HD23 ' A' ' 194' ' ' LEU . 24.8 mt -115.27 102.2 9.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.519999999999996 110.921 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.2 mt -72.71 173.35 9.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 72.400000000000006 110.897 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.6 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 64.040000000000006 110.896 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 215' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.79 0.329 . . . . 61.210000000000001 110.892 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -97.77 -13.2 21.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 62.409999999999997 110.884 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.694 ' CD1' HD12 ' A' ' 216' ' ' ILE . 5.3 tp 58.56 113.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.129999999999995 110.915 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.753 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 174.7 166.43 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 63.109999999999999 110.934 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.36 -26.32 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 73.239999999999995 110.853 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 160' ' ' ASN . 11.5 pm0 -78.58 -33.28 47.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 62.539999999999999 110.886 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.459 ' ND2' HD21 ' A' ' 157' ' ' ASN . 24.9 m-20 -100.87 -60.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 75.519999999999996 110.912 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 157' ' ' ASN . 9.3 p -42.18 -23.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 72.239999999999995 111.122 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.596 ' HA ' HD12 ' A' ' 165' ' ' LEU . 4.3 mt-10 -64.67 -55.01 22.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 50.119999999999997 110.891 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -40.78 45.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 74.540000000000006 110.889 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.662 HG11 ' HA ' ' A' ' 212' ' ' LEU . 25.2 t -71.38 -33.41 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 54.130000000000003 111.144 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 162' ' ' GLU . 9.1 mt -71.02 -28.78 64.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 70.209999999999994 110.931 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.486 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 29.4 m-80 -71.02 -8.21 51.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 62.5 110.898 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.94 -3.88 50.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 74.409999999999997 110.849 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.88 -36.9 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 72.239999999999995 111.127 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.518 ' NH2' ' NE2' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -52.99 -59.93 7.86 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 73.120000000000005 110.876 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.7 Cg_endo -69.79 -20.79 34.22 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.717 2.278 . . . . 74.109999999999999 112.331 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.661 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -69.2 -19.77 63.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.927 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.661 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.8 mt -79.51 -55.36 5.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 65.319999999999993 110.935 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -43.43 -28.66 0.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 53.100000000000001 111.086 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.57 -39.38 93.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 43.310000000000002 112.504 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 43.3 p -107.18 1.74 24.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 71.010000000000005 111.185 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 149.38 -56.09 0.48 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 63.219999999999999 112.46 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 110.5 173.78 20.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 61.149999999999999 112.476 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -161.04 -111.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 43.340000000000003 112.532 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -178.73 119.83 0.67 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.757 -0.735 . . . . 73.099999999999994 112.506 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 169' ' ' ARG . 0.5 OUTLIER -149.55 11.99 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.754 0.311 . . . . 64.219999999999999 110.91 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.518 ' NE2' ' NH2' ' A' ' 169' ' ' ARG . 6.0 tp-100 -35.02 104.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 53.310000000000002 110.907 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.731 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 22.0 t80 -34.69 125.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.310000000000002 110.858 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 89.8 mt -86.66 -74.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.919 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 22.8 ptp -165.11 -173.66 2.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 74.049999999999997 110.895 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 157' ' ' ASN . 5.9 mt -130.84 136.94 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 63.420000000000002 111.163 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -136.15 71.98 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 70.349999999999994 110.855 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 81.89 -145.3 24.61 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 73.219999999999999 112.527 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.516 ' HG2' HD12 ' A' ' 189' ' ' ILE . 53.9 Cg_endo -69.76 3.27 2.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 72.340000000000003 112.347 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.516 HD12 ' HG2' ' A' ' 188' ' ' PRO . 4.2 mp -122.83 112.09 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 70.140000000000001 111.156 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.409 HG21 ' HE1' ' A' ' 182' ' ' PHE . 7.4 p -92.16 142.1 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 61.219999999999999 111.098 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -99.87 141.56 32.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 70.239999999999995 110.933 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.7 t -154.51 147.87 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 71.200000000000003 111.122 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.779 ' O ' HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -87.93 166.82 14.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 62.530000000000001 110.869 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.78 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -159.16 96.63 1.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 72.109999999999999 110.938 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 15.7 p -125.5 179.94 4.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 63.299999999999997 111.157 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.96 -177.91 54.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 51.130000000000003 112.517 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -20.53 34.79 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.732 2.288 . . . . 74.430000000000007 112.349 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.24 -24.24 47.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 33.420000000000002 111.101 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.78 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -49.94 -63.03 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.150000000000006 111.145 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 200' ' ' VAL . 1.0 OUTLIER -119.99 96.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.116 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 201' ' ' VAL . 10.2 p -162.85 22.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 111.092 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.7 OUTLIER 59.46 152.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 110.862 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 2.5 m 81.15 -68.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.0 111.151 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 205' ' ' ARG . 92.7 t -44.39 -67.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 63.020000000000003 111.158 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 204' ' ' VAL . 6.8 ptm180 -36.72 -36.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 71.150000000000006 110.871 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.555 HG22 ' CD ' ' A' ' 210' ' ' LYS . 3.8 mp -77.26 -51.17 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 72.329999999999998 111.136 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -51.94 -16.43 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 65.420000000000002 111.152 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 86.3 t -89.51 -52.52 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 54.509999999999998 111.152 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.3 t -84.14 24.48 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.200000000000003 110.808 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.555 ' CD ' HG22 ' A' ' 206' ' ' ILE . 0.3 OUTLIER -111.24 -40.21 4.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 74.099999999999994 110.916 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -31.73 33.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 110.882 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.662 ' HA ' HG11 ' A' ' 164' ' ' VAL . 6.6 mt -69.54 -65.21 0.74 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.925 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -28.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 70.430000000000007 110.921 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -75.51 -68.19 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 64.430000000000007 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.456 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.7 OUTLIER -56.32 -56.61 18.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 75.519999999999996 110.896 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.694 HD12 ' CD1' ' A' ' 156' ' ' LEU . 3.5 pt -104.77 92.22 4.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.654 0.74 . . . . 72.340000000000003 111.095 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 53.5 Cg_endo -69.81 -22.53 31.72 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.655 2.237 . . . . 62.350000000000001 112.359 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . 0.407 ' HB3' HD22 ' A' ' 156' ' ' LEU . 0.3 OUTLIER -50.22 -20.45 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 110.842 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.6 mt -62.54 154.02 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 75.420000000000002 111.109 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.443 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -136.29 -37.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 63.109999999999999 110.928 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 189' ' ' ILE . 29.6 mm -152.09 105.31 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 74.200000000000003 111.151 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 74.3 t -81.29 118.77 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 52.439999999999998 111.124 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -101.91 108.03 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 72.310000000000002 110.913 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.766 ' HB3' HD23 ' A' ' 194' ' ' LEU . 3.3 mt -96.65 102.35 14.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 110.918 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 226' ' ' SER . 9.1 mp -70.94 173.42 7.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 64.200000000000003 110.904 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 225' ' ' LEU . 44.4 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.219999999999999 110.842 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 154' ' ' LEU . 10.5 mt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.782 0.325 . . . . 72.409999999999997 110.898 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.87 -7.99 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 110.858 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.841 HD13 HD12 ' A' ' 216' ' ' ILE . 6.8 tp 50.89 98.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 110.887 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.681 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -166.17 169.85 13.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.519999999999996 110.884 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.466 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 3.7 mt-10 -44.53 -29.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 54.140000000000001 110.876 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.459 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 3.7 pt-20 -70.66 -42.88 70.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 54.420000000000002 110.884 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 162' ' ' GLU . 96.1 m-20 -86.53 -63.5 1.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 63.130000000000003 110.864 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.758 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 33.8 m -37.51 -30.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 64.209999999999994 111.123 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.4 mt-10 -64.85 -51.93 59.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 74.200000000000003 110.883 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -58.57 -50.43 73.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 75.340000000000003 110.904 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.422 HG13 ' HD3' ' A' ' 215' ' ' LYS . 1.7 t -62.24 -30.2 48.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 111.085 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.575 HD11 ' CD1' ' A' ' 182' ' ' PHE . 18.2 mt -73.63 -28.48 61.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 75.099999999999994 110.926 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.487 ' O ' ' CD ' ' A' ' 170' ' ' PRO . 37.9 m-80 -71.38 -11.97 61.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 73.219999999999999 110.861 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.22 -18.33 39.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 110.938 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.494 HD11 HD23 ' A' ' 165' ' ' LEU . 2.9 pt -115.99 -24.54 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 52.149999999999999 111.163 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.58 ' HG3' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -55.97 -60.43 8.82 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.593 0.711 . . . . 73.510000000000005 110.908 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.487 ' CD ' ' O ' ' A' ' 166' ' ' ASN . 53.7 Cg_endo -69.81 -2.01 9.49 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 53.240000000000002 112.361 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.717 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -88.94 -42.89 11.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 71.140000000000001 110.899 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.717 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.4 mt -57.05 -45.79 82.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 63.119999999999997 110.929 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -45.43 107.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 53.049999999999997 111.134 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 133.5 -50.38 0.88 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.76 . . . . 23.43 112.487 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.9 t -133.23 22.34 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 52.030000000000001 111.092 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -153.6 -79.46 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 53.109999999999999 112.456 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 56.22 15.82 12.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.778 -0.725 . . . . 71.109999999999999 112.477 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.34 -93.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 64.140000000000001 112.507 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 193' ' ' ARG . . . 175.03 123.92 0.77 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 60.100000000000001 112.442 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.699 ' C ' HD12 ' A' ' 180' ' ' LEU . 2.7 pp -135.27 -0.22 2.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 70.340000000000003 110.941 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -30.73 117.62 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.510000000000005 110.873 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.758 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 19.3 t80 -55.63 129.62 39.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 70.329999999999998 110.856 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.67 -74.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 72.200000000000003 110.889 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 16.6 ptp -167.45 -170.77 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 63.530000000000001 110.844 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 157' ' ' ASN . 35.0 mt -138.36 133.46 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 111.097 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -130.91 59.8 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 73.129999999999995 110.925 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 99.12 -146.74 18.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.725 -0.75 . . . . 71.209999999999994 112.514 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 3.04 3.0 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.705 2.27 . . . . 70.209999999999994 112.335 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.4 mt -115.81 118.34 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 70.349999999999994 111.155 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 66.8 t -91.27 139.73 17.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 111.083 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 192' ' ' VAL . 7.8 mtmt -107.49 145.83 32.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 61.299999999999997 110.901 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 193' ' ' ARG . 70.6 t -158.73 158.18 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 61.530000000000001 111.112 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.541 ' O ' HD22 ' A' ' 194' ' ' LEU . 5.8 ttt180 -99.5 137.81 37.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.120000000000005 110.903 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.541 HD22 ' O ' ' A' ' 193' ' ' ARG . 1.8 mm? -130.46 84.47 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 71.230000000000004 110.926 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -112.32 170.09 8.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.319999999999993 111.145 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.42 ' N ' ' OG1' ' A' ' 195' ' ' THR . . . 84.06 -163.25 39.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 61.149999999999999 112.462 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -35.45 12.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.686 2.258 . . . . 64.019999999999996 112.338 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.724 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -84.59 32.29 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 71.340000000000003 111.063 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.48 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -72.19 -52.2 17.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 61.420000000000002 111.123 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.579 ' O ' HG13 ' A' ' 200' ' ' VAL . 7.1 p -164.66 69.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 70.120000000000005 111.111 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 202' ' ' ARG . 56.1 t -88.83 -83.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 74.340000000000003 111.1 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.504 ' N ' HG12 ' A' ' 201' ' ' VAL . 0.0 OUTLIER 172.08 41.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 75.409999999999997 110.9 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.492 ' N ' HD12 ' A' ' 206' ' ' ILE . 23.1 m -166.83 -57.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 63.329999999999998 111.186 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.724 HG11 ' HB1' ' A' ' 198' ' ' ALA . 31.9 t -60.11 -63.96 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 71.030000000000001 111.127 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -44.56 -29.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 71.430000000000007 110.855 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 203' ' ' THR . 3.0 mt -79.8 -45.25 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 71.030000000000001 111.149 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.28 -15.07 31.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 111.113 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 209' ' ' SER . 54.1 t -80.25 -85.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 70.310000000000002 111.143 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.593 ' HA ' HD23 ' A' ' 212' ' ' LEU . 1.6 t -33.43 -41.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 72.409999999999997 110.854 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.44 -54.7 7.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 52.210000000000001 110.896 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -56.31 19.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 75.040000000000006 110.862 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.695 ' H ' HD22 ' A' ' 212' ' ' LEU . 1.6 mm? -45.7 -74.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 70.129999999999995 110.881 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 212' ' ' LEU . 3.9 ttp180 -37.39 -52.49 1.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 74.049999999999997 110.874 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -46.36 -92.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.857 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.422 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -38.26 -54.26 1.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 63.229999999999997 110.883 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.841 HD12 HD13 ' A' ' 156' ' ' LEU . 11.2 pt -106.17 88.19 2.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.602 0.715 . . . . 74.430000000000007 111.122 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -23.21 31.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.648 2.232 . . . . 74.329999999999998 112.376 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.7 t -45.63 -28.54 1.0 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 72.549999999999997 110.862 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -55.65 157.15 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 75.420000000000002 111.1 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.498 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.5 OUTLIER -141.68 -37.84 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 62.520000000000003 110.964 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 220' ' ' GLN . 11.2 mt -140.93 85.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 54.140000000000001 111.128 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.04 115.9 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.519999999999996 111.094 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.491 ' O ' HD23 ' A' ' 224' ' ' LEU . 8.2 mm-40 -95.76 152.77 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 34.130000000000003 110.889 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 223' ' ' GLN . 20.4 mt -139.7 100.01 3.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 74.150000000000006 110.9 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 225' ' ' LEU . 0.3 OUTLIER -57.56 177.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 72.140000000000001 110.926 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 61.020000000000003 110.857 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' A' ' 160' ' ' ASN . 7.0 mp . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.815 0.34 . . . . 71.450000000000003 110.905 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.91 -18.05 14.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 70.519999999999996 110.911 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.751 HD13 HD12 ' A' ' 216' ' ' ILE . 6.6 tp 61.92 106.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 73.510000000000005 110.977 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.731 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -176.25 166.76 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 55.119999999999997 110.853 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -42.22 -38.97 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 70.030000000000001 110.834 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -65.18 -56.26 13.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 64.25 110.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.578 ' HB3' HD23 ' A' ' 154' ' ' LEU . 53.1 m-20 -76.52 -61.87 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 72.129999999999995 110.901 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 157' ' ' ASN . 6.1 p -38.69 -28.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 54.299999999999997 111.113 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 160' ' ' ASN . 2.4 mm-40 -59.52 -59.96 4.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 62.299999999999997 110.843 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -36.71 23.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 74.140000000000001 110.894 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.899 HG11 ' HA ' ' A' ' 212' ' ' LEU . 41.9 t -70.64 -45.85 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 54.140000000000001 111.121 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.582 HD22 HD12 ' A' ' 180' ' ' LEU . 75.7 mt -61.09 -24.08 65.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 73.319999999999993 110.932 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.41 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 24.3 m-80 -74.57 -5.86 45.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 63.399999999999999 110.894 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.09 -8.06 40.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 64.200000000000003 110.85 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.425 HD11 HD23 ' A' ' 165' ' ' LEU . 1.3 pt -123.22 -43.68 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 75.319999999999993 111.14 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -44.22 -59.95 3.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.576 0.703 . . . . 62.509999999999998 110.914 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.79 -30.48 22.09 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 75.519999999999996 112.373 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.616 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -63.76 -14.51 53.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 73.030000000000001 110.948 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.616 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.5 mt -79.56 -55.62 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 74.120000000000005 110.917 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.51 -54.24 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 111.127 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -40.71 -60.33 2.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.747 . . . . 75.030000000000001 112.452 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 82.8 p -64.92 -50.38 66.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 75.209999999999994 111.164 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -169.54 -40.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 52.520000000000003 112.455 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 127.44 164.44 11.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 71.400000000000006 112.509 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.21 -178.74 41.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 74.430000000000007 112.524 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -140.42 99.98 0.26 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 71.019999999999996 112.494 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.582 HD12 HD22 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -118.31 25.84 10.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.751 0.31 . . . . 74.519999999999996 110.89 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -35.77 119.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 110.944 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.603 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 19.5 t80 -48.5 116.2 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 71.420000000000002 110.862 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.26 -73.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 73.540000000000006 110.905 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 14.1 ptp -171.32 -171.05 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 110.912 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -131.78 131.12 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 73.140000000000001 111.132 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -135.43 74.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 61.219999999999999 110.931 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.33 -144.77 24.84 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 63.43 112.446 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 3.52 2.74 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.689 2.259 . . . . 72.400000000000006 112.314 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 44.5 mt -109.63 149.72 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 52.219999999999999 111.128 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.7 t -126.39 135.33 64.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 70.319999999999993 111.146 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -105.0 133.95 48.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 71.540000000000006 110.878 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 180' ' ' LEU . 66.3 t -153.41 129.63 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 53.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 179.42 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 72.420000000000002 110.833 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.25 67.92 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 71.239999999999995 110.919 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 73.4 p -90.42 -179.8 5.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 64.310000000000002 111.187 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 91.76 173.64 42.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 72.049999999999997 112.482 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -16.84 37.52 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.25 . . . . 45.039999999999999 112.345 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.46 -18.92 59.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 53.520000000000003 111.104 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.62 -45.63 81.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 111.107 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 30.9 m -92.0 49.3 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 61.530000000000001 111.159 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 83.6 t -138.81 125.57 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 75.120000000000005 111.164 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -55.79 158.05 3.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 73.109999999999999 110.879 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.428 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 1.9 m 79.73 -55.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.479 . . . . 74.310000000000002 111.191 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 208' ' ' VAL . 76.1 t -38.88 -60.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.049999999999997 111.121 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -43.97 39.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 74.230000000000004 110.87 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.53 HG22 ' HG3' ' A' ' 210' ' ' LYS . 70.1 mt -64.64 -53.77 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 71.019999999999996 111.168 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -44.53 -27.74 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 75.239999999999995 111.12 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 204' ' ' VAL . 2.6 t -73.05 -56.47 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 74.299999999999997 111.162 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.683 ' HB3' HG21 ' A' ' 222' ' ' VAL . 0.7 OUTLIER -83.31 20.39 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 73.310000000000002 110.85 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.53 ' HG3' HG22 ' A' ' 206' ' ' ILE . 3.7 mtpp -103.66 -40.26 6.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 75.530000000000001 110.895 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.38 -34.12 25.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 65.519999999999996 110.889 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.899 ' HA ' HG11 ' A' ' 164' ' ' VAL . 7.4 mt -68.32 -67.3 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 75.129999999999995 110.898 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.59 -24.16 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 60.539999999999999 110.904 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -78.7 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.904 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.423 ' O ' HD13 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -46.29 -51.43 14.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 72.510000000000005 110.931 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.751 HD12 HD13 ' A' ' 156' ' ' LEU . 2.2 pt -107.02 91.96 7.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.593 0.711 . . . . 72.430000000000007 111.141 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 216' ' ' ILE . 53.6 Cg_endo -69.76 -17.64 37.46 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.667 2.245 . . . . 74.129999999999995 112.329 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.6 t -54.46 -28.44 44.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 34.299999999999997 110.833 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.8 mt -57.64 153.12 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 72.329999999999998 111.127 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.75 ' HB3' HD12 ' A' ' 221' ' ' ILE . 2.0 mt-30 -133.12 -37.38 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.219999999999999 110.907 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 220' ' ' GLN . 3.8 mp -145.74 102.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 72.430000000000007 111.088 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.683 HG21 ' HB3' ' A' ' 209' ' ' SER . 0.4 OUTLIER -70.72 107.58 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 71.109999999999999 111.113 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -93.2 94.51 8.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.889 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.9 117.22 24.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 73.439999999999998 110.916 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.68 170.93 15.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 71.430000000000007 110.889 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 73.430000000000007 110.893 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.65 HD12 HG23 ' A' ' 216' ' ' ILE . 28.6 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.728 0.299 . . . . 75.409999999999997 110.946 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -110.69 -8.75 14.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 63.200000000000003 110.907 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.708 HD13 HD12 ' A' ' 216' ' ' ILE . 26.8 tp 58.19 97.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 64.409999999999997 110.9 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.639 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -159.06 164.27 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.922 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -46.58 -21.94 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.510000000000005 110.924 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -41.14 18.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 74.519999999999996 110.899 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.15 -57.13 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 74.400000000000006 110.873 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.863 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 29.5 m -45.96 -26.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 64.230000000000004 111.093 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -61.08 -59.44 5.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.91 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -42.33 42.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 72.329999999999998 110.907 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.887 HG11 ' HA ' ' A' ' 212' ' ' LEU . 2.0 t -70.6 -42.1 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 65.329999999999998 111.144 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.571 HD11 ' CD1' ' A' ' 182' ' ' PHE . 31.0 mt -61.86 -32.93 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 74.040000000000006 110.948 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -69.95 -3.66 17.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 110.887 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -94.43 -2.01 52.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.875 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.75 ' CD1' HG13 ' A' ' 208' ' ' VAL . 4.1 pt -136.59 -35.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 72.219999999999999 111.159 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.489 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -45.95 -60.02 4.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.535 0.683 . . . . 75.230000000000004 110.836 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.0 Cg_endo -69.73 3.29 2.84 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.713 2.276 . . . . 63.340000000000003 112.349 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.614 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -102.39 -23.56 13.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 70.409999999999997 110.927 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.614 HD23 ' CD2' ' A' ' 171' ' ' TYR . 2.5 mt -84.31 -36.95 22.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 65.209999999999994 110.889 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.27 -13.37 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 70.310000000000002 111.052 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.17 -40.96 8.25 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.71 -0.757 . . . . 74.120000000000005 112.425 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.0 t -105.16 4.49 31.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 75.439999999999998 111.108 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -179.24 -101.5 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 44.399999999999999 112.469 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.31 69.75 0.4 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.716 -0.754 . . . . 42.539999999999999 112.496 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.88 -123.31 1.89 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 53.229999999999997 112.477 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -138.14 112.47 0.89 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 64.409999999999997 112.455 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.857 ' H ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -122.11 6.65 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.729 0.299 . . . . 74.329999999999998 110.933 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 182' ' ' PHE . 0.0 OUTLIER -37.94 96.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 64.219999999999999 110.893 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.863 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 17.6 t80 -37.49 119.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 73.450000000000003 110.887 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.0 mt -77.54 -73.41 0.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 61.350000000000001 110.905 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 15.0 ptp -174.15 -174.36 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 61.409999999999997 110.891 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 157' ' ' ASN . 11.3 mt -133.33 137.01 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 54.350000000000001 111.178 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.8 57.05 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 72.120000000000005 110.862 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 91.72 -135.24 12.67 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 41.219999999999999 112.451 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.634 ' O ' HD13 ' A' ' 189' ' ' ILE . 53.7 Cg_endo -69.66 2.4 3.52 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.716 2.277 . . . . 72.140000000000001 112.342 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.872 HD12 ' HB ' ' A' ' 221' ' ' ILE . 26.9 mm -125.41 124.46 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 63.030000000000001 111.13 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 6.4 p -109.97 137.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 64.299999999999997 111.17 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 15.0 mtmt -101.16 146.46 27.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 72.129999999999995 110.9 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 91.0 t -158.94 152.69 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 72.239999999999995 111.127 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.528 ' NH1' HG21 ' A' ' 195' ' ' THR . 0.0 OUTLIER -84.5 155.26 22.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 110.877 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -153.16 84.41 1.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 70.319999999999993 110.941 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.528 HG21 ' NH1' ' A' ' 193' ' ' ARG . 11.9 p -120.18 -170.94 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.329999999999998 111.143 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 73.13 -168.6 53.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 41.32 112.503 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -15.69 37.13 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.256 . . . . 72.420000000000002 112.348 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 194' ' ' LEU . . . -96.21 52.25 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 51.5 111.087 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.673 ' C ' HG23 ' A' ' 200' ' ' VAL . . . -142.99 141.73 31.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 73.120000000000005 111.068 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.673 HG23 ' C ' ' A' ' 199' ' ' ALA . 2.7 t 81.45 -40.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.219999999999999 111.14 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 1.009 HG12 HG22 ' A' ' 203' ' ' THR . 87.9 t -47.46 139.24 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 52.039999999999999 111.129 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 1.7 tpt85 -85.55 78.23 9.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 70.140000000000001 110.879 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 1.009 HG22 HG12 ' A' ' 201' ' ' VAL . 2.5 t 174.33 -42.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 61.020000000000003 111.117 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.673 ' O ' HG23 ' A' ' 208' ' ' VAL . 45.7 t -70.08 -44.33 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.25 111.095 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -4.81 18.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 110.861 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.404 HG22 ' HG3' ' A' ' 210' ' ' LYS . 10.6 mm -91.31 -66.88 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 111.107 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -45.71 -21.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 75.409999999999997 111.091 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.75 HG13 ' CD1' ' A' ' 168' ' ' ILE . 87.7 t -74.79 -75.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 63.350000000000001 111.136 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.515 ' HA ' HD12 ' A' ' 212' ' ' LEU . 33.7 t -57.43 -12.5 2.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 74.519999999999996 110.852 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 206' ' ' ILE . 0.0 OUTLIER -72.22 -40.27 67.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 72.409999999999997 110.906 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.541 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -78.03 -32.92 51.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.852 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.887 ' HA ' HG11 ' A' ' 164' ' ' VAL . 9.2 mt -72.16 -60.37 2.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 73.010000000000005 110.945 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -46.33 -26.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 62.329999999999998 110.854 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.96 -74.27 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 75.120000000000005 110.88 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.51 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.8 OUTLIER -53.21 -52.71 58.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 75.099999999999994 110.914 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.708 HD12 HD13 ' A' ' 156' ' ' LEU . 6.8 pt -106.2 87.75 2.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.722 . . . . 74.120000000000005 111.159 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -5.82 17.12 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.664 2.243 . . . . 71.030000000000001 112.332 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.9 t -69.22 -1.6 8.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.439999999999998 110.873 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -78.96 154.84 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 65.150000000000006 111.192 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -138.12 -35.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.898 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.872 ' HB ' HD12 ' A' ' 189' ' ' ILE . 47.2 mt -152.71 103.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 111.146 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.463 HG21 ' OG ' ' A' ' 209' ' ' SER . 93.8 t -78.13 107.95 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 35.140000000000001 111.107 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -94.0 118.5 31.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.923 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -114.41 102.48 10.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.349999999999994 110.88 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.593 ' H ' HD12 ' A' ' 225' ' ' LEU . 5.1 mp -69.9 162.77 27.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 65.150000000000006 110.947 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 75.239999999999995 110.834 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.435 HD23 ' HB3' ' A' ' 160' ' ' ASN . 6.9 mp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.775 0.321 . . . . 72.349999999999994 110.925 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -103.37 -12.74 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.230000000000004 110.885 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.755 HD13 HD12 ' A' ' 216' ' ' ILE . 11.2 tp 60.85 115.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 71.019999999999996 110.942 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.676 ' O ' HG12 ' A' ' 161' ' ' VAL . 16.8 p30 174.76 -173.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 70.310000000000002 110.898 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -37.4 87.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.150000000000006 110.847 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.413 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 11.3 pt-20 -72.92 -24.2 60.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 73.25 110.869 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 162' ' ' GLU . 91.7 m-20 -101.07 -67.74 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 72.239999999999995 110.877 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.755 HG11 ' CZ ' ' A' ' 182' ' ' PHE . 4.0 p -36.82 -29.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 71.030000000000001 111.166 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.6 mt-10 -55.01 -59.32 4.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.340000000000003 110.92 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -36.39 62.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 64.310000000000002 110.866 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.915 HG11 ' HA ' ' A' ' 212' ' ' LEU . 93.1 t -65.23 -42.01 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 62.439999999999998 111.145 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.478 HD11 ' CD1' ' A' ' 182' ' ' PHE . 62.0 mt -69.43 -21.81 63.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 64.109999999999999 110.887 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -72.88 -16.12 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 64.530000000000001 110.877 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -89.72 6.35 41.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.329999999999998 110.86 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.692 HG21 ' HA ' ' A' ' 208' ' ' VAL . 0.9 OUTLIER -137.76 -34.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 111.122 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.7 -61.03 5.23 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.539 0.685 . . . . 75.450000000000003 110.889 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.78 -11.37 30.67 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.684 2.256 . . . . 71.120000000000005 112.335 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.543 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -84.86 -13.18 51.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 110.959 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.847 HD11 ' CD2' ' A' ' 180' ' ' LEU . 6.4 mt -80.39 -41.89 23.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.931 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -39.21 -48.59 1.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 111.119 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.3 -55.66 29.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 72.25 112.485 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.8 p -77.08 2.46 15.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.795 0.331 . . . . 71.349999999999994 111.12 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 151.1 -64.32 0.38 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.73 . . . . 72.510000000000005 112.496 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 124.44 32.41 0.83 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 42.310000000000002 112.482 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -46.35 174.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 72.510000000000005 112.483 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -126.69 117.57 2.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.752 -0.737 . . . . 64.319999999999993 112.487 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.847 ' CD2' HD11 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -118.14 25.23 10.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.788 0.328 . . . . 45.310000000000002 110.901 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 182' ' ' PHE . 0.0 OUTLIER -34.35 124.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 75.219999999999999 110.89 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.755 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 17.8 t80 -52.5 135.61 33.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.912 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 53.8 mt -94.28 -71.51 0.66 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 75.340000000000003 110.884 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.418 ' C ' HG13 ' A' ' 185' ' ' ILE . 6.8 ptp -176.06 -162.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 74.310000000000002 110.851 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.418 HG13 ' C ' ' A' ' 184' ' ' MET . 8.7 mt -146.41 127.42 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 51.030000000000001 111.12 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.13 48.66 1.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 51.009999999999998 110.875 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 106.73 -140.13 15.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 75.120000000000005 112.507 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 3.09 3.0 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.683 2.255 . . . . 62.130000000000003 112.357 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.49 135.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 73.349999999999994 111.126 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 156' ' ' LEU . 76.5 t -109.83 137.03 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 64.129999999999995 111.106 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -107.75 140.62 40.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 73.239999999999995 110.906 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 90.8 t -152.48 144.8 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 75.549999999999997 111.159 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.14 166.96 17.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 73.129999999999995 110.842 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -160.91 84.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 62.530000000000001 110.864 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.6 p -99.97 158.42 15.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 42.439999999999998 111.126 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 90.36 -177.58 42.57 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.659 -0.781 . . . . 54.439999999999998 112.435 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . 0.459 ' O ' HG23 ' A' ' 201' ' ' VAL . 53.9 Cg_endo -69.71 0.74 5.16 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.707 2.271 . . . . 72.340000000000003 112.352 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.934 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -87.93 16.87 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 32.219999999999999 111.104 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -120.52 49.39 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 61.020000000000003 111.075 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.3 p -177.56 -35.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 64.239999999999995 111.149 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 197' ' ' PRO . 20.2 t -47.94 137.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 71.150000000000006 111.122 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.421 ' C ' HD12 ' A' ' 206' ' ' ILE . 0.0 OUTLIER -80.36 42.85 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 73.450000000000003 110.893 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.1 m -160.59 -46.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 74.109999999999999 111.14 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.934 HG11 ' HB1' ' A' ' 198' ' ' ALA . 43.4 t -61.55 -64.78 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 75.519999999999996 111.12 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -50.59 -30.23 12.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 72.040000000000006 110.839 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 202' ' ' ARG . 18.5 mt -73.65 -35.69 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 72.439999999999998 111.113 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -58.32 -44.31 88.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 111.073 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.791 HG12 HD11 ' A' ' 212' ' ' LEU . 70.1 t -53.68 -80.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 71.25 111.157 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.4 t -42.84 -39.28 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 52.240000000000002 110.857 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.41 -40.31 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 44.240000000000002 110.934 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 212' ' ' LEU . 0.4 OUTLIER -85.11 -59.84 2.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 54.509999999999998 110.897 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.915 ' HA ' HG11 ' A' ' 164' ' ' VAL . 2.3 mt -32.72 -69.9 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 75.25 110.956 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.5 HH22 HG11 ' A' ' 222' ' ' VAL . 0.0 OUTLIER -49.35 -40.92 37.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 64.310000000000002 110.88 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 211' ' ' LYS . 2.0 mt-10 -64.53 -80.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 75.099999999999994 110.943 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.674 ' CB ' HG22 ' A' ' 164' ' ' VAL . 12.2 mmtt -40.99 -58.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 71.010000000000005 110.869 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.755 HD12 HD13 ' A' ' 156' ' ' LEU . 9.4 pt -106.97 88.42 3.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.625 0.726 . . . . 54.25 111.148 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -9.26 25.68 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.714 2.276 . . . . 73.340000000000003 112.365 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.69 -14.13 62.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 74.129999999999995 110.877 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 mt -61.11 146.02 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 111.135 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.788 ' HB3' HD12 ' A' ' 221' ' ' ILE . 13.0 mp0 -116.88 -38.28 3.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 73.129999999999995 110.873 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.788 HD12 ' HB3' ' A' ' 220' ' ' GLN . 4.7 mp -153.27 103.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 70.030000000000001 111.11 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.5 HG11 HH22 ' A' ' 213' ' ' ARG . 0.9 OUTLIER -72.9 115.56 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 55.25 111.09 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -100.66 108.11 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 71.120000000000005 110.948 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mt -99.37 113.6 26.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 75.200000000000003 110.944 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.9 mp -93.93 176.06 6.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 110.917 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 72.340000000000003 110.834 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.762 HD13 ' O ' ' A' ' 215' ' ' LYS . 6.7 mp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.753 0.311 . . . . 72.239999999999995 110.91 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -102.22 -21.56 14.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.010000000000005 110.886 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.619 HD12 HG22 ' A' ' 161' ' ' VAL . 5.5 tp 61.07 113.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 61.43 110.917 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.929 ' H ' HG23 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 174.71 -178.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 72.299999999999997 110.847 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -6.64 4.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 70.519999999999996 110.892 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.46 -43.68 7.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 54.439999999999998 110.895 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.523 ' HB3' HD23 ' A' ' 154' ' ' LEU . 61.1 m-20 -94.62 -49.48 5.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 61.039999999999999 110.902 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.929 HG23 ' H ' ' A' ' 157' ' ' ASN . 86.6 t -43.08 -44.02 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 72.129999999999995 111.155 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -57.49 -34.46 69.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 73.400000000000006 110.85 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -62.61 -45.13 94.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.919 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.958 HG11 ' HA ' ' A' ' 212' ' ' LEU . 23.1 t -70.4 -31.79 47.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 71.230000000000004 111.129 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 162' ' ' GLU . 46.5 mt -70.03 -27.8 64.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 73.040000000000006 110.936 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 14.5 m-80 -69.9 -9.35 54.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 110.83 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -87.94 -15.6 36.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 65.299999999999997 110.869 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.778 HD13 ' HA ' ' A' ' 208' ' ' VAL . 1.5 pt -118.34 -30.04 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 71.209999999999994 111.154 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.555 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.51 -61.05 5.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.703 . . . . 73.200000000000003 110.877 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.5 Cg_endo -69.74 1.78 4.12 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.702 2.268 . . . . 73.209999999999994 112.33 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.688 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -94.12 -31.53 14.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 75.140000000000001 110.924 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.688 HD23 ' CD2' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -77.61 -60.39 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 71.150000000000006 110.972 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -38.27 -52.38 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 54.100000000000001 111.076 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -38.71 -44.16 1.79 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 74.219999999999999 112.512 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.2 p -99.91 -15.09 18.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.373 . . . . 73.209999999999994 111.162 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -176.05 -88.08 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 53.340000000000003 112.473 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 114.18 99.67 2.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.695 -0.764 . . . . 73.340000000000003 112.452 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -93.25 -92.36 1.53 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 52.310000000000002 112.515 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.72 119.75 0.56 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.715 -0.755 . . . . 74.030000000000001 112.483 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.555 HD11 ' HD2' ' A' ' 169' ' ' ARG . 0.4 OUTLIER -139.78 17.8 2.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.756 0.312 . . . . 73.439999999999998 110.934 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.4 OUTLIER -34.28 96.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 72.319999999999993 110.945 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.626 ' CE1' HG11 ' A' ' 161' ' ' VAL . 91.4 t80 -36.47 118.71 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.861 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 46.8 mt -82.02 -78.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 72.439999999999998 110.922 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.9 -166.19 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 71.219999999999999 110.898 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.788 HD11 HG21 ' A' ' 161' ' ' VAL . 32.5 mt -142.55 139.91 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 52.399999999999999 111.182 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -128.5 69.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 62.119999999999997 110.917 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 89.8 -139.7 15.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 55.140000000000001 112.445 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 1.22 4.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.626 2.218 . . . . 75.329999999999998 112.333 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.5 127.55 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 70.109999999999999 111.141 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.689 HG23 HG12 ' A' ' 185' ' ' ILE . 6.2 p -105.17 144.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 73.5 111.169 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 10.7 mtmt -103.84 146.18 29.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 72.409999999999997 110.88 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 88.1 t -157.97 136.9 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 64.040000000000006 111.098 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.874 ' O ' HD22 ' A' ' 194' ' ' LEU . 11.3 ttt180 -73.69 161.35 30.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 71.540000000000006 110.848 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.879 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.2 OUTLIER -157.99 102.64 1.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 73.549999999999997 110.911 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.0 p -129.78 161.89 29.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 61.450000000000003 111.152 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.2 -177.78 38.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 71.450000000000003 112.519 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -43.8 2.46 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 74.420000000000002 112.326 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.565 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -62.8 -25.76 68.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 64.040000000000006 111.127 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.879 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -34.06 -85.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 55.310000000000002 111.149 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.03 112.2 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 71.319999999999993 111.18 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.7 HG13 ' H ' ' A' ' 202' ' ' ARG . 1.6 p -137.79 -61.49 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.17 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.7 ' H ' HG13 ' A' ' 201' ' ' VAL . 1.1 mtt-85 162.23 35.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 110.855 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.468 ' N ' ' CD1' ' A' ' 206' ' ' ILE . 43.7 m -168.29 -56.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 64.329999999999998 111.124 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.565 HG21 ' HB1' ' A' ' 198' ' ' ALA . 59.3 t -48.63 -70.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 60.439999999999998 111.098 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.49 -22.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.310000000000002 110.876 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 203' ' ' THR . 3.1 mp -89.89 -33.02 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 73.340000000000003 111.145 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -74.31 -11.67 60.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.519999999999996 111.066 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.778 ' HA ' HD13 ' A' ' 168' ' ' ILE . 64.1 t -85.53 -74.81 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 75.510000000000005 111.117 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.424 ' HA ' HD12 ' A' ' 212' ' ' LEU . 14.8 t -53.46 -15.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 63.409999999999997 110.872 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -64.65 -40.26 95.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.909 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.7 -41.23 12.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 75.209999999999994 110.911 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.958 ' HA ' HG11 ' A' ' 164' ' ' VAL . 24.7 mt -52.63 -66.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 72.239999999999995 110.903 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -50.43 -24.23 2.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 74.400000000000006 110.908 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.33 -68.46 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.906 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.762 ' O ' HD13 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -59.25 -48.3 82.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 110.912 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.497 HG23 HD22 ' A' ' 154' ' ' LEU . 1.7 pt -109.6 93.76 14.9 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.645 0.736 . . . . 64.409999999999997 111.17 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -22.09 32.96 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 65.040000000000006 112.324 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 21.0 t -54.71 -15.42 1.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 72.329999999999998 110.877 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.7 mt -70.87 143.53 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 71.230000000000004 111.159 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -127.05 -42.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 75.340000000000003 110.881 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.1 mt -140.91 102.64 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 74.219999999999999 111.123 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.21 116.22 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 111.077 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.51 135.2 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 64.400000000000006 110.91 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.515 ' HB3' HD23 ' A' ' 194' ' ' LEU . 30.1 mt -121.97 103.03 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 63.039999999999999 110.906 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.4 171.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 73.239999999999995 110.939 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 45.140000000000001 110.84 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.781 HD22 ' CG ' ' A' ' 160' ' ' ASN . 6.5 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.793 0.33 . . . . 72.439999999999998 110.928 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.507 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 4.4 mt-10 -108.55 -6.23 16.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 61.32 110.925 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.708 HD12 ' CG2' ' A' ' 161' ' ' VAL . 3.2 tp 61.17 119.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.549999999999997 110.943 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.93 ' H ' HG23 ' A' ' 161' ' ' VAL . 5.8 p30 169.37 179.53 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 74.439999999999998 110.891 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -26.5 65.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.857 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.429 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 11.6 pt-20 -84.24 -30.96 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.109999999999999 110.865 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.781 ' CG ' HD22 ' A' ' 154' ' ' LEU . 89.5 m-20 -97.32 -62.29 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 63.439999999999998 110.922 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.93 HG23 ' H ' ' A' ' 157' ' ' ASN . 50.0 t -38.78 -46.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 75.310000000000002 111.156 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.14 -56.02 5.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.854 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -43.07 30.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 65.25 110.902 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.77 HG11 ' HA ' ' A' ' 212' ' ' LEU . 33.6 t -70.14 -42.94 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 65.310000000000002 111.149 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.629 HD11 ' CD1' ' A' ' 182' ' ' PHE . 56.5 mt -63.84 -24.7 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 71.129999999999995 110.905 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -69.17 -10.84 59.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.299999999999997 110.876 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -84.73 -25.74 28.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 110.884 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 169' ' ' ARG . 1.7 pt -106.98 -45.33 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.147 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.837 ' HG3' HD21 ' A' ' 180' ' ' LEU . 2.8 mtt180 -34.48 -58.71 0.63 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.631 0.729 . . . . 74.219999999999999 110.877 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.76 -30.8 21.72 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 72.010000000000005 112.379 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.57 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -74.34 -15.0 60.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 73.219999999999999 110.915 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.57 HD23 ' CD2' ' A' ' 171' ' ' TYR . 3.8 mt -76.5 -43.02 41.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 54.109999999999999 110.912 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.19 -22.62 48.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 60.219999999999999 111.118 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -46.32 -49.37 15.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 62.030000000000001 112.459 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.7 t -125.98 48.78 2.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 63.350000000000001 111.167 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.18 -97.65 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 72.530000000000001 112.489 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.03 125.46 4.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 63.530000000000001 112.511 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -128.81 -102.54 1.07 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 64.230000000000004 112.492 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -169.34 119.33 0.82 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.709 -0.758 . . . . 65.430000000000007 112.465 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.837 HD21 ' HG3' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -140.95 6.08 1.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 72.319999999999993 110.893 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.449 ' N ' HD13 ' A' ' 180' ' ' LEU . 0.9 OUTLIER -35.0 111.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 74.400000000000006 110.9 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.774 ' CE1' HG11 ' A' ' 161' ' ' VAL . 27.3 t80 -37.78 122.19 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 75.040000000000006 110.865 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 38.1 mt -81.01 -77.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 75.409999999999997 110.965 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.423 ' C ' HG13 ' A' ' 185' ' ' ILE . 12.5 ptm -169.99 -172.91 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 74.340000000000003 110.883 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.423 HG13 ' C ' ' A' ' 184' ' ' MET . 2.4 mt -133.73 130.52 56.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 75.209999999999994 111.134 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.09 75.83 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 71.25 110.954 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 87.19 -151.16 23.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 24.210000000000001 112.496 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 2.93 3.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.687 2.258 . . . . 75.140000000000001 112.303 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 24.0 mt -113.71 124.38 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 62.140000000000001 111.118 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.0 137.97 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 111.177 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.404 ' C ' HG23 ' A' ' 192' ' ' VAL . 4.6 mtmm -104.94 142.16 35.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 110.901 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.404 HG23 ' C ' ' A' ' 191' ' ' LYS . 56.1 t -156.91 142.83 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 71.400000000000006 111.152 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.468 ' NH2' HG21 ' A' ' 195' ' ' THR . 1.0 OUTLIER -73.69 163.1 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 64.310000000000002 110.887 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.72 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -164.49 93.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.409999999999997 110.915 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.468 HG21 ' NH2' ' A' ' 193' ' ' ARG . 5.9 p -132.49 -168.84 2.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 54.200000000000003 111.094 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.79 -158.13 42.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 54.219999999999999 112.476 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.26 18.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.678 2.252 . . . . 74.439999999999998 112.364 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.614 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -90.22 -162.41 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 73.239999999999995 111.131 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.716 ' HB2' HD12 ' A' ' 194' ' ' LEU . . . 74.01 144.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 111.062 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 200' ' ' VAL . 22.0 m 34.05 42.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 72.340000000000003 111.169 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 199' ' ' ALA . 23.0 t -99.12 -16.63 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 111.16 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 70.47 40.17 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 75.120000000000005 110.859 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.83 -44.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 72.209999999999994 111.133 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.614 HG11 ' HB1' ' A' ' 198' ' ' ALA . 53.6 t -72.64 -47.34 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 72.230000000000004 111.125 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -61.54 -40.89 96.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 63.210000000000001 110.893 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.72 -37.3 58.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 60.509999999999998 111.104 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.8 -29.95 69.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 111.107 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 212' ' ' LEU . 67.3 t -65.04 -75.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 52.520000000000003 111.125 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.527 ' HA ' HD12 ' A' ' 212' ' ' LEU . 1.9 t -55.33 -19.0 7.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 60.439999999999998 110.872 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.409 ' O ' ' OE1' ' A' ' 214' ' ' GLU . 3.8 mtpp -61.93 -40.32 95.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 71.519999999999996 110.855 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.86 -32.81 17.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 75.450000000000003 110.87 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.77 ' HA ' HG11 ' A' ' 164' ' ' VAL . 10.5 mt -69.29 -67.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 74.109999999999999 110.932 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . 0.423 ' CZ ' ' OG ' ' A' ' 209' ' ' SER . 0.7 OUTLIER -45.07 -27.95 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.519999999999996 110.862 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 210' ' ' LYS . 0.4 OUTLIER -81.68 -76.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 71.129999999999995 110.902 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.509 ' CB ' HG22 ' A' ' 164' ' ' VAL . 16.4 mmtt -42.24 -59.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 65.150000000000006 110.893 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.523 HD13 HG22 ' A' ' 161' ' ' VAL . 3.4 pt -103.94 95.42 7.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.659 0.743 . . . . 71.409999999999997 111.167 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -22.04 32.58 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.673 2.249 . . . . 74.010000000000005 112.33 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 17.0 t -49.06 -35.74 16.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 63.310000000000002 110.851 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.457 HG21 HG22 ' A' ' 222' ' ' VAL . 4.5 mt -48.37 154.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.349999999999994 111.129 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.446 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.8 OUTLIER -134.94 -35.53 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 54.219999999999999 110.927 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.41 HG13 ' C ' ' A' ' 220' ' ' GLN . 53.4 mt -146.76 91.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 64.239999999999995 111.147 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 219' ' ' ILE . 39.8 t -65.05 109.82 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 73.030000000000001 111.096 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -100.9 130.58 46.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 64.549999999999997 110.856 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.72 HD22 HD23 ' A' ' 194' ' ' LEU . 14.2 mt -117.07 114.09 23.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 50.100000000000001 110.909 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.52 177.88 7.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 72.030000000000001 110.925 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 72.209999999999994 110.879 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 215' ' ' LYS . 12.4 mt . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.811 0.338 . . . . 71.219999999999999 110.897 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -104.13 -17.82 14.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.919 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.885 HD13 HD12 ' A' ' 216' ' ' ILE . 8.9 tp 59.71 111.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 73.420000000000002 110.95 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.629 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -175.99 171.96 2.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 53.420000000000002 110.867 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.18 -20.51 1.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 64.420000000000002 110.869 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.51 -35.22 25.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 73.150000000000006 110.903 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.636 ' ND2' HD22 ' A' ' 154' ' ' LEU . 4.2 m-20 -90.0 -55.85 3.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 73.019999999999996 110.882 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 157' ' ' ASN . 26.6 m -47.46 -26.72 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 63.32 111.092 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -62.79 -42.02 99.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.893 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -34.08 69.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 74.219999999999999 110.944 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.828 HG11 ' HA ' ' A' ' 212' ' ' LEU . 30.4 t -73.37 -42.93 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 71.540000000000006 111.087 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.944 HD22 ' CD1' ' A' ' 180' ' ' LEU . 85.0 mt -65.89 -23.59 66.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 74.319999999999993 110.915 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -73.37 -8.64 56.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 64.310000000000002 110.861 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.19 1.59 49.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 74.120000000000005 110.916 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.972 HD12 HG13 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -132.91 -35.19 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 64.420000000000002 111.103 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.717 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.19 -60.56 5.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 75.129999999999995 110.874 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.4 Cg_endo -69.77 -4.73 14.63 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.691 2.261 . . . . 60.219999999999999 112.305 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.596 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -90.53 -22.1 21.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 64.140000000000001 110.924 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.596 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.3 mt -76.37 -44.81 34.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 50.240000000000002 110.912 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.5 -38.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 62.25 111.13 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.69 152.1 19.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 45.119999999999997 112.501 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.0 t 40.14 56.26 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.33 . . . . 74.439999999999998 111.132 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 156.37 -86.72 0.12 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 25.050000000000001 112.46 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 89.34 89.24 1.23 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 73.510000000000005 112.526 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.33 -158.81 7.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 63.210000000000001 112.515 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.92 152.68 24.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 64.319999999999993 112.458 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.944 ' CD1' HD22 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -140.9 25.7 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 65.209999999999994 110.919 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.481 ' NE2' ' NH2' ' A' ' 169' ' ' ARG . 2.5 tp60 -32.71 110.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.956 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.569 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 5.7 t80 -46.95 133.15 11.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 75.540000000000006 110.889 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.79 -69.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 52.219999999999999 110.905 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.1 ptp -178.13 -176.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 64.310000000000002 110.859 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.2 mt -131.29 125.27 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 111.145 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -124.9 56.41 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 70.109999999999999 110.913 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 95.71 -141.77 15.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.747 -0.74 . . . . 40.340000000000003 112.424 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.422 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.7 Cg_endo -69.72 3.28 2.84 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 52.439999999999998 112.358 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.02 118.3 58.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 111.127 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 66.7 t -97.22 135.53 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 54.229999999999997 111.15 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -109.76 139.58 44.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 74.349999999999994 110.907 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 193' ' ' ARG . 40.2 t -152.23 160.58 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 63.140000000000001 111.117 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.536 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.0 OUTLIER -92.37 166.65 12.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 110.854 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -156.42 70.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 71.439999999999998 110.91 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 76.4 p -89.09 173.3 8.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 111.156 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 86.24 -179.49 49.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.761 . . . . 75.219999999999999 112.455 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -24.43 29.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.709 2.273 . . . . 73.239999999999995 112.342 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.674 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -79.85 103.43 9.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 73.409999999999997 111.074 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -165.0 -74.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 45.399999999999999 111.103 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 28.5 m -61.92 -11.01 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 111.146 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 13.2 t -64.02 128.82 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 111.131 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -77.58 58.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 61.43 110.871 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 96.6 m -163.65 -55.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 74.530000000000001 111.13 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.674 HG21 ' HB1' ' A' ' 198' ' ' ALA . 59.8 t -54.47 -61.44 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 64.129999999999995 111.112 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -53.73 -25.69 19.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.510000000000005 110.873 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.01 -28.73 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 71.040000000000006 111.114 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.93 -32.34 72.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 70.549999999999997 111.075 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 1.021 HG12 HD11 ' A' ' 212' ' ' LEU . 3.8 t -67.07 -70.26 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 63.43 111.114 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.617 ' HA ' HD12 ' A' ' 212' ' ' LEU . 7.8 t -50.35 -17.91 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 74.430000000000007 110.854 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -66.96 -41.09 87.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 73.239999999999995 110.918 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -88.49 -33.99 17.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.099999999999994 110.905 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 1.021 HD11 HG12 ' A' ' 208' ' ' VAL . 11.3 mt -63.88 -67.14 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -16.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 72.200000000000003 110.85 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.96 -78.45 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.129999999999995 110.871 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.681 ' O ' HD12 ' A' ' 154' ' ' LEU . 1.2 mttp -47.09 -55.87 7.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 72.430000000000007 110.863 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.885 HD12 HD13 ' A' ' 156' ' ' LEU . 4.1 pt -108.05 91.53 8.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 75.129999999999995 111.152 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -16.06 37.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.63 2.22 . . . . 74.540000000000006 112.37 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.78 -23.94 7.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 71.510000000000005 110.821 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 5.2 mt -58.81 158.14 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 72.230000000000004 111.112 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.498 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -137.59 -35.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 75.340000000000003 110.903 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 220' ' ' GLN . 72.9 mt -150.71 96.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 71.349999999999994 111.143 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 222' ' ' VAL . 28.7 m -67.89 121.52 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.129999999999995 111.134 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.63 119.18 38.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.91 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.48 119.16 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 72.129999999999995 110.959 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.31 168.87 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 70.040000000000006 110.928 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.230000000000004 110.852 -179.907 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.737 HD23 ' CG ' ' A' ' 160' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.747 0.308 . . . . 64.340000000000003 110.911 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -104.12 -17.05 15.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 75.319999999999993 110.894 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.721 ' CD1' HD12 ' A' ' 216' ' ' ILE . 9.4 tp 58.15 113.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.896 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.621 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 175.52 -177.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 110.875 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.421 ' HA ' HG12 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -52.89 -45.38 67.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 72.430000000000007 110.823 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -57.93 -56.17 25.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 72.030000000000001 110.927 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.737 ' CG ' HD23 ' A' ' 154' ' ' LEU . 94.8 m-20 -74.52 -65.85 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.909 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 157' ' ' ASN . 2.5 p -34.75 -33.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 54.340000000000003 111.147 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -56.22 -57.1 13.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.901 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.96 -43.71 77.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 71.409999999999997 110.908 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.882 HG11 ' HA ' ' A' ' 212' ' ' LEU . 17.8 t -63.81 -40.89 90.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 63.450000000000003 111.177 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 182' ' ' PHE . 54.0 mt -66.35 -32.79 74.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 110.891 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 4.5 m-80 -63.97 -13.13 43.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.310000000000002 110.844 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.02 1.13 48.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 63.210000000000001 110.877 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.702 HG21 ' HA ' ' A' ' 208' ' ' VAL . 0.6 OUTLIER -135.15 -34.61 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 62.219999999999999 111.157 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.42 -60.77 5.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 71.510000000000005 110.851 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.498 ' CG ' ' O ' ' A' ' 166' ' ' ASN . 53.8 Cg_endo -69.76 -0.39 6.83 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 63.329999999999998 112.34 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.639 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -92.99 -27.1 17.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 72.209999999999994 110.943 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.639 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.1 mt -75.63 -39.95 57.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 74.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -44.36 -50.33 9.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 75.209999999999994 111.157 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -45.3 -43.74 9.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 50.210000000000001 112.504 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.9 t -113.76 37.43 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 74.310000000000002 111.124 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.71 109.08 0.46 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 65.140000000000001 112.469 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -74.9 137.56 22.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.704 -0.76 . . . . 42.100000000000001 112.507 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.01 -106.44 2.9 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.718 -0.753 . . . . 61.039999999999999 112.474 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.08 113.81 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.752 . . . . 71.030000000000001 112.471 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 181' ' ' GLN . 1.7 pp -142.55 6.68 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.736 0.303 . . . . 71.530000000000001 110.905 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 182' ' ' PHE . 2.2 tp60 -36.19 105.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 74.519999999999996 110.897 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.604 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 10.0 t80 -34.09 129.44 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 62.200000000000003 110.876 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 89.0 mt -95.6 -72.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.510000000000005 110.923 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.404 ' C ' HG13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -166.06 -173.31 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 72.109999999999999 110.861 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 187' ' ' GLY . 4.1 mt -135.52 143.92 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 75.530000000000001 111.116 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . 0.475 ' CG ' ' HB ' ' A' ' 189' ' ' ILE . 7.9 ptpt -121.4 38.43 4.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 73.120000000000005 110.872 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.584 ' H ' HG22 ' A' ' 185' ' ' ILE . . . 93.35 -112.23 4.25 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 70.409999999999997 112.49 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.519 ' HG2' HD12 ' A' ' 189' ' ' ILE . 53.4 Cg_endo -69.82 -22.89 31.18 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.723 2.282 . . . . 70.5 112.314 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.519 HD12 ' HG2' ' A' ' 188' ' ' PRO . 2.6 mp -106.45 146.66 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 65.25 111.115 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.69 137.54 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 63.420000000000002 111.165 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -98.25 140.13 33.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 62.43 110.922 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 193' ' ' ARG . 41.4 t -151.03 149.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 62.219999999999999 111.109 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.441 ' O ' HG12 ' A' ' 192' ' ' VAL . 0.0 OUTLIER -83.97 161.4 20.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 110.842 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -173.12 61.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 65.150000000000006 110.983 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 22.6 p -80.42 -49.3 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 111.133 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -45.87 173.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.711 -0.757 . . . . 43.130000000000003 112.498 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.18 2.93 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 71.430000000000007 112.345 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 1.153 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -78.42 6.9 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 61.409999999999997 111.102 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 194' ' ' LEU . . . -91.76 -61.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 62.109999999999999 111.063 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 200' ' ' VAL . 21.3 t -76.12 50.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 31.02 111.115 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 198' ' ' ALA . 1.7 t -124.89 146.17 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.530000000000001 111.172 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -95.5 35.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 62.009999999999998 110.869 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.7 m -156.68 -66.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.144 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 1.153 HG11 ' HB1' ' A' ' 198' ' ' ALA . 57.9 t -44.78 -58.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 73.209999999999994 111.125 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -56.69 -21.86 30.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.896 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.437 HG22 ' HG3' ' A' ' 210' ' ' LYS . 15.6 mm -80.96 -52.22 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 65.409999999999997 111.158 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.98 -35.7 25.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 64.540000000000006 111.107 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.702 ' HA ' HG21 ' A' ' 168' ' ' ILE . 38.9 t -59.53 -83.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 64.200000000000003 111.117 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.588 ' N ' HG12 ' A' ' 208' ' ' VAL . 48.0 t -49.22 -18.49 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 64.510000000000005 110.863 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.437 ' HG3' HG22 ' A' ' 206' ' ' ILE . 3.0 mttm -60.48 -40.23 90.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 54.119999999999997 110.909 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 214' ' ' GLU . 1.4 mmtt -86.59 -54.56 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 70.120000000000005 110.847 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.882 ' HA ' HG11 ' A' ' 164' ' ' VAL . 1.5 mt -37.07 -70.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 65.299999999999997 110.877 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -53.49 -22.46 8.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 72.310000000000002 110.86 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -77.39 -67.42 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 70.310000000000002 110.923 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.67 ' O ' HD13 ' A' ' 154' ' ' LEU . 1.9 mptt -60.72 -46.39 90.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 64.510000000000005 110.916 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.721 HD12 ' CD1' ' A' ' 156' ' ' LEU . 4.4 pt -111.68 86.26 6.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.657 0.742 . . . . 72.310000000000002 111.111 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 0.26 5.92 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.688 2.259 . . . . 73.439999999999998 112.319 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.6 t -76.6 1.68 16.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 72.329999999999998 110.857 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 6.3 mt -83.65 157.88 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 74.450000000000003 111.13 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.501 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.1 OUTLIER -132.43 -33.13 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 74.010000000000005 110.932 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 189' ' ' ILE . 33.6 mm -153.62 108.89 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 70.510000000000005 111.13 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.2 t -82.52 117.83 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 71.420000000000002 111.087 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -107.87 136.25 47.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 72.230000000000004 110.891 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.8 mt -124.05 104.32 8.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 63.409999999999997 110.944 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.18 168.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 62.119999999999997 110.915 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 61.130000000000003 110.862 -179.908 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.501 ' CB ' HG22 ' A' ' 216' ' ' ILE . 11.4 mt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.815 0.341 . . . . 74.109999999999999 110.895 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.85 -18.09 18.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 62.200000000000003 110.873 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.623 HD12 HD12 ' A' ' 216' ' ' ILE . 5.6 tp 61.49 113.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 64.420000000000002 110.926 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.962 ' H ' HG23 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 171.8 173.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.883 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 162' ' ' GLU . 3.6 mt-10 -49.49 -37.03 24.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 63.420000000000002 110.901 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.8 -54.12 25.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 63.420000000000002 110.924 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.441 ' ND2' HD21 ' A' ' 157' ' ' ASN . 86.6 m-20 -79.32 -62.82 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 64.420000000000002 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.962 HG23 ' H ' ' A' ' 157' ' ' ASN . 72.7 t -34.56 -50.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 73.540000000000006 111.133 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 20.7 mm-40 -40.34 -60.2 1.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.129999999999995 110.865 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.28 -36.86 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 64.239999999999995 110.929 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.815 HG11 ' HA ' ' A' ' 212' ' ' LEU . 40.2 t -73.44 -34.39 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 71.420000000000002 111.082 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' A' ' 182' ' ' PHE . 27.8 mt -72.79 -30.93 64.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 71.340000000000003 110.927 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.82 -6.85 44.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.894 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -90.98 -12.87 34.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.319999999999993 110.871 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.514 HD13 HG22 ' A' ' 208' ' ' VAL . 0.8 OUTLIER -123.51 -28.33 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 72.400000000000006 111.119 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.652 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -51.61 -60.87 5.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 74.409999999999997 110.844 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.9 Cg_endo -69.73 2.62 3.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.675 2.25 . . . . 62.310000000000002 112.37 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.634 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -97.61 -28.44 13.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.927 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.634 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.3 mt -76.31 -43.08 42.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.925 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.17 38.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 65.329999999999998 111.062 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.53 -20.16 3.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 35.240000000000002 112.476 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.1 t -161.95 30.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 64.230000000000004 111.174 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -165.29 -69.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 54.43 112.507 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.98 127.34 3.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.698 -0.763 . . . . 70.120000000000005 112.493 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 158.86 176.16 30.6 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 74.209999999999994 112.475 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.23 -171.98 12.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 74.530000000000001 112.513 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.652 HD11 ' HD2' ' A' ' 169' ' ' ARG . 0.6 OUTLIER -163.66 30.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.816 0.341 . . . . 72.129999999999995 110.962 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 180' ' ' LEU . 9.3 tp60 -32.19 107.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 73.019999999999996 110.886 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.826 ' CE1' HG11 ' A' ' 161' ' ' VAL . 35.7 t80 -48.22 108.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 71.510000000000005 110.877 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.728 HD12 HD13 ' A' ' 225' ' ' LEU . 46.9 mt -64.92 -78.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 110.912 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 7.3 ptp -168.49 -174.64 2.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 71.540000000000006 110.885 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.1 mt -127.88 123.97 61.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 51.509999999999998 111.143 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.73 79.18 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 74.109999999999999 110.901 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 76.49 -146.56 33.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.724 . . . . 74.239999999999995 112.532 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 3.18 2.9 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.688 2.259 . . . . 73.25 112.363 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.9 mt -121.31 115.31 46.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.145 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.16 140.24 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 53.140000000000001 111.123 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.573 ' HG2' HD11 ' A' ' 225' ' ' LEU . 11.5 mtmt -101.94 136.64 41.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 54.210000000000001 110.89 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 193' ' ' ARG . 82.5 t -140.42 156.46 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 75.019999999999996 111.162 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.476 ' N ' HG12 ' A' ' 192' ' ' VAL . 2.8 ttt180 -91.25 174.2 7.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.855 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 199' ' ' ALA . 0.2 OUTLIER -175.24 81.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 74.439999999999998 110.896 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 62.5 p -100.99 179.1 4.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 75.430000000000007 111.153 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.49 175.84 48.12 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.765 -0.731 . . . . 64.329999999999998 112.432 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -0.12 6.5 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.685 2.257 . . . . 73.430000000000007 112.305 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.86 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -86.39 5.39 35.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 73.099999999999994 111.089 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.489 ' HB2' HD12 ' A' ' 194' ' ' LEU . . . -94.28 170.07 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 63.43 111.127 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 200' ' ' VAL . 8.3 p 39.56 38.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 73.530000000000001 111.104 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.467 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 1.5 p -113.1 -15.3 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 62.100000000000001 111.155 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.778 ' HD3' HD11 ' A' ' 206' ' ' ILE . 0.0 OUTLIER 80.7 -58.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 110.855 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.6 m -51.35 -63.24 1.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.010000000000005 111.111 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.86 HG21 ' HB1' ' A' ' 198' ' ' ALA . 42.9 t -49.47 -65.05 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 61.200000000000003 111.087 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . 0.473 ' HB2' ' CD1' ' A' ' 224' ' ' LEU . 0.1 OUTLIER -51.74 -34.03 37.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.878 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.778 HD11 ' HD3' ' A' ' 202' ' ' ARG . 14.1 mt -66.1 -56.72 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 70.329999999999998 111.163 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.78 -34.02 18.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 73.129999999999995 111.073 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.869 HG12 HD11 ' A' ' 212' ' ' LEU . 98.6 t -60.7 -69.23 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 61.539999999999999 111.094 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.582 ' HA ' HD12 ' A' ' 212' ' ' LEU . 0.9 OUTLIER -51.3 -17.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 75.230000000000004 110.837 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -73.93 -39.74 63.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 64.329999999999998 110.89 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.92 -34.4 26.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 74.049999999999997 110.867 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.869 HD11 HG12 ' A' ' 208' ' ' VAL . 8.2 mt -68.59 -70.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 71.430000000000007 110.889 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -21.82 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 71.219999999999999 110.866 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.82 -81.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 52.229999999999997 110.898 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -46.4 -47.74 18.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 75.409999999999997 110.893 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.623 HD12 HD12 ' A' ' 156' ' ' LEU . 2.5 pt -112.95 91.49 18.24 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.631 0.729 . . . . 73.099999999999994 111.092 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -13.53 34.89 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.689 2.259 . . . . 74.109999999999999 112.354 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.18 -11.17 5.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 73.450000000000003 110.873 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.576 HG12 HD13 ' A' ' 156' ' ' LEU . 1.1 mt -71.67 143.84 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.439999999999998 111.115 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -126.19 -41.53 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 74.439999999999998 110.89 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.4 mp -141.93 104.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 71.420000000000002 111.164 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.73 121.47 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 111.14 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -114.79 129.07 56.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.310000000000002 110.908 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.473 ' CD1' ' HB2' ' A' ' 205' ' ' ARG . 10.2 mt -113.14 140.56 47.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 60.009999999999998 110.917 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.728 HD13 HD12 ' A' ' 183' ' ' LEU . 5.7 mp -115.91 164.07 14.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 63.210000000000001 110.942 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 64.219999999999999 110.877 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 154' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.77 0.319 . . . . 75.5 110.904 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.401 ' O ' ' O ' ' A' ' 156' ' ' LEU . 2.0 tp10 -91.0 -23.88 20.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 63.310000000000002 110.9 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.589 HD11 ' CG1' ' A' ' 219' ' ' ILE . 9.6 tt 53.99 107.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 73.409999999999997 110.913 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.807 ' HA ' HD13 ' A' ' 185' ' ' ILE . 9.1 p30 -174.91 171.63 3.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 71.329999999999998 110.859 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -48.8 -22.84 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 65.129999999999995 110.805 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.96 -52.36 6.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 74.299999999999997 110.871 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -68.38 -53.78 21.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 74.040000000000006 110.937 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 157' ' ' ASN . 18.6 m -49.5 -27.46 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 64.400000000000006 111.108 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.38 -48.23 73.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 71.549999999999997 110.862 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.06 -40.3 80.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 54.310000000000002 110.919 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.644 HG12 ' HB3' ' A' ' 211' ' ' LYS . 4.1 t -78.22 -35.69 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 71.239999999999995 111.166 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 182' ' ' PHE . 32.5 mt -68.0 -25.3 65.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 70.319999999999993 110.941 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.416 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 19.9 m-20 -72.84 -9.5 58.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 75.439999999999998 110.847 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -94.38 -5.72 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 61.450000000000003 110.906 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.93 -40.19 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 65.230000000000004 111.155 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.558 ' HA ' HD21 ' A' ' 180' ' ' LEU . 1.8 mtt180 -48.01 -58.63 7.4 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.727 . . . . 65.340000000000003 110.829 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.69 -29.93 23.41 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.713 2.275 . . . . 71.200000000000003 112.355 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.73 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -58.91 -28.68 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 73.129999999999995 110.944 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.73 HD23 ' CD2' ' A' ' 171' ' ' TYR . 3.4 mt -68.57 -53.44 22.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 71.239999999999995 110.916 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -50.05 -26.53 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 73.030000000000001 111.137 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -47.78 -63.95 3.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 64.530000000000001 112.494 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.9 t -109.44 -1.76 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 72.040000000000006 111.164 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.35 101.02 0.2 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 55.009999999999998 112.483 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.476 ' HA2' ' CB ' ' A' ' 172' ' ' LEU . . . -82.1 164.02 43.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.76 -0.733 . . . . 51.149999999999999 112.518 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -136.03 -102.53 0.67 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.766 -0.73 . . . . 70.040000000000006 112.522 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -173.43 113.78 0.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.713 -0.756 . . . . 75.329999999999998 112.488 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 169' ' ' ARG . 0.7 OUTLIER -135.43 23.49 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 73.120000000000005 110.896 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 180' ' ' LEU . 1.1 tp60 -33.92 111.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 71.040000000000006 110.918 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 40.6 t80 -57.11 125.01 20.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 73.239999999999995 110.927 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.18 -77.01 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 72.540000000000006 110.915 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . 0.425 ' C ' HG13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -169.9 -173.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 72.5 110.905 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.807 HD13 ' HA ' ' A' ' 157' ' ' ASN . 1.7 mt -132.63 132.11 59.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 64.120000000000005 111.154 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -124.21 66.26 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.519999999999996 110.915 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 90.78 -139.01 14.66 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.752 -0.737 . . . . 72.430000000000007 112.492 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.408 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.1 Cg_endo -69.83 -4.99 15.2 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.68 2.253 . . . . 71.340000000000003 112.335 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.6 mt -114.63 120.86 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.439999999999998 111.143 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.74 HG22 HG23 ' A' ' 185' ' ' ILE . 25.1 t -100.25 136.04 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 54.210000000000001 111.155 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -104.31 156.81 17.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.140000000000001 110.926 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 193' ' ' ARG . 2.6 p 179.05 147.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 75.319999999999993 111.144 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . 0.412 ' O ' HG22 ' A' ' 192' ' ' VAL . 0.3 OUTLIER -72.37 170.76 13.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 52.43 110.905 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.667 HD23 HD22 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -168.32 88.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.400000000000006 110.932 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.2 p -116.78 -174.49 2.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 54.219999999999999 111.13 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.54 179.14 51.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.784 -0.722 . . . . 75.019999999999996 112.507 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 2.26 3.71 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.7 2.266 . . . . 73.230000000000004 112.323 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.979 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -106.16 42.32 1.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 74.030000000000001 111.149 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -96.67 -53.93 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 74.340000000000003 111.151 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 200' ' ' VAL . 3.5 p -142.15 86.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 75.040000000000006 111.151 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 201' ' ' VAL . 9.0 p -125.67 24.64 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 75.349999999999994 111.117 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.87 39.08 13.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 71.519999999999996 110.883 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.598 ' N ' HD12 ' A' ' 206' ' ' ILE . 55.8 m -164.5 -66.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 70.109999999999999 111.175 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.979 HG11 ' HB1' ' A' ' 198' ' ' ALA . 97.7 t -53.16 -70.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 42.350000000000001 111.117 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -38.96 -30.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 72.120000000000005 110.875 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . 0.598 HD12 ' N ' ' A' ' 203' ' ' THR . 3.5 mt -80.66 -44.53 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 111.108 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -52.67 -29.8 28.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 73.140000000000001 111.096 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 209' ' ' SER . 62.9 t -69.2 -85.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 55.030000000000001 111.13 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.483 ' N ' HG12 ' A' ' 208' ' ' VAL . 44.8 t -39.61 -25.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 70.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.544 ' CE ' HG22 ' A' ' 206' ' ' ILE . 1.2 mttt -61.6 -46.45 89.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 63.340000000000003 110.878 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.644 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -71.97 -49.54 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.219999999999999 110.888 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.714 ' H ' HD22 ' A' ' 212' ' ' LEU . 2.2 mm? -52.05 -74.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 74.519999999999996 110.909 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.01 -29.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 71.219999999999999 110.869 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.41 -74.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 73.010000000000005 110.922 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.455 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 1.6 mptt -62.49 -48.27 80.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 64.299999999999997 110.892 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.623 HD13 HG12 ' A' ' 161' ' ' VAL . 11.6 pt -106.52 87.64 2.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.622 0.725 . . . . 74.329999999999998 111.152 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -21.44 33.84 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.232 . . . . 74.219999999999999 112.4 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.5 t -46.31 -40.03 11.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 61.100000000000001 110.862 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.589 ' CG1' HD11 ' A' ' 156' ' ' LEU . 4.8 mt -39.41 155.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 74.010000000000005 111.103 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.478 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -135.69 -34.4 0.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 110.947 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 33.2 mm -153.05 104.93 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 64.219999999999999 111.128 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.63 115.39 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 73.540000000000006 111.153 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -105.29 129.51 53.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 70.439999999999998 110.922 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.667 HD22 HD23 ' A' ' 194' ' ' LEU . 5.8 mt -119.07 109.11 15.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 64.349999999999994 110.926 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.35 165.41 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 63.539999999999999 110.897 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 110.864 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.557 HD22 ' HB3' ' A' ' 160' ' ' ASN . 7.9 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.759 0.314 . . . . 75.329999999999998 110.956 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.576 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 1.6 mp0 -119.0 -2.58 10.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 110.893 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.788 HD13 HD12 ' A' ' 216' ' ' ILE . 20.2 tp 60.81 126.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 73.209999999999994 110.937 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.929 ' H ' HG23 ' A' ' 161' ' ' VAL . 3.6 p30 162.19 179.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 74.129999999999995 110.884 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.05 -19.28 62.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 60.020000000000003 110.86 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.431 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 10.7 pt-20 -90.07 -34.69 15.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 75.019999999999996 110.847 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.576 ' ND2' ' H ' ' A' ' 155' ' ' GLU . 94.1 m-20 -93.29 -59.75 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 61.539999999999999 110.841 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.929 HG23 ' H ' ' A' ' 157' ' ' ASN . 63.3 t -38.97 -43.35 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 73.219999999999999 111.115 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -45.82 -56.13 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 64.409999999999997 110.914 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -34.04 64.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 74.299999999999997 110.873 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.897 HG11 ' HA ' ' A' ' 212' ' ' LEU . 73.6 t -69.91 -50.89 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 53.420000000000002 111.128 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 22.1 mt -59.0 -22.92 61.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 53.420000000000002 110.893 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -72.32 -6.32 42.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 62.539999999999999 110.936 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -98.57 7.99 45.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 72.540000000000006 110.903 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -143.36 -35.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 72.219999999999999 111.188 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -50.37 -60.6 5.0 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.575 0.702 . . . . 75.530000000000001 110.845 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.79 0.87 5.04 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.678 2.252 . . . . 74.209999999999994 112.339 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.59 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -97.15 -21.43 17.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 110.928 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.59 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.4 mt -81.22 -43.95 18.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 52.329999999999998 110.935 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.58 -50.52 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 51.229999999999997 111.102 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.37 -45.0 97.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.801 -0.714 . . . . 74.140000000000001 112.501 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.0 p -88.41 21.88 2.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 74.25 111.109 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 177' ' ' GLY . . . 90.48 79.02 1.36 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 71.239999999999995 112.487 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 176' ' ' GLY . . . -37.05 156.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.789 -0.72 . . . . 51.340000000000003 112.489 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.67 -113.62 1.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 73.150000000000006 112.493 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -164.01 114.18 0.59 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.693 -0.765 . . . . 74.340000000000003 112.445 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.88 HD22 ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -138.75 14.15 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 73.439999999999998 110.882 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -32.15 95.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 63.039999999999999 110.899 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.749 ' CE1' HG11 ' A' ' 161' ' ' VAL . 54.9 t80 -36.04 118.9 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 72.099999999999994 110.894 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.501 HD12 HD13 ' A' ' 225' ' ' LEU . 42.2 mt -78.3 -78.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 73.430000000000007 110.915 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -167.59 -159.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 74.030000000000001 110.867 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 74.8 mt -146.24 135.83 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.349999999999994 111.092 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -128.55 57.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 60.420000000000002 110.933 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.58 -140.34 14.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 61.32 112.488 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -3.35 11.84 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 61.130000000000003 112.349 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 21.8 mt -110.94 138.28 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 63.329999999999998 111.126 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 185' ' ' ILE . 16.9 t -115.31 132.95 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 111.083 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.555 ' HG2' HD11 ' A' ' 225' ' ' LEU . 19.3 mtmt -98.25 142.55 29.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 65.319999999999993 110.873 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 88.0 t -155.35 139.61 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 72.420000000000002 111.159 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -73.92 169.75 16.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 110.932 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.775 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -160.88 96.84 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 74.040000000000006 110.93 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.15 153.84 38.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 70.510000000000005 111.108 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 121.12 -172.56 15.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 65.239999999999995 112.497 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -8.69 24.24 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 65.099999999999994 112.313 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.65 8.49 11.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 63.340000000000003 111.105 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.775 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -51.49 -61.59 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 60.530000000000001 111.099 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.07 107.96 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 73.450000000000003 111.142 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 202' ' ' ARG . 42.4 t -146.81 -79.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 62.43 111.104 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ARG . . . . . 0.473 ' N ' HG12 ' A' ' 201' ' ' VAL . 0.1 OUTLIER -175.25 137.11 0.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.439999999999998 110.898 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 204' ' ' VAL . 0.2 OUTLIER 77.86 -60.86 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.443 . . . . 71.400000000000006 111.153 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 203' ' ' THR . 98.9 t -35.44 -71.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 50.329999999999998 111.11 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.55 -49.3 1.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 63.009999999999998 110.855 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.39 -58.3 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.140000000000001 111.125 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -40.51 -35.72 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 64.230000000000004 111.059 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.59 -76.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 53.530000000000001 111.109 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.4 t -54.97 -14.15 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 62.530000000000001 110.858 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -65.13 -39.93 93.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 74.239999999999995 110.86 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 214' ' ' GLU . 0.9 OUTLIER -87.03 -62.61 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.418 . . . . 75.230000000000004 110.958 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.897 ' HA ' HG11 ' A' ' 164' ' ' VAL . 9.8 mt -31.72 -69.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.109999999999999 110.946 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -38.0 32.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 74.239999999999995 110.874 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.3 OUTLIER -66.91 -79.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 73.140000000000001 110.898 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.71 ' CB ' HG22 ' A' ' 164' ' ' VAL . 11.8 mmtm -45.16 -52.75 8.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 63.009999999999998 110.916 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.788 HD12 HD13 ' A' ' 156' ' ' LEU . 6.5 pt -110.57 93.68 17.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 73.040000000000006 111.136 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -23.24 31.23 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.714 2.276 . . . . 51.539999999999999 112.364 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.08 -26.28 2.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 60.140000000000001 110.838 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.9 mt -59.71 152.56 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 75.329999999999998 111.16 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLN . . . . . 0.415 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 2.2 mt-30 -131.19 -37.49 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 60.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.8 mt -141.72 112.38 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 43.219999999999999 111.086 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.09 114.29 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 72.439999999999998 111.074 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -103.91 129.54 51.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 63.109999999999999 110.94 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.678 ' HB3' HD23 ' A' ' 194' ' ' LEU . 14.2 mt -119.32 102.41 8.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 61.119999999999997 110.903 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . 0.555 HD11 ' HG2' ' A' ' 191' ' ' LYS . 4.9 mp -82.18 160.23 23.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 75.209999999999994 110.931 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 64.310000000000002 110.842 -179.929 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.792 0.329 . . . . 54.439999999999998 110.91 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.416 HD23 ' CG ' ' A' ' 160' ' ' ASN . 3.2 mp -90.28 -170.91 2.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 75.219999999999999 110.945 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.481 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 0.7 OUTLIER -109.18 -11.41 14.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 73.310000000000002 110.882 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.573 ' CD1' HD12 ' A' ' 216' ' ' ILE . 29.2 tp 59.62 92.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 64.230000000000004 110.955 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.784 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -175.31 175.21 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 74.329999999999998 110.86 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.47 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 9.6 mt-10 -42.7 -55.39 3.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 74.099999999999994 110.895 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.405 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -51.01 -30.97 16.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 60.420000000000002 110.905 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' A' ' 155' ' ' GLU . 21.1 m-20 -96.59 -72.53 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 110.932 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 157' ' ' ASN . 30.3 m -33.94 -34.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 75.540000000000006 111.13 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -55.16 -57.59 11.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 74.019999999999996 110.903 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -53.04 -54.45 35.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.140000000000001 110.898 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.613 HG12 ' HB3' ' A' ' 211' ' ' LYS . 3.4 t -62.87 -29.57 47.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 61.399999999999999 111.088 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' A' ' 182' ' ' PHE . 15.1 mt -71.39 -32.49 68.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 63.200000000000003 110.919 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -72.38 -5.58 37.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 64.319999999999993 110.905 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -93.16 -9.53 39.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 64.430000000000007 110.873 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.85 -31.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 54.32 111.147 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.812 ' NE ' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -51.16 -60.67 5.2 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.535 0.683 . . . . 71.530000000000001 110.901 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.9 Cg_endo -69.78 2.54 3.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.668 2.245 . . . . 33.030000000000001 112.343 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.631 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -96.41 -28.72 14.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 70.400000000000006 110.959 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.631 HD23 ' CD2' ' A' ' 171' ' ' TYR . 9.2 mt -72.79 -34.46 66.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.127 -0.488 . . . . 73.25 110.868 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -85.77 -11.31 53.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 74.099999999999994 111.1 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -88.69 2.86 84.85 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 70.329999999999998 112.456 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.5 t -130.57 9.92 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.84 0.352 . . . . 74.400000000000006 111.178 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.52 -56.8 0.58 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.741 -0.742 . . . . 72.230000000000004 112.487 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 169.09 162.03 20.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 60.299999999999997 112.475 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -173.58 -160.68 22.42 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.726 -0.75 . . . . 72.329999999999998 112.486 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 162.97 110.02 0.24 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.75 -0.738 . . . . 72.340000000000003 112.499 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.812 HD11 ' NE ' ' A' ' 169' ' ' ARG . 3.7 pp -113.18 -31.73 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.745 0.307 . . . . 72.120000000000005 110.887 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.596 ' N ' HD12 ' A' ' 180' ' ' LEU . 0.4 OUTLIER 33.63 90.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 62.310000000000002 110.906 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.705 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 28.0 t80 -42.4 114.06 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 53.409999999999997 110.876 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.98 -79.61 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 44.450000000000003 110.897 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 27.5 ptm -167.67 -170.81 1.48 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 61.140000000000001 110.847 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 157' ' ' ASN . 7.3 mt -131.61 144.44 37.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 72.5 111.104 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.8 68.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.484 . . . . 73.430000000000007 110.929 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 83.13 -141.87 21.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.749 -0.739 . . . . 64.420000000000002 112.502 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 54.0 Cg_endo -69.74 -1.18 8.01 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.231 . . . . 74.299999999999997 112.372 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 47.6 mt -117.92 124.25 72.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 73.329999999999998 111.138 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 191' ' ' LYS . 1.4 p -108.72 155.1 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 62.219999999999999 111.153 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.442 ' N ' ' CG2' ' A' ' 190' ' ' VAL . 13.9 mtmt -116.26 141.04 48.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 72.129999999999995 110.915 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.467 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 43.7 t -151.53 155.46 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 71.319999999999993 111.134 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.478 ' CB ' ' O ' ' A' ' 180' ' ' LEU . 0.7 OUTLIER -94.81 172.06 8.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 63.109999999999999 110.886 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.913 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -167.67 86.21 0.23 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 72.510000000000005 110.929 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.1 p -123.83 177.95 5.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 54.240000000000002 111.14 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 87.13 -172.16 43.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.743 -0.741 . . . . 70.019999999999996 112.477 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -1.33 8.27 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.65 2.233 . . . . 62.210000000000001 112.382 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.03 57.51 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.212 -0.449 . . . . 50.310000000000002 111.14 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.913 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -99.89 -94.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 62.100000000000001 111.105 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.26 59.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 61.43 111.105 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.469 ' O ' HG12 ' A' ' 201' ' ' VAL . 4.9 t -101.12 30.62 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 60.409999999999997 111.123 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.0 OUTLIER 67.56 133.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 73.340000000000003 110.865 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.625 ' HA ' HD12 ' A' ' 206' ' ' ILE . 0.6 OUTLIER 78.54 -51.25 0.47 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 52.549999999999997 111.162 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 47.9 t -40.5 -51.91 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 54.32 111.113 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -64.17 -35.4 80.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 74.530000000000001 110.888 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 203' ' ' THR . 18.1 mt -64.1 -50.36 77.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 70.0 111.11 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.98 -36.77 29.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 73.209999999999994 111.103 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.501 ' O ' HD22 ' A' ' 212' ' ' LEU . 58.0 t -59.22 -83.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 63.420000000000002 111.157 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.472 ' N ' HG12 ' A' ' 208' ' ' VAL . 29.0 t -48.86 -20.54 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.140000000000001 110.837 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -58.55 -46.22 87.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 55.240000000000002 110.89 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.613 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -82.59 -46.62 13.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 44.140000000000001 110.937 179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.501 HD22 ' O ' ' A' ' 208' ' ' VAL . 1.6 mm? -47.18 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 73.329999999999998 110.899 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.65 -52.2 3.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 73.340000000000003 110.9 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -41.21 -80.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 73.420000000000002 110.883 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.401 ' O ' ' HD3' ' A' ' 217' ' ' PRO . 0.9 OUTLIER -51.48 -51.41 55.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 63.130000000000003 110.865 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.573 HD12 ' CD1' ' A' ' 156' ' ' LEU . 5.2 pt -107.16 82.77 1.22 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.595 0.712 . . . . 73.420000000000002 111.096 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 53.7 Cg_endo -69.77 -5.69 16.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.667 2.244 . . . . 73.209999999999994 112.337 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 23.3 t -66.38 -22.95 66.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 72.209999999999994 110.862 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 7.3 mt -57.89 158.67 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 75.450000000000003 111.169 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.522 ' O ' HD13 ' A' ' 221' ' ' ILE . 1.1 mt-30 -134.84 -33.78 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.894 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.522 HD13 ' O ' ' A' ' 220' ' ' GLN . 37.5 mm -154.13 106.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 61.049999999999997 111.123 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 76.8 t -80.42 114.56 21.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 54.310000000000002 111.148 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -96.78 113.59 25.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 71.400000000000006 110.901 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.486 HD22 HD23 ' A' ' 194' ' ' LEU . 12.0 mt -100.53 102.72 13.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 110.893 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.91 -176.81 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 64.109999999999999 110.887 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.439999999999998 110.88 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 4.2 mmt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.818 0.342 . . . . 74.530000000000001 110.868 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.778 HD12 ' O ' ' A' ' 215' ' ' LYS . 5.9 mt -117.65 -175.75 2.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 63.310000000000002 110.924 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -117.54 -0.82 11.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 65.409999999999997 110.873 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.706 HD13 HD12 ' A' ' 216' ' ' ILE . 20.4 tp 52.86 97.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 75.400000000000006 110.867 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.586 ' O ' HG22 ' A' ' 161' ' ' VAL . 3.6 p30 -159.14 164.43 35.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 75.510000000000005 110.876 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 16.8 mt-10 -45.15 -30.57 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 72.430000000000007 110.871 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.36 -44.45 52.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.945 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -80.51 -59.64 2.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 50.350000000000001 110.861 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.75 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 21.7 m -39.09 -33.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 71.439999999999998 111.107 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.34 -51.09 62.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 110.91 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -40.51 68.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 54.310000000000002 110.929 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.863 HG11 ' HA ' ' A' ' 212' ' ' LEU . 21.5 t -79.47 -34.79 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 70.109999999999999 111.083 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.487 HD23 HD11 ' A' ' 168' ' ' ILE . 27.9 mt -71.12 -21.31 62.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 110.912 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.415 ' O ' ' CD ' ' A' ' 170' ' ' PRO . 61.3 m-20 -74.5 -12.26 60.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 75.200000000000003 110.901 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -83.01 -14.16 54.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 71.319999999999993 110.876 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.763 HD13 ' HA ' ' A' ' 208' ' ' VAL . 3.2 pt -121.14 -31.16 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 72.349999999999994 111.09 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.731 ' HG2' HD13 ' A' ' 180' ' ' LEU . 1.1 mtt180 -49.04 -60.86 4.01 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.643 0.735 . . . . 73.310000000000002 110.871 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.0 Cg_endo -69.72 1.92 3.98 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.741 2.294 . . . . 74.530000000000001 112.341 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.518 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -105.66 -17.57 14.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 71.540000000000006 110.907 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.979 HD12 HD23 ' A' ' 180' ' ' LEU . 2.9 mt -77.84 -28.9 50.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.117 -0.492 . . . . 63.109999999999999 110.912 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.9 42.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 72.129999999999995 111.065 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -132.87 -33.59 0.37 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.769 -0.729 . . . . 53.450000000000003 112.499 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.9 t -144.59 9.51 1.37 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.787 0.327 . . . . 61.439999999999998 111.107 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 149.63 90.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.762 -0.733 . . . . 63.43 112.488 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . -125.08 168.55 17.15 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 61.030000000000001 112.495 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 154.44 -14.07 0.53 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.77 -0.728 . . . . 71.109999999999999 112.502 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -134.42 116.89 1.7 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.705 -0.76 . . . . 74.430000000000007 112.553 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.979 HD23 HD12 ' A' ' 172' ' ' LEU . 0.3 OUTLIER -173.9 -32.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 73.430000000000007 110.898 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 180' ' ' LEU . 8.3 tp60 -36.22 99.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 75.439999999999998 110.953 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.75 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 15.0 t80 -46.52 116.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 64.120000000000005 110.878 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 80.3 mt -76.0 -73.6 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 71.099999999999994 110.876 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.402 ' C ' HG13 ' A' ' 185' ' ' ILE . 28.0 ptm -173.4 -168.95 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 75.140000000000001 110.902 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.402 HG13 ' C ' ' A' ' 184' ' ' MET . 8.0 mt -136.25 129.26 46.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 74.010000000000005 111.137 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.37 56.14 1.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 73.349999999999994 110.911 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.91 -145.59 16.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.758 -0.734 . . . . 63.210000000000001 112.486 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 3.27 2.91 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.688 2.258 . . . . 72.129999999999995 112.322 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 221' ' ' ILE . 3.9 mp -115.21 130.49 69.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.539999999999999 111.123 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 84.0 t -104.6 148.59 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 75.420000000000002 111.087 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -116.79 140.88 48.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 71.030000000000001 110.887 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 193' ' ' ARG . 21.4 t -151.95 166.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 62.350000000000001 111.143 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.615 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.1 OUTLIER -92.87 143.11 26.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 74.230000000000004 110.909 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.666 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -143.61 87.31 1.92 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 71.420000000000002 110.888 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.05 -171.47 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 64.209999999999994 111.118 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.81 -169.85 55.01 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.723 -0.751 . . . . 44.310000000000002 112.506 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.53 ' O ' HG13 ' A' ' 201' ' ' VAL . 54.0 Cg_endo -69.67 0.43 5.59 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.702 2.268 . . . . 35.109999999999999 112.397 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.684 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -103.68 -5.6 22.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 42.420000000000002 111.104 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.628 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -80.53 42.06 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.510000000000005 111.069 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 8.4 p 179.34 -29.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 111.093 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 198' ' ' ALA . 27.5 m -56.93 127.09 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 52.409999999999997 111.109 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -79.71 77.5 6.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 73.219999999999999 110.9 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 t 176.03 -44.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 63.229999999999997 111.155 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.684 HG11 ' HB1' ' A' ' 198' ' ' ALA . 41.0 t -72.21 -42.68 66.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 70.200000000000003 111.149 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -65.88 -7.13 14.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.838 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 3.9 mm -90.55 -57.54 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 111.115 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.28 -20.48 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 73.510000000000005 111.093 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.763 ' HA ' HD13 ' A' ' 168' ' ' ILE . 88.9 t -72.29 -62.28 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 62.009999999999998 111.119 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 222' ' ' VAL . 32.1 t -80.59 14.5 2.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 71.030000000000001 110.853 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -39.86 9.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 74.200000000000003 110.932 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.62 -35.68 22.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 74.319999999999993 110.903 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.863 ' HA ' HG11 ' A' ' 164' ' ' VAL . 7.7 mt -68.72 -65.4 0.71 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 64.219999999999999 110.91 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.03 -21.71 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 110.878 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.409 ' N ' ' C ' ' A' ' 212' ' ' LEU . 20.9 tt0 -85.14 -72.49 0.48 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 74.439999999999998 110.881 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.778 ' O ' HD12 ' A' ' 154' ' ' LEU . 2.0 mptt -51.51 -54.04 31.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 74.319999999999993 110.92 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.715 HG23 HD13 ' A' ' 154' ' ' LEU . 2.0 pt -103.37 95.07 6.5 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.589 0.709 . . . . 54.25 111.15 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.67 -24.94 29.53 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.711 2.274 . . . . 64.129999999999995 112.358 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 46.0 t -47.37 -29.16 2.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 62.210000000000001 110.855 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.3 mt -59.37 153.3 3.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 73.219999999999999 111.122 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.431 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -139.66 -38.39 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 110.886 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 189' ' ' ILE . 21.8 mt -140.67 98.53 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 65.340000000000003 111.12 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.466 HG21 ' OG ' ' A' ' 209' ' ' SER . 67.1 t -74.89 109.15 7.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 72.530000000000001 111.135 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -97.68 138.89 34.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.966 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.666 HD22 HD23 ' A' ' 194' ' ' LEU . 8.2 mt -122.01 127.33 50.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 72.5 110.915 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 225' ' ' LEU . 2.1 mm? -96.63 172.16 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 75.310000000000002 110.888 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 43.229999999999997 110.8 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.785 0.326 . . . . 75.340000000000003 110.902 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.535 HD23 ' CG ' ' A' ' 160' ' ' ASN . 4.8 mp -86.01 -176.31 5.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 71.430000000000007 110.912 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -108.88 -13.23 14.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 63.439999999999998 110.875 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.728 HD13 HD12 ' A' ' 216' ' ' ILE . 15.7 tp 58.29 100.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 72.310000000000002 110.919 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.692 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -167.08 161.24 14.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 70.420000000000002 110.882 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.441 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 0.0 OUTLIER -34.89 -35.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.463 . . . . 75.209999999999994 110.869 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' ASN . 0.2 OUTLIER -71.82 -53.68 12.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.857 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.535 ' CG ' HD23 ' A' ' 154' ' ' LEU . 12.2 m-20 -67.78 -56.17 10.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 64.010000000000005 110.878 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.855 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 33.6 m -48.79 -27.87 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.161 -0.472 . . . . 62.229999999999997 111.147 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -61.46 -58.59 7.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 72.420000000000002 110.878 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.42 -45.07 45.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 72.329999999999998 110.892 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.779 HG11 ' HA ' ' A' ' 212' ' ' LEU . 1.3 t -68.63 -42.31 83.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 65.319999999999993 111.134 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.514 HD11 ' CD1' ' A' ' 182' ' ' PHE . 49.7 mt -63.41 -20.64 65.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 110.941 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.485 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 16.3 m-20 -76.48 -9.48 58.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 51.310000000000002 110.862 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.65 1.75 56.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 74.239999999999995 110.847 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.753 HG21 ' HA ' ' A' ' 208' ' ' VAL . 1.1 pt -131.75 -45.46 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 75.040000000000006 111.148 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.49 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -46.23 -60.28 3.82 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.607 0.718 . . . . 74.400000000000006 110.858 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.79 -11.12 30.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.653 2.235 . . . . 63.329999999999998 112.397 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.55 ' O ' ' CD1' ' A' ' 171' ' ' TYR . 0.1 OUTLIER -88.15 -12.4 44.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 72.230000000000004 110.885 -179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.509 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.3 mt -84.27 -53.57 5.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 74.349999999999994 110.961 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 175' ' ' THR . . . -58.12 -54.3 48.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 71.510000000000005 111.134 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -35.02 -31.59 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 54.200000000000003 112.44 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.491 ' N ' ' O ' ' A' ' 173' ' ' ALA . 1.2 t -134.21 64.86 1.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 72.239999999999995 111.191 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.93 -69.71 0.23 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.744 . . . . 74.430000000000007 112.519 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . 120.34 175.75 15.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 72.519999999999996 112.443 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -158.56 -123.37 0.72 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.723 -0.751 . . . . 53.049999999999997 112.468 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 163.32 114.49 0.31 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.725 -0.75 . . . . 74.129999999999995 112.502 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.464 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 3.4 pp -133.56 -39.5 0.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.744 0.307 . . . . 63.350000000000001 110.919 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.451 ' C ' ' O ' ' A' ' 180' ' ' LEU . 20.9 tp60 34.3 90.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 73.409999999999997 110.904 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.855 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 25.9 t80 -36.96 107.78 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 73.209999999999994 110.89 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 36.0 mt -68.38 -79.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 74.510000000000005 110.935 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 5.2 ptp -165.3 -171.67 2.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 52.439999999999998 110.915 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.4 mt -133.28 134.43 57.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.265 -0.425 . . . . 65.420000000000002 111.085 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.75 66.53 1.45 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 74.549999999999997 110.887 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 89.62 -146.0 18.65 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.757 -0.735 . . . . 52.219999999999999 112.452 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.8 Cg_endo -69.73 3.2 2.89 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.674 2.249 . . . . 72.329999999999998 112.36 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.2 mt -123.23 110.46 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 74.0 111.18 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.6 p -96.25 132.3 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 75.430000000000007 111.132 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.441 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 14.8 mtmt -89.49 146.27 24.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 75.299999999999997 110.946 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 193' ' ' ARG . 97.4 t -158.93 156.56 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.257 -0.429 . . . . 75.420000000000002 111.17 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.477 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.1 OUTLIER -90.12 172.5 8.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 73.25 110.85 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.57 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -162.6 81.46 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 74.019999999999996 110.919 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 2.0 p -114.24 -169.66 1.57 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.179 -0.464 . . . . 75.420000000000002 111.15 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 74.11 -179.09 42.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 62.399999999999999 112.513 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -2.1 9.61 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.68 2.253 . . . . 55.229999999999997 112.342 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 1.025 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -82.57 -17.45 44.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 73.310000000000002 111.092 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -56.27 -62.68 1.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.441 . . . . 72.099999999999994 111.118 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 98.2 t -109.32 97.76 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 75.040000000000006 111.153 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.527 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 7.3 p -159.79 -33.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 75.420000000000002 111.123 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.527 ' CB ' ' O ' ' A' ' 201' ' ' VAL . 9.9 ttp180 85.35 142.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.400000000000006 110.859 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.479 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 2.7 m 83.03 -32.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 61.399999999999999 111.156 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 1.025 HG11 ' HB1' ' A' ' 198' ' ' ALA . 33.3 t -70.14 -71.61 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 111.148 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -40.22 -43.39 1.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 72.109999999999999 110.912 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.556 HG22 ' CD ' ' A' ' 210' ' ' LYS . 3.1 mp -60.11 -44.13 94.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 55.109999999999999 111.116 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.39 -36.55 22.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 52.200000000000003 111.091 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.753 ' HA ' HG21 ' A' ' 168' ' ' ILE . 55.1 t -65.77 -85.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 74.209999999999994 111.149 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.697 ' HA ' HD23 ' A' ' 212' ' ' LEU . 40.9 m -34.01 -43.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 61.409999999999997 110.853 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.556 ' CD ' HG22 ' A' ' 206' ' ' ILE . 14.0 mtpt -47.84 -51.45 22.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 73.150000000000006 110.909 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.544 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -61.87 -66.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 75.129999999999995 110.899 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.82 ' H ' HD22 ' A' ' 212' ' ' LEU . 1.4 mm? -35.0 -73.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 73.019999999999996 110.956 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.34 -35.28 0.96 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.457 . . . . 74.349999999999994 110.856 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 211' ' ' LYS . 2.6 tp10 -57.14 -72.1 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 71.040000000000006 110.883 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 217' ' ' PRO . 5.2 mttp -63.57 -48.73 76.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.911 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.728 HD12 HD13 ' A' ' 156' ' ' LEU . 7.1 pt -107.03 83.24 1.28 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.639 0.733 . . . . 73.430000000000007 111.104 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 53.5 Cg_endo -69.82 -5.35 16.03 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.701 2.267 . . . . 74.200000000000003 112.33 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.15 -11.7 43.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 72.140000000000001 110.897 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.49 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 5.1 mt -68.77 158.3 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.071 -0.513 . . . . 61.130000000000003 111.151 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.872 ' HB3' HD12 ' A' ' 221' ' ' ILE . 0.2 OUTLIER -136.89 -34.91 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 71.140000000000001 110.907 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.872 HD12 ' HB3' ' A' ' 220' ' ' GLN . 4.5 mp -150.61 108.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 62.539999999999999 111.123 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 79.1 t -86.57 112.69 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 62.130000000000003 111.116 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -100.59 115.59 30.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.209999999999994 110.916 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.57 HD22 HD23 ' A' ' 194' ' ' LEU . 4.0 mt -103.51 101.71 11.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 65.310000000000002 110.921 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.35 174.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.449 . . . . 73.040000000000006 110.904 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 65.230000000000004 110.824 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.846 0.355 . . . . 54.340000000000003 110.838 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 215' ' ' LYS . 1.0 OUTLIER -96.72 -175.08 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 55.340000000000003 110.937 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -101.62 -2.79 29.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 64.109999999999999 110.894 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.725 HD13 HD12 ' A' ' 216' ' ' ILE . 10.9 tp 54.48 89.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 61.450000000000003 110.938 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.812 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -149.76 178.98 8.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.881 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.32 -48.93 77.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.340000000000003 110.857 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -58.84 -46.61 87.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 71.129999999999995 110.889 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.676 ' CG ' HD22 ' A' ' 154' ' ' LEU . 98.1 m-20 -71.07 -69.43 0.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 65.219999999999999 110.925 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.856 HG21 ' CE2' ' A' ' 182' ' ' PHE . 20.7 m -36.95 -31.88 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 63.140000000000001 111.127 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.7 mt-10 -55.38 -58.08 9.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 70.420000000000002 110.951 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.22 -39.59 56.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 64.430000000000007 110.93 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.963 HG11 ' HA ' ' A' ' 212' ' ' LEU . 21.4 t -64.3 -53.45 43.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 111.13 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.46 ' CD1' ' HB2' ' A' ' 182' ' ' PHE . 16.2 mt -58.15 -24.56 59.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 62.329999999999998 110.897 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -72.23 -6.85 45.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 63.020000000000003 110.865 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -100.66 4.92 43.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 63.009999999999998 110.886 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.7 -34.54 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 75.400000000000006 111.099 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.717 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -54.71 -60.58 7.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.578 0.704 . . . . 71.430000000000007 110.889 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.0 Cg_endo -69.82 -5.94 17.45 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.71 2.273 . . . . 50.130000000000003 112.286 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.584 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -86.42 -22.45 26.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.434 . . . . 71.400000000000006 110.889 -179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.584 HD23 ' CD2' ' A' ' 171' ' ' TYR . 7.2 mt -78.21 -53.61 7.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 74.200000000000003 110.954 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -36.73 -51.74 0.88 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 111.078 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -39.41 -44.44 2.31 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.79 -0.719 . . . . 74.030000000000001 112.452 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 53.2 p -88.15 -33.38 18.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 54.119999999999997 111.126 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 170.38 -42.28 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.68 -0.771 . . . . 72.549999999999997 112.461 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.1 162.83 28.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 50.310000000000002 112.478 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -151.05 -94.19 0.11 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.7 -0.762 . . . . 64.150000000000006 112.446 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 169.99 122.34 0.63 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.69 -0.767 . . . . 64.439999999999998 112.459 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.717 HD11 ' HD2' ' A' ' 169' ' ' ARG . 1.1 pp -150.07 13.15 0.78 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.742 0.306 . . . . 75.349999999999994 110.902 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 182' ' ' PHE . 0.5 OUTLIER -35.34 105.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 72.019999999999996 110.917 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.856 ' CE2' HG21 ' A' ' 161' ' ' VAL . 8.8 t80 -34.25 121.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 110.877 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.424 ' CD1' HD13 ' A' ' 225' ' ' LEU . 77.5 mt -80.82 -68.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 110.923 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 12.1 ptp -177.51 -175.65 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 74.019999999999996 110.897 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.2 mt -130.31 124.32 57.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 72.299999999999997 111.126 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.32 74.99 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.0 110.951 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 85.24 -149.04 23.51 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 73.219999999999999 112.495 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 3.53 2.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.704 2.269 . . . . 73.209999999999994 112.369 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.2 mt -117.06 123.48 71.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 71.549999999999997 111.101 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 41.0 t -99.09 143.69 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 71.219999999999999 111.136 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -107.56 142.33 37.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 74.5 110.887 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 193' ' ' ARG . 59.5 t -154.4 155.41 6.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 50.240000000000002 111.159 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.459 ' N ' HG12 ' A' ' 192' ' ' VAL . 7.5 tpt180 -94.26 154.74 17.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 110.849 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -149.91 76.84 1.31 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 75.329999999999998 110.922 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.5 p -108.17 -169.55 1.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 111.119 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.01 -178.15 33.94 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.766 -0.731 . . . . 63.340000000000003 112.48 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -0.78 7.41 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.699 2.266 . . . . 75.129999999999995 112.388 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.479 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -85.76 -6.39 59.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.453 . . . . 54.210000000000001 111.116 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.596 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -72.03 -50.64 26.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 111.087 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 200' ' ' VAL . 2.7 p -93.0 71.85 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 63.299999999999997 111.131 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.941 HG12 HG22 ' A' ' 203' ' ' THR . 15.1 t -155.02 117.54 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.491 . . . . 73.310000000000002 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.03 71.17 1.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.886 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.941 HG22 HG12 ' A' ' 201' ' ' VAL . 14.6 t -179.35 -33.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.109999999999999 111.146 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.479 HG21 ' HB1' ' A' ' 198' ' ' ALA . 20.0 t -67.69 -68.96 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.450000000000003 111.16 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -45.97 -33.14 3.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 72.140000000000001 110.868 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.7 mp -71.22 -42.84 75.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 65.439999999999998 111.134 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.74 -33.68 76.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 54.310000000000002 111.125 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.676 HG12 HD11 ' A' ' 212' ' ' LEU . 94.5 t -62.57 -75.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 75.209999999999994 111.125 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.587 ' HA ' HD12 ' A' ' 212' ' ' LEU . 5.6 t -53.55 -15.61 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 54.409999999999997 110.853 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -40.65 86.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 63.229999999999997 110.898 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -86.81 -35.04 19.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.459 . . . . 74.010000000000005 110.909 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.963 ' HA ' HG11 ' A' ' 164' ' ' VAL . 8.5 mt -66.41 -64.45 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 61.509999999999998 110.927 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.88 -22.19 1.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.886 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -83.95 -79.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 42.119999999999997 110.884 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.819 ' O ' HD12 ' A' ' 154' ' ' LEU . 14.8 mmtt -41.23 -55.9 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.501 . . . . 75.109999999999999 110.927 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.725 HD12 HD13 ' A' ' 156' ' ' LEU . 4.4 pt -108.35 85.58 2.89 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.614 0.721 . . . . 71.120000000000005 111.161 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -1.8 9.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.638 2.225 . . . . 71.340000000000003 112.316 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.412 ' HB3' ' CB ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -71.79 -6.29 40.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 63.109999999999999 110.857 -179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 220' ' ' GLN . 3.2 mt -73.36 154.69 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 62.140000000000001 111.146 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.565 ' O ' HD13 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -126.3 -33.7 2.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 71.040000000000006 110.882 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 220' ' ' GLN . 30.1 mm -151.74 107.69 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 73.040000000000006 111.147 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 41.8 t -78.77 109.07 13.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.073 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -99.44 119.69 38.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 70.340000000000003 110.907 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.7 mt -110.86 105.7 14.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 64.549999999999997 110.887 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.424 HD13 ' CD1' ' A' ' 183' ' ' LEU . 4.9 mp -81.45 162.98 23.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 75.340000000000003 110.9 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 63.409999999999997 110.881 -179.95 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.499 ' C ' HD13 ' A' ' 154' ' ' LEU . 4.7 mtp . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.844 0.354 . . . . 74.150000000000006 110.904 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.636 ' N ' HD22 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -115.43 -149.58 0.45 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 74.099999999999994 110.931 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.531 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 17.7 tt0 -112.01 -0.32 15.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 74.430000000000007 110.912 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.732 ' CD1' HD12 ' A' ' 216' ' ' ILE . 8.0 tp 61.73 110.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 75.420000000000002 110.896 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.931 ' H ' HG23 ' A' ' 161' ' ' VAL . 0.1 OUTLIER 169.64 164.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 75.129999999999995 110.876 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 157' ' ' ASN . 0.0 OUTLIER -33.97 -60.22 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 73.0 110.887 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -44.92 -60.85 1.85 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.409999999999997 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.796 ' ND2' HD21 ' A' ' 157' ' ' ASN . 53.1 m-20 -73.86 -67.39 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.912 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.931 HG23 ' H ' ' A' ' 157' ' ' ASN . 90.0 t -33.29 -46.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 65.239999999999995 111.137 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 30.0 mm-40 -47.39 -56.78 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 110.885 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.79 -49.8 19.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 73.519999999999996 110.89 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.491 HG11 ' HA ' ' A' ' 212' ' ' LEU . 1.9 t -63.44 -42.72 97.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 50.350000000000001 111.137 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.59 HD22 HD12 ' A' ' 180' ' ' LEU . 75.9 mt -61.18 -28.9 69.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 110.924 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -71.25 -6.06 36.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.902 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.67 -12.08 24.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 70.439999999999998 110.864 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 1.1 pt -117.75 -34.19 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 62.399999999999999 111.12 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.519 ' HG3' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.05 -60.96 5.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 75.239999999999995 110.925 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.4 Cg_endo -69.75 1.36 4.5 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.66 2.24 . . . . 62.240000000000002 112.363 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.627 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -94.89 -23.43 17.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 43.240000000000002 110.932 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.627 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.9 mt -80.98 -36.28 30.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 75.209999999999994 110.887 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.69 60.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 111.078 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -54.72 -44.78 80.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.743 -0.742 . . . . 71.439999999999998 112.481 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 175' ' ' THR . 5.8 t -143.2 99.99 3.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.895 0.379 . . . . 65.439999999999998 111.15 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.43 63.59 3.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.778 -0.725 . . . . 54.039999999999999 112.497 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 172' ' ' LEU . . . -62.56 100.31 0.31 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.7 -0.762 . . . . 63.240000000000002 112.454 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -79.96 -153.34 8.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.753 -0.737 . . . . 72.340000000000003 112.477 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -136.67 115.0 1.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.715 -0.755 . . . . 70.040000000000006 112.435 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.59 HD12 HD22 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -121.24 21.03 11.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.781 0.324 . . . . 53.219999999999999 110.95 -179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.437 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -34.57 107.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 110.939 179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.911 ' CE1' HG11 ' A' ' 161' ' ' VAL . 24.5 t80 -50.42 104.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 64.319999999999993 110.852 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 15.2 mt -65.82 -74.97 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.467 . . . . 72.530000000000001 110.91 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.46 ' CG ' ' HE3' ' A' ' 191' ' ' LYS . 1.8 ptt? -169.24 -171.37 1.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 72.420000000000002 110.898 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 157' ' ' ASN . 1.8 mt -132.61 125.94 53.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 43.439999999999998 111.139 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.63 77.73 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 74.450000000000003 110.885 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.423 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 75.75 -142.37 28.71 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.772 -0.728 . . . . 62.039999999999999 112.446 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.423 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.5 Cg_endo -69.78 3.3 2.86 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.711 2.274 . . . . 75.439999999999998 112.328 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 18.6 mt -120.55 122.9 69.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 73.030000000000001 111.128 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.2 p -106.25 135.2 45.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 72.540000000000006 111.125 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.46 ' HE3' ' CG ' ' A' ' 184' ' ' MET . 15.7 mtmt -93.77 142.47 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 70.549999999999997 110.877 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 85.9 t -156.65 130.52 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.196 -0.457 . . . . 74.219999999999999 111.137 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.61 167.43 18.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 110.842 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.473 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -157.26 85.03 0.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 60.350000000000001 110.883 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 66.1 p -114.15 -177.22 3.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 44.43 111.161 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.41 -177.54 51.6 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 61.219999999999999 112.471 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -12.84 33.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.661 2.24 . . . . 71.519999999999996 112.358 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.448 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -100.92 60.18 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 51.299999999999997 111.125 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -124.83 3.71 8.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 51.039999999999999 111.06 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 200' ' ' VAL . 9.5 p -169.0 76.87 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 72.420000000000002 111.138 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 201' ' ' VAL . 7.1 p -137.19 7.95 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 75.140000000000001 111.142 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.37 47.74 19.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 75.239999999999995 110.873 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.9 m -163.91 -64.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 75.049999999999997 111.14 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.621 HG23 HG11 ' A' ' 201' ' ' VAL . 77.3 t -47.75 -59.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 73.219999999999999 111.104 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.8 -22.99 6.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 75.109999999999999 110.877 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 10.9 mm -77.52 -47.16 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 75.439999999999998 111.139 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.25 -18.8 17.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 65.439999999999998 111.135 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.554 ' O ' HD22 ' A' ' 212' ' ' LEU . 59.9 t -73.81 -83.49 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 65.310000000000002 111.118 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.461 ' N ' HG12 ' A' ' 208' ' ' VAL . 2.7 t -42.28 -23.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 64.0 110.84 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 208' ' ' VAL . 19.5 mttt -58.8 -59.45 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 74.420000000000002 110.897 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.463 ' HB3' HG12 ' A' ' 164' ' ' VAL . 7.6 mmtt -65.34 -45.25 84.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 74.129999999999995 110.899 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 208' ' ' VAL . 1.5 mm? -54.03 -65.93 0.48 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 72.349999999999994 110.942 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -49.54 -32.35 12.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 74.150000000000006 110.897 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.4 -71.33 0.22 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 73.030000000000001 110.896 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.539 ' O ' HD22 ' A' ' 154' ' ' LEU . 7.5 mptt -56.65 -52.34 65.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 71.030000000000001 110.942 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.732 HD12 ' CD1' ' A' ' 156' ' ' LEU . 8.4 pt -106.48 86.24 2.09 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.593 0.711 . . . . 73.329999999999998 111.144 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -7.05 20.09 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.726 2.284 . . . . 54.119999999999997 112.296 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.76 -3.91 10.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 54.450000000000003 110.883 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.4 mt -74.19 152.59 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.145 -0.48 . . . . 63.299999999999997 111.152 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.879 ' HB3' HD12 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -132.02 -37.1 1.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.200000000000003 110.904 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 220' ' ' GLN . 4.6 mp -150.81 104.89 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 74.530000000000001 111.122 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 67.3 t -78.97 114.74 20.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 73.430000000000007 111.133 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.09 129.85 51.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.877 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.473 HD22 HD23 ' A' ' 194' ' ' LEU . 7.2 mt -118.76 126.83 52.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 71.049999999999997 110.899 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.547 ' N ' HD12 ' A' ' 225' ' ' LEU . 4.1 mp -94.42 168.32 10.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 72.120000000000005 110.923 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 110.859 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 5.1 mmt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.805 0.336 . . . . 73.340000000000003 110.874 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.486 HD22 ' CG ' ' A' ' 160' ' ' ASN . 16.3 mt -123.13 -174.46 2.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 74.430000000000007 110.931 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.471 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 2.0 tt0 -103.49 -13.53 16.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.894 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.654 ' HA ' HG21 ' A' ' 216' ' ' ILE . 6.7 tp 58.24 109.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 65.230000000000004 110.928 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.672 ' HA ' HD13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -177.52 -171.87 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.925 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -69.86 -4.35 19.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.865 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.484 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 7.2 mm-40 -102.15 -41.59 6.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 71.540000000000006 110.849 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.486 ' CG ' HD22 ' A' ' 154' ' ' LEU . 95.7 m-20 -88.13 -41.9 12.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 65.150000000000006 110.841 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 182' ' ' PHE . 2.8 p -58.99 -30.34 43.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 73.209999999999994 111.175 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.77 -57.34 12.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 73.109999999999999 110.875 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.34 -44.37 23.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 73.209999999999994 110.868 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.979 HG11 ' HA ' ' A' ' 212' ' ' LEU . 20.6 t -68.04 -45.84 82.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 111.18 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.488 HD23 HD11 ' A' ' 168' ' ' ILE . 48.3 mt -61.03 -24.91 66.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 55.119999999999997 110.891 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -76.81 -2.01 31.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 70.310000000000002 110.893 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -102.62 8.7 39.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 63.100000000000001 110.919 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.746 HD13 ' HA ' ' A' ' 208' ' ' VAL . 0.7 OUTLIER -142.96 -37.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.230000000000004 111.178 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.485 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -48.7 -60.7 4.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.596 0.713 . . . . 75.530000000000001 110.868 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.78 2.86 3.17 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.715 2.276 . . . . 54.439999999999998 112.301 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.657 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -98.3 -21.41 16.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 63.310000000000002 110.923 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.657 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.9 mt -82.51 -45.88 14.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 75.150000000000006 110.87 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -50.1 -20.67 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 64.349999999999994 111.149 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -92.56 42.69 2.67 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.766 -0.73 . . . . 74.5 112.521 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 176.73 -50.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.843 0.354 . . . . 75.530000000000001 111.113 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -178.63 70.58 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 74.129999999999995 112.498 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -57.05 163.13 6.89 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.714 -0.755 . . . . 63.420000000000002 112.496 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -144.84 -102.58 0.37 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.771 -0.728 . . . . 61.439999999999998 112.481 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -157.58 112.53 0.53 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.741 . . . . 74.150000000000006 112.477 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.528 ' CD2' ' C ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -136.62 6.26 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.785 0.326 . . . . 61.340000000000003 110.912 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.479 ' N ' HD22 ' A' ' 180' ' ' LEU . 2.5 tp60 -35.12 109.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 75.200000000000003 110.886 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.668 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 22.7 t80 -43.81 121.51 2.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 70.319999999999993 110.879 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 225' ' ' LEU . 19.4 mt -83.7 -73.25 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 65.209999999999994 110.875 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.6 -170.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 65.019999999999996 110.86 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.672 HD13 ' HA ' ' A' ' 157' ' ' ASN . 7.6 mt -136.22 138.27 47.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 111.13 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -130.25 48.37 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 64.549999999999997 110.872 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.409 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 100.54 -138.67 13.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 72.349999999999994 112.46 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.409 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.6 Cg_endo -69.82 0.35 5.81 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.635 2.223 . . . . 74.099999999999994 112.326 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.84 101.35 8.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 73.439999999999998 111.13 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.91 142.11 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 50.420000000000002 111.134 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.456 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 5.5 mtmt -100.42 146.31 27.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.944 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 98.5 t -159.13 147.48 7.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 73.540000000000006 111.117 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.5 165.34 23.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.892 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.746 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -161.77 71.5 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 52.439999999999998 110.92 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 17.1 p -113.89 176.53 4.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 63.439999999999998 111.081 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.19 -163.22 26.44 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.744 -0.741 . . . . 52.310000000000002 112.486 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -38.21 8.12 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.691 2.26 . . . . 73.340000000000003 112.358 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.754 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -83.26 49.39 1.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 71.519999999999996 111.087 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.746 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -105.93 -62.01 1.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 63.210000000000001 111.115 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.1 m -95.15 28.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 71.219999999999999 111.122 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 29.0 m -99.66 136.7 29.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 64.519999999999996 111.14 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.413 ' C ' HG22 ' A' ' 203' ' ' THR . 5.2 mmt180 -89.96 84.76 6.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 65.239999999999995 110.872 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.474 ' HA ' HD12 ' A' ' 206' ' ' ILE . 0.7 OUTLIER 168.54 -45.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 74.329999999999998 111.135 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.754 HG11 ' HB1' ' A' ' 198' ' ' ALA . 75.4 t -73.12 -55.35 13.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 74.439999999999998 111.155 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -51.14 -34.41 30.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 75.540000000000006 110.895 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.731 HG22 ' HG3' ' A' ' 210' ' ' LYS . 6.1 mt -68.78 -58.63 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 64.439999999999998 111.133 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -39.36 -50.25 2.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.420000000000002 111.106 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.746 ' HA ' HD13 ' A' ' 168' ' ' ILE . 40.5 t -45.34 -84.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 62.439999999999998 111.1 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.6 ' N ' HG12 ' A' ' 208' ' ' VAL . 48.8 m -47.85 -34.57 8.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 62.509999999999998 110.834 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.731 ' HG3' HG22 ' A' ' 206' ' ' ILE . 0.0 OUTLIER -49.88 -40.19 42.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 74.420000000000002 110.889 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -86.35 -38.64 17.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 61.210000000000001 110.874 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.979 ' HA ' HG11 ' A' ' 164' ' ' VAL . 15.1 mt -62.6 -67.65 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 72.219999999999999 110.887 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.1 -31.28 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 71.319999999999993 110.867 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -68.86 -73.24 0.15 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.120000000000005 110.842 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.615 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.7 OUTLIER -51.69 -51.2 57.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 72.0 110.913 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.654 HG21 ' HA ' ' A' ' 156' ' ' LEU . 1.7 pt -105.53 89.79 3.61 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.595 0.712 . . . . 63.329999999999998 111.12 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 215' ' ' LYS . 54.0 Cg_endo -69.72 -16.33 37.67 Favored 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.702 2.268 . . . . 52.450000000000003 112.374 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 47.4 m -58.27 -19.85 37.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 72.129999999999995 110.836 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.468 HG21 ' CG2' ' A' ' 222' ' ' VAL . 3.3 mt -67.99 152.28 9.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 111.121 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.443 ' C ' HG13 ' A' ' 221' ' ' ILE . 0.2 OUTLIER -133.42 -37.92 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 54.5 110.904 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.443 HG13 ' C ' ' A' ' 220' ' ' GLN . 50.9 mt -145.38 96.26 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 111.111 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.468 ' CG2' HG21 ' A' ' 219' ' ' ILE . 58.1 t -74.13 104.77 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 73.129999999999995 111.144 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -88.4 113.98 24.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 74.319999999999993 110.889 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.462 ' HB3' HD23 ' A' ' 194' ' ' LEU . 1.3 mt -110.26 100.82 9.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.277 -0.42 . . . . 70.349999999999994 110.934 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.445 HD13 HD12 ' A' ' 183' ' ' LEU . 4.3 mp -65.76 159.5 25.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 74.010000000000005 110.917 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 52.109999999999999 110.84 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.846 0.355 . . . . 62.119999999999997 110.855 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 6.0 mt -96.15 -171.55 2.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 62.140000000000001 110.96 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -96.46 -9.4 29.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 70.219999999999999 110.903 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.84 HD13 HD12 ' A' ' 216' ' ' ILE . 13.3 tp 51.77 100.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 73.010000000000005 110.915 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -171.07 167.28 7.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 70.340000000000003 110.849 179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.458 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 4.5 mt-10 -37.64 -54.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 61.539999999999999 110.898 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -48.79 -52.5 23.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 72.439999999999998 110.869 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 163' ' ' LYS . 37.0 m-20 -73.87 -70.32 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 74.510000000000005 110.883 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.571 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 13.3 m -33.78 -37.74 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.47 . . . . 62.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.448 ' O ' ' ND2' ' A' ' 166' ' ' ASN . 0.8 OUTLIER -60.08 -50.01 75.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 52.420000000000002 110.879 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.0 OUTLIER -55.83 -54.19 47.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 71.420000000000002 110.895 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.536 HG12 ' HB3' ' A' ' 211' ' ' LYS . 3.5 t -61.86 -41.11 89.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 75.099999999999994 111.144 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 37.4 mt -61.2 -27.78 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 43.539999999999999 110.915 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 162' ' ' GLU . 45.1 m-80 -71.07 -8.67 55.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 74.040000000000006 110.881 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -88.57 -15.73 34.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.49 . . . . 72.209999999999994 110.929 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.473 HG21 ' HA ' ' A' ' 208' ' ' VAL . 1.2 pt -117.72 -33.13 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 73.530000000000001 111.098 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.723 ' HG3' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -50.42 -60.29 5.61 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.596 0.712 . . . . 64.310000000000002 110.849 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.79 -3.42 11.99 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.643 2.229 . . . . 62.240000000000002 112.34 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.762 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -92.29 -16.81 25.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.310000000000002 110.908 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.762 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.8 mt -83.44 -28.94 28.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 72.239999999999995 110.897 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 175' ' ' THR . . . -79.81 -39.29 31.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 111.115 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -36.87 -33.04 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.744 -0.741 . . . . 60.539999999999999 112.485 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.409 ' N ' ' O ' ' A' ' 173' ' ' ALA . 1.7 t -154.42 74.46 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.802 0.334 . . . . 74.219999999999999 111.158 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 146.93 -106.95 0.38 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.739 . . . . 63.020000000000003 112.523 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -145.54 -98.39 0.24 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.786 -0.721 . . . . 73.319999999999993 112.483 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 129.85 123.12 2.5 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 74.049999999999997 112.542 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -163.45 107.37 0.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 71.340000000000003 112.504 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.723 HD21 ' HG3' ' A' ' 169' ' ' ARG . 4.3 pp -144.11 -40.16 0.28 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.776 0.322 . . . . 61.340000000000003 110.93 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.591 ' N ' HD12 ' A' ' 180' ' ' LEU . 13.5 tp60 34.24 90.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 75.150000000000006 110.923 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.571 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 31.5 t80 -34.49 113.76 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 74.0 110.919 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.439 HD12 ' HB3' ' A' ' 191' ' ' LYS . 14.2 mt -66.78 -79.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 110.923 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 18.5 ptp -171.88 -174.59 1.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 62.039999999999999 110.852 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.4 mt -130.47 143.55 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 74.340000000000003 111.122 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.88 39.19 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 73.310000000000002 110.931 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.411 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 112.7 -139.3 15.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.687 -0.768 . . . . 72.140000000000001 112.503 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.8 Cg_endo -69.73 0.27 5.87 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.668 2.245 . . . . 64.140000000000001 112.347 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.2 mp -116.78 127.72 74.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 62.530000000000001 111.122 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.7 t -107.78 145.25 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 51.32 111.095 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.439 ' HB3' HD12 ' A' ' 183' ' ' LEU . 22.2 mtmt -112.81 145.49 40.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 75.230000000000004 110.869 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.481 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 21.7 t -158.23 154.12 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 111.089 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.568 ' O ' HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -91.67 169.84 10.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.847 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.568 HD22 ' O ' ' A' ' 193' ' ' ARG . 0.2 OUTLIER -163.33 92.31 0.73 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 63.140000000000001 110.929 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.13 167.92 19.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.457 . . . . 73.099999999999994 111.134 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 100.19 -160.96 19.18 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.728 -0.749 . . . . 74.430000000000007 112.473 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -0.94 7.65 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.665 2.243 . . . . 70.209999999999994 112.33 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.545 ' O ' HG11 ' A' ' 204' ' ' VAL . . . -137.88 50.14 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 50.229999999999997 111.103 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.541 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -74.88 -27.32 60.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 63.509999999999998 111.09 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 200' ' ' VAL . 1.1 p 166.14 92.39 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 74.530000000000001 111.132 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 8.5 p -116.76 -36.94 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 111.148 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.53 ' C ' HD12 ' A' ' 206' ' ' ILE . 0.6 OUTLIER 162.96 -85.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 70.120000000000005 110.899 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 37.0 p -59.63 -25.7 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 70.019999999999996 111.161 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.667 ' O ' HG23 ' A' ' 208' ' ' VAL . 53.9 t -58.23 -56.21 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 64.340000000000003 111.141 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.31 -32.03 60.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 54.439999999999998 110.874 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.537 HG22 ' HE3' ' A' ' 210' ' ' LYS . 36.3 mt -64.01 -56.78 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 111.186 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -54.01 -32.45 54.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 72.409999999999997 111.12 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 204' ' ' VAL . 55.3 t -63.12 -86.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 54.43 111.166 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.652 ' HA ' HD23 ' A' ' 212' ' ' LEU . 24.5 m -33.94 -45.4 0.19 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 61.119999999999997 110.844 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.537 ' HE3' HG22 ' A' ' 206' ' ' ILE . 3.2 mtmt -44.46 -50.3 9.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 72.109999999999999 110.906 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.536 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -64.93 -66.73 0.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 61.219999999999999 110.889 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.82 ' H ' HD22 ' A' ' 212' ' ' LEU . 1.0 OUTLIER -37.4 -67.36 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.912 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -29.54 3.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 74.329999999999998 110.835 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.9 OUTLIER -68.25 -75.59 0.1 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 64.310000000000002 110.938 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -56.63 -52.88 63.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 60.109999999999999 110.878 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.84 HD12 HD13 ' A' ' 156' ' ' LEU . 5.6 pt -107.16 84.46 1.68 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.661 0.743 . . . . 61.310000000000002 111.152 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -11.3 30.53 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.665 2.243 . . . . 50.509999999999998 112.32 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 45.5 t -58.26 -22.09 51.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 72.430000000000007 110.875 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.7 mt -57.7 155.51 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 70.430000000000007 111.118 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.448 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 1.1 tt0 -132.48 -34.57 1.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.474 . . . . 71.0 110.875 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 27.9 mm -149.25 106.56 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.245 -0.434 . . . . 61.439999999999998 111.157 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.473 HG12 ' HG ' ' A' ' 224' ' ' LEU . 95.1 t -74.71 110.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 70.040000000000006 111.161 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -96.41 104.24 16.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 71.310000000000002 110.919 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.473 ' HG ' HG12 ' A' ' 222' ' ' VAL . 1.1 mt -105.54 115.39 30.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.895 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.0 mp -98.66 159.83 14.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 62.340000000000003 110.953 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 72.530000000000001 110.833 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.798 0.332 . . . . 70.299999999999997 110.876 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.694 HD22 ' ND2' ' A' ' 160' ' ' ASN . 10.4 mt -159.36 -177.2 6.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 75.099999999999994 110.911 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -102.54 -1.29 30.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.129999999999995 110.887 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.633 HD13 HD12 ' A' ' 216' ' ' ILE . 12.4 tp 60.1 108.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 65.040000000000006 110.877 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.873 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -168.22 -178.98 3.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.891 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -60.11 -49.07 79.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 74.099999999999994 110.899 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -59.58 -32.53 70.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 62.020000000000003 110.901 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.694 ' ND2' HD22 ' A' ' 154' ' ' LEU . 77.4 m-20 -83.48 -70.28 0.57 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.914 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 157' ' ' ASN . 29.5 m -35.63 -30.93 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 65.140000000000001 111.084 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 160' ' ' ASN . 2.8 mt-10 -55.31 -58.85 6.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 110.868 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.0 -51.06 56.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 52.350000000000001 110.903 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.74 HG11 ' HA ' ' A' ' 212' ' ' LEU . 1.4 t -65.25 -31.03 52.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 63.229999999999997 111.121 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 165' ' ' LEU . 14.1 mt -72.6 -32.14 65.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.48 . . . . 71.340000000000003 110.895 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.474 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 60.7 m-20 -67.39 -14.29 62.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 63.219999999999999 110.921 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -89.53 4.98 47.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 71.400000000000006 110.871 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 169' ' ' ARG . 0.3 OUTLIER -139.91 -55.48 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 52.409999999999997 111.148 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -35.34 -58.89 0.73 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.709 . . . . 73.25 110.879 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.69 -27.87 26.26 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.281 . . . . 64.540000000000006 112.366 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.622 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -73.08 -16.03 61.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 71.319999999999993 110.91 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.6 mt -75.61 -46.37 32.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 72.030000000000001 110.909 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.439 ' O ' ' C ' ' A' ' 174' ' ' GLY . . . -58.03 -42.56 85.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 45.43 111.101 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 173' ' ' ALA . . . -34.82 -78.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.748 -0.739 . . . . 63.299999999999997 112.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 10.1 t -94.97 40.95 1.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.818 0.342 . . . . 73.099999999999994 111.152 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . 96.67 94.93 1.84 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.765 -0.731 . . . . 73.400000000000006 112.542 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 172' ' ' LEU . . . -82.98 171.48 50.74 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 64.340000000000003 112.47 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -126.22 -87.36 0.64 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.721 -0.752 . . . . 22.440000000000001 112.468 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 157.63 109.72 0.29 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.757 -0.735 . . . . 55.229999999999997 112.453 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 192' ' ' VAL . 2.9 pp -112.1 -34.15 6.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.32 . . . . 75.040000000000006 110.879 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.5 OUTLIER 33.85 89.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 75.420000000000002 110.919 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 28.6 t80 -38.52 107.72 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 74.0 110.881 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 191' ' ' LYS . 14.4 mt -66.22 -80.46 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 75.420000000000002 110.948 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -166.08 -168.93 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 75.299999999999997 110.896 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 157' ' ' ASN . 7.6 mt -135.53 124.79 40.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 75.439999999999998 111.166 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.76 72.52 1.22 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.221 -0.445 . . . . 73.310000000000002 110.887 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.421 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 82.87 -140.71 20.39 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.716 -0.754 . . . . 72.519999999999996 112.488 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.421 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 54.0 Cg_endo -69.75 0.01 6.25 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.66 2.24 . . . . 73.019999999999996 112.36 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 25.5 mt -117.76 136.16 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 71.120000000000005 111.099 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.6 p -119.51 130.86 73.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 52.119999999999997 111.131 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.506 ' HB3' HD12 ' A' ' 183' ' ' LEU . 14.5 mtmt -90.54 142.58 27.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 52.340000000000003 110.946 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 180' ' ' LEU . 55.7 t -153.67 151.43 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 75.430000000000007 111.156 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.866 ' O ' HD22 ' A' ' 194' ' ' LEU . 0.2 OUTLIER -86.73 163.55 17.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 74.099999999999994 110.914 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 193' ' ' ARG . 0.3 OUTLIER -158.21 79.63 0.83 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.459 . . . . 75.230000000000004 110.944 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 1.2 p -113.32 171.34 7.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.483 . . . . 61.240000000000002 111.115 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 86.83 -169.56 40.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.707 -0.759 . . . . 64.120000000000005 112.498 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -19.29 36.38 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.69 2.26 . . . . 65.519999999999996 112.34 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.916 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -97.83 42.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 64.25 111.14 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -96.14 92.03 6.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 62.32 111.089 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.457 HG13 ' HE ' ' A' ' 205' ' ' ARG . 76.8 t 45.06 90.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 62.240000000000002 111.151 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 202' ' ' ARG . 43.5 t -125.66 -82.19 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 72.439999999999998 111.127 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.77 ' O ' HG23 ' A' ' 203' ' ' THR . 0.0 OUTLIER -176.21 47.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.439999999999998 110.869 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 202' ' ' ARG . 0.7 OUTLIER -174.57 -60.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 72.129999999999995 111.13 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.916 HG21 ' HB1' ' A' ' 198' ' ' ALA . 93.4 t -58.75 -70.89 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 43.229999999999997 111.136 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.457 ' HE ' HG13 ' A' ' 200' ' ' VAL . 0.0 OUTLIER -35.33 -44.22 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 72.530000000000001 110.872 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.444 HD12 ' N ' ' A' ' 203' ' ' THR . 2.9 mt -54.11 -50.42 54.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.114 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -62.71 -32.86 74.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 74.239999999999995 111.1 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.678 ' C ' HD23 ' A' ' 212' ' ' LEU . 40.8 t -80.38 0.99 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 72.439999999999998 111.164 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 32.6 t -134.57 7.38 3.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 75.329999999999998 110.897 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -111.59 -40.64 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.506 . . . . 74.409999999999997 110.887 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -80.64 -27.32 37.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 53.009999999999998 110.878 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.74 ' HA ' HG11 ' A' ' 164' ' ' VAL . 2.4 mm? -69.08 -71.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 72.340000000000003 110.894 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -45.18 -21.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.869 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.404 ' N ' ' C ' ' A' ' 212' ' ' LEU . 1.2 tp10 -70.77 -66.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.224 -0.443 . . . . 74.5 110.867 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.491 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.4 OUTLIER -67.22 -44.3 79.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.120000000000005 110.926 179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.633 HD12 HD13 ' A' ' 156' ' ' LEU . 4.8 pt -111.57 89.18 10.35 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.597 0.713 . . . . 73.109999999999999 111.101 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -20.68 34.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 71.420000000000002 112.354 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.06 -22.88 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 70.109999999999999 110.815 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.6 mt -58.51 148.14 6.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 73.120000000000005 111.156 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.465 ' O ' HD13 ' A' ' 221' ' ' ILE . 0.9 OUTLIER -129.44 -39.18 1.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 74.420000000000002 110.92 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.465 HD13 ' O ' ' A' ' 220' ' ' GLN . 27.3 mm -150.67 114.43 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 64.530000000000001 111.087 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 85.6 t -86.81 121.49 37.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.019999999999996 111.103 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -108.5 122.87 47.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.340000000000003 110.961 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.752 ' HB3' HD23 ' A' ' 194' ' ' LEU . 24.8 mt -115.27 102.2 9.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.519999999999996 110.921 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.2 mt -72.71 173.35 9.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 72.400000000000006 110.897 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 11.6 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 64.040000000000006 110.896 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.456 ' HB2' ' CG ' ' A' ' 217' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.764 0.316 . . . . 75.340000000000003 110.922 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 215' ' ' LYS . 0.5 OUTLIER -144.85 -174.07 4.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 61.210000000000001 110.892 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -97.77 -13.2 21.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 62.409999999999997 110.884 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.694 ' CD1' HD12 ' A' ' 216' ' ' ILE . 5.3 tp 58.56 113.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.129999999999995 110.915 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.753 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 174.7 166.43 0.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 63.109999999999999 110.934 179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.36 -26.32 3.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 73.239999999999995 110.853 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.417 ' HG2' ' N ' ' A' ' 160' ' ' ASN . 11.5 pm0 -78.58 -33.28 47.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 62.539999999999999 110.886 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.459 ' ND2' HD21 ' A' ' 157' ' ' ASN . 24.9 m-20 -100.87 -60.86 1.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 75.519999999999996 110.912 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 157' ' ' ASN . 9.3 p -42.18 -23.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 72.239999999999995 111.122 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.596 ' HA ' HD12 ' A' ' 165' ' ' LEU . 4.3 mt-10 -64.67 -55.01 22.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 50.119999999999997 110.891 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -40.78 45.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.093 -0.503 . . . . 74.540000000000006 110.889 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.662 HG11 ' HA ' ' A' ' 212' ' ' LEU . 25.2 t -71.38 -33.41 50.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 54.130000000000003 111.144 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.596 HD12 ' HA ' ' A' ' 162' ' ' GLU . 9.1 mt -71.02 -28.78 64.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 70.209999999999994 110.931 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.486 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 29.4 m-80 -71.02 -8.21 51.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 62.5 110.898 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.94 -3.88 50.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 74.409999999999997 110.849 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.88 -36.9 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 72.239999999999995 111.127 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.518 ' NH2' ' NE2' ' A' ' 181' ' ' GLN . 0.0 OUTLIER -52.99 -59.93 7.86 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 73.120000000000005 110.876 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.7 Cg_endo -69.79 -20.79 34.22 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.717 2.278 . . . . 74.109999999999999 112.331 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.661 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -69.2 -19.77 63.98 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 73.430000000000007 110.927 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.661 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.8 mt -79.51 -55.36 5.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 65.319999999999993 110.935 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -43.43 -28.66 0.37 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 53.100000000000001 111.086 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.57 -39.38 93.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.734 . . . . 43.310000000000002 112.504 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 43.3 p -107.18 1.74 24.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.833 0.349 . . . . 71.010000000000005 111.185 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 149.38 -56.09 0.48 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.734 -0.746 . . . . 63.219999999999999 112.46 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 110.5 173.78 20.28 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.711 -0.757 . . . . 61.149999999999999 112.476 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -161.04 -111.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 43.340000000000003 112.532 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -178.73 119.83 0.67 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.757 -0.735 . . . . 73.099999999999994 112.506 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.499 HD21 ' HA ' ' A' ' 169' ' ' ARG . 0.5 OUTLIER -149.55 11.99 0.79 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.754 0.311 . . . . 64.219999999999999 110.91 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.518 ' NE2' ' NH2' ' A' ' 169' ' ' ARG . 6.0 tp-100 -35.02 104.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 53.310000000000002 110.907 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.731 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 22.0 t80 -34.69 125.2 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.310000000000002 110.858 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 89.8 mt -86.66 -74.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 73.109999999999999 110.919 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 22.8 ptp -165.11 -173.66 2.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 74.049999999999997 110.895 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.426 HD13 ' HA ' ' A' ' 157' ' ' ASN . 5.9 mt -130.84 136.94 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 63.420000000000002 111.163 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 7.3 mttt -136.15 71.98 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 70.349999999999994 110.855 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.404 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 81.89 -145.3 24.61 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.777 -0.725 . . . . 73.219999999999999 112.527 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.516 ' HG2' HD12 ' A' ' 189' ' ' ILE . 53.9 Cg_endo -69.76 3.27 2.87 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 72.340000000000003 112.347 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.516 HD12 ' HG2' ' A' ' 188' ' ' PRO . 4.2 mp -122.83 112.09 32.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 70.140000000000001 111.156 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.409 HG21 ' HE1' ' A' ' 182' ' ' PHE . 7.4 p -92.16 142.1 13.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 61.219999999999999 111.098 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -99.87 141.56 32.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 70.239999999999995 110.933 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.7 t -154.51 147.87 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 71.200000000000003 111.122 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.779 ' O ' HD22 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -87.93 166.82 14.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 62.530000000000001 110.869 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.78 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -159.16 96.63 1.33 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 72.109999999999999 110.938 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 15.7 p -125.5 179.94 4.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 63.299999999999997 111.157 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.96 -177.91 54.07 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 51.130000000000003 112.517 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -20.53 34.79 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.732 2.288 . . . . 74.430000000000007 112.349 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -78.24 -24.24 47.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 33.420000000000002 111.101 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.78 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -49.94 -63.03 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 74.150000000000006 111.145 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 200' ' ' VAL . 1.0 OUTLIER -119.99 96.48 4.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.116 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 201' ' ' VAL . 10.2 p -162.85 22.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 111.092 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.7 OUTLIER 59.46 152.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 110.862 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.427 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 2.5 m 81.15 -68.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.0 111.151 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 205' ' ' ARG . 92.7 t -44.39 -67.21 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 63.020000000000003 111.158 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 204' ' ' VAL . 6.8 ptm180 -36.72 -36.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 71.150000000000006 110.871 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.555 HG22 ' CD ' ' A' ' 210' ' ' LYS . 3.8 mp -77.26 -51.17 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 72.329999999999998 111.136 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -51.94 -16.43 0.73 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 65.420000000000002 111.152 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 86.3 t -89.51 -52.52 10.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 54.509999999999998 111.152 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.3 t -84.14 24.48 0.94 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.200000000000003 110.808 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.555 ' CD ' HG22 ' A' ' 206' ' ' ILE . 0.3 OUTLIER -111.24 -40.21 4.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.162 -0.472 . . . . 74.099999999999994 110.916 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.23 -31.73 33.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 110.882 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.662 ' HA ' HG11 ' A' ' 164' ' ' VAL . 6.6 mt -69.54 -65.21 0.74 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 62.32 110.925 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.69 -28.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 70.430000000000007 110.921 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -75.51 -68.19 0.59 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 64.430000000000007 110.917 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.456 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.7 OUTLIER -56.32 -56.61 18.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 75.519999999999996 110.896 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.694 HD12 ' CD1' ' A' ' 156' ' ' LEU . 3.5 pt -104.77 92.22 4.93 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.654 0.74 . . . . 72.340000000000003 111.095 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.456 ' CG ' ' HB2' ' A' ' 153' ' ' MET . 53.5 Cg_endo -69.81 -22.53 31.72 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.655 2.237 . . . . 62.350000000000001 112.359 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . 0.407 ' HB3' HD22 ' A' ' 156' ' ' LEU . 0.3 OUTLIER -50.22 -20.45 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 110.842 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.6 mt -62.54 154.02 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 75.420000000000002 111.109 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.443 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -136.29 -37.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.137 -0.483 . . . . 63.109999999999999 110.928 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.406 ' O ' HG23 ' A' ' 189' ' ' ILE . 29.6 mm -152.09 105.31 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 74.200000000000003 111.151 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 74.3 t -81.29 118.77 29.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 52.439999999999998 111.124 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -101.91 108.03 19.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 72.310000000000002 110.913 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.766 ' HB3' HD23 ' A' ' 194' ' ' LEU . 3.3 mt -96.65 102.35 14.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 110.918 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 226' ' ' SER . 9.1 mp -70.94 173.42 7.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 64.200000000000003 110.904 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.439 ' C ' ' O ' ' A' ' 225' ' ' LEU . 44.4 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.219999999999999 110.842 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 49.2 mtt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.85 0.357 . . . . 73.329999999999998 110.916 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 154' ' ' LEU . 10.5 mt -119.99 -174.71 2.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 72.409999999999997 110.898 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -104.87 -7.99 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 110.858 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.841 HD13 HD12 ' A' ' 216' ' ' ILE . 6.8 tp 50.89 98.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 110.887 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.681 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -166.17 169.85 13.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.519999999999996 110.884 179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.466 ' HA ' ' CG2' ' A' ' 161' ' ' VAL . 3.7 mt-10 -44.53 -29.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 54.140000000000001 110.876 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.459 ' CG ' ' OD1' ' A' ' 157' ' ' ASN . 3.7 pt-20 -70.66 -42.88 70.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 54.420000000000002 110.884 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 162' ' ' GLU . 96.1 m-20 -86.53 -63.5 1.3 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 63.130000000000003 110.864 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.758 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 33.8 m -37.51 -30.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 64.209999999999994 111.123 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.449 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.4 mt-10 -64.85 -51.93 59.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 74.200000000000003 110.883 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -58.57 -50.43 73.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 75.340000000000003 110.904 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.422 HG13 ' HD3' ' A' ' 215' ' ' LYS . 1.7 t -62.24 -30.2 48.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 111.085 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.575 HD11 ' CD1' ' A' ' 182' ' ' PHE . 18.2 mt -73.63 -28.48 61.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 75.099999999999994 110.926 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.487 ' O ' ' CD ' ' A' ' 170' ' ' PRO . 37.9 m-80 -71.38 -11.97 61.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 73.219999999999999 110.861 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -83.22 -18.33 39.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 110.938 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.494 HD11 HD23 ' A' ' 165' ' ' LEU . 2.9 pt -115.99 -24.54 3.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 52.149999999999999 111.163 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.58 ' HG3' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -55.97 -60.43 8.82 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.593 0.711 . . . . 73.510000000000005 110.908 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.487 ' CD ' ' O ' ' A' ' 166' ' ' ASN . 53.7 Cg_endo -69.81 -2.01 9.49 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.705 2.27 . . . . 53.240000000000002 112.361 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.717 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -88.94 -42.89 11.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 71.140000000000001 110.899 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.717 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.4 mt -57.05 -45.79 82.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 63.119999999999997 110.929 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -45.43 107.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 53.049999999999997 111.134 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 133.5 -50.38 0.88 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.703 -0.76 . . . . 23.43 112.487 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 8.9 t -133.23 22.34 4.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 52.030000000000001 111.092 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -153.6 -79.46 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.738 -0.744 . . . . 53.109999999999999 112.456 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 56.22 15.82 12.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.778 -0.725 . . . . 71.109999999999999 112.477 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -57.34 -93.86 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.687 -0.768 . . . . 64.140000000000001 112.507 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.4 ' O ' ' O ' ' A' ' 193' ' ' ARG . . . 175.03 123.92 0.77 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 60.100000000000001 112.442 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.699 ' C ' HD12 ' A' ' 180' ' ' LEU . 2.7 pp -135.27 -0.22 2.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 70.340000000000003 110.941 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -30.73 117.62 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.510000000000005 110.873 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.758 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 19.3 t80 -55.63 129.62 39.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 70.329999999999998 110.856 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 43.0 mt -89.67 -74.21 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 72.200000000000003 110.889 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 16.6 ptp -167.45 -170.77 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 63.530000000000001 110.844 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 157' ' ' ASN . 35.0 mt -138.36 133.46 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 111.097 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 22.4 mmtt -130.91 59.8 1.67 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 73.129999999999995 110.925 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 99.12 -146.74 18.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.725 -0.75 . . . . 71.209999999999994 112.514 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 3.04 3.0 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.705 2.27 . . . . 70.209999999999994 112.335 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.4 mt -115.81 118.34 58.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 70.349999999999994 111.155 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 66.8 t -91.27 139.73 17.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 111.083 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.473 ' O ' HG23 ' A' ' 192' ' ' VAL . 7.8 mtmt -107.49 145.83 32.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 61.299999999999997 110.901 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.492 HG12 ' N ' ' A' ' 193' ' ' ARG . 70.6 t -158.73 158.18 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 61.530000000000001 111.112 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.541 ' O ' HD22 ' A' ' 194' ' ' LEU . 5.8 ttt180 -99.5 137.81 37.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.120000000000005 110.903 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.541 HD22 ' O ' ' A' ' 193' ' ' ARG . 1.8 mm? -130.46 84.47 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 71.230000000000004 110.926 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 196' ' ' GLY . 0.1 OUTLIER -112.32 170.09 8.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.319999999999993 111.145 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.42 ' N ' ' OG1' ' A' ' 195' ' ' THR . . . 84.06 -163.25 39.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 61.149999999999999 112.462 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 -35.45 12.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.686 2.258 . . . . 64.019999999999996 112.338 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.724 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -84.59 32.29 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 71.340000000000003 111.063 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.48 ' O ' HD12 ' A' ' 194' ' ' LEU . . . -72.19 -52.2 17.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 61.420000000000002 111.123 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.579 ' O ' HG13 ' A' ' 200' ' ' VAL . 7.1 p -164.66 69.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 70.120000000000005 111.111 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 202' ' ' ARG . 56.1 t -88.83 -83.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 74.340000000000003 111.1 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.504 ' N ' HG12 ' A' ' 201' ' ' VAL . 0.0 OUTLIER 172.08 41.8 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 75.409999999999997 110.9 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.492 ' N ' HD12 ' A' ' 206' ' ' ILE . 23.1 m -166.83 -57.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 63.329999999999998 111.186 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.724 HG11 ' HB1' ' A' ' 198' ' ' ALA . 31.9 t -60.11 -63.96 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 71.030000000000001 111.127 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -44.56 -29.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 71.430000000000007 110.855 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.492 HD12 ' N ' ' A' ' 203' ' ' THR . 3.0 mt -79.8 -45.25 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 71.030000000000001 111.149 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.28 -15.07 31.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 111.113 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 209' ' ' SER . 54.1 t -80.25 -85.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 70.310000000000002 111.143 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.593 ' HA ' HD23 ' A' ' 212' ' ' LEU . 1.6 t -33.43 -41.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.462 . . . . 72.409999999999997 110.854 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.44 -54.7 7.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 52.210000000000001 110.896 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -56.31 19.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 75.040000000000006 110.862 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.695 ' H ' HD22 ' A' ' 212' ' ' LEU . 1.6 mm? -45.7 -74.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 70.129999999999995 110.881 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 212' ' ' LEU . 3.9 ttp180 -37.39 -52.49 1.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 74.049999999999997 110.874 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -46.36 -92.08 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.857 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.422 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -38.26 -54.26 1.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 63.229999999999997 110.883 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.841 HD12 HD13 ' A' ' 156' ' ' LEU . 11.2 pt -106.17 88.19 2.98 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.602 0.715 . . . . 74.430000000000007 111.122 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -23.21 31.1 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.648 2.232 . . . . 74.329999999999998 112.376 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 33.7 t -45.63 -28.54 1.0 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 72.549999999999997 110.862 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -55.65 157.15 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.131 -0.486 . . . . 75.420000000000002 111.1 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.498 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.5 OUTLIER -141.68 -37.84 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 62.520000000000003 110.964 179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 220' ' ' GLN . 11.2 mt -140.93 85.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 54.140000000000001 111.128 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 1.3 p -66.04 115.9 4.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.519999999999996 111.094 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.491 ' O ' HD23 ' A' ' 224' ' ' LEU . 8.2 mm-40 -95.76 152.77 18.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 34.130000000000003 110.889 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 223' ' ' GLN . 20.4 mt -139.7 100.01 3.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 74.150000000000006 110.9 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 225' ' ' LEU . 0.3 OUTLIER -57.56 177.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 72.140000000000001 110.926 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 61.020000000000003 110.857 -179.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 14.1 mtt . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.824 0.345 . . . . 63.219999999999999 110.861 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' A' ' 160' ' ' ASN . 7.0 mp -123.52 -174.5 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 71.450000000000003 110.905 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.91 -18.05 14.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 70.519999999999996 110.911 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.751 HD13 HD12 ' A' ' 216' ' ' ILE . 6.6 tp 61.92 106.9 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 73.510000000000005 110.977 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.731 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -176.25 166.76 2.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 55.119999999999997 110.853 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -42.22 -38.97 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 70.030000000000001 110.834 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -65.18 -56.26 13.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 64.25 110.902 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.578 ' HB3' HD23 ' A' ' 154' ' ' LEU . 53.1 m-20 -76.52 -61.87 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 72.129999999999995 110.901 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 157' ' ' ASN . 6.1 p -38.69 -28.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 54.299999999999997 111.113 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 160' ' ' ASN . 2.4 mm-40 -59.52 -59.96 4.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 62.299999999999997 110.843 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -36.71 23.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 74.140000000000001 110.894 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.899 HG11 ' HA ' ' A' ' 212' ' ' LEU . 41.9 t -70.64 -45.85 72.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 54.140000000000001 111.121 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.582 HD22 HD12 ' A' ' 180' ' ' LEU . 75.7 mt -61.09 -24.08 65.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 73.319999999999993 110.932 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.41 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 24.3 m-80 -74.57 -5.86 45.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 63.399999999999999 110.894 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.09 -8.06 40.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 64.200000000000003 110.85 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.425 HD11 HD23 ' A' ' 165' ' ' LEU . 1.3 pt -123.22 -43.68 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 75.319999999999993 111.14 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -44.22 -59.95 3.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.576 0.703 . . . . 62.509999999999998 110.914 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.79 -30.48 22.09 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 75.519999999999996 112.373 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.616 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -63.76 -14.51 53.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 73.030000000000001 110.948 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.616 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.5 mt -79.56 -55.62 4.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 74.120000000000005 110.917 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.51 -54.24 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 111.127 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -40.71 -60.33 2.15 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.747 . . . . 75.030000000000001 112.452 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 82.8 p -64.92 -50.38 66.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.837 0.351 . . . . 75.209999999999994 111.164 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -169.54 -40.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 52.520000000000003 112.455 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 127.44 164.44 11.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 71.400000000000006 112.509 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -170.21 -178.74 41.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.757 -0.735 . . . . 74.430000000000007 112.524 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -140.42 99.98 0.26 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 71.019999999999996 112.494 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.582 HD12 HD22 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -118.31 25.84 10.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.751 0.31 . . . . 74.519999999999996 110.89 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -35.77 119.14 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 110.944 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.603 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 19.5 t80 -48.5 116.2 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 71.420000000000002 110.862 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 11.3 mt -73.26 -73.2 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 73.540000000000006 110.905 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 14.1 ptp -171.32 -171.05 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 110.912 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -131.78 131.12 62.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 73.140000000000001 111.132 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -135.43 74.32 1.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 61.219999999999999 110.931 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 81.33 -144.77 24.84 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 63.43 112.446 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 3.52 2.74 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.689 2.259 . . . . 72.400000000000006 112.314 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 44.5 mt -109.63 149.72 12.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 52.219999999999999 111.128 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 56.7 t -126.39 135.33 64.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 70.319999999999993 111.146 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt -105.0 133.95 48.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 71.540000000000006 110.878 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 180' ' ' LEU . 66.3 t -153.41 129.63 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 53.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 179.42 3.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 72.420000000000002 110.833 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.25 67.92 0.11 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 71.239999999999995 110.919 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 73.4 p -90.42 -179.8 5.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 64.310000000000002 111.187 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 91.76 173.64 42.7 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.701 -0.762 . . . . 72.049999999999997 112.482 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -16.84 37.52 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.25 . . . . 45.039999999999999 112.345 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -75.46 -18.92 59.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 53.520000000000003 111.104 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -56.62 -45.63 81.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 111.107 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 30.9 m -92.0 49.3 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 61.530000000000001 111.159 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 83.6 t -138.81 125.57 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 75.120000000000005 111.164 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -55.79 158.05 3.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 73.109999999999999 110.879 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.428 ' CB ' ' O ' ' A' ' 202' ' ' ARG . 1.9 m 79.73 -55.6 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.479 . . . . 74.310000000000002 111.191 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.606 ' O ' HG23 ' A' ' 208' ' ' VAL . 76.1 t -38.88 -60.11 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.049999999999997 111.121 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.86 -43.97 39.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 74.230000000000004 110.87 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.53 HG22 ' HG3' ' A' ' 210' ' ' LYS . 70.1 mt -64.64 -53.77 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 71.019999999999996 111.168 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -44.53 -27.74 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 75.239999999999995 111.12 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 204' ' ' VAL . 2.6 t -73.05 -56.47 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 74.299999999999997 111.162 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.683 ' HB3' HG21 ' A' ' 222' ' ' VAL . 0.7 OUTLIER -83.31 20.39 1.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.46 . . . . 73.310000000000002 110.85 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.53 ' HG3' HG22 ' A' ' 206' ' ' ILE . 3.7 mtpp -103.66 -40.26 6.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.088 -0.506 . . . . 75.530000000000001 110.895 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.38 -34.12 25.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 65.519999999999996 110.889 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.899 ' HA ' HG11 ' A' ' 164' ' ' VAL . 7.4 mt -68.32 -67.3 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 75.129999999999995 110.898 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -45.59 -24.16 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 60.539999999999999 110.904 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -78.7 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.904 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.423 ' O ' HD13 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -46.29 -51.43 14.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 72.510000000000005 110.931 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.751 HD12 HD13 ' A' ' 156' ' ' LEU . 2.2 pt -107.02 91.96 7.09 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.593 0.711 . . . . 72.430000000000007 111.141 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 216' ' ' ILE . 53.6 Cg_endo -69.76 -17.64 37.46 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.667 2.245 . . . . 74.129999999999995 112.329 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 5.6 t -54.46 -28.44 44.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 34.299999999999997 110.833 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.8 mt -57.64 153.12 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 72.329999999999998 111.127 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.75 ' HB3' HD12 ' A' ' 221' ' ' ILE . 2.0 mt-30 -133.12 -37.38 0.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 73.219999999999999 110.907 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 220' ' ' GLN . 3.8 mp -145.74 102.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 72.430000000000007 111.088 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.683 HG21 ' HB3' ' A' ' 209' ' ' SER . 0.4 OUTLIER -70.72 107.58 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 71.109999999999999 111.113 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -93.2 94.51 8.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.889 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.9 117.22 24.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 73.439999999999998 110.916 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -80.68 170.93 15.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 71.430000000000007 110.889 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 73.430000000000007 110.893 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.821 0.343 . . . . 63.020000000000003 110.869 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.65 HD12 HG23 ' A' ' 216' ' ' ILE . 28.6 mt -88.14 176.92 7.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.946 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -110.69 -8.75 14.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 63.200000000000003 110.907 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.708 HD13 HD12 ' A' ' 216' ' ' ILE . 26.8 tp 58.19 97.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 64.409999999999997 110.9 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.639 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.0 OUTLIER -159.06 164.27 35.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.922 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -46.58 -21.94 0.23 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.510000000000005 110.924 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.28 -41.14 18.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 74.519999999999996 110.899 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -79.15 -57.13 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.094 -0.503 . . . . 74.400000000000006 110.873 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.863 HG21 ' CZ ' ' A' ' 182' ' ' PHE . 29.5 m -45.96 -26.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 64.230000000000004 111.093 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -61.08 -59.44 5.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.91 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.45 -42.33 42.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 72.329999999999998 110.907 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.887 HG11 ' HA ' ' A' ' 212' ' ' LEU . 2.0 t -70.6 -42.1 77.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 65.329999999999998 111.144 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.571 HD11 ' CD1' ' A' ' 182' ' ' PHE . 31.0 mt -61.86 -32.93 73.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 74.040000000000006 110.948 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -69.95 -3.66 17.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.420000000000002 110.887 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -94.43 -2.01 52.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.875 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.75 ' CD1' HG13 ' A' ' 208' ' ' VAL . 4.1 pt -136.59 -35.67 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 72.219999999999999 111.159 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.489 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -45.95 -60.02 4.03 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.535 0.683 . . . . 75.230000000000004 110.836 179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.0 Cg_endo -69.73 3.29 2.84 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.713 2.276 . . . . 63.340000000000003 112.349 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.614 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.4 OUTLIER -102.39 -23.56 13.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 70.409999999999997 110.927 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.614 HD23 ' CD2' ' A' ' 171' ' ' TYR . 2.5 mt -84.31 -36.95 22.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 65.209999999999994 110.889 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.27 -13.37 27.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 70.310000000000002 111.052 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.17 -40.96 8.25 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.71 -0.757 . . . . 74.120000000000005 112.425 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 15.0 t -105.16 4.49 31.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 75.439999999999998 111.108 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -179.24 -101.5 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 44.399999999999999 112.469 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.31 69.75 0.4 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.716 -0.754 . . . . 42.539999999999999 112.496 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.88 -123.31 1.89 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 53.229999999999997 112.477 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -138.14 112.47 0.89 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 64.409999999999997 112.455 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.857 ' H ' HD22 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -122.11 6.65 9.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.729 0.299 . . . . 74.329999999999998 110.933 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.413 ' O ' ' C ' ' A' ' 182' ' ' PHE . 0.0 OUTLIER -37.94 96.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 64.219999999999999 110.893 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.863 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 17.6 t80 -37.49 119.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.425 . . . . 73.450000000000003 110.887 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.0 mt -77.54 -73.41 0.31 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 61.350000000000001 110.905 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 15.0 ptp -174.15 -174.36 0.89 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 61.409999999999997 110.891 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 157' ' ' ASN . 11.3 mt -133.33 137.01 54.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 54.350000000000001 111.178 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -129.8 57.05 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 72.120000000000005 110.862 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 91.72 -135.24 12.67 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 41.219999999999999 112.451 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.634 ' O ' HD13 ' A' ' 189' ' ' ILE . 53.7 Cg_endo -69.66 2.4 3.52 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.716 2.277 . . . . 72.140000000000001 112.342 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.872 HD12 ' HB ' ' A' ' 221' ' ' ILE . 26.9 mm -125.41 124.46 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.449 . . . . 63.030000000000001 111.13 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 6.4 p -109.97 137.6 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 64.299999999999997 111.17 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 15.0 mtmt -101.16 146.46 27.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 72.129999999999995 110.9 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 91.0 t -158.94 152.69 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 72.239999999999995 111.127 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.528 ' NH1' HG21 ' A' ' 195' ' ' THR . 0.0 OUTLIER -84.5 155.26 22.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 110.877 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.62 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.1 OUTLIER -153.16 84.41 1.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 70.319999999999993 110.941 -179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.528 HG21 ' NH1' ' A' ' 193' ' ' ARG . 11.9 p -120.18 -170.94 2.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.461 . . . . 73.329999999999998 111.143 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 73.13 -168.6 53.61 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.751 -0.738 . . . . 41.32 112.503 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -15.69 37.13 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.685 2.256 . . . . 72.420000000000002 112.348 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.497 ' O ' ' CD1' ' A' ' 194' ' ' LEU . . . -96.21 52.25 1.26 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 51.5 111.087 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.673 ' C ' HG23 ' A' ' 200' ' ' VAL . . . -142.99 141.73 31.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 73.120000000000005 111.068 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.673 HG23 ' C ' ' A' ' 199' ' ' ALA . 2.7 t 81.45 -40.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.219999999999999 111.14 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 1.009 HG12 HG22 ' A' ' 203' ' ' THR . 87.9 t -47.46 139.24 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 52.039999999999999 111.129 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 1.7 tpt85 -85.55 78.23 9.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 70.140000000000001 110.879 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 1.009 HG22 HG12 ' A' ' 201' ' ' VAL . 2.5 t 174.33 -42.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 61.020000000000003 111.117 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.673 ' O ' HG23 ' A' ' 208' ' ' VAL . 45.7 t -70.08 -44.33 78.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.25 111.095 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.11 -4.81 18.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 110.861 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.404 HG22 ' HG3' ' A' ' 210' ' ' LYS . 10.6 mm -91.31 -66.88 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 111.107 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -45.71 -21.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 75.409999999999997 111.091 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.75 HG13 ' CD1' ' A' ' 168' ' ' ILE . 87.7 t -74.79 -75.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 63.350000000000001 111.136 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.515 ' HA ' HD12 ' A' ' 212' ' ' LEU . 33.7 t -57.43 -12.5 2.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 74.519999999999996 110.852 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 206' ' ' ILE . 0.0 OUTLIER -72.22 -40.27 67.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.11 -0.496 . . . . 72.409999999999997 110.906 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.541 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -78.03 -32.92 51.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.852 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.887 ' HA ' HG11 ' A' ' 164' ' ' VAL . 9.2 mt -72.16 -60.37 2.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 73.010000000000005 110.945 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -46.33 -26.01 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 62.329999999999998 110.854 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.96 -74.27 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 75.120000000000005 110.88 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.51 ' HD3' HG13 ' A' ' 164' ' ' VAL . 0.8 OUTLIER -53.21 -52.71 58.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 75.099999999999994 110.914 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.708 HD12 HD13 ' A' ' 156' ' ' LEU . 6.8 pt -106.2 87.75 2.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.722 . . . . 74.120000000000005 111.159 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -5.82 17.12 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.664 2.243 . . . . 71.030000000000001 112.332 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.9 t -69.22 -1.6 8.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 71.439999999999998 110.873 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.459 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 4.5 mt -78.96 154.84 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 65.150000000000006 111.192 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.459 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -138.12 -35.91 0.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.340000000000003 110.898 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.872 ' HB ' HD12 ' A' ' 189' ' ' ILE . 47.2 mt -152.71 103.19 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 111.146 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.463 HG21 ' OG ' ' A' ' 209' ' ' SER . 93.8 t -78.13 107.95 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 35.140000000000001 111.107 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -94.0 118.5 31.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.923 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 16.7 mt -114.41 102.48 10.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.349999999999994 110.88 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.593 ' H ' HD12 ' A' ' 225' ' ' LEU . 5.1 mp -69.9 162.77 27.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 65.150000000000006 110.947 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 75.239999999999995 110.834 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.856 ' O ' HD12 ' A' ' 154' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.762 0.315 . . . . 74.540000000000006 110.917 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.856 HD12 ' O ' ' A' ' 153' ' ' MET . 6.9 mp -139.05 -171.37 3.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 72.349999999999994 110.925 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -103.37 -12.74 17.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.230000000000004 110.885 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.755 HD13 HD12 ' A' ' 216' ' ' ILE . 11.2 tp 60.85 115.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 71.019999999999996 110.942 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.676 ' O ' HG12 ' A' ' 161' ' ' VAL . 16.8 p30 174.76 -173.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 70.310000000000002 110.898 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -37.4 87.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.150000000000006 110.847 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.413 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 11.3 pt-20 -72.92 -24.2 60.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 73.25 110.869 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 162' ' ' GLU . 91.7 m-20 -101.07 -67.74 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 72.239999999999995 110.877 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.755 HG11 ' CZ ' ' A' ' 182' ' ' PHE . 4.0 p -36.82 -29.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 71.030000000000001 111.166 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 160' ' ' ASN . 1.6 mt-10 -55.01 -59.32 4.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 73.340000000000003 110.92 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -36.39 62.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 64.310000000000002 110.866 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.915 HG11 ' HA ' ' A' ' 212' ' ' LEU . 93.1 t -65.23 -42.01 92.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.427 . . . . 62.439999999999998 111.145 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.478 HD11 ' CD1' ' A' ' 182' ' ' PHE . 62.0 mt -69.43 -21.81 63.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 64.109999999999999 110.887 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -72.88 -16.12 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 64.530000000000001 110.877 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -89.72 6.35 41.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 73.329999999999998 110.86 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.692 HG21 ' HA ' ' A' ' 208' ' ' VAL . 0.9 OUTLIER -137.76 -34.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 111.122 180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.7 -61.03 5.23 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.539 0.685 . . . . 75.450000000000003 110.889 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.78 -11.37 30.67 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.684 2.256 . . . . 71.120000000000005 112.335 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.543 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -84.86 -13.18 51.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 110.959 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.847 HD11 ' CD2' ' A' ' 180' ' ' LEU . 6.4 mt -80.39 -41.89 23.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.931 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -39.21 -48.59 1.8 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 111.119 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -58.3 -55.66 29.48 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 72.25 112.485 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.8 p -77.08 2.46 15.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.795 0.331 . . . . 71.349999999999994 111.12 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 151.1 -64.32 0.38 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.73 . . . . 72.510000000000005 112.496 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 124.44 32.41 0.83 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 42.310000000000002 112.482 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -46.35 174.03 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 72.510000000000005 112.483 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -126.69 117.57 2.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.752 -0.737 . . . . 64.319999999999993 112.487 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.847 ' CD2' HD11 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -118.14 25.23 10.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.788 0.328 . . . . 45.310000000000002 110.901 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' A' ' 182' ' ' PHE . 0.0 OUTLIER -34.35 124.17 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.47 . . . . 75.219999999999999 110.89 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.755 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 17.8 t80 -52.5 135.61 33.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.912 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 53.8 mt -94.28 -71.51 0.66 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.181 -0.463 . . . . 75.340000000000003 110.884 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.418 ' C ' HG13 ' A' ' 185' ' ' ILE . 6.8 ptp -176.06 -162.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 74.310000000000002 110.851 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.418 HG13 ' C ' ' A' ' 184' ' ' MET . 8.7 mt -146.41 127.42 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 51.030000000000001 111.12 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -120.13 48.66 1.53 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 51.009999999999998 110.875 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 106.73 -140.13 15.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 75.120000000000005 112.507 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 3.09 3.0 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.683 2.255 . . . . 62.130000000000003 112.357 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.1 mt -114.49 135.41 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 73.349999999999994 111.126 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 156' ' ' LEU . 76.5 t -109.83 137.03 43.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 64.129999999999995 111.106 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -107.75 140.62 40.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 73.239999999999995 110.906 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 90.8 t -152.48 144.8 15.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 75.549999999999997 111.159 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.14 166.96 17.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 73.129999999999995 110.842 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.426 ' HA ' HD13 ' A' ' 194' ' ' LEU . 0.0 OUTLIER -160.91 84.65 0.68 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 62.530000000000001 110.864 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 18.6 p -99.97 158.42 15.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 42.439999999999998 111.126 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 90.36 -177.58 42.57 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.659 -0.781 . . . . 54.439999999999998 112.435 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . 0.459 ' O ' HG23 ' A' ' 201' ' ' VAL . 53.9 Cg_endo -69.71 0.74 5.16 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.707 2.271 . . . . 72.340000000000003 112.352 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.934 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -87.93 16.87 5.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 32.219999999999999 111.104 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -120.52 49.39 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 61.020000000000003 111.075 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.3 p -177.56 -35.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 64.239999999999995 111.149 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 197' ' ' PRO . 20.2 t -47.94 137.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 71.150000000000006 111.122 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.421 ' C ' HD12 ' A' ' 206' ' ' ILE . 0.0 OUTLIER -80.36 42.85 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 73.450000000000003 110.893 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 55.1 m -160.59 -46.15 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.149 -0.478 . . . . 74.109999999999999 111.14 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.934 HG11 ' HB1' ' A' ' 198' ' ' ALA . 43.4 t -61.55 -64.78 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 75.519999999999996 111.12 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -50.59 -30.23 12.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.189 -0.46 . . . . 72.040000000000006 110.839 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.421 HD12 ' C ' ' A' ' 202' ' ' ARG . 18.5 mt -73.65 -35.69 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 72.439999999999998 111.113 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -58.32 -44.31 88.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 74.209999999999994 111.073 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.791 HG12 HD11 ' A' ' 212' ' ' LEU . 70.1 t -53.68 -80.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 71.25 111.157 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 1.4 t -42.84 -39.28 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 52.240000000000002 110.857 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.41 -40.31 7.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 44.240000000000002 110.934 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 212' ' ' LEU . 0.4 OUTLIER -85.11 -59.84 2.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 54.509999999999998 110.897 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.915 ' HA ' HG11 ' A' ' 164' ' ' VAL . 2.3 mt -32.72 -69.9 0.08 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 75.25 110.956 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.5 HH22 HG11 ' A' ' 222' ' ' VAL . 0.0 OUTLIER -49.35 -40.92 37.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 64.310000000000002 110.88 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 211' ' ' LYS . 2.0 mt-10 -64.53 -80.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 75.099999999999994 110.943 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.674 ' CB ' HG22 ' A' ' 164' ' ' VAL . 12.2 mmtt -40.99 -58.84 1.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 71.010000000000005 110.869 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.755 HD12 HD13 ' A' ' 156' ' ' LEU . 9.4 pt -106.97 88.42 3.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.625 0.726 . . . . 54.25 111.148 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -9.26 25.68 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.714 2.276 . . . . 73.340000000000003 112.365 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.69 -14.13 62.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 74.129999999999995 110.877 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.2 mt -61.11 146.02 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 74.120000000000005 111.135 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.788 ' HB3' HD12 ' A' ' 221' ' ' ILE . 13.0 mp0 -116.88 -38.28 3.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 73.129999999999995 110.873 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.788 HD12 ' HB3' ' A' ' 220' ' ' GLN . 4.7 mp -153.27 103.0 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 70.030000000000001 111.11 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.5 HG11 HH22 ' A' ' 213' ' ' ARG . 0.9 OUTLIER -72.9 115.56 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 55.25 111.09 179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -100.66 108.11 19.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 71.120000000000005 110.948 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.9 mt -99.37 113.6 26.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 75.200000000000003 110.944 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 1.9 mp -93.93 176.06 6.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 110.917 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 72.340000000000003 110.834 -179.894 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.8 tpt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.813 0.34 . . . . 70.140000000000001 110.887 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.762 HD13 ' O ' ' A' ' 215' ' ' LYS . 6.7 mp -121.14 -171.92 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 72.239999999999995 110.91 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -102.22 -21.56 14.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.010000000000005 110.886 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.619 HD12 HG22 ' A' ' 161' ' ' VAL . 5.5 tp 61.07 113.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 61.43 110.917 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.929 ' H ' HG23 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 174.71 -178.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 72.299999999999997 110.847 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -6.64 4.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 70.519999999999996 110.892 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.46 -43.68 7.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 54.439999999999998 110.895 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.523 ' HB3' HD23 ' A' ' 154' ' ' LEU . 61.1 m-20 -94.62 -49.48 5.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 61.039999999999999 110.902 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.929 HG23 ' H ' ' A' ' 157' ' ' ASN . 86.6 t -43.08 -44.02 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 72.129999999999995 111.155 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.52 ' HA ' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -57.49 -34.46 69.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 73.400000000000006 110.85 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -62.61 -45.13 94.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.919 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.958 HG11 ' HA ' ' A' ' 212' ' ' LEU . 23.1 t -70.4 -31.79 47.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 71.230000000000004 111.129 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 162' ' ' GLU . 46.5 mt -70.03 -27.8 64.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 73.040000000000006 110.936 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.408 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 14.5 m-80 -69.9 -9.35 54.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 75.340000000000003 110.83 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -87.94 -15.6 36.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 65.299999999999997 110.869 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.778 HD13 ' HA ' ' A' ' 208' ' ' VAL . 1.5 pt -118.34 -30.04 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 71.209999999999994 111.154 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.555 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.51 -61.05 5.11 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.703 . . . . 73.200000000000003 110.877 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.5 Cg_endo -69.74 1.78 4.12 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.702 2.268 . . . . 73.209999999999994 112.33 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.688 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -94.12 -31.53 14.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 75.140000000000001 110.924 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.688 HD23 ' CD2' ' A' ' 171' ' ' TYR . 0.6 OUTLIER -77.61 -60.39 2.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 71.150000000000006 110.972 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -38.27 -52.38 1.49 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 54.100000000000001 111.076 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -38.71 -44.16 1.79 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.724 -0.75 . . . . 74.219999999999999 112.512 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.2 p -99.91 -15.09 18.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.882 0.373 . . . . 73.209999999999994 111.162 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -176.05 -88.08 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 53.340000000000003 112.473 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 114.18 99.67 2.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.695 -0.764 . . . . 73.340000000000003 112.452 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -93.25 -92.36 1.53 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 52.310000000000002 112.515 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 174.72 119.75 0.56 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.715 -0.755 . . . . 74.030000000000001 112.483 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.555 HD11 ' HD2' ' A' ' 169' ' ' ARG . 0.4 OUTLIER -139.78 17.8 2.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.756 0.312 . . . . 73.439999999999998 110.934 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.452 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.4 OUTLIER -34.28 96.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 72.319999999999993 110.945 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.626 ' CE1' HG11 ' A' ' 161' ' ' VAL . 91.4 t80 -36.47 118.71 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.861 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 46.8 mt -82.02 -78.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 72.439999999999998 110.922 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -167.9 -166.19 0.71 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 71.219999999999999 110.898 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.788 HD11 HG21 ' A' ' 161' ' ' VAL . 32.5 mt -142.55 139.91 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.259 -0.428 . . . . 52.399999999999999 111.182 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -128.5 69.78 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 62.119999999999997 110.917 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 89.8 -139.7 15.21 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 55.140000000000001 112.445 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 1.22 4.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.626 2.218 . . . . 75.329999999999998 112.333 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.2 mp -123.5 127.55 74.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 70.109999999999999 111.141 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.689 HG23 HG12 ' A' ' 185' ' ' ILE . 6.2 p -105.17 144.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 73.5 111.169 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.421 ' O ' ' CG2' ' A' ' 192' ' ' VAL . 10.7 mtmt -103.84 146.18 29.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.465 . . . . 72.409999999999997 110.88 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 191' ' ' LYS . 88.1 t -157.97 136.9 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 64.040000000000006 111.098 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.874 ' O ' HD22 ' A' ' 194' ' ' LEU . 11.3 ttt180 -73.69 161.35 30.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 71.540000000000006 110.848 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.879 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.2 OUTLIER -157.99 102.64 1.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 73.549999999999997 110.911 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 3.0 p -129.78 161.89 29.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 61.450000000000003 111.152 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.2 -177.78 38.27 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 71.450000000000003 112.519 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -43.8 2.46 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 2.254 . . . . 74.420000000000002 112.326 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.565 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -62.8 -25.76 68.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 64.040000000000006 111.127 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.879 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -34.06 -85.86 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 55.310000000000002 111.149 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 2.4 p -121.03 112.2 34.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 71.319999999999993 111.18 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.7 HG13 ' H ' ' A' ' 202' ' ' ARG . 1.6 p -137.79 -61.49 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.17 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.7 ' H ' HG13 ' A' ' 201' ' ' VAL . 1.1 mtt-85 162.23 35.22 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 110.855 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.468 ' N ' ' CD1' ' A' ' 206' ' ' ILE . 43.7 m -168.29 -56.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 64.329999999999998 111.124 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.565 HG21 ' HB1' ' A' ' 198' ' ' ALA . 59.3 t -48.63 -70.06 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 60.439999999999998 111.098 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.49 -22.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 75.310000000000002 110.876 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.468 ' CD1' ' N ' ' A' ' 203' ' ' THR . 3.1 mp -89.89 -33.02 5.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 73.340000000000003 111.145 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -74.31 -11.67 60.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.519999999999996 111.066 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.778 ' HA ' HD13 ' A' ' 168' ' ' ILE . 64.1 t -85.53 -74.81 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 75.510000000000005 111.117 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.424 ' HA ' HD12 ' A' ' 212' ' ' LEU . 14.8 t -53.46 -15.5 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 63.409999999999997 110.872 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -64.65 -40.26 95.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 74.310000000000002 110.909 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.7 -41.23 12.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 75.209999999999994 110.911 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.958 ' HA ' HG11 ' A' ' 164' ' ' VAL . 24.7 mt -52.63 -66.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 72.239999999999995 110.903 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -50.43 -24.23 2.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 74.400000000000006 110.908 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.33 -68.46 0.56 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 110.906 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.762 ' O ' HD13 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -59.25 -48.3 82.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 110.912 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.497 HG23 HD22 ' A' ' 154' ' ' LEU . 1.7 pt -109.6 93.76 14.9 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.645 0.736 . . . . 64.409999999999997 111.17 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -22.09 32.96 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.708 2.272 . . . . 65.040000000000006 112.324 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 21.0 t -54.71 -15.42 1.84 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 72.329999999999998 110.877 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 1.7 mt -70.87 143.53 14.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 71.230000000000004 111.159 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -127.05 -42.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 75.340000000000003 110.881 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 3.1 mt -140.91 102.64 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 74.219999999999999 111.123 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.3 t -78.21 116.22 21.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 74.450000000000003 111.077 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.51 135.2 42.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 64.400000000000006 110.91 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.515 ' HB3' HD23 ' A' ' 194' ' ' LEU . 30.1 mt -121.97 103.03 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 63.039999999999999 110.906 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.4 171.67 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 73.239999999999995 110.939 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 45.140000000000001 110.84 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.783 0.325 . . . . 72.340000000000003 110.881 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.781 HD22 ' CG ' ' A' ' 160' ' ' ASN . 6.5 mt -148.41 -173.1 4.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 72.439999999999998 110.928 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.507 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 4.4 mt-10 -108.55 -6.23 16.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 61.32 110.925 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.708 HD12 ' CG2' ' A' ' 161' ' ' VAL . 3.2 tp 61.17 119.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 74.549999999999997 110.943 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.93 ' H ' HG23 ' A' ' 161' ' ' VAL . 5.8 p30 169.37 179.53 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 74.439999999999998 110.891 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.92 -26.5 65.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.857 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.429 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 11.6 pt-20 -84.24 -30.96 25.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 75.109999999999999 110.865 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.781 ' CG ' HD22 ' A' ' 154' ' ' LEU . 89.5 m-20 -97.32 -62.29 1.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 63.439999999999998 110.922 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.93 HG23 ' H ' ' A' ' 157' ' ' ASN . 50.0 t -38.78 -46.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 75.310000000000002 111.156 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.14 -56.02 5.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.854 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.11 -43.07 30.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 65.25 110.902 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.77 HG11 ' HA ' ' A' ' 212' ' ' LEU . 33.6 t -70.14 -42.94 79.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 65.310000000000002 111.149 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.629 HD11 ' CD1' ' A' ' 182' ' ' PHE . 56.5 mt -63.84 -24.7 67.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 71.129999999999995 110.905 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -69.17 -10.84 59.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.299999999999997 110.876 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -84.73 -25.74 28.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 110.884 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' A' ' 169' ' ' ARG . 1.7 pt -106.98 -45.33 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.147 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.837 ' HG3' HD21 ' A' ' 180' ' ' LEU . 2.8 mtt180 -34.48 -58.71 0.63 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.631 0.729 . . . . 74.219999999999999 110.877 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 54.1 Cg_endo -69.76 -30.8 21.72 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.657 2.238 . . . . 72.010000000000005 112.379 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.57 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -74.34 -15.0 60.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 73.219999999999999 110.915 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.57 HD23 ' CD2' ' A' ' 171' ' ' TYR . 3.8 mt -76.5 -43.02 41.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 54.109999999999999 110.912 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.19 -22.62 48.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 60.219999999999999 111.118 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -46.32 -49.37 15.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 62.030000000000001 112.459 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.7 t -125.98 48.78 2.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.818 0.342 . . . . 63.350000000000001 111.167 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.18 -97.65 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 72.530000000000001 112.489 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 115.03 125.46 4.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 63.530000000000001 112.511 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -128.81 -102.54 1.07 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 64.230000000000004 112.492 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -169.34 119.33 0.82 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.709 -0.758 . . . . 65.430000000000007 112.465 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.837 HD21 ' HG3' ' A' ' 169' ' ' ARG . 0.0 OUTLIER -140.95 6.08 1.97 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.747 0.308 . . . . 72.319999999999993 110.893 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.449 ' N ' HD13 ' A' ' 180' ' ' LEU . 0.9 OUTLIER -35.0 111.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 74.400000000000006 110.9 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.774 ' CE1' HG11 ' A' ' 161' ' ' VAL . 27.3 t80 -37.78 122.19 0.96 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 75.040000000000006 110.865 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 38.1 mt -81.01 -77.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 75.409999999999997 110.965 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.423 ' C ' HG13 ' A' ' 185' ' ' ILE . 12.5 ptm -169.99 -172.91 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 74.340000000000003 110.883 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.423 HG13 ' C ' ' A' ' 184' ' ' MET . 2.4 mt -133.73 130.52 56.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 75.209999999999994 111.134 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -138.09 75.83 1.54 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 71.25 110.954 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 87.19 -151.16 23.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.714 -0.755 . . . . 24.210000000000001 112.496 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 2.93 3.11 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.687 2.258 . . . . 75.140000000000001 112.303 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 24.0 mt -113.71 124.38 70.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 62.140000000000001 111.118 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 54.7 t -102.0 137.97 27.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 111.177 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.404 ' C ' HG23 ' A' ' 192' ' ' VAL . 4.6 mtmm -104.94 142.16 35.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 73.140000000000001 110.901 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.404 HG23 ' C ' ' A' ' 191' ' ' LYS . 56.1 t -156.91 142.83 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 71.400000000000006 111.152 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.468 ' NH2' HG21 ' A' ' 195' ' ' THR . 1.0 OUTLIER -73.69 163.1 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 64.310000000000002 110.887 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.72 HD23 HD22 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -164.49 93.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.409999999999997 110.915 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.468 HG21 ' NH2' ' A' ' 193' ' ' ARG . 5.9 p -132.49 -168.84 2.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 54.200000000000003 111.094 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.79 -158.13 42.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.754 -0.736 . . . . 54.219999999999999 112.476 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.26 18.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.678 2.252 . . . . 74.439999999999998 112.364 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.614 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -90.22 -162.41 0.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.458 . . . . 73.239999999999995 111.131 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.716 ' HB2' HD12 ' A' ' 194' ' ' LEU . . . 74.01 144.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 111.062 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 200' ' ' VAL . 22.0 m 34.05 42.04 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 72.340000000000003 111.169 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 199' ' ' ALA . 23.0 t -99.12 -16.63 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 111.16 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 70.47 40.17 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 75.120000000000005 110.859 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.83 -44.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 72.209999999999994 111.133 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.614 HG11 ' HB1' ' A' ' 198' ' ' ALA . 53.6 t -72.64 -47.34 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 72.230000000000004 111.125 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -61.54 -40.89 96.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 63.210000000000001 110.893 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.72 -37.3 58.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 60.509999999999998 111.104 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.8 -29.95 69.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 111.107 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.685 HG12 HD11 ' A' ' 212' ' ' LEU . 67.3 t -65.04 -75.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 52.520000000000003 111.125 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.527 ' HA ' HD12 ' A' ' 212' ' ' LEU . 1.9 t -55.33 -19.0 7.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 60.439999999999998 110.872 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.409 ' O ' ' OE1' ' A' ' 214' ' ' GLU . 3.8 mtpp -61.93 -40.32 95.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.073 -0.512 . . . . 71.519999999999996 110.855 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.86 -32.81 17.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.435 . . . . 75.450000000000003 110.87 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.77 ' HA ' HG11 ' A' ' 164' ' ' VAL . 10.5 mt -69.29 -67.67 0.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 74.109999999999999 110.932 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . 0.423 ' CZ ' ' OG ' ' A' ' 209' ' ' SER . 0.7 OUTLIER -45.07 -27.95 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.519999999999996 110.862 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.409 ' OE1' ' O ' ' A' ' 210' ' ' LYS . 0.4 OUTLIER -81.68 -76.85 0.23 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 71.129999999999995 110.902 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.509 ' CB ' HG22 ' A' ' 164' ' ' VAL . 16.4 mmtt -42.24 -59.57 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 65.150000000000006 110.893 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.523 HD13 HG22 ' A' ' 161' ' ' VAL . 3.4 pt -103.94 95.42 7.76 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.659 0.743 . . . . 71.409999999999997 111.167 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -22.04 32.58 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.673 2.249 . . . . 74.010000000000005 112.33 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 17.0 t -49.06 -35.74 16.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 63.310000000000002 110.851 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.457 HG21 HG22 ' A' ' 222' ' ' VAL . 4.5 mt -48.37 154.43 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.349999999999994 111.129 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.446 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.8 OUTLIER -134.94 -35.53 0.85 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 54.219999999999999 110.927 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.41 HG13 ' C ' ' A' ' 220' ' ' GLN . 53.4 mt -146.76 91.67 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 64.239999999999995 111.147 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.457 HG22 HG21 ' A' ' 219' ' ' ILE . 39.8 t -65.05 109.82 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 73.030000000000001 111.096 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -100.9 130.58 46.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 64.549999999999997 110.856 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.72 HD22 HD23 ' A' ' 194' ' ' LEU . 14.2 mt -117.07 114.09 23.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 50.100000000000001 110.909 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.52 177.88 7.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 72.030000000000001 110.925 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 72.209999999999994 110.879 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.809 0.337 . . . . 62.119999999999997 110.891 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.681 HD12 ' O ' ' A' ' 215' ' ' LYS . 12.4 mt -83.58 -176.3 6.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 71.219999999999999 110.897 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -104.13 -17.82 14.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 110.919 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.885 HD13 HD12 ' A' ' 216' ' ' ILE . 8.9 tp 59.71 111.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 73.420000000000002 110.95 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.629 ' O ' HG22 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -175.99 171.96 2.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 53.420000000000002 110.867 179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.18 -20.51 1.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 64.420000000000002 110.869 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.51 -35.22 25.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 73.150000000000006 110.903 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.636 ' ND2' HD22 ' A' ' 154' ' ' LEU . 4.2 m-20 -90.0 -55.85 3.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 73.019999999999996 110.882 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 157' ' ' ASN . 26.6 m -47.46 -26.72 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 63.32 111.092 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -62.79 -42.02 99.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.893 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -34.08 69.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 74.219999999999999 110.944 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.828 HG11 ' HA ' ' A' ' 212' ' ' LEU . 30.4 t -73.37 -42.93 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 71.540000000000006 111.087 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.944 HD22 ' CD1' ' A' ' 180' ' ' LEU . 85.0 mt -65.89 -23.59 66.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.229 -0.441 . . . . 74.319999999999993 110.915 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -73.37 -8.64 56.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 64.310000000000002 110.861 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.19 1.59 49.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.203 -0.453 . . . . 74.120000000000005 110.916 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.972 HD12 HG13 ' A' ' 208' ' ' VAL . 0.5 OUTLIER -132.91 -35.19 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 64.420000000000002 111.103 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.717 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -52.19 -60.56 5.98 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.586 0.708 . . . . 75.129999999999995 110.874 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.4 Cg_endo -69.77 -4.73 14.63 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.691 2.261 . . . . 60.219999999999999 112.305 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.596 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -90.53 -22.1 21.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 64.140000000000001 110.924 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.596 HD23 ' CD2' ' A' ' 171' ' ' TYR . 5.3 mt -76.37 -44.81 34.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 50.240000000000002 110.912 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.5 -38.68 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 62.25 111.13 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.69 152.1 19.86 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 45.119999999999997 112.501 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 6.0 t 40.14 56.26 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.794 0.33 . . . . 74.439999999999998 111.132 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 156.37 -86.72 0.12 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.746 -0.74 . . . . 25.050000000000001 112.46 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 89.34 89.24 1.23 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 73.510000000000005 112.526 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.33 -158.81 7.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 63.210000000000001 112.515 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -149.92 152.68 24.57 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 64.319999999999993 112.458 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.944 ' CD1' HD22 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -140.9 25.7 2.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 65.209999999999994 110.919 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.481 ' NE2' ' NH2' ' A' ' 169' ' ' ARG . 2.5 tp60 -32.71 110.12 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.956 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.569 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 5.7 t80 -46.95 133.15 11.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.452 . . . . 75.540000000000006 110.889 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.79 -69.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 52.219999999999999 110.905 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 4.1 ptp -178.13 -176.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 64.310000000000002 110.859 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.2 mt -131.29 125.27 56.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.252 -0.431 . . . . 75.140000000000001 111.145 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -124.9 56.41 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 70.109999999999999 110.913 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 95.71 -141.77 15.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.747 -0.74 . . . . 40.340000000000003 112.424 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.422 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.7 Cg_endo -69.72 3.28 2.84 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.71 2.273 . . . . 52.439999999999998 112.358 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.5 mt -115.02 118.3 58.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 75.519999999999996 111.127 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 66.7 t -97.22 135.53 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 54.229999999999997 111.15 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 10.9 mtmt -109.76 139.58 44.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 74.349999999999994 110.907 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.536 HG12 ' N ' ' A' ' 193' ' ' ARG . 40.2 t -152.23 160.58 3.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 63.140000000000001 111.117 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.536 ' N ' HG12 ' A' ' 192' ' ' VAL . 0.0 OUTLIER -92.37 166.65 12.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 110.854 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' A' ' 198' ' ' ALA . 0.0 OUTLIER -156.42 70.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 71.439999999999998 110.91 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 76.4 p -89.09 173.3 8.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 74.519999999999996 111.156 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 86.24 -179.49 49.52 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.761 . . . . 75.219999999999999 112.455 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -24.43 29.84 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.709 2.273 . . . . 73.239999999999995 112.342 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.674 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -79.85 103.43 9.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 73.409999999999997 111.074 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . . . . . . . . . . . -165.0 -74.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 45.399999999999999 111.103 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 28.5 m -61.92 -11.01 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 74.140000000000001 111.146 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 13.2 t -64.02 128.82 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 74.439999999999998 111.131 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -77.58 58.05 1.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 61.43 110.871 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 96.6 m -163.65 -55.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 74.530000000000001 111.13 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.674 HG21 ' HB1' ' A' ' 198' ' ' ALA . 59.8 t -54.47 -61.44 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 64.129999999999995 111.112 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -53.73 -25.69 19.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.510000000000005 110.873 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.01 -28.73 7.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 71.040000000000006 111.114 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.93 -32.34 72.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 70.549999999999997 111.075 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 1.021 HG12 HD11 ' A' ' 212' ' ' LEU . 3.8 t -67.07 -70.26 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 63.43 111.114 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.617 ' HA ' HD12 ' A' ' 212' ' ' LEU . 7.8 t -50.35 -17.91 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 74.430000000000007 110.854 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -66.96 -41.09 87.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 73.239999999999995 110.918 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -88.49 -33.99 17.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 72.099999999999994 110.905 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 1.021 HD11 HG12 ' A' ' 208' ' ' VAL . 11.3 mt -63.88 -67.14 0.45 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 74.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.55 -16.15 0.85 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 72.200000000000003 110.85 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -86.96 -78.45 0.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 71.129999999999995 110.871 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.681 ' O ' HD12 ' A' ' 154' ' ' LEU . 1.2 mttp -47.09 -55.87 7.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.462 . . . . 72.430000000000007 110.863 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.885 HD12 HD13 ' A' ' 156' ' ' LEU . 4.1 pt -108.05 91.53 8.01 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 75.129999999999995 111.152 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -16.06 37.15 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.63 2.22 . . . . 74.540000000000006 112.37 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.78 -23.94 7.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 71.510000000000005 110.821 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 5.2 mt -58.81 158.14 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 72.230000000000004 111.112 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.498 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -137.59 -35.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 75.340000000000003 110.903 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 220' ' ' GLN . 72.9 mt -150.71 96.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 71.349999999999994 111.143 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 222' ' ' VAL . 28.7 m -67.89 121.52 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 74.129999999999995 111.134 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.63 119.18 38.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 73.319999999999993 110.91 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -111.48 119.16 37.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 72.129999999999995 110.959 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.31 168.87 9.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 70.040000000000006 110.928 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 71.230000000000004 110.852 -179.907 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.192 0 CA-C-O 120.807 0.337 . . . . 75.019999999999996 110.849 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.737 HD23 ' CG ' ' A' ' 160' ' ' ASN . 0.5 OUTLIER -138.31 -170.26 2.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 64.340000000000003 110.911 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -104.12 -17.05 15.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 75.319999999999993 110.894 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.721 ' CD1' HD12 ' A' ' 216' ' ' ILE . 9.4 tp 58.15 113.89 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 74.200000000000003 110.896 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.621 ' O ' HG12 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 175.52 -177.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.239999999999995 110.875 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.421 ' HA ' HG12 ' A' ' 161' ' ' VAL . 0.1 OUTLIER -52.89 -45.38 67.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 72.430000000000007 110.823 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -57.93 -56.17 25.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 72.030000000000001 110.927 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.737 ' CG ' HD23 ' A' ' 154' ' ' LEU . 94.8 m-20 -74.52 -65.85 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.909 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.621 HG12 ' O ' ' A' ' 157' ' ' ASN . 2.5 p -34.75 -33.82 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 54.340000000000003 111.147 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 160' ' ' ASN . 0.8 OUTLIER -56.22 -57.1 13.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.901 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.96 -43.71 77.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 71.409999999999997 110.908 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.882 HG11 ' HA ' ' A' ' 212' ' ' LEU . 17.8 t -63.81 -40.89 90.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.231 -0.44 . . . . 63.450000000000003 111.177 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 182' ' ' PHE . 54.0 mt -66.35 -32.79 74.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 74.409999999999997 110.891 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.498 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 4.5 m-80 -63.97 -13.13 43.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.310000000000002 110.844 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -85.02 1.13 48.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 63.210000000000001 110.877 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.702 HG21 ' HA ' ' A' ' 208' ' ' VAL . 0.6 OUTLIER -135.15 -34.61 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 62.219999999999999 111.157 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -52.42 -60.77 5.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 71.510000000000005 110.851 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.498 ' CG ' ' O ' ' A' ' 166' ' ' ASN . 53.8 Cg_endo -69.76 -0.39 6.83 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.663 2.242 . . . . 63.329999999999998 112.34 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.639 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.1 OUTLIER -92.99 -27.1 17.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 72.209999999999994 110.943 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.639 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.1 mt -75.63 -39.95 57.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 74.0 110.927 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -44.36 -50.33 9.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 75.209999999999994 111.157 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -45.3 -43.74 9.98 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 50.210000000000001 112.504 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 9.9 t -113.76 37.43 3.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 74.310000000000002 111.124 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 82.71 109.08 0.46 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 65.140000000000001 112.469 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -74.9 137.56 22.42 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.704 -0.76 . . . . 42.100000000000001 112.507 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.01 -106.44 2.9 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.718 -0.753 . . . . 61.039999999999999 112.474 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -161.08 113.81 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.722 -0.752 . . . . 71.030000000000001 112.471 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 181' ' ' GLN . 1.7 pp -142.55 6.68 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.736 0.303 . . . . 71.530000000000001 110.905 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 182' ' ' PHE . 2.2 tp60 -36.19 105.11 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 74.519999999999996 110.897 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.604 ' CZ ' HG11 ' A' ' 161' ' ' VAL . 10.0 t80 -34.09 129.44 0.36 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 62.200000000000003 110.876 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 89.0 mt -95.6 -72.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.510000000000005 110.923 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.404 ' C ' HG13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -166.06 -173.31 2.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 72.109999999999999 110.861 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.584 HG22 ' H ' ' A' ' 187' ' ' GLY . 4.1 mt -135.52 143.92 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 75.530000000000001 111.116 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.475 ' CG ' ' HB ' ' A' ' 189' ' ' ILE . 7.9 ptpt -121.4 38.43 4.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 73.120000000000005 110.872 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.584 ' H ' HG22 ' A' ' 185' ' ' ILE . . . 93.35 -112.23 4.25 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 70.409999999999997 112.49 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.519 ' HG2' HD12 ' A' ' 189' ' ' ILE . 53.4 Cg_endo -69.82 -22.89 31.18 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.723 2.282 . . . . 70.5 112.314 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.519 HD12 ' HG2' ' A' ' 188' ' ' PRO . 2.6 mp -106.45 146.66 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 65.25 111.115 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.69 137.54 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 63.420000000000002 111.165 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -98.25 140.13 33.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 62.43 110.922 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 193' ' ' ARG . 41.4 t -151.03 149.73 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 62.219999999999999 111.109 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.441 ' O ' HG12 ' A' ' 192' ' ' VAL . 0.0 OUTLIER -83.97 161.4 20.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 110.842 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -173.12 61.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.216 -0.447 . . . . 65.150000000000006 110.983 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 22.6 p -80.42 -49.3 11.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 111.133 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -45.87 173.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.711 -0.757 . . . . 43.130000000000003 112.498 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 3.18 2.93 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.694 2.263 . . . . 71.430000000000007 112.345 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 1.153 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -78.42 6.9 7.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 61.409999999999997 111.102 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 194' ' ' LEU . . . -91.76 -61.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.435 . . . . 62.109999999999999 111.063 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 200' ' ' VAL . 21.3 t -76.12 50.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 31.02 111.115 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 198' ' ' ALA . 1.7 t -124.89 146.17 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 75.530000000000001 111.172 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -95.5 35.07 1.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 62.009999999999998 110.869 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 5.7 m -156.68 -66.03 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.144 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 1.153 HG11 ' HB1' ' A' ' 198' ' ' ALA . 57.9 t -44.78 -58.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 73.209999999999994 111.125 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -56.69 -21.86 30.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.896 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.437 HG22 ' HG3' ' A' ' 210' ' ' LYS . 15.6 mm -80.96 -52.22 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 65.409999999999997 111.158 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.98 -35.7 25.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 64.540000000000006 111.107 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.702 ' HA ' HG21 ' A' ' 168' ' ' ILE . 38.9 t -59.53 -83.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 64.200000000000003 111.117 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.588 ' N ' HG12 ' A' ' 208' ' ' VAL . 48.0 t -49.22 -18.49 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 64.510000000000005 110.863 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.437 ' HG3' HG22 ' A' ' 206' ' ' ILE . 3.0 mttm -60.48 -40.23 90.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 54.119999999999997 110.909 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 214' ' ' GLU . 1.4 mmtt -86.59 -54.56 4.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 70.120000000000005 110.847 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.882 ' HA ' HG11 ' A' ' 164' ' ' VAL . 1.5 mt -37.07 -70.05 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 65.299999999999997 110.877 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -53.49 -22.46 8.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 72.310000000000002 110.86 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -77.39 -67.42 0.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.46 . . . . 70.310000000000002 110.923 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.67 ' O ' HD13 ' A' ' 154' ' ' LEU . 1.9 mptt -60.72 -46.39 90.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 64.510000000000005 110.916 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.721 HD12 ' CD1' ' A' ' 156' ' ' LEU . 4.4 pt -111.68 86.26 6.89 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.657 0.742 . . . . 72.310000000000002 111.111 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 0.26 5.92 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.688 2.259 . . . . 73.439999999999998 112.319 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.6 t -76.6 1.68 16.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 72.329999999999998 110.857 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.501 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 6.3 mt -83.65 157.88 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 74.450000000000003 111.13 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.501 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.1 OUTLIER -132.43 -33.13 1.28 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 74.010000000000005 110.932 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 189' ' ' ILE . 33.6 mm -153.62 108.89 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 70.510000000000005 111.13 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 55.2 t -82.52 117.83 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 71.420000000000002 111.087 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -107.87 136.25 47.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 72.230000000000004 110.891 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.8 mt -124.05 104.32 8.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 63.409999999999997 110.944 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -51.18 168.26 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 62.119999999999997 110.915 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 61.130000000000003 110.862 -179.908 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.822 0.344 . . . . 73.510000000000005 110.839 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.501 ' CB ' HG22 ' A' ' 216' ' ' ILE . 11.4 mt -141.94 -175.74 4.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 110.895 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.85 -18.09 18.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 62.200000000000003 110.873 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.623 HD12 HD12 ' A' ' 216' ' ' ILE . 5.6 tp 61.49 113.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 64.420000000000002 110.926 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.962 ' H ' HG23 ' A' ' 161' ' ' VAL . 0.0 OUTLIER 171.8 173.69 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.883 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.432 ' O ' ' CG ' ' A' ' 162' ' ' GLU . 3.6 mt-10 -49.49 -37.03 24.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 63.420000000000002 110.901 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.8 -54.12 25.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.119 -0.491 . . . . 63.420000000000002 110.924 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.441 ' ND2' HD21 ' A' ' 157' ' ' ASN . 86.6 m-20 -79.32 -62.82 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 64.420000000000002 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.962 HG23 ' H ' ' A' ' 157' ' ' ASN . 72.7 t -34.56 -50.43 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.486 . . . . 73.540000000000006 111.133 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.432 ' CG ' ' O ' ' A' ' 158' ' ' GLU . 20.7 mm-40 -40.34 -60.2 1.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.129999999999995 110.865 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.28 -36.86 14.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 64.239999999999995 110.929 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.815 HG11 ' HA ' ' A' ' 212' ' ' LEU . 40.2 t -73.44 -34.39 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 71.420000000000002 111.082 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' A' ' 182' ' ' PHE . 27.8 mt -72.79 -30.93 64.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 71.340000000000003 110.927 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.82 -6.85 44.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.894 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -90.98 -12.87 34.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.319999999999993 110.871 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.514 HD13 HG22 ' A' ' 208' ' ' VAL . 0.8 OUTLIER -123.51 -28.33 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 72.400000000000006 111.119 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.652 ' HD2' HD11 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -51.61 -60.87 5.03 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 74.409999999999997 110.844 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.9 Cg_endo -69.73 2.62 3.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.675 2.25 . . . . 62.310000000000002 112.37 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.634 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -97.61 -28.44 13.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.927 -179.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.634 HD23 ' CD2' ' A' ' 171' ' ' TYR . 4.3 mt -76.31 -43.08 42.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.925 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.17 38.08 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 65.329999999999998 111.062 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -121.53 -20.16 3.29 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 35.240000000000002 112.476 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 14.1 t -161.95 30.21 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 64.230000000000004 111.174 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -165.29 -69.77 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.772 -0.728 . . . . 54.43 112.507 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 117.98 127.34 3.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.698 -0.763 . . . . 70.120000000000005 112.493 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 158.86 176.16 30.6 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 74.209999999999994 112.475 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -141.23 -171.98 12.92 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 74.530000000000001 112.513 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.652 HD11 ' HD2' ' A' ' 169' ' ' ARG . 0.6 OUTLIER -163.66 30.53 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.816 0.341 . . . . 72.129999999999995 110.962 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.469 ' C ' ' O ' ' A' ' 180' ' ' LEU . 9.3 tp60 -32.19 107.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 73.019999999999996 110.886 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.826 ' CE1' HG11 ' A' ' 161' ' ' VAL . 35.7 t80 -48.22 108.51 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 71.510000000000005 110.877 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.728 HD12 HD13 ' A' ' 225' ' ' LEU . 46.9 mt -64.92 -78.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 72.140000000000001 110.912 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 7.3 ptp -168.49 -174.64 2.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 71.540000000000006 110.885 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.1 mt -127.88 123.97 61.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 51.509999999999998 111.143 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.73 79.18 1.9 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 74.109999999999999 110.901 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 76.49 -146.56 33.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.781 -0.724 . . . . 74.239999999999995 112.532 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 3.18 2.9 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.688 2.259 . . . . 73.25 112.363 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.9 mt -121.31 115.31 46.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.145 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.5 p -100.16 140.24 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 53.140000000000001 111.123 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.573 ' HG2' HD11 ' A' ' 225' ' ' LEU . 11.5 mtmt -101.94 136.64 41.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 54.210000000000001 110.89 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 193' ' ' ARG . 82.5 t -140.42 156.46 23.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.462 . . . . 75.019999999999996 111.162 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.476 ' N ' HG12 ' A' ' 192' ' ' VAL . 2.8 ttt180 -91.25 174.2 7.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.855 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 199' ' ' ALA . 0.2 OUTLIER -175.24 81.16 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 74.439999999999998 110.896 179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 62.5 p -100.99 179.1 4.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 75.430000000000007 111.153 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.49 175.84 48.12 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.765 -0.731 . . . . 64.329999999999998 112.432 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -0.12 6.5 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.685 2.257 . . . . 73.430000000000007 112.305 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.86 ' HB1' HG21 ' A' ' 204' ' ' VAL . . . -86.39 5.39 35.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 73.099999999999994 111.089 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.489 ' HB2' HD12 ' A' ' 194' ' ' LEU . . . -94.28 170.07 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 63.43 111.127 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.732 HG22 ' O ' ' A' ' 200' ' ' VAL . 8.3 p 39.56 38.22 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 73.530000000000001 111.104 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.467 ' O ' ' CB ' ' A' ' 202' ' ' ARG . 1.5 p -113.1 -15.3 10.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.162 -0.472 . . . . 62.100000000000001 111.155 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.778 ' HD3' HD11 ' A' ' 206' ' ' ILE . 0.0 OUTLIER 80.7 -58.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 110.855 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 91.6 m -51.35 -63.24 1.2 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.010000000000005 111.111 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.86 HG21 ' HB1' ' A' ' 198' ' ' ALA . 42.9 t -49.47 -65.05 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 61.200000000000003 111.087 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.473 ' HB2' ' CD1' ' A' ' 224' ' ' LEU . 0.1 OUTLIER -51.74 -34.03 37.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.878 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.778 HD11 ' HD3' ' A' ' 202' ' ' ARG . 14.1 mt -66.1 -56.72 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 70.329999999999998 111.163 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -49.78 -34.02 18.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 73.129999999999995 111.073 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.869 HG12 HD11 ' A' ' 212' ' ' LEU . 98.6 t -60.7 -69.23 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 61.539999999999999 111.094 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.582 ' HA ' HD12 ' A' ' 212' ' ' LEU . 0.9 OUTLIER -51.3 -17.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 75.230000000000004 110.837 -179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.1 mttp -73.93 -39.74 63.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 64.329999999999998 110.89 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.92 -34.4 26.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 74.049999999999997 110.867 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.869 HD11 HG12 ' A' ' 208' ' ' VAL . 8.2 mt -68.59 -70.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 71.430000000000007 110.889 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.05 -21.82 0.17 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 71.219999999999999 110.866 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.82 -81.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 52.229999999999997 110.898 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -46.4 -47.74 18.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 75.409999999999997 110.893 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.623 HD12 HD12 ' A' ' 156' ' ' LEU . 2.5 pt -112.95 91.49 18.24 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.631 0.729 . . . . 73.099999999999994 111.092 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -13.53 34.89 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.689 2.259 . . . . 74.109999999999999 112.354 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.18 -11.17 5.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 73.450000000000003 110.873 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.576 HG12 HD13 ' A' ' 156' ' ' LEU . 1.1 mt -71.67 143.84 13.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 75.439999999999998 111.115 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -126.19 -41.53 1.91 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 74.439999999999998 110.89 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.4 mp -141.93 104.44 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 71.420000000000002 111.164 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.73 121.47 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 111.14 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -114.79 129.07 56.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.310000000000002 110.908 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.473 ' CD1' ' HB2' ' A' ' 205' ' ' ARG . 10.2 mt -113.14 140.56 47.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 60.009999999999998 110.917 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.728 HD13 HD12 ' A' ' 183' ' ' LEU . 5.7 mp -115.91 164.07 14.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 63.210000000000001 110.942 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 64.219999999999999 110.877 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.843 0.354 . . . . 71.140000000000001 110.875 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 154' ' ' LEU . 0.8 OUTLIER -95.48 -171.07 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 75.5 110.904 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.401 ' O ' ' O ' ' A' ' 156' ' ' LEU . 2.0 tp10 -91.0 -23.88 20.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 63.310000000000002 110.9 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.589 HD11 ' CG1' ' A' ' 219' ' ' ILE . 9.6 tt 53.99 107.19 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 73.409999999999997 110.913 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.807 ' HA ' HD13 ' A' ' 185' ' ' ILE . 9.1 p30 -174.91 171.63 3.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.456 . . . . 71.329999999999998 110.859 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -48.8 -22.84 0.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 65.129999999999995 110.805 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.96 -52.36 6.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 74.299999999999997 110.871 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -68.38 -53.78 21.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 74.040000000000006 110.937 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 157' ' ' ASN . 18.6 m -49.5 -27.46 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 64.400000000000006 111.108 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -65.38 -48.23 73.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 71.549999999999997 110.862 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.06 -40.3 80.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 54.310000000000002 110.919 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.644 HG12 ' HB3' ' A' ' 211' ' ' LYS . 4.1 t -78.22 -35.69 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.449 . . . . 71.239999999999995 111.166 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.574 HD11 ' CD1' ' A' ' 182' ' ' PHE . 32.5 mt -68.0 -25.3 65.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 70.319999999999993 110.941 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.416 ' O ' ' CG ' ' A' ' 170' ' ' PRO . 19.9 m-20 -72.84 -9.5 58.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 75.439999999999998 110.847 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -94.38 -5.72 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 61.450000000000003 110.906 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.93 -40.19 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 65.230000000000004 111.155 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.558 ' HA ' HD21 ' A' ' 180' ' ' LEU . 1.8 mtt180 -48.01 -58.63 7.4 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.626 0.727 . . . . 65.340000000000003 110.829 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.8 Cg_endo -69.69 -29.93 23.41 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.713 2.275 . . . . 71.200000000000003 112.355 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.73 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.0 OUTLIER -58.91 -28.68 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 73.129999999999995 110.944 -179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.73 HD23 ' CD2' ' A' ' 171' ' ' TYR . 3.4 mt -68.57 -53.44 22.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.507 . . . . 71.239999999999995 110.916 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -50.05 -26.53 4.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 73.030000000000001 111.137 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -47.78 -63.95 3.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 64.530000000000001 112.494 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 3.9 t -109.44 -1.76 18.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 72.040000000000006 111.164 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 152.35 101.02 0.2 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 55.009999999999998 112.483 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.476 ' HA2' ' CB ' ' A' ' 172' ' ' LEU . . . -82.1 164.02 43.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.76 -0.733 . . . . 51.149999999999999 112.518 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -136.03 -102.53 0.67 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.766 -0.73 . . . . 70.040000000000006 112.522 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -173.43 113.78 0.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.713 -0.756 . . . . 75.329999999999998 112.488 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 169' ' ' ARG . 0.7 OUTLIER -135.43 23.49 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.764 0.316 . . . . 73.120000000000005 110.896 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 180' ' ' LEU . 1.1 tp60 -33.92 111.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 71.040000000000006 110.918 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.64 ' CZ ' HG21 ' A' ' 161' ' ' VAL . 40.6 t80 -57.11 125.01 20.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 73.239999999999995 110.927 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 20.9 mt -84.18 -77.01 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 72.540000000000006 110.915 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . 0.425 ' C ' HG13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER -169.9 -173.93 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 72.5 110.905 179.821 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.807 HD13 ' HA ' ' A' ' 157' ' ' ASN . 1.7 mt -132.63 132.11 59.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 64.120000000000005 111.154 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -124.21 66.26 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 73.519999999999996 110.915 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 188' ' ' PRO . . . 90.78 -139.01 14.66 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.752 -0.737 . . . . 72.430000000000007 112.492 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.408 ' HD2' ' HA3' ' A' ' 187' ' ' GLY . 53.1 Cg_endo -69.83 -4.99 15.2 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.68 2.253 . . . . 71.340000000000003 112.335 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 2.6 mt -114.63 120.86 65.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 63.439999999999998 111.143 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.74 HG22 HG23 ' A' ' 185' ' ' ILE . 25.1 t -100.25 136.04 33.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.165 -0.47 . . . . 54.210000000000001 111.155 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 19.5 mtmt -104.31 156.81 17.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 75.140000000000001 110.926 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 193' ' ' ARG . 2.6 p 179.05 147.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 75.319999999999993 111.144 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.412 ' O ' HG22 ' A' ' 192' ' ' VAL . 0.3 OUTLIER -72.37 170.76 13.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 52.43 110.905 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.667 HD23 HD22 ' A' ' 224' ' ' LEU . 0.1 OUTLIER -168.32 88.69 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 71.400000000000006 110.932 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 6.2 p -116.78 -174.49 2.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 54.219999999999999 111.13 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 79.54 179.14 51.97 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.784 -0.722 . . . . 75.019999999999996 112.507 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 2.26 3.71 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.7 2.266 . . . . 73.230000000000004 112.323 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.979 ' HB1' HG11 ' A' ' 204' ' ' VAL . . . -106.16 42.32 1.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 74.030000000000001 111.149 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -96.67 -53.93 3.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 74.340000000000003 111.151 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.51 ' O ' HG13 ' A' ' 200' ' ' VAL . 3.5 p -142.15 86.27 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 75.040000000000006 111.151 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 201' ' ' VAL . 9.0 p -125.67 24.64 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 75.349999999999994 111.117 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.87 39.08 13.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 71.519999999999996 110.883 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.598 ' N ' HD12 ' A' ' 206' ' ' ILE . 55.8 m -164.5 -66.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 70.109999999999999 111.175 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.979 HG11 ' HB1' ' A' ' 198' ' ' ALA . 97.7 t -53.16 -70.0 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 42.350000000000001 111.117 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -38.96 -30.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 72.120000000000005 110.875 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . 0.598 HD12 ' N ' ' A' ' 203' ' ' THR . 3.5 mt -80.66 -44.53 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 71.310000000000002 111.108 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 204' ' ' VAL . . . -52.67 -29.8 28.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 73.140000000000001 111.096 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 209' ' ' SER . 62.9 t -69.2 -85.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 55.030000000000001 111.13 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.483 ' N ' HG12 ' A' ' 208' ' ' VAL . 44.8 t -39.61 -25.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 70.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.544 ' CE ' HG22 ' A' ' 206' ' ' ILE . 1.2 mttt -61.6 -46.45 89.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 63.340000000000003 110.878 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.644 ' HB3' HG12 ' A' ' 164' ' ' VAL . 0.0 OUTLIER -71.97 -49.54 36.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 74.219999999999999 110.888 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.714 ' H ' HD22 ' A' ' 212' ' ' LEU . 2.2 mm? -52.05 -74.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.463 . . . . 74.519999999999996 110.909 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.01 -29.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 71.219999999999999 110.869 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.41 -74.35 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 73.010000000000005 110.922 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.455 ' HB2' ' CG2' ' A' ' 164' ' ' VAL . 1.6 mptt -62.49 -48.27 80.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 64.299999999999997 110.892 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.623 HD13 HG12 ' A' ' 161' ' ' VAL . 11.6 pt -106.52 87.64 2.84 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.622 0.725 . . . . 74.329999999999998 111.152 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -21.44 33.84 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.232 . . . . 74.219999999999999 112.4 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 2.5 t -46.31 -40.03 11.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 61.100000000000001 110.862 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.589 ' CG1' HD11 ' A' ' 156' ' ' LEU . 4.8 mt -39.41 155.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 74.010000000000005 111.103 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.478 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 0.0 OUTLIER -135.69 -34.4 0.83 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 110.947 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 33.2 mm -153.05 104.93 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 64.219999999999999 111.128 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 54.5 t -76.63 115.39 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 73.540000000000006 111.153 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -105.29 129.51 53.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 70.439999999999998 110.922 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.667 HD22 HD23 ' A' ' 194' ' ' LEU . 5.8 mt -119.07 109.11 15.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 64.349999999999994 110.926 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 6.8 mp -75.35 165.41 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 63.539999999999999 110.897 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 110.864 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 7.8 mmt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.825 0.345 . . . . 64.219999999999999 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.557 HD22 ' HB3' ' A' ' 160' ' ' ASN . 7.9 mt -107.52 -174.64 2.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 75.329999999999998 110.956 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.576 ' H ' ' ND2' ' A' ' 160' ' ' ASN . 1.6 mp0 -119.0 -2.58 10.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 110.893 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.788 HD13 HD12 ' A' ' 216' ' ' ILE . 20.2 tp 60.81 126.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.154 -0.475 . . . . 73.209999999999994 110.937 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.929 ' H ' HG23 ' A' ' 161' ' ' VAL . 3.6 p30 162.19 179.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 74.129999999999995 110.884 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.05 -19.28 62.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 60.020000000000003 110.86 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.431 ' HG2' ' CG ' ' A' ' 157' ' ' ASN . 10.7 pt-20 -90.07 -34.69 15.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 75.019999999999996 110.847 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.576 ' ND2' ' H ' ' A' ' 155' ' ' GLU . 94.1 m-20 -93.29 -59.75 1.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 61.539999999999999 110.841 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.929 HG23 ' H ' ' A' ' 157' ' ' ASN . 63.3 t -38.97 -43.35 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 73.219999999999999 111.115 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -45.82 -56.13 5.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 64.409999999999997 110.914 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -34.04 64.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 74.299999999999997 110.873 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.897 HG11 ' HA ' ' A' ' 212' ' ' LEU . 73.6 t -69.91 -50.89 45.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 53.420000000000002 111.128 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 22.1 mt -59.0 -22.92 61.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 53.420000000000002 110.893 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -72.32 -6.32 42.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 62.539999999999999 110.936 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -98.57 7.99 45.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 72.540000000000006 110.903 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -143.36 -35.77 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.134 -0.484 . . . . 72.219999999999999 111.188 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -50.37 -60.6 5.0 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.575 0.702 . . . . 75.530000000000001 110.845 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 169' ' ' ARG . 53.3 Cg_endo -69.79 0.87 5.04 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.678 2.252 . . . . 74.209999999999994 112.339 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.59 ' CD2' HD23 ' A' ' 172' ' ' LEU . 0.2 OUTLIER -97.15 -21.43 17.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 110.928 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.59 HD23 ' CD2' ' A' ' 171' ' ' TYR . 6.4 mt -81.22 -43.95 18.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.097 -0.501 . . . . 52.329999999999998 110.935 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 172' ' ' LEU . . . -35.58 -50.52 0.61 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 51.229999999999997 111.102 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -61.37 -45.0 97.31 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.801 -0.714 . . . . 74.140000000000001 112.501 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 24.0 p -88.41 21.88 2.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 74.25 111.109 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 177' ' ' GLY . . . 90.48 79.02 1.36 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.76 -0.733 . . . . 71.239999999999995 112.487 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 176' ' ' GLY . . . -37.05 156.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.789 -0.72 . . . . 51.340000000000003 112.489 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.67 -113.62 1.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.767 -0.73 . . . . 73.150000000000006 112.493 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -164.01 114.18 0.59 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.693 -0.765 . . . . 74.340000000000003 112.445 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.88 HD22 ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -138.75 14.15 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 73.439999999999998 110.882 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -32.15 95.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 63.039999999999999 110.899 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.749 ' CE1' HG11 ' A' ' 161' ' ' VAL . 54.9 t80 -36.04 118.9 0.54 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 72.099999999999994 110.894 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.501 HD12 HD13 ' A' ' 225' ' ' LEU . 42.2 mt -78.3 -78.08 0.15 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.489 . . . . 73.430000000000007 110.915 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -167.59 -159.73 0.32 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 74.030000000000001 110.867 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 157' ' ' ASN . 74.8 mt -146.24 135.83 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 74.349999999999994 111.092 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -128.55 57.42 1.6 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 60.420000000000002 110.933 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 101.58 -140.34 14.82 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 61.32 112.488 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -3.35 11.84 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.679 2.253 . . . . 61.130000000000003 112.349 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 21.8 mt -110.94 138.28 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 63.329999999999998 111.126 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 185' ' ' ILE . 16.9 t -115.31 132.95 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 75.409999999999997 111.083 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.555 ' HG2' HD11 ' A' ' 225' ' ' LEU . 19.3 mtmt -98.25 142.55 29.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 65.319999999999993 110.873 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 88.0 t -155.35 139.61 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 72.420000000000002 111.159 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -73.92 169.75 16.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 110.932 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.775 HD12 ' HA ' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -160.88 96.84 1.14 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 74.040000000000006 110.93 -179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.15 153.84 38.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.475 . . . . 70.510000000000005 111.108 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 121.12 -172.56 15.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 65.239999999999995 112.497 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -8.69 24.24 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.678 2.252 . . . . 65.099999999999994 112.313 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -118.65 8.49 11.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 63.340000000000003 111.105 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.775 ' HA ' HD12 ' A' ' 194' ' ' LEU . . . -51.49 -61.59 2.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 60.530000000000001 111.099 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.07 107.96 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 73.450000000000003 111.142 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 202' ' ' ARG . 42.4 t -146.81 -79.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 62.43 111.104 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.473 ' N ' HG12 ' A' ' 201' ' ' VAL . 0.1 OUTLIER -175.25 137.11 0.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.439999999999998 110.898 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 204' ' ' VAL . 0.2 OUTLIER 77.86 -60.86 0.41 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.443 . . . . 71.400000000000006 111.153 -179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 203' ' ' THR . 98.9 t -35.44 -71.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 50.329999999999998 111.11 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -38.55 -49.3 1.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 63.009999999999998 110.855 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.39 -58.3 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 74.140000000000001 111.125 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -40.51 -35.72 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 64.230000000000004 111.059 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.59 -76.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 53.530000000000001 111.109 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 15.4 t -54.97 -14.15 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 62.530000000000001 110.858 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -65.13 -39.93 93.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 74.239999999999995 110.86 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 214' ' ' GLU . 0.9 OUTLIER -87.03 -62.61 1.46 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.418 . . . . 75.230000000000004 110.958 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.897 ' HA ' HG11 ' A' ' 164' ' ' VAL . 9.8 mt -31.72 -69.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 75.109999999999999 110.946 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.83 -38.0 32.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 74.239999999999995 110.874 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 211' ' ' LYS . 0.3 OUTLIER -66.91 -79.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 73.140000000000001 110.898 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.71 ' CB ' HG22 ' A' ' 164' ' ' VAL . 11.8 mmtm -45.16 -52.75 8.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.113 -0.494 . . . . 63.009999999999998 110.916 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.788 HD12 HD13 ' A' ' 156' ' ' LEU . 6.5 pt -110.57 93.68 17.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.644 0.735 . . . . 73.040000000000006 111.136 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -23.24 31.23 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.714 2.276 . . . . 51.539999999999999 112.364 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -49.08 -26.28 2.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 60.140000000000001 110.838 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 220' ' ' GLN . 3.9 mt -59.71 152.56 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 75.329999999999998 111.16 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLN . . . . . 0.415 ' N ' ' CG2' ' A' ' 219' ' ' ILE . 2.2 mt-30 -131.19 -37.49 1.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 60.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 2.8 mt -141.72 112.38 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 43.219999999999999 111.086 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.09 114.29 24.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.484 . . . . 72.439999999999998 111.074 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 19.5 mm-40 -103.91 129.54 51.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 63.109999999999999 110.94 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.678 ' HB3' HD23 ' A' ' 194' ' ' LEU . 14.2 mt -119.32 102.41 8.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 61.119999999999997 110.903 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . 0.555 HD11 ' HG2' ' A' ' 191' ' ' LYS . 4.9 mp -82.18 160.23 23.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 75.209999999999994 110.931 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 64.310000000000002 110.842 -179.929 . . . . . . . . 0 0 . 1 stop_ save_